Column1;docid;isValid;passage;passageid
0;AIMed.d3;FALSE;Temporally following this growth arrest, the cells develop a senescence morphology an PROTEIN1 ( PROTEIN2 .;AIMed.d3.s30
1;AIMed.d3;FALSE;Temporally following this growth arrest, the cells develop a senescence morphology and PROTEIN ( PROTEIN2 .;AIMed.d3.s30
2;AIMed.d3;FALSE;Temporally following this growth arrest, the cells develop a senescence morphology and PROTEIN2 ( PROTEIN .;AIMed.d3.s30
3;AIMed.d3;FALSE;Levels of PROTEIN PROTEIN1 and PROTEIN PROTEIN rise in HUCs during progressive passages, whereas only PROTEIN2 increases in HPEC cultures.;AIMed.d3.s31
4;AIMed.d3;FALSE;Levels of PROTEIN PROTEIN and PROTEIN1 PROTEIN rise in HUCs during progressive passages, whereas only PROTEIN2 increases in HPEC cultures.;AIMed.d3.s31
5;AIMed.d3;FALSE;Levels of PROTEIN PROTEIN and PROTEIN PROTEIN1 rise in HUCs during progressive passages, whereas only PROTEIN2 increases in HPEC cultures.;AIMed.d3.s31
6;AIMed.d3;FALSE;Levels of PROTEIN1 PROTEIN and PROTEIN PROTEIN rise in HUCs during progressive passages, whereas only PROTEIN2 increases in HPEC cultures.;AIMed.d3.s31
7;AIMed.d3;FALSE;Levels of PROTEIN PROTEIN1 and PROTEIN2 PROTEIN rise in HUCs during progressive passages, whereas only PROTEIN increases in HPEC cultures.;AIMed.d3.s31
8;AIMed.d3;FALSE;Levels of PROTEIN PROTEIN1 and PROTEIN PROTEIN2 rise in HUCs during progressive passages, whereas only PROTEIN increases in HPEC cultures.;AIMed.d3.s31
9;AIMed.d3;FALSE;Levels of PROTEIN1 PROTEIN2 and PROTEIN PROTEIN rise in HUCs during progressive passages, whereas only PROTEIN increases in HPEC cultures.;AIMed.d3.s31
10;AIMed.d3;FALSE;Levels of PROTEIN PROTEIN and PROTEIN1 PROTEIN2 rise in HUCs during progressive passages, whereas only PROTEIN increases in HPEC cultures.;AIMed.d3.s31
11;AIMed.d3;FALSE;Levels of PROTEIN1 PROTEIN and PROTEIN2 PROTEIN rise in HUCs during progressive passages, whereas only PROTEIN increases in HPEC cultures.;AIMed.d3.s31
12;AIMed.d3;FALSE;Levels of PROTEIN1 PROTEIN and PROTEIN PROTEIN2 rise in HUCs during progressive passages, whereas only PROTEIN increases in HPEC cultures.;AIMed.d3.s31
13;AIMed.d3;FALSE;The induced expression of PROTEIN1 similar to PROTEIN2 produces a senescent-like phenotype.;AIMed.d3.s32
14;AIMed.d3;FALSE; PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN2 PROTEIN decrease in both cell types.;AIMed.d3.s33
15;AIMed.d3;FALSE; PROTEIN1 PROTEIN2 PROTEIN PROTEIN and PROTEIN PROTEIN decrease in both cell types.;AIMed.d3.s33
16;AIMed.d3;FALSE; PROTEIN PROTEIN1 PROTEIN PROTEIN2 and PROTEIN PROTEIN decrease in both cell types.;AIMed.d3.s33
17;AIMed.d3;FALSE; PROTEIN PROTEIN1 PROTEIN2 PROTEIN and PROTEIN PROTEIN decrease in both cell types.;AIMed.d3.s33
18;AIMed.d3;FALSE; PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN PROTEIN2 decrease in both cell types.;AIMed.d3.s33
19;AIMed.d3;FALSE; PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN2 PROTEIN decrease in both cell types.;AIMed.d3.s33
20;AIMed.d3;FALSE; PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN2 PROTEIN decrease in both cell types.;AIMed.d3.s33
21;AIMed.d3;FALSE; PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN2 PROTEIN decrease in both cell types.;AIMed.d3.s33
22;AIMed.d3;FALSE; PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN1 PROTEIN2 decrease in both cell types.;AIMed.d3.s33
23;AIMed.d3;FALSE; PROTEIN1 PROTEIN PROTEIN PROTEIN2 and PROTEIN PROTEIN decrease in both cell types.;AIMed.d3.s33
24;AIMed.d3;FALSE; PROTEIN1 PROTEIN PROTEIN2 PROTEIN and PROTEIN PROTEIN decrease in both cell types.;AIMed.d3.s33
25;AIMed.d3;FALSE; PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN2 decrease in both cell types.;AIMed.d3.s33
26;AIMed.d3;FALSE; PROTEIN PROTEIN PROTEIN1 PROTEIN2 and PROTEIN PROTEIN decrease in both cell types.;AIMed.d3.s33
27;AIMed.d3;FALSE; PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN PROTEIN2 decrease in both cell types.;AIMed.d3.s33
28;AIMed.d3;FALSE; PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN PROTEIN2 decrease in both cell types.;AIMed.d3.s33
29;AIMed.d3;FALSE;We find that PROTEIN1 PROTEIN PROTEIN2 and PROTEIN PROTEIN are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.;AIMed.d3.s34
30;AIMed.d3;FALSE;We find that PROTEIN PROTEIN PROTEIN1 and PROTEIN2 PROTEIN are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.;AIMed.d3.s34
31;AIMed.d3;FALSE;We find that PROTEIN PROTEIN1 PROTEIN2 and PROTEIN PROTEIN are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.;AIMed.d3.s34
32;AIMed.d3;FALSE;We find that PROTEIN PROTEIN PROTEIN1 and PROTEIN PROTEIN2 are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.;AIMed.d3.s34
33;AIMed.d3;FALSE;We find that PROTEIN1 PROTEIN PROTEIN and PROTEIN2 PROTEIN are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.;AIMed.d3.s34
34;AIMed.d3;FALSE;We find that PROTEIN1 PROTEIN2 PROTEIN and PROTEIN PROTEIN are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.;AIMed.d3.s34
35;AIMed.d3;FALSE;We find that PROTEIN1 PROTEIN PROTEIN and PROTEIN PROTEIN2 are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.;AIMed.d3.s34
36;AIMed.d3;FALSE;We find that PROTEIN PROTEIN1 PROTEIN and PROTEIN2 PROTEIN are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.;AIMed.d3.s34
37;AIMed.d3;FALSE;We find that PROTEIN PROTEIN PROTEIN and PROTEIN1 PROTEIN2 are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.;AIMed.d3.s34
38;AIMed.d3;FALSE;We find that PROTEIN PROTEIN1 PROTEIN and PROTEIN PROTEIN2 are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.;AIMed.d3.s34
39;AIMed.d3;FALSE;Analysis of PROTEIN1 PROTEIN PROTEIN , PROTEIN PROTEIN , PROTEIN PROTEIN , and PROTEIN PROTEIN2 reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
40;AIMed.d3;FALSE;Analysis of PROTEIN1 PROTEIN PROTEIN , PROTEIN2 PROTEIN , PROTEIN PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
41;AIMed.d3;FALSE;Analysis of PROTEIN1 PROTEIN2 PROTEIN , PROTEIN PROTEIN , PROTEIN PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
42;AIMed.d3;FALSE;Analysis of PROTEIN1 PROTEIN PROTEIN , PROTEIN PROTEIN2 , PROTEIN PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
43;AIMed.d3;FALSE;Analysis of PROTEIN1 PROTEIN PROTEIN , PROTEIN PROTEIN , PROTEIN PROTEIN , and PROTEIN2 PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
44;AIMed.d3;FALSE;Analysis of PROTEIN1 PROTEIN PROTEIN , PROTEIN PROTEIN , PROTEIN2 PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
45;AIMed.d3;FALSE;Analysis of PROTEIN1 PROTEIN PROTEIN , PROTEIN PROTEIN , PROTEIN PROTEIN2 , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
46;AIMed.d3;FALSE;Analysis of PROTEIN1 PROTEIN PROTEIN2 , PROTEIN PROTEIN , PROTEIN PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
47;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN1 PROTEIN , PROTEIN PROTEIN , and PROTEIN PROTEIN2 reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
48;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN1 PROTEIN , PROTEIN PROTEIN , PROTEIN PROTEIN , and PROTEIN PROTEIN2 reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
49;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN PROTEIN1 , PROTEIN PROTEIN , and PROTEIN PROTEIN2 reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
50;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN PROTEIN , PROTEIN PROTEIN , and PROTEIN1 PROTEIN2 reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
51;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN PROTEIN , PROTEIN1 PROTEIN , and PROTEIN PROTEIN2 reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
52;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN PROTEIN , PROTEIN PROTEIN1 , and PROTEIN PROTEIN2 reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
53;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN1 , PROTEIN PROTEIN , PROTEIN PROTEIN , and PROTEIN PROTEIN2 reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
54;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN1 PROTEIN , PROTEIN2 PROTEIN , PROTEIN PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
55;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN1 PROTEIN2 , PROTEIN PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
56;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN1 PROTEIN , PROTEIN PROTEIN , and PROTEIN2 PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
57;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN1 PROTEIN , PROTEIN2 PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
58;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN1 PROTEIN , PROTEIN PROTEIN2 , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
59;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN1 , PROTEIN2 PROTEIN , PROTEIN PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
60;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN1 PROTEIN , PROTEIN PROTEIN2 , PROTEIN PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
61;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN1 PROTEIN , PROTEIN PROTEIN , PROTEIN PROTEIN , and PROTEIN2 PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
62;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN1 PROTEIN , PROTEIN PROTEIN , PROTEIN2 PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
63;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN1 PROTEIN , PROTEIN PROTEIN , PROTEIN PROTEIN2 , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
64;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN1 PROTEIN2 , PROTEIN PROTEIN , PROTEIN PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
65;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN PROTEIN1 , PROTEIN PROTEIN , and PROTEIN2 PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
66;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN PROTEIN1 , PROTEIN2 PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
67;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN PROTEIN1 , PROTEIN PROTEIN2 , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
68;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN1 , PROTEIN PROTEIN2 , PROTEIN PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
69;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN PROTEIN , PROTEIN1 PROTEIN , and PROTEIN2 PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
70;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN PROTEIN , PROTEIN PROTEIN1 , and PROTEIN2 PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
71;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN1 , PROTEIN PROTEIN , PROTEIN PROTEIN , and PROTEIN2 PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
72;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN , PROTEIN PROTEIN , PROTEIN1 PROTEIN2 , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
73;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN1 , PROTEIN PROTEIN , PROTEIN2 PROTEIN , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
74;AIMed.d3;FALSE;Analysis of PROTEIN PROTEIN PROTEIN1 , PROTEIN PROTEIN , PROTEIN PROTEIN2 , and PROTEIN PROTEIN reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.;AIMed.d3.s35
75;AIMed.d4;FALSE;Positive inotropic responses mediated by endothelin PROTEIN1 and PROTEIN2 receptors in human myocardial trabeculae.;AIMed.d4.s37
76;AIMed.d4;FALSE;The aim of the present study was to determine possible inotropic effects mediated by endothelin PROTEIN1 and PROTEIN2 receptors in human myocardial trabeculae from the right atrium and the left ventricle.;AIMed.d4.s38
77;AIMed.d4;FALSE; PROTEIN1 ( PROTEIN and PROTEIN2 had a strong positive inotropic effect in all trabeculae.;AIMed.d4.s40
78;AIMed.d4;FALSE; PROTEIN1 ( PROTEIN2 and PROTEIN had a strong positive inotropic effect in all trabeculae.;AIMed.d4.s40
79;AIMed.d4;FALSE; PROTEIN ( PROTEIN1 and PROTEIN2 had a strong positive inotropic effect in all trabeculae.;AIMed.d4.s40
80;AIMed.d4;FALSE; PROTEIN1 was significantly more potent than PROTEIN2 in both atrial (P < 0.001) and ventricular (P < 0.05) trabeculae.;AIMed.d4.s41
81;AIMed.d4;FALSE;Preincubation with the PROTEIN1 antagonist FR139317 (1 microM) decreased significantly (P < 0.005) the potency of PROTEIN2 in both atrial and ventricular trabeculae, without any significant changes in Emax (maximum effect obtained with an agonist).;AIMed.d4.s42
82;AIMed.d4;FALSE;The PROTEIN1 agonist IRL 1620 had a positive inotropic effect only in some trabeculae, and the PROTEIN2 antagonist BQ 788 (1 microM) almost completely blocked this effect.;AIMed.d4.s43
83;AIMed.d4;FALSE;These results suggest that both PROTEIN1 and PROTEIN2 receptors mediate positive inotropic responses at both the atrial and ventricular level in the human heart.;AIMed.d4.s44
84;AIMed.d6;FALSE;Apoptotic proteins. PROTEIN1 and PROTEIN2 related pathways.;AIMed.d6.s50
85;AIMed.d6;FALSE; PROTEIN1 and PROTEIN2 are two proteins that have critical roles in the regulation of apoptosis and the cell cycle.;AIMed.d6.s51
86;AIMed.d7;FALSE;A comparative study of PROTEIN1 and PROTEIN2 expression in de novo and ex adenoma carcinoma of the colorectum.;AIMed.d7.s53
87;AIMed.d7;FALSE;The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule ( PROTEIN1 and protease [ PROTEIN ( PROTEIN2 ] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.;AIMed.d7.s56
88;AIMed.d7;FALSE;The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule ( PROTEIN1 and protease [ PROTEIN2 ( PROTEIN ] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.;AIMed.d7.s56
89;AIMed.d7;FALSE;The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule ( PROTEIN and protease [ PROTEIN1 ( PROTEIN2 ] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.;AIMed.d7.s56
90;AIMed.d7;FALSE;The rates of extensive PROTEIN1 expression and decreased PROTEIN2 expression were significantly higher in the de novo group (P=0.014 and 0.005, respectively).;AIMed.d7.s57
91;AIMed.d11;FALSE;BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members ( PROTEIN neu/ PROTEIN PROTEIN1 and PROTEIN2 and tumor recurrence.;AIMed.d11.s88
92;AIMed.d11;FALSE;BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members ( PROTEIN neu/ PROTEIN1 PROTEIN2 and PROTEIN and tumor recurrence.;AIMed.d11.s88
93;AIMed.d11;FALSE;BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members ( PROTEIN1 neu/ PROTEIN PROTEIN2 and PROTEIN and tumor recurrence.;AIMed.d11.s88
94;AIMed.d11;FALSE;BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members ( PROTEIN neu/ PROTEIN1 PROTEIN and PROTEIN2 and tumor recurrence.;AIMed.d11.s88
95;AIMed.d11;FALSE;BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members ( PROTEIN1 neu/ PROTEIN PROTEIN and PROTEIN2 and tumor recurrence.;AIMed.d11.s88
96;AIMed.d11;FALSE;BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members ( PROTEIN1 neu/ PROTEIN2 PROTEIN and PROTEIN and tumor recurrence.;AIMed.d11.s88
97;AIMed.d11;FALSE;RESULTS: Using Cox univariate analysis, we determined that angiolymphatic tumor emboli and non-well-differentiated tumor cells were two significant conventional pathologic predictors of tumor recurrence, and that PROTEIN1 and PROTEIN2 were also significant predictors.;AIMed.d11.s90
98;AIMed.d13;FALSE;We performed cell-free in vitro infection of primary bone marrow derived PROTEIN1 cells using semi-purified HHV8 and a mature PROTEIN2 dependent T cell line, KIT 225, using highly concentrated viral stocks prepared from an infectious molecular clone of HTLV-1.;AIMed.d13.s109
99;AIMed.d13;FALSE;Of these 400, PROTEIN ( PROTEIN1 , PROTEIN2 TBP-associated factor, eukaryotic elongation factor and PROTEIN were up-regulated more than 3.5 fold.;AIMed.d13.s112
100;AIMed.d13;FALSE;Of these 400, PROTEIN1 ( PROTEIN , PROTEIN2 TBP-associated factor, eukaryotic elongation factor and PROTEIN were up-regulated more than 3.5 fold.;AIMed.d13.s112
101;AIMed.d13;FALSE;Of these 400, PROTEIN ( PROTEIN , PROTEIN1 TBP-associated factor, eukaryotic elongation factor and PROTEIN2 were up-regulated more than 3.5 fold.;AIMed.d13.s112
102;AIMed.d13;FALSE;Of these 400, PROTEIN1 ( PROTEIN2 , PROTEIN TBP-associated factor, eukaryotic elongation factor and PROTEIN were up-regulated more than 3.5 fold.;AIMed.d13.s112
103;AIMed.d13;FALSE;Of these 400, PROTEIN ( PROTEIN1 , PROTEIN TBP-associated factor, eukaryotic elongation factor and PROTEIN2 were up-regulated more than 3.5 fold.;AIMed.d13.s112
104;AIMed.d13;FALSE;Of these 400, PROTEIN1 ( PROTEIN , PROTEIN TBP-associated factor, eukaryotic elongation factor and PROTEIN2 were up-regulated more than 3.5 fold.;AIMed.d13.s112
105;AIMed.d19;FALSE;Several genes are involved in this process, and two have been the focus of recent interest: the PROTEIN ( PROTEIN1 gene and the genes coding for the PROTEIN2 ;AIMed.d19.s162
106;AIMed.d19;FALSE;Several genes are involved in this process, and two have been the focus of recent interest: the PROTEIN1 ( PROTEIN gene and the genes coding for the PROTEIN2 ;AIMed.d19.s162
107;AIMed.d19;FALSE;Several genes are involved in this process, and two have been the focus of recent interest: the PROTEIN1 ( PROTEIN2 gene and the genes coding for the PROTEIN ;AIMed.d19.s162
108;AIMed.d21;FALSE;Many of the same signaling molecules, including PROTEIN ( PROTEIN1 , PROTEIN2 ( PROTEIN , and protein phosphatase, regulate the transporters for different neurotransmitters.;AIMed.d21.s176
109;AIMed.d21;FALSE;Many of the same signaling molecules, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN2 , and protein phosphatase, regulate the transporters for different neurotransmitters.;AIMed.d21.s176
110;AIMed.d21;FALSE;Many of the same signaling molecules, including PROTEIN1 ( PROTEIN , PROTEIN2 ( PROTEIN , and protein phosphatase, regulate the transporters for different neurotransmitters.;AIMed.d21.s176
111;AIMed.d21;FALSE;Many of the same signaling molecules, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN2 , and protein phosphatase, regulate the transporters for different neurotransmitters.;AIMed.d21.s176
112;AIMed.d21;FALSE;Many of the same signaling molecules, including PROTEIN1 ( PROTEIN2 , PROTEIN ( PROTEIN , and protein phosphatase, regulate the transporters for different neurotransmitters.;AIMed.d21.s176
113;AIMed.d21;FALSE;Many of the same signaling molecules, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN2 , and protein phosphatase, regulate the transporters for different neurotransmitters.;AIMed.d21.s176
114;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
115;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
116;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
117;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
118;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
119;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
120;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
121;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
122;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN2 across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
123;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
124;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN2 across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
125;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
126;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
127;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN2 across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
128;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN2 across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
129;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
130;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
131;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
132;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
133;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
134;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
135;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
136;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
137;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
138;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
139;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
140;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
141;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
142;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
143;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
144;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
145;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
146;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
147;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
148;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
149;AIMed.d24;FALSE;Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 and PROTEIN across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.;AIMed.d24.s200
150;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN ( PROTEIN , and its human receptor ( PROTEIN1 , an ortholog of the recently discovered m PROTEIN2 PROTEIN [4].;AIMed.d28.s234
151;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN1 ligand ( PROTEIN , and its human receptor ( PROTEIN2 , an ortholog of the recently discovered m PROTEIN PROTEIN [4].;AIMed.d28.s234
152;AIMed.d28;TRUE;We have identified a new TNF-related ligand, designated human PROTEIN1 ( PROTEIN , and its human receptor ( PROTEIN2 , an ortholog of the recently discovered m PROTEIN PROTEIN [4].;AIMed.d28.s234
153;AIMed.d28;TRUE;We have identified a new TNF-related ligand, designated human PROTEIN ( PROTEIN1 , and its human receptor ( PROTEIN2 , an ortholog of the recently discovered m PROTEIN PROTEIN [4].;AIMed.d28.s234
154;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN ( PROTEIN , and its human receptor ( PROTEIN1 , an ortholog of the recently discovered mu PROTEIN PROTEIN2 [4].;AIMed.d28.s234
155;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN1 ligand ( PROTEIN , and its human receptor ( PROTEIN , an ortholog of the recently discovered m PROTEIN2 PROTEIN [4].;AIMed.d28.s234
156;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN1 ( PROTEIN , and its human receptor ( PROTEIN , an ortholog of the recently discovered m PROTEIN2 PROTEIN [4].;AIMed.d28.s234
157;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN ( PROTEIN1 , and its human receptor ( PROTEIN , an ortholog of the recently discovered m PROTEIN2 PROTEIN [4].;AIMed.d28.s234
158;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN ( PROTEIN , and its human receptor ( PROTEIN , an ortholog of the recently discovered mu PROTEIN2 PROTEIN1 [4].;AIMed.d28.s234
159;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN1 ( PROTEIN , and its human receptor ( PROTEIN , an ortholog of the recently discovered m PROTEIN PROTEIN [4].;AIMed.d28.s234
160;AIMed.d28;TRUE;We have identified a new TNF-related ligand, designated human PROTEIN1 ligand ( PROTEIN2 , and its human receptor ( PROTEIN , an ortholog of the recently discovered m PROTEIN PROTEIN [4].;AIMed.d28.s234
161;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN1 ligand ( PROTEIN , and its human receptor ( PROTEIN , an ortholog of the recently discovered mu PROTEIN PROTEIN2 [4].;AIMed.d28.s234
162;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN1 ( PROTEIN2 , and its human receptor ( PROTEIN , an ortholog of the recently discovered m PROTEIN PROTEIN [4].;AIMed.d28.s234
163;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN1 ( PROTEIN , and its human receptor ( PROTEIN , an ortholog of the recently discovered mu PROTEIN PROTEIN2 [4].;AIMed.d28.s234
164;AIMed.d28;FALSE;We have identified a new TNF-related ligand, designated human PROTEIN ( PROTEIN1 , and its human receptor ( PROTEIN , an ortholog of the recently discovered mu PROTEIN PROTEIN2 [4].;AIMed.d28.s234
165;AIMed.d28;FALSE;The PROTEIN1 gene mapped to chromosome 1q23, near the gene for the TNF homolog PROTEIN2 PROTEIN [5].;AIMed.d28.s235
166;AIMed.d28;FALSE;The PROTEIN1 gene mapped to chromosome 1q23, near the gene for the TNF homolog PROTEIN PROTEIN2 [5].;AIMed.d28.s235
167;AIMed.d28;FALSE;The PROTEIN gene mapped to chromosome 1q23, near the gene for the TNF homolog PROTEIN1 PROTEIN2 [5].;AIMed.d28.s235
168;AIMed.d28;FALSE;We found PROTEIN1 mRNA in several peripheral tissues, and detected PROTEIN2 protein on cultured vascular endothelial cells.;AIMed.d28.s237
169;AIMed.d28;FALSE;"The levels of PROTEIN1 mRNA in tissues were generally low; in peripheral blood T cells, however, antigen-receptor stimulation led to a substantial induction of PROTEIN2 transcripts.";AIMed.d28.s238
170;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN1 in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN2 via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN ( PROTEIN [8].;AIMed.d28.s239
171;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN1 in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN2 ( PROTEIN [7] and PROTEIN ( PROTEIN [8].;AIMed.d28.s239
172;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN1 in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN2 [7] and PROTEIN ( PROTEIN [8].;AIMed.d28.s239
173;AIMed.d28;FALSE;Cotransfection of PROTEIN1 and PROTEIN2 in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN ( PROTEIN [8].;AIMed.d28.s239
174;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN1 in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN2 inducing kinase ( PROTEIN [8].;AIMed.d28.s239
175;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN1 in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN2 ( PROTEIN [8].;AIMed.d28.s239
176;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN1 in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN ( PROTEIN2 [8].;AIMed.d28.s239
177;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN1 via a pathway that appeared to involve PROTEIN2 ( PROTEIN [7] and PROTEIN ( PROTEIN [8].;AIMed.d28.s239
178;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN1 via a pathway that appeared to involve PROTEIN ( PROTEIN2 [7] and PROTEIN ( PROTEIN [8].;AIMed.d28.s239
179;AIMed.d28;FALSE;Cotransfection of PROTEIN1 and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN2 via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN ( PROTEIN [8].;AIMed.d28.s239
180;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN1 via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN2 inducing kinase ( PROTEIN [8].;AIMed.d28.s239
181;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN1 via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN2 ( PROTEIN [8].;AIMed.d28.s239
182;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN1 via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN ( PROTEIN2 [8].;AIMed.d28.s239
183;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN1 ( PROTEIN2 [7] and PROTEIN ( PROTEIN [8].;AIMed.d28.s239
184;AIMed.d28;FALSE;Cotransfection of PROTEIN1 and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN2 ( PROTEIN [7] and PROTEIN ( PROTEIN [8].;AIMed.d28.s239
185;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN1 ( PROTEIN [7] and PROTEIN2 inducing kinase ( PROTEIN [8].;AIMed.d28.s239
186;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN1 ( PROTEIN [7] and PROTEIN2 ( PROTEIN [8].;AIMed.d28.s239
187;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN1 ( PROTEIN [7] and PROTEIN ( PROTEIN2 [8].;AIMed.d28.s239
188;AIMed.d28;FALSE;Cotransfection of PROTEIN1 and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN2 [7] and PROTEIN ( PROTEIN [8].;AIMed.d28.s239
189;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN1 [7] and PROTEIN2 inducing kinase ( PROTEIN [8].;AIMed.d28.s239
190;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN1 [7] and PROTEIN2 ( PROTEIN [8].;AIMed.d28.s239
191;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN1 [7] and PROTEIN ( PROTEIN2 [8].;AIMed.d28.s239
192;AIMed.d28;FALSE;Cotransfection of PROTEIN1 and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN2 inducing kinase ( PROTEIN [8].;AIMed.d28.s239
193;AIMed.d28;FALSE;Cotransfection of PROTEIN1 and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN2 ( PROTEIN [8].;AIMed.d28.s239
194;AIMed.d28;FALSE;Cotransfection of PROTEIN1 and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN ( PROTEIN2 [8].;AIMed.d28.s239
195;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN1 ( PROTEIN [8].;AIMed.d28.s239
196;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN1 inducing kinase ( PROTEIN2 [8].;AIMed.d28.s239
197;AIMed.d28;FALSE;Cotransfection of PROTEIN and PROTEIN in embryonic kidney 293 cells activated the anti-apoptotic transcription factor PROTEIN via a pathway that appeared to involve PROTEIN ( PROTEIN [7] and PROTEIN1 ( PROTEIN2 [8].;AIMed.d28.s239
198;AIMed.d28;FALSE;Cotransfection of PROTEIN1 and PROTEIN2 in Jurkat T leukemia cells inhibited antigen-receptor-induced cell death.;AIMed.d28.s240
199;AIMed.d28;FALSE;Thus, PROTEIN1 and PROTEIN2 may modulate T lymphocyte survival in peripheral tissues.;AIMed.d28.s241
200;AIMed.d31;FALSE;A newly identified member of tumor necrosis factor receptor superfamily ( PROTEIN1 suppresses PROTEIN2 mediated apoptosis.;AIMed.d31.s256
201;AIMed.d31;FALSE; PROTEIN ( PROTEIN1 ( PROTEIN2 ) is a new member of the tumor necrosis factor receptor (TNFR) family.;AIMed.d31.s257
202;AIMed.d31;FALSE; PROTEIN1 ( PROTEIN2 ( PROTEIN ) is a new member of the tumor necrosis factor receptor (TNFR) family.;AIMed.d31.s257
203;AIMed.d31;FALSE; PROTEIN1 ( PROTEIN ( PROTEIN2 ) is a new member of the tumor necrosis factor receptor (TNFR) family.;AIMed.d31.s257
204;AIMed.d31;TRUE;Here, we demonstrate that PROTEIN1 specifically binds two cellular ligands, PROTEIN ( PROTEIN IN and PROTEIN ( PROTEIN2 PROTEIN .;AIMed.d31.s262
205;AIMed.d31;TRUE;Here, we demonstrate that PROTEIN1 specifically binds two cellular ligands, PROTEIN ( PROTEIN IN and PROTEIN2 ( PROTEIN PROTEIN .;AIMed.d31.s262
206;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN1 specifically binds two cellular ligands, PROTEIN ( PROTEIN2 IN and PROTEIN ( PROTEIN PROTEIN .;AIMed.d31.s262
207;AIMed.d31;TRUE;Here, we demonstrate that PROTEIN1 specifically binds two cellular ligands, PROTEIN ( P PROTEIN N2 and PROTEIN ( PROTEIN PROTEIN .;AIMed.d31.s262
208;AIMed.d31;TRUE;Here, we demonstrate that PROTEIN1 specifically binds two cellular ligands, PROTEIN ( PROTEIN IN and PROTEIN ( PROTEIN PROTEIN2 .;AIMed.d31.s262
209;AIMed.d31;TRUE;Here, we demonstrate that PROTEIN1 specifically binds two cellular ligands, PROTEIN2 ( PROTEIN IN and PROTEIN ( PROTEIN PROTEIN .;AIMed.d31.s262
210;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN ( PROTEIN IN and PROTEIN1 ( PROTEIN2 PROTEIN .;AIMed.d31.s262
211;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN ( PROTEIN1 IN and PROTEIN ( PROTEIN2 PROTEIN .;AIMed.d31.s262
212;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN ( P PROTEIN N1 and PROTEIN ( PROTEIN2 PROTEIN .;AIMed.d31.s262
213;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN ( PROTEIN IN and PROTEIN ( PROTEIN1 PROTEIN2 .;AIMed.d31.s262
214;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN1 ( PROTEIN IN and PROTEIN ( PROTEIN2 PROTEIN .;AIMed.d31.s262
215;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN ( PROTEIN1 IN and PROTEIN2 ( PROTEIN PROTEIN .;AIMed.d31.s262
216;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN ( P PROTEIN N1 and PROTEIN2 ( PROTEIN PROTEIN .;AIMed.d31.s262
217;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN ( PROTEIN IN and PROTEIN1 ( PROTEIN PROTEIN2 .;AIMed.d31.s262
218;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN1 ( PROTEIN IN and PROTEIN2 ( PROTEIN PROTEIN .;AIMed.d31.s262
219;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN ( P PROTEIN2 N1 and PROTEIN ( PROTEIN PROTEIN .;AIMed.d31.s262
220;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN ( PROTEIN1 IN and PROTEIN ( PROTEIN PROTEIN2 .;AIMed.d31.s262
221;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN1 ( PROTEIN2 IN and PROTEIN ( PROTEIN PROTEIN .;AIMed.d31.s262
222;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN ( P PROTEIN N1 and PROTEIN ( PROTEIN PROTEIN2 .;AIMed.d31.s262
223;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN1 ( P PROTEIN N2 and PROTEIN ( PROTEIN PROTEIN .;AIMed.d31.s262
224;AIMed.d31;FALSE;Here, we demonstrate that PROTEIN specifically binds two cellular ligands, PROTEIN1 ( PROTEIN IN and PROTEIN ( PROTEIN PROTEIN2 .;AIMed.d31.s262
225;AIMed.d31;FALSE; PROTEIN1 inhibited PROTEIN2 induced cytotoxicity in HT29 cells.;AIMed.d31.s264
226;AIMed.d31;FALSE;It has been shown that PROTEIN1 triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN2 receptor ( PROTEIN and PROTEIN PROTEIN receptors.;AIMed.d31.s265
227;AIMed.d31;FALSE;It has been shown that PROTEIN1 triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN ( PROTEIN and PROTEIN PROTEIN2 receptors.;AIMed.d31.s265
228;AIMed.d31;FALSE;It has been shown that PROTEIN1 triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN2 ( PROTEIN and PROTEIN PROTEIN receptors.;AIMed.d31.s265
229;AIMed.d31;FALSE;It has been shown that PROTEIN1 triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN ( PROTEIN and PROTEIN2 PROTEIN receptors.;AIMed.d31.s265
230;AIMed.d31;FALSE;It has been shown that PROTEIN1 triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN ( PROTEIN2 and PROTEIN PROTEIN receptors.;AIMed.d31.s265
231;AIMed.d31;FALSE;It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN1 receptor ( PROTEIN and PROTEIN PROTEIN2 receptors.;AIMed.d31.s265
232;AIMed.d31;FALSE;It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN1 ( PROTEIN and PROTEIN PROTEIN receptors.;AIMed.d31.s265
233;AIMed.d31;FALSE;It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN1 receptor ( PROTEIN and PROTEIN2 PROTEIN receptors.;AIMed.d31.s265
234;AIMed.d31;TRUE;It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN1 receptor ( PROTEIN2 and PROTEIN PROTEIN receptors.;AIMed.d31.s265
235;AIMed.d31;FALSE;It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN1 ( PROTEIN and PROTEIN PROTEIN2 receptors.;AIMed.d31.s265
236;AIMed.d31;FALSE;It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN ( PROTEIN and PROTEIN1 PROTEIN2 receptors.;AIMed.d31.s265
237;AIMed.d31;FALSE;It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN ( PROTEIN1 and PROTEIN PROTEIN2 receptors.;AIMed.d31.s265
238;AIMed.d31;FALSE;It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN1 ( PROTEIN and PROTEIN2 PROTEIN receptors.;AIMed.d31.s265
239;AIMed.d31;FALSE;It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN1 ( PROTEIN2 and PROTEIN PROTEIN receptors.;AIMed.d31.s265
240;AIMed.d31;FALSE;It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN ( PROTEIN1 and PROTEIN2 PROTEIN receptors.;AIMed.d31.s265
241;AIMed.d31;FALSE;Our data suggest that PROTEIN1 inhibits the interactions of PROTEIN with PROTEIN PROTEIN and PROTEIN thereby suppressing PROTEIN2 mediated HT29 cell death.;AIMed.d31.s266
242;AIMed.d31;FALSE;Our data suggest that PROTEIN1 inhibits the interactions of PROTEIN with PROTEIN PROTEIN and PROTEIN2 thereby suppressing PROTEIN mediated HT29 cell death.;AIMed.d31.s266
243;AIMed.d31;FALSE;Our data suggest that PROTEIN1 inhibits the interactions of PROTEIN2 with PROTEIN PROTEIN and PROTEIN thereby suppressing PROTEIN mediated HT29 cell death.;AIMed.d31.s266
244;AIMed.d31;FALSE;Our data suggest that PROTEIN1 inhibits the interactions of PROTEIN with PROTEIN2 PROTEIN and PROTEIN thereby suppressing PROTEIN mediated HT29 cell death.;AIMed.d31.s266
245;AIMed.d31;FALSE;Our data suggest that PROTEIN1 inhibits the interactions of PROTEIN with PROTEIN PROTEIN2 and PROTEIN thereby suppressing PROTEIN mediated HT29 cell death.;AIMed.d31.s266
246;AIMed.d31;FALSE;Our data suggest that PROTEIN inhibits the interactions of PROTEIN with PROTEIN PROTEIN and PROTEIN1 thereby suppressing PROTEIN2 mediated HT29 cell death.;AIMed.d31.s266
247;AIMed.d31;FALSE;Our data suggest that PROTEIN inhibits the interactions of PROTEIN1 with PROTEIN PROTEIN and PROTEIN thereby suppressing PROTEIN2 mediated HT29 cell death.;AIMed.d31.s266
248;AIMed.d31;FALSE;Our data suggest that PROTEIN inhibits the interactions of PROTEIN with PROTEIN1 PROTEIN and PROTEIN thereby suppressing PROTEIN2 mediated HT29 cell death.;AIMed.d31.s266
249;AIMed.d31;FALSE;Our data suggest that PROTEIN inhibits the interactions of PROTEIN with PROTEIN PROTEIN1 and PROTEIN thereby suppressing PROTEIN2 mediated HT29 cell death.;AIMed.d31.s266
250;AIMed.d31;TRUE;Our data suggest that PROTEIN inhibits the interactions of PROTEIN1 with PROTEIN PROTEIN and PROTEIN2 thereby suppressing PROTEIN mediated HT29 cell death.;AIMed.d31.s266
251;AIMed.d31;FALSE;Our data suggest that PROTEIN inhibits the interactions of PROTEIN with PROTEIN1 PROTEIN and PROTEIN2 thereby suppressing PROTEIN mediated HT29 cell death.;AIMed.d31.s266
252;AIMed.d31;FALSE;Our data suggest that PROTEIN inhibits the interactions of PROTEIN with PROTEIN PROTEIN1 and PROTEIN2 thereby suppressing PROTEIN mediated HT29 cell death.;AIMed.d31.s266
253;AIMed.d31;TRUE;Our data suggest that PROTEIN inhibits the interactions of PROTEIN1 with PROTEIN2 PROTEIN and PROTEIN thereby suppressing PROTEIN mediated HT29 cell death.;AIMed.d31.s266
254;AIMed.d31;TRUE;Our data suggest that PROTEIN inhibits the interactions of PROTEIN1 with PROTEIN PROTEIN2 and PROTEIN thereby suppressing PROTEIN mediated HT29 cell death.;AIMed.d31.s266
255;AIMed.d31;FALSE;Our data suggest that PROTEIN inhibits the interactions of PROTEIN with PROTEIN1 PROTEIN2 and PROTEIN thereby suppressing PROTEIN mediated HT29 cell death.;AIMed.d31.s266
256;AIMed.d31;FALSE;Thus, PROTEIN may play a regulatory role for suppressing in PROTEIN1 and PROTEIN2 mediated cell death.;AIMed.d31.s267
257;AIMed.d31;FALSE;Thus, PROTEIN1 may play a regulatory role for suppressing in PROTEIN and PROTEIN2 mediated cell death.;AIMed.d31.s267
258;AIMed.d31;FALSE;Thus, PROTEIN1 may play a regulatory role for suppressing in PROTEIN2 and PROTEIN mediated cell death.;AIMed.d31.s267
259;AIMed.d34;FALSE; PROTEIN1 ( PROTEIN2 mutations account for the majority of early-onset dominant cases of familial Alzheimer's disease.;AIMed.d34.s285
260;AIMed.d34;TRUE;We report an interaction between the human PROTEIN or PROTEIN1 hydrophilic loop and PROTEIN2 a small GTPase belonging to the Ras-related superfamily.;AIMed.d34.s288
261;AIMed.d34;TRUE;We report an interaction between the human PROTEIN1 or PROTEIN hydrophilic loop and PROTEIN2 a small GTPase belonging to the Ras-related superfamily.;AIMed.d34.s288
262;AIMed.d34;FALSE;We report an interaction between the human PROTEIN1 or PROTEIN2 hydrophilic loop and PROTEIN a small GTPase belonging to the Ras-related superfamily.;AIMed.d34.s288
263;AIMed.d34;TRUE;Interaction domains were mapped to codons 374-400 for PROTEIN1 and to codons 106-179 for PROTEIN2 a region including the fourth GTP-binding domain.;AIMed.d34.s289
264;AIMed.d38;TRUE;Molecular cloning of a novel human CC chemokine ( PROTEIN1 that is a functional ligand of PROTEIN2 ;AIMed.d38.s320
265;AIMed.d38;FALSE;Previously, we mapped the novel CC chemokine PROTEIN1 ( PROTEIN2 / PROTEIN to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O. (1998) Genomics 49, 339-340).;AIMed.d38.s321
266;AIMed.d38;FALSE;Previously, we mapped the novel CC chemokine PROTEIN1 ( PROTEIN / PROTEIN2 to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O. (1998) Genomics 49, 339-340).;AIMed.d38.s321
267;AIMed.d38;FALSE;Previously, we mapped the novel CC chemokine PROTEIN ( PROTEIN1 / PROTEIN2 to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O. (1998) Genomics 49, 339-340).;AIMed.d38.s321
268;AIMed.d38;FALSE;Prompted by this hypothesis, we analyzed the genomic region containing the gene for PROTEIN1 PROTEIN ( PROTEIN2 and have identified a novel CC chemokine termed PROTEIN ;AIMed.d38.s323
269;AIMed.d38;FALSE;Prompted by this hypothesis, we analyzed the genomic region containing the gene for PROTEIN PROTEIN ( PROTEIN1 and have identified a novel CC chemokine termed PROTEIN2 ;AIMed.d38.s323
270;AIMed.d38;FALSE;Prompted by this hypothesis, we analyzed the genomic region containing the gene for PROTEIN PROTEIN1 ( PROTEIN2 and have identified a novel CC chemokine termed PROTEIN ;AIMed.d38.s323
271;AIMed.d38;FALSE;Prompted by this hypothesis, we analyzed the genomic region containing the gene for PROTEIN1 PROTEIN ( PROTEIN and have identified a novel CC chemokine termed PROTEIN2 ;AIMed.d38.s323
272;AIMed.d38;FALSE;Prompted by this hypothesis, we analyzed the genomic region containing the gene for PROTEIN1 PROTEIN2 ( PROTEIN and have identified a novel CC chemokine termed PROTEIN ;AIMed.d38.s323
273;AIMed.d38;FALSE;Prompted by this hypothesis, we analyzed the genomic region containing the gene for PROTEIN PROTEIN1 ( PROTEIN and have identified a novel CC chemokine termed PROTEIN2 ;AIMed.d38.s323
274;AIMed.d38;FALSE;The genes for PROTEIN PROTEIN ( PROTEIN1 and PROTEIN2 ( PROTEIN are localized within a region of approximately 40 kilobases.;AIMed.d38.s324
275;AIMed.d38;FALSE;The genes for PROTEIN1 PROTEIN ( PROTEIN2 and PROTEIN ( PROTEIN are localized within a region of approximately 40 kilobases.;AIMed.d38.s324
276;AIMed.d38;FALSE;The genes for PROTEIN PROTEIN1 ( PROTEIN2 and PROTEIN ( PROTEIN are localized within a region of approximately 40 kilobases.;AIMed.d38.s324
277;AIMed.d38;FALSE;The genes for PROTEIN PROTEIN ( PROTEIN1 and PROTEIN ( PROTEIN2 are localized within a region of approximately 40 kilobases.;AIMed.d38.s324
278;AIMed.d38;FALSE;The genes for PROTEIN1 PROTEIN ( PROTEIN and PROTEIN2 ( PROTEIN are localized within a region of approximately 40 kilobases.;AIMed.d38.s324
279;AIMed.d38;FALSE;The genes for PROTEIN PROTEIN1 ( PROTEIN and PROTEIN2 ( PROTEIN are localized within a region of approximately 40 kilobases.;AIMed.d38.s324
280;AIMed.d38;FALSE;The genes for PROTEIN PROTEIN ( PROTEIN and PROTEIN1 ( PROTEIN2 are localized within a region of approximately 40 kilobases.;AIMed.d38.s324
281;AIMed.d38;FALSE;The genes for PROTEIN1 PROTEIN2 ( PROTEIN and PROTEIN ( PROTEIN are localized within a region of approximately 40 kilobases.;AIMed.d38.s324
282;AIMed.d38;FALSE;The genes for PROTEIN1 PROTEIN ( PROTEIN and PROTEIN ( PROTEIN2 are localized within a region of approximately 40 kilobases.;AIMed.d38.s324
283;AIMed.d38;FALSE;The genes for PROTEIN PROTEIN1 ( PROTEIN and PROTEIN ( PROTEIN2 are localized within a region of approximately 40 kilobases.;AIMed.d38.s324
284;AIMed.d38;FALSE; PROTEIN1 induced transient calcium mobilization specifically in PROTEIN ( PROTEIN2 -expressing L1.2 cells with an EC(50) of 3 nM.;AIMed.d38.s327
285;AIMed.d38;FALSE; PROTEIN1 induced transient calcium mobilization specifically in PROTEIN2 ( PROTEIN -expressing L1.2 cells with an EC(50) of 3 nM.;AIMed.d38.s327
286;AIMed.d38;FALSE; PROTEIN induced transient calcium mobilization specifically in PROTEIN1 ( PROTEIN2 -expressing L1.2 cells with an EC(50) of 3 nM.;AIMed.d38.s327
287;AIMed.d38;TRUE; PROTEIN competed the binding of (125) PROTEIN1 to PROTEIN2 expressing L1.2 cells with an IC(50) of 13 nM.;AIMed.d38.s328
288;AIMed.d38;TRUE; PROTEIN1 competed the binding of (125) PROTEIN to PROTEIN2 expressing L1.2 cells with an IC(50) of 13 nM.;AIMed.d38.s328
289;AIMed.d38;FALSE; PROTEIN1 competed the binding of (125) PROTEIN2 to PROTEIN expressing L1.2 cells with an IC(50) of 13 nM.;AIMed.d38.s328
290;AIMed.d38;TRUE;Collectively, PROTEIN1 is yet another functional ligand for PROTEIN2 ;AIMed.d38.s330
291;AIMed.d38;TRUE;The potency of PROTEIN1 as a PROTEIN2 ligand seems, however, to be approximately 10-fold less than that of PROTEIN ;AIMed.d38.s331
292;AIMed.d38;TRUE;The potency of PROTEIN as a PROTEIN1 ligand seems, however, to be approximately 10-fold less than that of PROTEIN2 ;AIMed.d38.s331
293;AIMed.d38;FALSE;The potency of PROTEIN1 as a PROTEIN ligand seems, however, to be approximately 10-fold less than that of PROTEIN2 ;AIMed.d38.s331
294;AIMed.d38;FALSE;Identification of PROTEIN1 will further promote our understanding of the control of eosinophil trafficking and other PROTEIN2 mediated biological phenomena.;AIMed.d38.s332
295;AIMed.d45;FALSE;A mutant form of human PROTEIN1 ( PROTEIN2 that binds one PROTEIN alpha chain ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
296;AIMed.d45;FALSE;A mutant form of human PROTEIN1 ( PROTEIN SC1) that binds one PROTEIN2 receptor alpha chain ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
297;AIMed.d45;FALSE;A mutant form of human PROTEIN1 ( PROTEIN SC1) that binds one PROTEIN2 ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
298;AIMed.d45;FALSE;A mutant form of human PROTEIN1 ( PROTEIN2 SC1) that binds one PROTEIN alpha chain ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
299;AIMed.d45;FALSE;A mutant form of human PROTEIN1 ( PROTEIN SC1) that binds one PROTEIN alpha chain ( PROTEIN2 has been designed and characterized.;AIMed.d45.s390
300;AIMed.d45;FALSE;A mutant form of human PROTEIN1 ( PROTEIN SC1) that binds one PROTEIN2 alpha chain ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
301;AIMed.d45;FALSE;A mutant form of human PROTEIN1 ( PROTEIN SC1) that binds one PROTEIN alpha chain ( PROTEIN2 R alpha) has been designed and characterized.;AIMed.d45.s390
302;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN1 that binds one PROTEIN2 receptor alpha chain ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
303;AIMed.d45;TRUE;A mutant form of human PROTEIN ( PROTEIN1 that binds one PROTEIN2 ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
304;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN1 SC1) that binds one PROTEIN alpha chain ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
305;AIMed.d45;TRUE;A mutant form of human PROTEIN ( PROTEIN1 that binds one PROTEIN alpha chain ( PROTEIN2 has been designed and characterized.;AIMed.d45.s390
306;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN1 that binds one PROTEIN2 alpha chain ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
307;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN1 that binds one PROTEIN alpha chain ( PROTEIN2 R alpha) has been designed and characterized.;AIMed.d45.s390
308;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN SC1) that binds one PROTEIN1 ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
309;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN1 SC1) that binds one PROTEIN2 receptor alpha chain ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
310;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN SC1) that binds one PROTEIN1 receptor alpha chain ( PROTEIN2 has been designed and characterized.;AIMed.d45.s390
311;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN SC1) that binds one PROTEIN1 alpha chain ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
312;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN SC1) that binds one PROTEIN1 receptor alpha chain ( PROTEIN2 R alpha) has been designed and characterized.;AIMed.d45.s390
313;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN1 SC1) that binds one PROTEIN2 ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
314;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN SC1) that binds one PROTEIN1 ( PROTEIN2 has been designed and characterized.;AIMed.d45.s390
315;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN SC1) that binds one PROTEIN1 alpha chain ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
316;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN SC1) that binds one PROTEIN1 ( PROTEIN2 R alpha) has been designed and characterized.;AIMed.d45.s390
317;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN1 SC1) that binds one PROTEIN alpha chain ( PROTEIN2 has been designed and characterized.;AIMed.d45.s390
318;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN1 SC1) that binds one PROTEIN2 alpha chain ( PROTEIN R alpha) has been designed and characterized.;AIMed.d45.s390
319;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN1 SC1) that binds one PROTEIN alpha chain ( PROTEIN2 R alpha) has been designed and characterized.;AIMed.d45.s390
320;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN SC1) that binds one PROTEIN1 alpha chain ( PROTEIN2 has been designed and characterized.;AIMed.d45.s390
321;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN SC1) that binds one PROTEIN alpha chain ( PROTEIN1 R alpha) has been designed and characterized.;AIMed.d45.s390
322;AIMed.d45;FALSE;A mutant form of human PROTEIN ( PROTEIN SC1) that binds one PROTEIN1 alpha chain ( PROTEIN2 R alpha) has been designed and characterized.;AIMed.d45.s390
323;AIMed.d45;FALSE; PROTEIN1 SC1 was derived by linking the two peptide chains of the PROTEIN2 dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.;AIMed.d45.s391
324;AIMed.d45;FALSE; PROTEIN1 was derived by linking the two peptide chains of the PROTEIN2 dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.;AIMed.d45.s391
325;AIMed.d45;FALSE; PROTEIN1 SC1 was derived by linking the two peptide chains of the PROTEIN dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.;AIMed.d45.s391
326;AIMed.d45;FALSE;Isothermal titration calorimetry shows that PROTEIN1 forms a 1:1 complex with its high-affinity receptor ( PROTEIN R alpha) with an affinity of 27(+/- 9) nM.;AIMed.d45.s392
327;AIMed.d45;FALSE;Isothermal titration calorimetry shows that PROTEIN1 SC1 forms a 1:1 complex with its high-affinity receptor ( PROTEIN2 R alpha) with an affinity of 27(+/- 9) nM.;AIMed.d45.s392
328;AIMed.d45;FALSE;Isothermal titration calorimetry shows that PROTEIN1 SC1 forms a 1:1 complex with its high-affinity receptor ( PROTEIN2 with an affinity of 27(+/- 9) nM.;AIMed.d45.s392
329;AIMed.d45;FALSE;Isothermal titration calorimetry shows that PROTEIN1 forms a 1:1 complex with its high-affinity receptor ( PROTEIN2 R alpha) with an affinity of 27(+/- 9) nM.;AIMed.d45.s392
330;AIMed.d45;TRUE;Isothermal titration calorimetry shows that PROTEIN1 forms a 1:1 complex with its high-affinity receptor ( PROTEIN2 with an affinity of 27(+/- 9) nM.;AIMed.d45.s392
331;AIMed.d45;FALSE;Isothermal titration calorimetry shows that PROTEIN forms a 1:1 complex with its high-affinity receptor ( PROTEIN1 R alpha) with an affinity of 27(+/- 9) nM.;AIMed.d45.s392
332;AIMed.d45;FALSE;The crystal structure of PROTEIN1 SC1 has been determined at 2.9 A resolution from crystals grown in 1.4 M citrate solutions at pH 7.6.;AIMed.d45.s393
333;AIMed.d45;FALSE;Comparison of the wild-type receptor-binding domain and the Asp111-containing domain of PROTEIN1 show that they are structurally equivalent but have very different electrostatic surface potentials.;AIMed.d45.s394
334;AIMed.d45;FALSE;The AB loops of PROTEIN1 adopt conformations similar to the ordered loops of PROTEIN2 observed in the crystal structure of the PROTEIN PROTEIN R alpha complex.;AIMed.d45.s396
335;AIMed.d45;FALSE;The AB loops of PROTEIN1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the PROTEIN2 PROTEIN R alpha complex.;AIMed.d45.s396
336;AIMed.d45;FALSE;The AB loops of PROTEIN1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the PROTEIN PROTEIN2 R alpha complex.;AIMed.d45.s396
337;AIMed.d45;FALSE;The AB loops of PROTEIN1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the PROTEIN PROTEIN2 complex.;AIMed.d45.s396
338;AIMed.d45;FALSE;The AB loops of PROTEIN adopt conformations similar to the ordered loops of PROTEIN1 observed in the crystal structure of the PROTEIN2 PROTEIN R alpha complex.;AIMed.d45.s396
339;AIMed.d45;FALSE;The AB loops of PROTEIN adopt conformations similar to the ordered loops of PROTEIN1 observed in the crystal structure of the PROTEIN PROTEIN2 R alpha complex.;AIMed.d45.s396
340;AIMed.d45;FALSE;The AB loops of PROTEIN adopt conformations similar to the ordered loops of PROTEIN1 observed in the crystal structure of the PROTEIN PROTEIN2 complex.;AIMed.d45.s396
341;AIMed.d45;FALSE;The AB loops of PROTEIN adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the PROTEIN1 PROTEIN2 R alpha complex.;AIMed.d45.s396
342;AIMed.d45;TRUE;The AB loops of PROTEIN adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the PROTEIN1 PROTEIN2 complex.;AIMed.d45.s396
343;AIMed.d45;FALSE;The AB loops of PROTEIN adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the PROTEIN PROTEIN1 R alpha complex.;AIMed.d45.s396
344;AIMed.d45;FALSE;Thus, PROTEIN1 R alpha binding does not result in a large conformational change in the AB loop as previously suggested.;AIMed.d45.s397
345;AIMed.d45;FALSE;The structure also reveals the final six C-terminal amino acid residues of PROTEIN1 (residues 253-258) that have not been observed in any other reported PROTEIN2 structures.;AIMed.d45.s398
346;AIMed.d45;FALSE;The structure also reveals the final six C-terminal amino acid residues of PROTEIN1 SC1 (residues 253-258) that have not been observed in any other reported PROTEIN structures.;AIMed.d45.s398
347;AIMed.d45;FALSE;The structure also reveals the final six C-terminal amino acid residues of PROTEIN1 SC1 (residues 253-258) that have not been observed in any other reported PROTEIN2 structures.;AIMed.d45.s398
348;AIMed.d45;FALSE;Despite binding to only one PROTEIN1 PROTEIN is biologically active in cell proliferation, MHC class I induction, and anti-viral assays.;AIMed.d45.s399
349;AIMed.d45;FALSE;Despite binding to only one PROTEIN1 R alpha, PROTEIN2 is biologically active in cell proliferation, MHC class I induction, and anti-viral assays.;AIMed.d45.s399
350;AIMed.d45;TRUE;Despite binding to only one PROTEIN1 PROTEIN2 is biologically active in cell proliferation, MHC class I induction, and anti-viral assays.;AIMed.d45.s399
351;AIMed.d45;FALSE;This suggests that one domain of PROTEIN1 is sufficient to recruit PROTEIN2 R alpha and PROTEIN into a complex competent for eliciting biological activity.;AIMed.d45.s400
352;AIMed.d45;TRUE;This suggests that one domain of PROTEIN1 is sufficient to recruit PROTEIN2 and PROTEIN into a complex competent for eliciting biological activity.;AIMed.d45.s400
353;AIMed.d45;FALSE;This suggests that one domain of PROTEIN1 is sufficient to recruit PROTEIN and PROTEIN2 R beta into a complex competent for eliciting biological activity.;AIMed.d45.s400
354;AIMed.d45;TRUE;This suggests that one domain of PROTEIN1 is sufficient to recruit PROTEIN and PROTEIN2 into a complex competent for eliciting biological activity.;AIMed.d45.s400
355;AIMed.d45;FALSE;This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN1 and PROTEIN into a complex competent for eliciting biological activity.;AIMed.d45.s400
356;AIMed.d45;FALSE;This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN1 R alpha and PROTEIN2 R beta into a complex competent for eliciting biological activity.;AIMed.d45.s400
357;AIMed.d45;FALSE;This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN1 R alpha and PROTEIN2 into a complex competent for eliciting biological activity.;AIMed.d45.s400
358;AIMed.d45;FALSE;This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN1 and PROTEIN2 R beta into a complex competent for eliciting biological activity.;AIMed.d45.s400
359;AIMed.d45;FALSE;This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN1 and PROTEIN2 into a complex competent for eliciting biological activity.;AIMed.d45.s400
360;AIMed.d45;FALSE;This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN and PROTEIN1 into a complex competent for eliciting biological activity.;AIMed.d45.s400
361;AIMed.d45;FALSE;The current data are consistent with the main role of the PROTEIN1 dimer being to decrease the dissociation constant of PROTEIN2 for its cellular receptors.;AIMed.d45.s401
362;AIMed.d55;TRUE;Human PROTEIN PROTEIN1 is a functional ligand for PROTEIN PROTEIN and PROTEIN2 and constitutively expressed by hepatocytes.;AIMed.d55.s481
363;AIMed.d55;FALSE;Human PROTEIN1 PROTEIN2 is a functional ligand for PROTEIN PROTEIN and PROTEIN and constitutively expressed by hepatocytes.;AIMed.d55.s481
364;AIMed.d55;TRUE;Human PROTEIN PROTEIN1 is a functional ligand for PROTEIN PROTEIN2 and PROTEIN and constitutively expressed by hepatocytes.;AIMed.d55.s481
365;AIMed.d55;TRUE;Human PROTEIN PROTEIN1 is a functional ligand for PROTEIN2 PROTEIN and PROTEIN and constitutively expressed by hepatocytes.;AIMed.d55.s481
366;AIMed.d55;TRUE;Human PROTEIN1 PROTEIN is a functional ligand for PROTEIN PROTEIN and PROTEIN2 and constitutively expressed by hepatocytes.;AIMed.d55.s481
367;AIMed.d55;FALSE;Human PROTEIN PROTEIN is a functional ligand for PROTEIN PROTEIN1 and PROTEIN2 and constitutively expressed by hepatocytes.;AIMed.d55.s481
368;AIMed.d55;FALSE;Human PROTEIN PROTEIN is a functional ligand for PROTEIN1 PROTEIN and PROTEIN2 and constitutively expressed by hepatocytes.;AIMed.d55.s481
369;AIMed.d55;TRUE;Human PROTEIN1 PROTEIN is a functional ligand for PROTEIN PROTEIN2 and PROTEIN and constitutively expressed by hepatocytes.;AIMed.d55.s481
370;AIMed.d55;TRUE;Human PROTEIN1 PROTEIN is a functional ligand for PROTEIN2 PROTEIN and PROTEIN and constitutively expressed by hepatocytes.;AIMed.d55.s481
371;AIMed.d55;FALSE;Human PROTEIN PROTEIN is a functional ligand for PROTEIN1 PROTEIN2 and PROTEIN and constitutively expressed by hepatocytes.;AIMed.d55.s481
372;AIMed.d55;FALSE; PROTEIN1 ( PROTEIN2 / PROTEIN is a human CC chemokine selectively expressed in the liver.;AIMed.d55.s482
373;AIMed.d55;FALSE; PROTEIN1 ( PROTEIN / PROTEIN2 is a human CC chemokine selectively expressed in the liver.;AIMed.d55.s482
374;AIMed.d55;FALSE; PROTEIN ( PROTEIN1 / PROTEIN2 is a human CC chemokine selectively expressed in the liver.;AIMed.d55.s482
375;AIMed.d55;TRUE;At relatively high concentrations, PROTEIN1 induced calcium mobilization and chemotaxis via PROTEIN and PROTEIN2 ;AIMed.d55.s484
376;AIMed.d55;FALSE;At relatively high concentrations, PROTEIN induced calcium mobilization and chemotaxis via PROTEIN1 and PROTEIN2 ;AIMed.d55.s484
377;AIMed.d55;TRUE;At relatively high concentrations, PROTEIN1 induced calcium mobilization and chemotaxis via PROTEIN2 and PROTEIN ;AIMed.d55.s484
378;AIMed.d55;TRUE; PROTEIN1 also induced calcium mobilization, but marginal chemotaxis via PROTEIN2 ;AIMed.d55.s485
379;AIMed.d55;TRUE;Consistently, PROTEIN1 was found to bind to PROTEIN PROTEIN2 and PROTEIN with relatively low affinities.;AIMed.d55.s486
380;AIMed.d55;TRUE;Consistently, PROTEIN1 was found to bind to PROTEIN PROTEIN and PROTEIN2 with relatively low affinities.;AIMed.d55.s486
381;AIMed.d55;TRUE;Consistently, PROTEIN1 was found to bind to PROTEIN2 PROTEIN and PROTEIN with relatively low affinities.;AIMed.d55.s486
382;AIMed.d55;FALSE;Consistently, PROTEIN was found to bind to PROTEIN PROTEIN1 and PROTEIN2 with relatively low affinities.;AIMed.d55.s486
383;AIMed.d55;FALSE;Consistently, PROTEIN was found to bind to PROTEIN1 PROTEIN2 and PROTEIN with relatively low affinities.;AIMed.d55.s486
384;AIMed.d55;FALSE;Consistently, PROTEIN was found to bind to PROTEIN1 PROTEIN and PROTEIN2 with relatively low affinities.;AIMed.d55.s486
385;AIMed.d55;TRUE;The binding of PROTEIN1 to PROTEIN2 was much less significant.;AIMed.d55.s487
386;AIMed.d55;TRUE;In spite of its binding to PROTEIN1 PROTEIN2 was unable to inhibit infection of an R5-type HIV-1 to activated human peripheral blood mononuclear cells even at high concentrations.;AIMed.d55.s488
387;AIMed.d55;TRUE;Taken together, PROTEIN1 is a new low-affinity functional ligand for PROTEIN PROTEIN2 and PROTEIN and is constitutively expressed by liver parenchymal cells.;AIMed.d55.s492
388;AIMed.d55;TRUE;Taken together, PROTEIN1 is a new low-affinity functional ligand for PROTEIN2 PROTEIN and PROTEIN and is constitutively expressed by liver parenchymal cells.;AIMed.d55.s492
389;AIMed.d55;TRUE;Taken together, PROTEIN1 is a new low-affinity functional ligand for PROTEIN PROTEIN and PROTEIN2 and is constitutively expressed by liver parenchymal cells.;AIMed.d55.s492
390;AIMed.d55;FALSE;Taken together, PROTEIN is a new low-affinity functional ligand for PROTEIN1 PROTEIN2 and PROTEIN and is constitutively expressed by liver parenchymal cells.;AIMed.d55.s492
391;AIMed.d55;FALSE;Taken together, PROTEIN is a new low-affinity functional ligand for PROTEIN PROTEIN1 and PROTEIN2 and is constitutively expressed by liver parenchymal cells.;AIMed.d55.s492
392;AIMed.d55;FALSE;Taken together, PROTEIN is a new low-affinity functional ligand for PROTEIN1 PROTEIN and PROTEIN2 and is constitutively expressed by liver parenchymal cells.;AIMed.d55.s492
393;AIMed.d62;FALSE;The crystal structure of the homodimeric PROTEIN1 ( PROTEIN2 has been determined by X-ray analysis to 3.0 A resolution.;AIMed.d62.s541
394;AIMed.d66;FALSE;Human PROTEIN1 a new cyclin that interacts with two members of the PROTEIN2 gene family.;AIMed.d66.s562
395;AIMed.d66;TRUE; PROTEIN1 showed genetic interactions with the PROTEIN2 gene, suggesting that it functioned at START by interacting with the PROTEIN protein.;AIMed.d66.s564
396;AIMed.d66;FALSE; PROTEIN showed genetic interactions with the PROTEIN1 gene, suggesting that it functioned at START by interacting with the PROTEIN2 protein.;AIMed.d66.s564
397;AIMed.d66;TRUE; PROTEIN1 showed genetic interactions with the PROTEIN gene, suggesting that it functioned at START by interacting with the PROTEIN2 protein.;AIMed.d66.s564
398;AIMed.d66;FALSE;Two human genes were identified that could interact with PROTEIN1 to perform START in yeast containing a PROTEIN2 mutation.;AIMed.d66.s565
399;AIMed.d66;FALSE;One was PROTEIN1 HS, and the second was the human homolog of Xenopus PROTEIN ;AIMed.d66.s566
400;AIMed.d66;FALSE;One was PROTEIN1 and the second was the human homolog of Xenopus PROTEIN2 ;AIMed.d66.s566
401;AIMed.d66;FALSE;One was PROTEIN1 HS, and the second was the human homolog of Xenopus PROTEIN2 ;AIMed.d66.s566
402;AIMed.d66;FALSE; PROTEIN produced in E. coli bound and activated the PROTEIN1 protein in extracts from human G1 cells, and antibodies against PROTEIN2 immunoprecipitated a histone H1 kinase from HeLa cells.;AIMed.d66.s567
403;AIMed.d66;TRUE; PROTEIN1 produced in E. coli bound and activated the PROTEIN2 protein in extracts from human G1 cells, and antibodies against PROTEIN immunoprecipitated a histone H1 kinase from HeLa cells.;AIMed.d66.s567
404;AIMed.d66;FALSE; PROTEIN1 produced in E. coli bound and activated the PROTEIN protein in extracts from human G1 cells, and antibodies against PROTEIN2 immunoprecipitated a histone H1 kinase from HeLa cells.;AIMed.d66.s567
405;AIMed.d66;TRUE;The interactions between PROTEIN1 and PROTEIN2 or PROTEIN may be important at the G1 to S transition in human cells.;AIMed.d66.s568
406;AIMed.d66;TRUE;The interactions between PROTEIN1 and PROTEIN or PROTEIN2 may be important at the G1 to S transition in human cells.;AIMed.d66.s568
407;AIMed.d66;FALSE;The interactions between PROTEIN and PROTEIN1 or PROTEIN2 may be important at the G1 to S transition in human cells.;AIMed.d66.s568
408;AIMed.d72;FALSE;A cellular protein that competes with PROTEIN1 for binding to the PROTEIN2 gene product.;AIMed.d72.s609
409;AIMed.d72;FALSE;Tumour-suppressor genes, such as the human PROTEIN1 ( PROTEIN2 , are widely recognized as being vital in the control of cell growth and tumour formation.;AIMed.d72.s610
410;AIMed.d72;FALSE;How PROTEIN acts to bring about this suppression is not clear but one clue is that the PROTEIN1 protein forms complexes with the transforming oncoproteins of several DNA tumour viruses, and that two regions of PROTEIN2 essential for such binding frequently contain mutations in tumour cells.;AIMed.d72.s612
411;AIMed.d72;FALSE;How PROTEIN1 acts to bring about this suppression is not clear but one clue is that the PROTEIN2 protein forms complexes with the transforming oncoproteins of several DNA tumour viruses, and that two regions of PROTEIN essential for such binding frequently contain mutations in tumour cells.;AIMed.d72.s612
412;AIMed.d72;FALSE;How PROTEIN1 acts to bring about this suppression is not clear but one clue is that the PROTEIN protein forms complexes with the transforming oncoproteins of several DNA tumour viruses, and that two regions of PROTEIN2 essential for such binding frequently contain mutations in tumour cells.;AIMed.d72.s612
413;AIMed.d72;FALSE;We report here the identification of one such human cellular PROTEIN1 of relative molecular mass 46,000 (46K) ( PROTEIN .;AIMed.d72.s614
414;AIMed.d72;FALSE;We report here the identification of one such human cellular PROTEIN1 associated protein of relative molecular mass 46,000 (46K) ( PROTEIN2 .;AIMed.d72.s614
415;AIMed.d72;FALSE;We report here the identification of one such human cellular PROTEIN1 of relative molecular mass 46,000 (46K) ( PROTEIN2 .;AIMed.d72.s614
416;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN1 have homologous PROTEIN binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN2 ;AIMed.d72.s615
417;AIMed.d72;TRUE;Two lines of evidence support the notion that PROTEIN and PROTEIN1 have homologous PROTEIN2 binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN ;AIMed.d72.s615
418;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN1 have homologous PROTEIN binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN2 for binding to PROTEIN ;AIMed.d72.s615
419;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN1 have homologous PROTEIN binding properties: first, several mutated PROTEIN2 proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN ;AIMed.d72.s615
420;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN1 and PROTEIN2 have homologous PROTEIN binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN ;AIMed.d72.s615
421;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN1 have homologous PROTEIN binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN2 and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN ;AIMed.d72.s615
422;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN have homologous PROTEIN1 binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN2 ;AIMed.d72.s615
423;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN have homologous PROTEIN binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN1 for binding to PROTEIN2 ;AIMed.d72.s615
424;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN have homologous PROTEIN binding properties: first, several mutated PROTEIN1 proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN2 ;AIMed.d72.s615
425;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN1 and PROTEIN have homologous PROTEIN binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN2 ;AIMed.d72.s615
426;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN have homologous PROTEIN binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN1 and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN2 ;AIMed.d72.s615
427;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN have homologous PROTEIN1 binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN2 for binding to PROTEIN ;AIMed.d72.s615
428;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN have homologous PROTEIN1 binding properties: first, several mutated PROTEIN2 proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN ;AIMed.d72.s615
429;AIMed.d72;TRUE;Two lines of evidence support the notion that PROTEIN1 and PROTEIN have homologous PROTEIN2 binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN ;AIMed.d72.s615
430;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN have homologous PROTEIN1 binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN2 and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN ;AIMed.d72.s615
431;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN have homologous PROTEIN binding properties: first, several mutated PROTEIN1 proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN2 for binding to PROTEIN ;AIMed.d72.s615
432;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN1 and PROTEIN have homologous PROTEIN binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN2 for binding to PROTEIN ;AIMed.d72.s615
433;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN have homologous PROTEIN binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN1 and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN2 for binding to PROTEIN ;AIMed.d72.s615
434;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN1 and PROTEIN have homologous PROTEIN binding properties: first, several mutated PROTEIN2 proteins that failed to bind to T also did not associate with PROTEIN and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN ;AIMed.d72.s615
435;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN and PROTEIN have homologous PROTEIN binding properties: first, several mutated PROTEIN1 proteins that failed to bind to T also did not associate with PROTEIN2 and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN ;AIMed.d72.s615
436;AIMed.d72;FALSE;Two lines of evidence support the notion that PROTEIN1 and PROTEIN have homologous PROTEIN binding properties: first, several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN2 and second, both T antigen and T peptide (amino acids 101-118) were able to compete with PROTEIN for binding to PROTEIN ;AIMed.d72.s615
437;AIMed.d72;TRUE;The apparent targeting of the PROTEIN1 PROTEIN2 interaction by oncoproteins of DNA tumour viruses strongly suggests that formation of this complex is functionally important.;AIMed.d72.s616
438;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN and the PROTEIN ( PROTEIN with the PROTEIN1 ( PROTEIN2 receptor in the yeast two-hybrid system.;AIMed.d84.s711
439;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN1 and the PROTEIN ( PROTEIN with the PROTEIN2 ( PROTEIN receptor in the yeast two-hybrid system.;AIMed.d84.s711
440;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN and the PROTEIN ( PROTEIN1 with the PROTEIN2 ( PROTEIN receptor in the yeast two-hybrid system.;AIMed.d84.s711
441;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN and the PROTEIN1 ( PROTEIN with the PROTEIN2 ( PROTEIN receptor in the yeast two-hybrid system.;AIMed.d84.s711
442;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN and the PROTEIN ( PROTEIN with the PROTEIN1 ( PROTEIN receptor in the yeast two-hybrid system.;AIMed.d84.s711
443;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN1 and the PROTEIN ( PROTEIN with the PROTEIN ( PROTEIN2 receptor in the yeast two-hybrid system.;AIMed.d84.s711
444;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN and the PROTEIN ( PROTEIN1 with the PROTEIN ( PROTEIN2 receptor in the yeast two-hybrid system.;AIMed.d84.s711
445;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN and the PROTEIN1 ( PROTEIN with the PROTEIN ( PROTEIN2 receptor in the yeast two-hybrid system.;AIMed.d84.s711
446;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN and the PROTEIN ( PROTEIN wit PROTEIN2 PROTEIN1 in the yeast two-hybrid system.;AIMed.d84.s711
447;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN1 and the PROTEIN ( PROTEIN2 with the PROTEIN ( PROTEIN receptor in the yeast two-hybrid system.;AIMed.d84.s711
448;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN1 and the PROTEIN2 ( PROTEIN with the PROTEIN ( PROTEIN receptor in the yeast two-hybrid system.;AIMed.d84.s711
449;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN1 and the PROTEIN ( PROTEIN wit PROTEIN PROTEIN2 in the yeast two-hybrid system.;AIMed.d84.s711
450;AIMed.d84;FALSE;Evidence for a differential interaction of PROTEIN and the PROTEIN1 ( PROTEIN2 with the PROTEIN ( PROTEIN receptor in the yeast two-hybrid system.;AIMed.d84.s711
451;AIMed.d84;TRUE;Evidence for a differential interaction of PROTEIN and the PROTEIN ( PROTEIN1 wit PROTEIN PROTEIN2 in the yeast two-hybrid system.;AIMed.d84.s711
452;AIMed.d84;TRUE;Evidence for a differential interaction of PROTEIN and the PROTEIN1 ( PROTEIN wit PROTEIN PROTEIN2 in the yeast two-hybrid system.;AIMed.d84.s711
453;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN1 and the PROTEIN2 substrate-1 ( PROTEIN .;AIMed.d84.s712
454;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN2 substrate-1 ( PROTEIN .;AIMed.d84.s712
455;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN2 substrate-1 ( PROTEIN .;AIMed.d84.s712
456;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN1 ( PROTEIN .;AIMed.d84.s712
457;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN1 and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN2 substrate-1 ( PROTEIN .;AIMed.d84.s712
458;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN1 ( PROTEIN with their two known substrates PROTEIN and the PROTEIN2 substrate-1 ( PROTEIN .;AIMed.d84.s712
459;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN1 substrate-1 ( PROTEIN2 .;AIMed.d84.s712
460;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN1 with their two known substrates PROTEIN and the PROTEIN2 substrate-1 ( PROTEIN .;AIMed.d84.s712
461;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN2 and the PROTEIN ( PROTEIN .;AIMed.d84.s712
462;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN2 and the PROTEIN ( PROTEIN .;AIMed.d84.s712
463;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN1 and the PROTEIN2 ( PROTEIN .;AIMed.d84.s712
464;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN1 and the PROTEIN ( PROTEIN with their two known substrates PROTEIN2 and the PROTEIN ( PROTEIN .;AIMed.d84.s712
465;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN1 ( PROTEIN with their two known substrates PROTEIN2 and the PROTEIN ( PROTEIN .;AIMed.d84.s712
466;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN1 and the PROTEIN ( PROTEIN2 .;AIMed.d84.s712
467;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN1 with their two known substrates PROTEIN2 and the PROTEIN ( PROTEIN .;AIMed.d84.s712
468;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN ( PROTEIN .;AIMed.d84.s712
469;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN2 ( PROTEIN .;AIMed.d84.s712
470;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN2 and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN ( PROTEIN .;AIMed.d84.s712
471;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN and the PROTEIN2 ( PROTEIN with their two known substrates PROTEIN and the PROTEIN ( PROTEIN .;AIMed.d84.s712
472;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN ( PROTEIN2 .;AIMed.d84.s712
473;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN and the PROTEIN ( PROTEIN2 with their two known substrates PROTEIN and the PROTEIN ( PROTEIN .;AIMed.d84.s712
474;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN2 ( PROTEIN .;AIMed.d84.s712
475;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 ( PROTEIN2 and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN ( PROTEIN .;AIMed.d84.s712
476;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 ( PROTEIN and the PROTEIN2 ( PROTEIN with their two known substrates PROTEIN and the PROTEIN ( PROTEIN .;AIMed.d84.s712
477;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN ( PROTEIN2 .;AIMed.d84.s712
478;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN1 ( PROTEIN and the PROTEIN ( PROTEIN2 with their two known substrates PROTEIN and the PROTEIN ( PROTEIN .;AIMed.d84.s712
479;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN1 and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN2 ( PROTEIN .;AIMed.d84.s712
480;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN1 ( PROTEIN with their two known substrates PROTEIN and the PROTEIN2 ( PROTEIN .;AIMed.d84.s712
481;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN1 ( PROTEIN2 .;AIMed.d84.s712
482;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN1 with their two known substrates PROTEIN and the PROTEIN2 ( PROTEIN .;AIMed.d84.s712
483;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN1 and the PROTEIN2 ( PROTEIN with their two known substrates PROTEIN and the PROTEIN ( PROTEIN .;AIMed.d84.s712
484;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN1 and the PROTEIN ( PROTEIN with their two known substrates PROTEIN and the PROTEIN ( PROTEIN2 .;AIMed.d84.s712
485;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN1 and the PROTEIN ( PROTEIN2 with their two known substrates PROTEIN and the PROTEIN ( PROTEIN .;AIMed.d84.s712
486;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN1 ( PROTEIN with their two known substrates PROTEIN and the PROTEIN ( PROTEIN2 .;AIMed.d84.s712
487;AIMed.d84;FALSE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN1 ( PROTEIN2 with their two known substrates PROTEIN and the PROTEIN ( PROTEIN .;AIMed.d84.s712
488;AIMed.d84;TRUE;Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN1 with their two known substrates PROTEIN and the PROTEIN ( PROTEIN2 .;AIMed.d84.s712
489;AIMed.d84;FALSE;We also mapped the specific domains of the PROTEIN1 and PROTEIN2 participating in these interactions.;AIMed.d84.s713
490;AIMed.d84;TRUE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN and PROTEIN2 (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
491;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN1 and PROTEIN2 (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
492;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN1 (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN2 and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
493;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN1 (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN2 PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
494;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN1 (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN2 and the PROTEIN ;AIMed.d84.s714
495;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN1 (ii) PROTEIN and PROTEIN2 bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
496;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN1 (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN2 ;AIMed.d84.s714
497;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN1 (ii) PROTEIN2 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
498;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN1 (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN2 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
499;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN1 (ii) PROTEIN and PROTEIN bind to the PROTEIN2 in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
500;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN1 (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN2 is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
501;AIMed.d84;TRUE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN2 and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
502;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN2 and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
503;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN2 PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
504;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN2 and the PROTEIN ;AIMed.d84.s714
505;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN2 bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
506;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN2 ;AIMed.d84.s714
507;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN2 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
508;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN2 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
509;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN2 in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
510;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN2 is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
511;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN1 and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN2 and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
512;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN1 and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN2 PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
513;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN1 and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN2 and the PROTEIN ;AIMed.d84.s714
514;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN1 and PROTEIN (ii) PROTEIN and PROTEIN2 bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
515;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN1 and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN2 ;AIMed.d84.s714
516;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN1 and PROTEIN (ii) PROTEIN2 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
517;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN1 and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN2 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
518;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN1 and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN2 in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
519;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN1 and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN2 is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
520;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN1 PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN2 and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
521;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN1 and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN2 and the PROTEIN ;AIMed.d84.s714
522;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN1 bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN2 and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
523;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN1 and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN2 ;AIMed.d84.s714
524;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN1 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN2 and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
525;AIMed.d84;TRUE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN2 and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
526;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN1 in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN2 and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
527;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN1 and (iv) the amino-terminal domain of PROTEIN2 is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
528;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN1 PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN2 and the PROTEIN ;AIMed.d84.s714
529;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN1 bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN2 PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
530;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN1 PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN2 ;AIMed.d84.s714
531;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN1 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN2 PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
532;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN1 PROTEIN2 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
533;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN1 in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN2 PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
534;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN1 PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN2 is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
535;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN1 bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN2 and the PROTEIN ;AIMed.d84.s714
536;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN1 and the PROTEIN2 ;AIMed.d84.s714
537;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN1 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN2 and the PROTEIN ;AIMed.d84.s714
538;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN2 and the PROTEIN ;AIMed.d84.s714
539;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN1 in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN2 and the PROTEIN ;AIMed.d84.s714
540;AIMed.d84;TRUE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN1 is required for its association with the PROTEIN2 and the PROTEIN ;AIMed.d84.s714
541;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN1 bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN2 ;AIMed.d84.s714
542;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN1 and PROTEIN2 bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
543;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN1 bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN2 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
544;AIMed.d84;TRUE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN1 bind to the PROTEIN2 in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
545;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN1 bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN2 is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
546;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN1 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN2 ;AIMed.d84.s714
547;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN2 ;AIMed.d84.s714
548;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN1 in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN2 ;AIMed.d84.s714
549;AIMed.d84;TRUE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN1 is required for its association with the PROTEIN and the PROTEIN2 ;AIMed.d84.s714
550;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN1 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN2 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
551;AIMed.d84;TRUE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN1 and PROTEIN bind to the PROTEIN2 in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
552;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN1 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN2 is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
553;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN1 in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN2 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
554;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN2 is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
555;AIMed.d84;FALSE;Our findings can be summarized as follows: (i) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN (ii) PROTEIN and PROTEIN bind to the PROTEIN1 in the NPEY-juxtamembrane motif, (iii) contrary to PROTEIN PROTEIN binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the PROTEIN and (iv) the amino-terminal domain of PROTEIN2 is required for its association with the PROTEIN and the PROTEIN ;AIMed.d84.s714
556;AIMed.d84;FALSE;We propose that (i) the PROTEIN1 and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN and (ii) PROTEIN2 interacts with the PROTEIN in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
557;AIMed.d84;FALSE;We propose that (i) the PROTEIN1 and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN and (ii) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN2 ;AIMed.d84.s715
558;AIMed.d84;TRUE;We propose that (i) the PROTEIN1 and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN2 and (ii) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
559;AIMed.d84;FALSE;We propose that (i) the PROTEIN1 and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN and (ii) PROTEIN interacts with the PROTEIN2 in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
560;AIMed.d84;FALSE;We propose that (i) the PROTEIN1 and the PROTEIN2 share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN and (ii) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
561;AIMed.d84;TRUE;We propose that (i) the PROTEIN1 and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN2 and PROTEIN and (ii) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
562;AIMed.d84;FALSE;We propose that (i) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN and (ii) PROTEIN1 interacts with the PROTEIN in a fashion that is different from that used by PROTEIN2 ;AIMed.d84.s715
563;AIMed.d84;FALSE;We propose that (i) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN1 and (ii) PROTEIN2 interacts with the PROTEIN in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
564;AIMed.d84;TRUE;We propose that (i) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN and (ii) PROTEIN1 interacts with the PROTEIN2 in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
565;AIMed.d84;FALSE;We propose that (i) the PROTEIN and the PROTEIN1 share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN and (ii) PROTEIN2 interacts with the PROTEIN in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
566;AIMed.d84;FALSE;We propose that (i) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN1 and PROTEIN and (ii) PROTEIN2 interacts with the PROTEIN in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
567;AIMed.d84;FALSE;We propose that (i) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN1 and (ii) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN2 ;AIMed.d84.s715
568;AIMed.d84;TRUE;We propose that (i) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN and (ii) PROTEIN interacts with the PROTEIN1 in a fashion that is different from that used by PROTEIN2 ;AIMed.d84.s715
569;AIMed.d84;FALSE;We propose that (i) the PROTEIN and the PROTEIN1 share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN and (ii) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN2 ;AIMed.d84.s715
570;AIMed.d84;FALSE;We propose that (i) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN1 and PROTEIN and (ii) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN2 ;AIMed.d84.s715
571;AIMed.d84;FALSE;We propose that (i) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN1 and (ii) PROTEIN interacts with the PROTEIN2 in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
572;AIMed.d84;TRUE;We propose that (i) the PROTEIN and the PROTEIN1 share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN2 and (ii) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
573;AIMed.d84;FALSE;We propose that (i) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN1 and PROTEIN2 and (ii) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
574;AIMed.d84;FALSE;We propose that (i) the PROTEIN and the PROTEIN1 share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN and PROTEIN and (ii) PROTEIN interacts with the PROTEIN2 in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
575;AIMed.d84;FALSE;We propose that (i) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN1 and PROTEIN and (ii) PROTEIN interacts with the PROTEIN2 in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
576;AIMed.d84;TRUE;We propose that (i) the PROTEIN and the PROTEIN1 share at least in part the same molecular mechanism underlying their interplay with their two substrates, PROTEIN2 and PROTEIN and (ii) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN ;AIMed.d84.s715
577;AIMed.d84;FALSE;Finally, our data highlight the crucial role of the juxtamembrane domain in signaling by both the PROTEIN1 and the PROTEIN2 ;AIMed.d84.s716
578;AIMed.d86;FALSE;For the calibration, we used two sets of proteins, the PROTEIN1 PROTEIN2 PROTEIN helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.;AIMed.d86.s728
579;AIMed.d86;FALSE;For the calibration, we used two sets of proteins, the PROTEIN1 PROTEIN PROTEIN2 helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.;AIMed.d86.s728
580;AIMed.d86;FALSE;For the calibration, we used two sets of proteins, the PROTEIN PROTEIN1 PROTEIN2 helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.;AIMed.d86.s728
581;AIMed.d88;TRUE;Interaction of the protein PROTEIN1 with PROTEIN2 as revealed by the yeast two-hybrid system.;AIMed.d88.s742
582;AIMed.d88;TRUE;The specificity of intehraction between PROTEIN1 and PROTEIN2 was confirmed by an in vitro binding assay using recombinant proteins.;AIMed.d88.s749
583;AIMed.d88;FALSE;Transfection of PROTEIN and PROTEIN in COS cells increased PROTEIN1 expression relative to cells transfected with PROTEIN2 and mock vector.;AIMed.d88.s750
584;AIMed.d88;FALSE;Transfection of PROTEIN1 and PROTEIN in COS cells increased PROTEIN2 expression relative to cells transfected with PROTEIN and mock vector.;AIMed.d88.s750
585;AIMed.d88;FALSE;Transfection of PROTEIN and PROTEIN1 in COS cells increased PROTEIN2 expression relative to cells transfected with PROTEIN and mock vector.;AIMed.d88.s750
586;AIMed.d88;FALSE;Transfection of PROTEIN1 and PROTEIN in COS cells increased PROTEIN expression relative to cells transfected with PROTEIN2 and mock vector.;AIMed.d88.s750
587;AIMed.d88;FALSE;Transfection of PROTEIN and PROTEIN1 in COS cells increased PROTEIN expression relative to cells transfected with PROTEIN2 and mock vector.;AIMed.d88.s750
588;AIMed.d88;FALSE;Transfection of PROTEIN1 and PROTEIN2 in COS cells increased PROTEIN expression relative to cells transfected with PROTEIN and mock vector.;AIMed.d88.s750
589;AIMed.d106;TRUE; PROTEIN1 interaction with PROTEIN2 ties mitogenic signal transduction to cell cycle activation.;AIMed.d106.s893
590;AIMed.d106;FALSE;The PROTEIN1 and PROTEIN2 proto-oncogenes transduce extracellular signals that promote cell growth.;AIMed.d106.s894
591;AIMed.d106;TRUE;We show here that PROTEIN1 associates with PROTEIN2 in somatic mammalian cells and in meiotic frog oocytes.;AIMed.d106.s896
592;AIMed.d106;TRUE;Furthermore, PROTEIN1 can be activated in vitro in a PROTEIN2 dependent manner.;AIMed.d106.s897
593;AIMed.d106;FALSE;We suggest that activation of the cell cycle by the PROTEIN1 PROTEIN pathways might be mediated in part by PROTEIN2 ;AIMed.d106.s898
594;AIMed.d106;FALSE;We suggest that activation of the cell cycle by the PROTEIN1 PROTEIN2 pathways might be mediated in part by PROTEIN ;AIMed.d106.s898
595;AIMed.d106;FALSE;We suggest that activation of the cell cycle by the PROTEIN PROTEIN1 pathways might be mediated in part by PROTEIN2 ;AIMed.d106.s898
596;AIMed.d107;TRUE;A direct interaction between PROTEIN1 subunits and the PROTEIN2 ;AIMed.d107.s899
597;AIMed.d107;FALSE; PROTEIN1 is a serine/threonine protein kinase positioned downstream of PROTEIN in the PROTEIN2 cascade.;AIMed.d107.s900
598;AIMed.d107;FALSE; PROTEIN1 is a serine/threonine protein kinase positioned downstream of PROTEIN2 in the PROTEIN cascade.;AIMed.d107.s900
599;AIMed.d107;FALSE; PROTEIN is a serine/threonine protein kinase positioned downstream of PROTEIN1 in the PROTEIN2 cascade.;AIMed.d107.s900
600;AIMed.d107;TRUE;Using a yeast two-hybrid strategy to identify other proteins that interact with and potentially regulate PROTEIN1 we isolated a clone encoding the carboxyl-terminal half of the PROTEIN2 of heterotrimeric G-proteins.;AIMed.d107.s901
601;AIMed.d107;TRUE;In vitro, purified PROTEIN1 subunits specifically bound to a GST fusion protein encoding amino acids 1-330 of PROTEIN ( PROTEIN2 .;AIMed.d107.s902
602;AIMed.d107;FALSE;In vitro, purified PROTEIN subunits specifically bound to a GST fusion protein encoding amino acids 1-330 of PROTEIN1 ( PROTEIN2 .;AIMed.d107.s902
603;AIMed.d107;TRUE;In vitro, purified PROTEIN1 subunits specifically bound to a GST fusion protein encoding amino acids 1-330 of PROTEIN2 ( PROTEIN .;AIMed.d107.s902
604;AIMed.d107;FALSE;Binding assays with truncation mutants of GST- PROTEIN1 indicate that the region located between amino acids 136 and 239 is a primary determinant for interaction with PROTEIN2 ;AIMed.d107.s903
605;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN ( PROTEIN1 blocked the binding of PROTEIN2 to PROTEIN however, the PROTEIN binding proteins, PROTEIN and 14-3-3, had no effect.;AIMed.d107.s904
606;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN ( PROTEIN1 blocked the binding of PROTEIN to PROTEIN however, the PROTEIN2 binding proteins, PROTEIN and 14-3-3, had no effect.;AIMed.d107.s904
607;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN ( PROTEIN1 blocked the binding of PROTEIN to PROTEIN however, the PROTEIN binding proteins, PROTEIN2 and 14-3-3, had no effect.;AIMed.d107.s904
608;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN ( PROTEIN1 blocked the binding of PROTEIN to PROTEIN2 however, the PROTEIN binding proteins, PROTEIN and 14-3-3, had no effect.;AIMed.d107.s904
609;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN1 ( PROTEIN2 blocked the binding of PROTEIN to PROTEIN however, the PROTEIN binding proteins, PROTEIN and 14-3-3, had no effect.;AIMed.d107.s904
610;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN ( PROTEIN blocked the binding of PROTEIN1 to PROTEIN however, the PROTEIN2 binding proteins, PROTEIN and 14-3-3, had no effect.;AIMed.d107.s904
611;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN ( PROTEIN blocked the binding of PROTEIN1 to PROTEIN however, the PROTEIN binding proteins, PROTEIN2 and 14-3-3, had no effect.;AIMed.d107.s904
612;AIMed.d107;TRUE;In competition experiments, the carboxyl terminus of PROTEIN ( PROTEIN blocked the binding of PROTEIN1 to PROTEIN2 however, the PROTEIN binding proteins, PROTEIN and 14-3-3, had no effect.;AIMed.d107.s904
613;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN1 ( PROTEIN blocked the binding of PROTEIN2 to PROTEIN however, the PROTEIN binding proteins, PROTEIN and 14-3-3, had no effect.;AIMed.d107.s904
614;AIMed.d107;TRUE;In competition experiments, the carboxyl terminus of PROTEIN ( PROTEIN blocked the binding of PROTEIN to PROTEIN however, the PROTEIN1 binding proteins, PROTEIN2 and 14-3-3, had no effect.;AIMed.d107.s904
615;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN ( PROTEIN blocked the binding of PROTEIN to PROTEIN1 however, the PROTEIN2 binding proteins, PROTEIN and 14-3-3, had no effect.;AIMed.d107.s904
616;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN1 ( PROTEIN blocked the binding of PROTEIN to PROTEIN however, the PROTEIN2 binding proteins, PROTEIN and 14-3-3, had no effect.;AIMed.d107.s904
617;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN ( PROTEIN blocked the binding of PROTEIN to PROTEIN1 however, the PROTEIN binding proteins, PROTEIN2 and 14-3-3, had no effect.;AIMed.d107.s904
618;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN1 ( PROTEIN blocked the binding of PROTEIN to PROTEIN however, the PROTEIN binding proteins, PROTEIN2 and 14-3-3, had no effect.;AIMed.d107.s904
619;AIMed.d107;FALSE;In competition experiments, the carboxyl terminus of PROTEIN1 ( PROTEIN blocked the binding of PROTEIN to PROTEIN2 however, the PROTEIN binding proteins, PROTEIN and 14-3-3, had no effect.;AIMed.d107.s904
620;AIMed.d107;FALSE;Scatchard analysis of in vitro binding between PROTEIN1 and PROTEIN revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between PROTEIN and PROTEIN2 (Kd = 87 +/- 24 nM).;AIMed.d107.s905
621;AIMed.d107;TRUE;Scatchard analysis of in vitro binding between PROTEIN1 and PROTEIN2 revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between PROTEIN and PROTEIN (Kd = 87 +/- 24 nM).;AIMed.d107.s905
622;AIMed.d107;FALSE;Scatchard analysis of in vitro binding between PROTEIN1 and PROTEIN revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between PROTEIN2 and PROTEIN (Kd = 87 +/- 24 nM).;AIMed.d107.s905
623;AIMed.d107;FALSE;Scatchard analysis of in vitro binding between PROTEIN and PROTEIN1 revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between PROTEIN and PROTEIN2 (Kd = 87 +/- 24 nM).;AIMed.d107.s905
624;AIMed.d107;TRUE;Scatchard analysis of in vitro binding between PROTEIN and PROTEIN revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between PROTEIN1 and PROTEIN2 (Kd = 87 +/- 24 nM).;AIMed.d107.s905
625;AIMed.d107;FALSE;Scatchard analysis of in vitro binding between PROTEIN and PROTEIN1 revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between PROTEIN2 and PROTEIN (Kd = 87 +/- 24 nM).;AIMed.d107.s905
626;AIMed.d107;FALSE;The formation of native heterotrimeric PROTEIN1 complexes, as measured by pertussis toxin ADP-ribosylation of G alpha, could be disrupted by increasing amounts of PROTEIN2 with an EC50 of approximately 200 nM, in close agreement with the estimated binding affinity.;AIMed.d107.s906
627;AIMed.d107;FALSE;In vivo complexes of PROTEIN1 and PROTEIN were isolated from human embryonic kidney 293-T cells transfected with epitope-tagged PROTEIN2 ;AIMed.d107.s907
628;AIMed.d107;FALSE;In vivo complexes of PROTEIN and PROTEIN1 were isolated from human embryonic kidney 293-T cells transfected with epitope-tagged PROTEIN2 ;AIMed.d107.s907
629;AIMed.d107;TRUE;In vivo complexes of PROTEIN1 and PROTEIN2 were isolated from human embryonic kidney 293-T cells transfected with epitope-tagged PROTEIN ;AIMed.d107.s907
630;AIMed.d111;FALSE;Mutagenesis of the regulatory subunit ( PROTEIN1 of PROTEIN reveals hydrophobic amino acids that are essential for PROTEIN2 dimerization and/or anchoring PROTEIN to the cytoskeleton.;AIMed.d111.s930
631;AIMed.d111;FALSE;Mutagenesis of the regulatory subunit ( PROTEIN of PROTEIN1 reveals hydrophobic amino acids that are essential for PROTEIN2 dimerization and/or anchoring PROTEIN to the cytoskeleton.;AIMed.d111.s930
632;AIMed.d111;FALSE;Mutagenesis of the regulatory subunit ( PROTEIN of PROTEIN reveals hydrophobic amino acids that are essential for PROTEIN1 dimerization and/or anchoring PROTEIN2 to the cytoskeleton.;AIMed.d111.s930
633;AIMed.d111;FALSE;Mutagenesis of the regulatory subunit ( PROTEIN1 of PROTEIN2 reveals hydrophobic amino acids that are essential for PROTEIN dimerization and/or anchoring PROTEIN to the cytoskeleton.;AIMed.d111.s930
634;AIMed.d111;FALSE;Mutagenesis of the regulatory subunit ( PROTEIN1 of PROTEIN reveals hydrophobic amino acids that are essential for PROTEIN dimerization and/or anchoring PROTEIN2 to the cytoskeleton.;AIMed.d111.s930
635;AIMed.d111;FALSE;Mutagenesis of the regulatory subunit ( PROTEIN of PROTEIN1 reveals hydrophobic amino acids that are essential for PROTEIN dimerization and/or anchoring PROTEIN2 to the cytoskeleton.;AIMed.d111.s930
636;AIMed.d111;FALSE;In neurons PROTEIN1 ( PROTEIN2 is sequestered in the dendritic cytoskeleton because the regulatory subunit ( PROTEIN of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).;AIMed.d111.s931
637;AIMed.d111;FALSE;In neurons PROTEIN1 ( PROTEIN is sequestered in the dendritic cytoskeleton because the regulatory subunit ( PROTEIN2 of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).;AIMed.d111.s931
638;AIMed.d111;FALSE;In neurons PROTEIN ( PROTEIN1 is sequestered in the dendritic cytoskeleton because the regulatory subunit ( PROTEIN2 of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).;AIMed.d111.s931
639;AIMed.d111;TRUE;The prototypic neuronal anchor protein PROTEIN1 has a COOH-terminal 22-residue PROTEIN2 binding (tethering) site.;AIMed.d111.s932
640;AIMed.d111;TRUE;Mutagenesis, recombinant protein expression, and physicochemical characterization were used to investigate the structural basis for the homodimerization and PROTEIN1 binding activities of PROTEIN2 ;AIMed.d111.s934
641;AIMed.d111;FALSE;Substitution of Ala for Leu13 or Phe36 generates monomeric PROTEIN1 subunits that cannot bind PROTEIN2 ;AIMed.d111.s936
642;AIMed.d111;FALSE;The results are not due to general misfolding since mutant PROTEIN1 monomers bind cAMP and inhibit the catalytic subunit of PROTEIN with the same affinity and efficacy as wild-type PROTEIN2 dimers.;AIMed.d111.s937
643;AIMed.d111;FALSE;The results are not due to general misfolding since mutant PROTEIN monomers bind cAMP and inhibit the catalytic subunit of PROTEIN1 with the same affinity and efficacy as wild-type PROTEIN2 dimers.;AIMed.d111.s937
644;AIMed.d111;FALSE;The results are not due to general misfolding since mutant PROTEIN1 monomers bind cAMP and inhibit the catalytic subunit of PROTEIN2 with the same affinity and efficacy as wild-type PROTEIN dimers.;AIMed.d111.s937
645;AIMed.d111;TRUE;Evidently, large hydrophobic side chains of Leu13 and Phe36 play pivotal roles in stabilizing PROTEIN1 PROTEIN2 interactions.;AIMed.d111.s939
646;AIMed.d111;FALSE;A secondary consequence of destabilizing PROTEIN1 dimers is the loss of intracellular targeting/anchoring capacity because monomers fail to bind PROTEIN2 ;AIMed.d111.s940
647;AIMed.d111;TRUE;Other NH2-terminal residues directly modulate the affinity of PROTEIN1 dimers for the PROTEIN2 tethering site.;AIMed.d111.s941
648;AIMed.d111;TRUE;Replacement of Val20-Leu21 with Ala-Ala produced a dimeric PROTEIN1 protein that binds PROTEIN2 approximately 4% as avidly as wild-type PROTEIN ;AIMed.d111.s942
649;AIMed.d111;FALSE;Replacement of Val20-Leu21 with Ala-Ala produced a dimeric PROTEIN1 protein that binds PROTEIN approximately 4% as avidly as wild-type PROTEIN2 ;AIMed.d111.s942
650;AIMed.d111;FALSE;Replacement of Val20-Leu21 with Ala-Ala produced a dimeric PROTEIN protein that binds PROTEIN1 approximately 4% as avidly as wild-type PROTEIN2 ;AIMed.d111.s942
651;AIMed.d133;TRUE; PROTEIN1 a protein kinase stimulated by UV light and PROTEIN that binds and phosphorylates the PROTEIN2 activation domain.;AIMed.d133.s1132
652;AIMed.d133;FALSE; PROTEIN1 a protein kinase stimulated by UV light and PROTEIN2 that binds and phosphorylates the PROTEIN activation domain.;AIMed.d133.s1132
653;AIMed.d133;FALSE; PROTEIN a protein kinase stimulated by UV light and PROTEIN1 that binds and phosphorylates the PROTEIN2 activation domain.;AIMed.d133.s1132
654;AIMed.d133;FALSE;The ultraviolet (UV) response of mammalian cells is characterized by a rapid and selective increase in gene expression mediated by PROTEIN1 and PROTEIN2 ;AIMed.d133.s1133
655;AIMed.d133;FALSE;The effect on PROTEIN1 transcriptional activity results, in part, from enhanced phosphorylation of the PROTEIN2 NH2-terminal activation domain.;AIMed.d133.s1134
656;AIMed.d133;FALSE;Here, we describe the molecular cloning and characterization of PROTEIN1 a distant relative of the PROTEIN2 group that is activated by dual phosphorylation at Thr and Tyr during the UV response.;AIMed.d133.s1135
657;AIMed.d133;TRUE;Significantly, PROTEIN1 partially activates PROTEIN2 and potentiates the activation caused by UV.;AIMed.d133.s1136
658;AIMed.d133;TRUE; PROTEIN1 binds to the PROTEIN2 transactivation domain and phosphorylates it on Ser-63 and Ser-73.;AIMed.d133.s1137
659;AIMed.d134;FALSE; PROTEIN is a ligand for the PROTEIN1 receptor protein-tyrosine kinase.;AIMed.d134.s1140
660;AIMed.d134;TRUE; PROTEIN1 is a ligand for the PROTEIN2 ;AIMed.d134.s1140
661;AIMed.d134;FALSE; PROTEIN1 is a ligand for the PROTEIN2 receptor protein-tyrosine kinase.;AIMed.d134.s1140
662;AIMed.d134;FALSE;A protein ligand for the PROTEIN1 has been isolated by using the extracellular domain ( PROTEIN2 X) of the receptor as an affinity reagent.;AIMed.d134.s1141
663;AIMed.d134;FALSE;A protein ligand for the PROTEIN1 receptor protein-tyrosine kinase has been isolated by using the extracellular domain ( PROTEIN X) of the receptor as an affinity reagent.;AIMed.d134.s1141
664;AIMed.d134;FALSE;A protein ligand for the PROTEIN1 receptor protein-tyrosine kinase has been isolated by using the extracellular domain ( PROTEIN2 X) of the receptor as an affinity reagent.;AIMed.d134.s1141
665;AIMed.d134;FALSE;Subsequently, supernatants from selected cell lines were fractionated directly by receptor affinity chromatography, resulting in the single-step purification of PROTEIN1 a protein previously identified as the product of an early response gene induced by PROTEIN2 ;AIMed.d134.s1143
666;AIMed.d134;FALSE;We report here that recombinant PROTEIN1 induces autophosphorylation of PROTEIN in intact cells, consistent with PROTEIN being an authentic ligand for PROTEIN2 ;AIMed.d134.s1144
667;AIMed.d134;FALSE;We report here that recombinant PROTEIN induces autophosphorylation of PROTEIN1 in intact cells, consistent with PROTEIN being an authentic ligand for PROTEIN2 ;AIMed.d134.s1144
668;AIMed.d134;TRUE;We report here that recombinant PROTEIN induces autophosphorylation of PROTEIN in intact cells, consistent with PROTEIN1 being an authentic ligand for PROTEIN2 ;AIMed.d134.s1144
669;AIMed.d134;TRUE;We report here that recombinant PROTEIN1 induces autophosphorylation of PROTEIN2 in intact cells, consistent with PROTEIN being an authentic ligand for PROTEIN ;AIMed.d134.s1144
670;AIMed.d134;FALSE;We report here that recombinant PROTEIN1 induces autophosphorylation of PROTEIN in intact cells, consistent with PROTEIN2 being an authentic ligand for PROTEIN ;AIMed.d134.s1144
671;AIMed.d134;FALSE;We report here that recombinant PROTEIN induces autophosphorylation of PROTEIN1 in intact cells, consistent with PROTEIN2 being an authentic ligand for PROTEIN ;AIMed.d134.s1144
672;AIMed.d134;FALSE; PROTEIN1 is a member of a large orphan receptor protein-tyrosine kinase family headed by EPH, and we suggest that ligands for other members of this family will be related to PROTEIN2 and can be isolated in the same way.;AIMed.d134.s1145
673;AIMed.d140;TRUE; PROTEIN1 a human G1 and S phase protein phosphatase that associates with PROTEIN2 ;AIMed.d140.s1180
674;AIMed.d140;FALSE;We used the interaction trap, a yeast genetic selection for interacting proteins, to isolate human PROTEIN1 ( PROTEIN2 .;AIMed.d140.s1181
675;AIMed.d140;FALSE;In yeast, PROTEIN1 interacts with cyclin-dependent kinases, including human PROTEIN PROTEIN and PROTEIN but not with PROTEIN2 ;AIMed.d140.s1182
676;AIMed.d140;FALSE;In yeast, PROTEIN interacts with cyclin-dependent kinases, including human PROTEIN PROTEIN and PROTEIN1 but not with PROTEIN2 ;AIMed.d140.s1182
677;AIMed.d140;FALSE;In yeast, PROTEIN interacts with cyclin-dependent kinases, including human PROTEIN1 PROTEIN and PROTEIN but not with PROTEIN2 ;AIMed.d140.s1182
678;AIMed.d140;FALSE;In yeast, PROTEIN interacts with cyclin-dependent kinases, including human PROTEIN PROTEIN1 and PROTEIN but not with PROTEIN2 ;AIMed.d140.s1182
679;AIMed.d140;TRUE;In yeast, PROTEIN1 interacts with cyclin-dependent kinases, including human PROTEIN PROTEIN and PROTEIN2 but not with PROTEIN ;AIMed.d140.s1182
680;AIMed.d140;TRUE;In yeast, PROTEIN1 interacts with cyclin-dependent kinases, including human PROTEIN2 PROTEIN and PROTEIN but not with PROTEIN ;AIMed.d140.s1182
681;AIMed.d140;TRUE;In yeast, PROTEIN1 interacts with cyclin-dependent kinases, including human PROTEIN PROTEIN2 and PROTEIN but not with PROTEIN ;AIMed.d140.s1182
682;AIMed.d140;FALSE;In yeast, PROTEIN interacts with cyclin-dependent kinases, including human PROTEIN1 PROTEIN and PROTEIN2 but not with PROTEIN ;AIMed.d140.s1182
683;AIMed.d140;FALSE;In yeast, PROTEIN interacts with cyclin-dependent kinases, including human PROTEIN PROTEIN1 and PROTEIN2 but not with PROTEIN ;AIMed.d140.s1182
684;AIMed.d140;FALSE;In yeast, PROTEIN interacts with cyclin-dependent kinases, including human PROTEIN1 PROTEIN2 and PROTEIN but not with PROTEIN ;AIMed.d140.s1182
685;AIMed.d140;TRUE;In HeLa cells, PROTEIN1 is expressed at the G1 to S transition, and the protein forms stable complexes with PROTEIN2 ;AIMed.d140.s1183
686;AIMed.d140;FALSE;"Overexpression of wild-type PROTEIN1 delays progression through the cell cycle in yeast and HeLa cells; delay is dependent on PROTEIN2 phosphatase activity.";AIMed.d140.s1186
687;AIMed.d149;FALSE;The SH2/SH3 domain-containing protein PROTEIN interacts with tyrosine-phosphorylated PROTEIN1 and PROTEIN2 implications for insulin control of PROTEIN signalling.;AIMed.d149.s1262
688;AIMed.d149;FALSE;The SH2/SH3 domain-containing protein PROTEIN interacts with tyrosine-phosphorylated PROTEIN1 and PROTEIN implications for insulin control of PROTEIN2 signalling.;AIMed.d149.s1262
689;AIMed.d149;TRUE;The SH2/SH3 domain-containing protein PROTEIN1 interacts with tyrosine-phosphorylated PROTEIN2 and PROTEIN implications for insulin control of PROTEIN signalling.;AIMed.d149.s1262
690;AIMed.d149;FALSE;The SH2/SH3 domain-containing protein PROTEIN interacts with tyrosine-phosphorylated PROTEIN and PROTEIN1 implications for insulin control of PROTEIN2 signalling.;AIMed.d149.s1262
691;AIMed.d149;TRUE;The SH2/SH3 domain-containing protein PROTEIN1 interacts with tyrosine-phosphorylated PROTEIN and PROTEIN2 implications for insulin control of PROTEIN signalling.;AIMed.d149.s1262
692;AIMed.d149;FALSE;The SH2/SH3 domain-containing protein PROTEIN1 interacts with tyrosine-phosphorylated PROTEIN and PROTEIN implications for insulin control of PROTEIN2 signalling.;AIMed.d149.s1262
693;AIMed.d149;FALSE; PROTEIN1 a small protein comprising one SH2 domain and two SH3 domains, represents the human homologue of the Caenorhabditis elegans protein, PROTEIN2 ;AIMed.d149.s1263
694;AIMed.d149;FALSE;Both PROTEIN1 and PROTEIN have been implicated in a highly conserved mechanism that regulates PROTEIN2 signalling by receptor tyrosine kinases.;AIMed.d149.s1264
695;AIMed.d149;FALSE;Both PROTEIN and PROTEIN1 have been implicated in a highly conserved mechanism that regulates PROTEIN2 signalling by receptor tyrosine kinases.;AIMed.d149.s1264
696;AIMed.d149;FALSE;Both PROTEIN1 and PROTEIN2 have been implicated in a highly conserved mechanism that regulates PROTEIN signalling by receptor tyrosine kinases.;AIMed.d149.s1264
697;AIMed.d149;FALSE;In this report we show that in response to PROTEIN1 PROTEIN2 forms a stable complex with two tyrosine-phosphorylated proteins.;AIMed.d149.s1265
698;AIMed.d149;FALSE;One protein is the major insulin receptor substrate PROTEIN1 and the second is the SH2 domain-containing oncogenic protein, PROTEIN2 ;AIMed.d149.s1266
699;AIMed.d149;FALSE;The interactions between PROTEIN and these two proteins require ligand activation of the PROTEIN1 and are mediated by the binding of the SH2 domain of PROTEIN to phosphotyrosines on both PROTEIN2 and PROTEIN ;AIMed.d149.s1267
700;AIMed.d149;FALSE;The interactions between PROTEIN and these two proteins require ligand activation of the PROTEIN1 and are mediated by the binding of the SH2 domain of PROTEIN2 to phosphotyrosines on both PROTEIN and PROTEIN ;AIMed.d149.s1267
701;AIMed.d149;FALSE;The interactions between PROTEIN1 and these two proteins require ligand activation of the PROTEIN2 and are mediated by the binding of the SH2 domain of PROTEIN to phosphotyrosines on both PROTEIN and PROTEIN ;AIMed.d149.s1267
702;AIMed.d149;FALSE;The interactions between PROTEIN and these two proteins require ligand activation of the PROTEIN1 and are mediated by the binding of the SH2 domain of PROTEIN to phosphotyrosines on both PROTEIN and PROTEIN2 ;AIMed.d149.s1267
703;AIMed.d149;TRUE;The interactions between PROTEIN and these two proteins require ligand activation of the PROTEIN and are mediated by the binding of the SH2 domain of PROTEIN1 to phosphotyrosines on both PROTEIN2 and PROTEIN ;AIMed.d149.s1267
704;AIMed.d149;FALSE;The interactions between PROTEIN1 and these two proteins require ligand activation of the PROTEIN and are mediated by the binding of the SH2 domain of PROTEIN to phosphotyrosines on both PROTEIN2 and PROTEIN ;AIMed.d149.s1267
705;AIMed.d149;FALSE;The interactions between PROTEIN and these two proteins require ligand activation of the PROTEIN and are mediated by the binding of the SH2 domain of PROTEIN to phosphotyrosines on both PROTEIN1 and PROTEIN2 ;AIMed.d149.s1267
706;AIMed.d149;FALSE;The interactions between PROTEIN1 and these two proteins require ligand activation of the PROTEIN and are mediated by the binding of the SH2 domain of PROTEIN2 to phosphotyrosines on both PROTEIN and PROTEIN ;AIMed.d149.s1267
707;AIMed.d149;TRUE;The interactions between PROTEIN and these two proteins require ligand activation of the PROTEIN and are mediated by the binding of the SH2 domain of PROTEIN1 to phosphotyrosines on both PROTEIN and PROTEIN2 ;AIMed.d149.s1267
708;AIMed.d149;FALSE;The interactions between PROTEIN1 and these two proteins require ligand activation of the PROTEIN and are mediated by the binding of the SH2 domain of PROTEIN to phosphotyrosines on both PROTEIN and PROTEIN2 ;AIMed.d149.s1267
709;AIMed.d149;FALSE;Although PROTEIN associates with PROTEIN and PROTEIN1 it is not tyrosine-phosphorylated after PROTEIN2 stimulation, implying that PROTEIN is not a substrate for the insulin receptor.;AIMed.d149.s1268
710;AIMed.d149;FALSE;Although PROTEIN associates with PROTEIN and PROTEIN it is not tyrosine-phosphorylated after PROTEIN1 stimulation, implying that PROTEIN2 is not a substrate for the insulin receptor.;AIMed.d149.s1268
711;AIMed.d149;FALSE;Although PROTEIN1 associates with PROTEIN and PROTEIN it is not tyrosine-phosphorylated after PROTEIN2 stimulation, implying that PROTEIN is not a substrate for the insulin receptor.;AIMed.d149.s1268
712;AIMed.d149;FALSE;Although PROTEIN associates with PROTEIN1 and PROTEIN it is not tyrosine-phosphorylated after PROTEIN2 stimulation, implying that PROTEIN is not a substrate for the insulin receptor.;AIMed.d149.s1268
713;AIMed.d149;FALSE;Although PROTEIN associates with PROTEIN and PROTEIN1 it is not tyrosine-phosphorylated after PROTEIN stimulation, implying that PROTEIN2 is not a substrate for the insulin receptor.;AIMed.d149.s1268
714;AIMed.d149;TRUE;Although PROTEIN1 associates with PROTEIN and PROTEIN2 it is not tyrosine-phosphorylated after PROTEIN stimulation, implying that PROTEIN is not a substrate for the insulin receptor.;AIMed.d149.s1268
715;AIMed.d149;FALSE;Although PROTEIN associates with PROTEIN1 and PROTEIN2 it is not tyrosine-phosphorylated after PROTEIN stimulation, implying that PROTEIN is not a substrate for the insulin receptor.;AIMed.d149.s1268
716;AIMed.d149;FALSE;Although PROTEIN1 associates with PROTEIN and PROTEIN it is not tyrosine-phosphorylated after PROTEIN stimulation, implying that PROTEIN2 is not a substrate for the insulin receptor.;AIMed.d149.s1268
717;AIMed.d149;FALSE;Although PROTEIN associates with PROTEIN1 and PROTEIN it is not tyrosine-phosphorylated after PROTEIN stimulation, implying that PROTEIN2 is not a substrate for the insulin receptor.;AIMed.d149.s1268
718;AIMed.d149;TRUE;Although PROTEIN1 associates with PROTEIN2 and PROTEIN it is not tyrosine-phosphorylated after PROTEIN stimulation, implying that PROTEIN is not a substrate for the insulin receptor.;AIMed.d149.s1268
719;AIMed.d149;FALSE;Furthermore, we have identified a short sequence motif (YV/IN) present in PROTEIN1 PROTEIN and PROTEIN2 which specifically binds the SH2 domain of PROTEIN with high affinity.;AIMed.d149.s1269
720;AIMed.d149;FALSE;Furthermore, we have identified a short sequence motif (YV/IN) present in PROTEIN PROTEIN1 and PROTEIN2 which specifically binds the SH2 domain of PROTEIN with high affinity.;AIMed.d149.s1269
721;AIMed.d149;TRUE;Furthermore, we have identified a short sequence motif (YV/IN) present in PROTEIN PROTEIN and PROTEIN1 which specifically binds the SH2 domain of PROTEIN2 with high affinity.;AIMed.d149.s1269
722;AIMed.d149;FALSE;Furthermore, we have identified a short sequence motif (YV/IN) present in PROTEIN1 PROTEIN2 and PROTEIN which specifically binds the SH2 domain of PROTEIN with high affinity.;AIMed.d149.s1269
723;AIMed.d149;TRUE;Furthermore, we have identified a short sequence motif (YV/IN) present in PROTEIN1 PROTEIN and PROTEIN which specifically binds the SH2 domain of PROTEIN2 with high affinity.;AIMed.d149.s1269
724;AIMed.d149;TRUE;Furthermore, we have identified a short sequence motif (YV/IN) present in PROTEIN PROTEIN1 and PROTEIN which specifically binds the SH2 domain of PROTEIN2 with high affinity.;AIMed.d149.s1269
725;AIMed.d149;FALSE;Interestingly, both PROTEIN1 and PROTEIN2 can simultaneously bind distinct tyrosine phosphorylated regions on the same PROTEIN molecule, suggesting a mechanism whereby PROTEIN could provide the core for a large signalling complex.;AIMed.d149.s1270
726;AIMed.d149;FALSE;Interestingly, both PROTEIN and PROTEIN1 can simultaneously bind distinct tyrosine phosphorylated regions on the same PROTEIN molecule, suggesting a mechanism whereby PROTEIN2 could provide the core for a large signalling complex.;AIMed.d149.s1270
727;AIMed.d149;TRUE;Interestingly, both PROTEIN and PROTEIN1 can simultaneously bind distinct tyrosine phosphorylated regions on the same PROTEIN2 molecule, suggesting a mechanism whereby PROTEIN could provide the core for a large signalling complex.;AIMed.d149.s1270
728;AIMed.d149;FALSE;Interestingly, both PROTEIN1 and PROTEIN can simultaneously bind distinct tyrosine phosphorylated regions on the same PROTEIN molecule, suggesting a mechanism whereby PROTEIN2 could provide the core for a large signalling complex.;AIMed.d149.s1270
729;AIMed.d149;TRUE;Interestingly, both PROTEIN1 and PROTEIN can simultaneously bind distinct tyrosine phosphorylated regions on the same PROTEIN2 molecule, suggesting a mechanism whereby PROTEIN could provide the core for a large signalling complex.;AIMed.d149.s1270
730;AIMed.d149;FALSE;Interestingly, both PROTEIN and PROTEIN can simultaneously bind distinct tyrosine phosphorylated regions on the same PROTEIN1 molecule, suggesting a mechanism whereby PROTEIN2 could provide the core for a large signalling complex.;AIMed.d149.s1270
731;AIMed.d149;TRUE;We propose a model whereby insulin stimulation leads to formation of multiple protein--protein interactions between PROTEIN1 and the two targets PROTEIN and PROTEIN2 ;AIMed.d149.s1271
732;AIMed.d149;TRUE;We propose a model whereby insulin stimulation leads to formation of multiple protein--protein interactions between PROTEIN1 and the two targets PROTEIN2 and PROTEIN ;AIMed.d149.s1271
733;AIMed.d149;FALSE;We propose a model whereby insulin stimulation leads to formation of multiple protein--protein interactions between PROTEIN and the two targets PROTEIN1 and PROTEIN2 ;AIMed.d149.s1271
734;AIMed.d155;FALSE;The general transcription factor PROTEIN1 nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced PROTEIN recruitment or conformational changes in PROTEIN2 promoter complexes.;AIMed.d155.s1316
735;AIMed.d155;FALSE;The general transcription factor PROTEIN1 nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced PROTEIN2 recruitment or conformational changes in PROTEIN promoter complexes.;AIMed.d155.s1316
736;AIMed.d155;FALSE;The general transcription factor PROTEIN nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced PROTEIN1 recruitment or conformational changes in PROTEIN2 promoter complexes.;AIMed.d155.s1316
737;AIMed.d155;FALSE;Molecular studies of the multiprotein PROTEIN1 complex have identified a primary PROTEIN2 ( PROTEIN , TBP-associated factors (TAFs) that interact with and mediate the function of activators and intersubunit interactions but have yielded relatively little insight into the structural organization of the complex or the actual mechanism of transcriptional activation.;AIMed.d155.s1317
738;AIMed.d155;FALSE;Molecular studies of the multiprotein PROTEIN complex have identified a primary PROTEIN1 ( PROTEIN2 , TBP-associated factors (TAFs) that interact with and mediate the function of activators and intersubunit interactions but have yielded relatively little insight into the structural organization of the complex or the actual mechanism of transcriptional activation.;AIMed.d155.s1317
739;AIMed.d155;FALSE;Molecular studies of the multiprotein PROTEIN1 complex have identified a primary PROTEIN ( PROTEIN2 , TBP-associated factors (TAFs) that interact with and mediate the function of activators and intersubunit interactions but have yielded relatively little insight into the structural organization of the complex or the actual mechanism of transcriptional activation.;AIMed.d155.s1317
740;AIMed.d155;FALSE;Here we present biochemical evidence for the structural relevance of histone homologies in the human PROTEIN1 subunits PROTEIN PROTEIN and PROTEIN2 ;AIMed.d155.s1318
741;AIMed.d155;FALSE;Here we present biochemical evidence for the structural relevance of histone homologies in the human PROTEIN subunits PROTEIN1 PROTEIN and PROTEIN2 ;AIMed.d155.s1318
742;AIMed.d155;FALSE;Here we present biochemical evidence for the structural relevance of histone homologies in the human PROTEIN subunits PROTEIN PROTEIN1 and PROTEIN2 ;AIMed.d155.s1318
743;AIMed.d155;FALSE;Here we present biochemical evidence for the structural relevance of histone homologies in the human PROTEIN1 subunits PROTEIN2 PROTEIN and PROTEIN ;AIMed.d155.s1318
744;AIMed.d155;FALSE;Here we present biochemical evidence for the structural relevance of histone homologies in the human PROTEIN1 subunits PROTEIN PROTEIN2 and PROTEIN ;AIMed.d155.s1318
745;AIMed.d155;FALSE;Here we present biochemical evidence for the structural relevance of histone homologies in the human PROTEIN subunits PROTEIN1 PROTEIN2 and PROTEIN ;AIMed.d155.s1318
746;AIMed.d155;FALSE;Together with analyses of native PROTEIN1 complexes and accompanying crystallographic studies, the results suggest that there is a histone octamer-like TAF complex within PROTEIN2 ;AIMed.d155.s1319
747;AIMed.d156;TRUE; PROTEIN1 a kinase associated with the PROTEIN2 ;AIMed.d156.s1320
748;AIMed.d156;FALSE;The pleiotropic biological activities of PROTEIN1 ( PROTEIN2 are mediated by its type I receptor ( PROTEIN .;AIMed.d156.s1321
749;AIMed.d156;TRUE;The pleiotropic biological activities of PROTEIN1 ( PROTEIN are mediated by its type I receptor ( PROTEIN2 .;AIMed.d156.s1321
750;AIMed.d156;TRUE;The pleiotropic biological activities of PROTEIN ( PROTEIN1 are mediated by its type I receptor ( PROTEIN2 .;AIMed.d156.s1321
751;AIMed.d156;FALSE;When the ligand binds, PROTEIN1 initiates a signaling cascade that results in the activation of the transcription regulator PROTEIN2 ( PROTEIN .;AIMed.d156.s1322
752;AIMed.d156;FALSE;When the ligand binds, PROTEIN1 initiates a signaling cascade that results in the activation of the transcription regulator PROTEIN ( PROTEIN2 .;AIMed.d156.s1322
753;AIMed.d156;FALSE;When the ligand binds, PROTEIN initiates a signaling cascade that results in the activation of the transcription regulator PROTEIN1 ( PROTEIN2 .;AIMed.d156.s1322
754;AIMed.d156;FALSE;A protein kinase designated PROTEIN ( PROTEIN1 receptor-associated kinase) was purified, and its complementary DNA was molecularly cloned.;AIMed.d156.s1323
755;AIMed.d156;FALSE;A protein kinase designated PROTEIN1 ( PROTEIN2 was purified, and its complementary DNA was molecularly cloned.;AIMed.d156.s1323
756;AIMed.d156;FALSE;A protein kinase designated PROTEIN1 ( PROTEIN2 receptor-associated kinase) was purified, and its complementary DNA was molecularly cloned.;AIMed.d156.s1323
757;AIMed.d156;FALSE;When human embryonic kidney cells (cell line 293) over-expressing PROTEIN or HeLa cells were exposed to PROTEIN1 PROTEIN rapidly associated with the PROTEIN2 complex and was phosphorylated.;AIMed.d156.s1324
758;AIMed.d156;FALSE;When human embryonic kidney cells (cell line 293) over-expressing PROTEIN1 or HeLa cells were exposed to PROTEIN2 PROTEIN rapidly associated with the PROTEIN complex and was phosphorylated.;AIMed.d156.s1324
759;AIMed.d156;FALSE;When human embryonic kidney cells (cell line 293) over-expressing PROTEIN or HeLa cells were exposed to PROTEIN1 PROTEIN2 rapidly associated with the PROTEIN complex and was phosphorylated.;AIMed.d156.s1324
760;AIMed.d156;FALSE;When human embryonic kidney cells (cell line 293) over-expressing PROTEIN1 or HeLa cells were exposed to PROTEIN PROTEIN rapidly associated with the PROTEIN2 complex and was phosphorylated.;AIMed.d156.s1324
761;AIMed.d156;TRUE;When human embryonic kidney cells (cell line 293) over-expressing PROTEIN or HeLa cells were exposed to PROTEIN PROTEIN1 rapidly associated with the PROTEIN2 complex and was phosphorylated.;AIMed.d156.s1324
762;AIMed.d156;FALSE;When human embryonic kidney cells (cell line 293) over-expressing PROTEIN1 or HeLa cells were exposed to PROTEIN PROTEIN2 rapidly associated with the PROTEIN complex and was phosphorylated.;AIMed.d156.s1324
763;AIMed.d156;FALSE;The primary amino acid sequence of PROTEIN1 shares similarity with that of pelle,a protein kinase that is essential for the activation of a PROTEIN2 homolog in Drosophila.;AIMed.d156.s1325
764;AIMed.d170;TRUE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN1 and PROTEIN that translocate to membrane and bind to PROTEIN2 ;AIMed.d170.s1438
765;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN1 and three cytosol proteins ( PROTEIN PROTEIN2 and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
766;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN1 and PROTEIN2 that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
767;AIMed.d170;TRUE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN1 PROTEIN2 and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
768;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN1 (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN2 and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
769;AIMed.d170;FALSE;The phagocyte PROTEIN1 is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN2 and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
770;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN1 and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN2 and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
771;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN1 and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN2 ;AIMed.d170.s1438
772;AIMed.d170;TRUE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN1 that translocate to membrane and bind to PROTEIN2 ;AIMed.d170.s1438
773;AIMed.d170;TRUE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN1 PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN2 ;AIMed.d170.s1438
774;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN1 (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN2 ;AIMed.d170.s1438
775;AIMed.d170;FALSE;The phagocyte PROTEIN1 is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN2 ;AIMed.d170.s1438
776;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN1 and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN2 ;AIMed.d170.s1438
777;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN1 and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN2 that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
778;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN1 and three cytosol proteins ( PROTEIN2 PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
779;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN1 (comprised of subunits PROTEIN and PROTEIN2 and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
780;AIMed.d170;FALSE;The phagocyte PROTEIN1 is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN2 and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
781;AIMed.d170;TRUE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN1 and PROTEIN2 and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
782;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN1 PROTEIN and PROTEIN2 that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
783;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN1 (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN2 that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
784;AIMed.d170;FALSE;The phagocyte PROTEIN1 is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN2 that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
785;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN1 and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN2 that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
786;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN1 (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN2 PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
787;AIMed.d170;FALSE;The phagocyte PROTEIN1 is a complex of membrane PROTEIN (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN2 PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
788;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN (comprised of subunits PROTEIN1 and PROTEIN and three cytosol proteins ( PROTEIN2 PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
789;AIMed.d170;FALSE;The phagocyte PROTEIN1 is a complex of membrane PROTEIN2 (comprised of subunits PROTEIN and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
790;AIMed.d170;FALSE;The phagocyte PROTEIN is a complex of membrane PROTEIN1 (comprised of subunits PROTEIN2 and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
791;AIMed.d170;FALSE;The phagocyte PROTEIN1 is a complex of membrane PROTEIN (comprised of subunits PROTEIN2 and PROTEIN and three cytosol proteins ( PROTEIN PROTEIN and PROTEIN that translocate to membrane and bind to PROTEIN ;AIMed.d170.s1438
792;AIMed.d170;TRUE;This is the first report to demonstrate that two of cytosolic components of PROTEIN PROTEIN1 binding to PROTEIN2 each other.;AIMed.d170.s1439
793;AIMed.d170;FALSE;This is the first report to demonstrate that two of cytosolic components of PROTEIN1 PROTEIN2 binding to PROTEIN each other.;AIMed.d170.s1439
794;AIMed.d170;FALSE;This is the first report to demonstrate that two of cytosolic components of PROTEIN1 PROTEIN binding to PROTEIN2 each other.;AIMed.d170.s1439
795;AIMed.d178;TRUE;In vitro and in nonproliferating cells, PROTEIN1 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either PROTEIN PROTEIN2 or PROTEIN ;AIMed.d178.s1508
796;AIMed.d178;FALSE;In vitro and in nonproliferating cells, PROTEIN associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either PROTEIN1 PROTEIN2 or PROTEIN ;AIMed.d178.s1508
797;AIMed.d178;FALSE;In vitro and in nonproliferating cells, PROTEIN associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either PROTEIN PROTEIN1 or PROTEIN2 ;AIMed.d178.s1508
798;AIMed.d178;TRUE;In vitro and in nonproliferating cells, PROTEIN1 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either PROTEIN2 PROTEIN or PROTEIN ;AIMed.d178.s1508
799;AIMed.d178;TRUE;In vitro and in nonproliferating cells, PROTEIN1 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either PROTEIN PROTEIN or PROTEIN2 ;AIMed.d178.s1508
800;AIMed.d178;FALSE;In vitro and in nonproliferating cells, PROTEIN associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either PROTEIN1 PROTEIN or PROTEIN2 ;AIMed.d178.s1508
801;AIMed.d178;FALSE;Although many different types of proliferating cells contain PROTEIN1 protein, neither the interactions of PROTEIN2 with cyclin/CDK complexes nor the consequences of this interaction during the mitotic cycle have been fully explored.;AIMed.d178.s1509
802;AIMed.d178;TRUE;In addition, PROTEIN1 associates with three different CDKs: PROTEIN2 PROTEIN and PROTEIN ;AIMed.d178.s1511
803;AIMed.d178;FALSE;In addition, PROTEIN associates with three different CDKs: PROTEIN1 PROTEIN and PROTEIN2 ;AIMed.d178.s1511
804;AIMed.d178;FALSE;In addition, PROTEIN associates with three different CDKs: PROTEIN1 PROTEIN2 and PROTEIN ;AIMed.d178.s1511
805;AIMed.d178;TRUE;In addition, PROTEIN1 associates with three different CDKs: PROTEIN PROTEIN and PROTEIN2 ;AIMed.d178.s1511
806;AIMed.d178;TRUE;In addition, PROTEIN1 associates with three different CDKs: PROTEIN PROTEIN2 and PROTEIN ;AIMed.d178.s1511
807;AIMed.d178;FALSE;In addition, PROTEIN associates with three different CDKs: PROTEIN PROTEIN1 and PROTEIN2 ;AIMed.d178.s1511
808;AIMed.d178;FALSE;Furthermore, the amount of PROTEIN1 is significantly lower than the amount of PROTEIN2 in these cells.;AIMed.d178.s1512
809;AIMed.d178;FALSE;"The amount of PROTEIN and PROTEIN associated with PROTEIN1 does not change in a cell cycle-dependent fashion; in contrast, the amount of PROTEIN associated with PROTEIN2 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.";AIMed.d178.s1513
810;AIMed.d178;FALSE;"The amount of PROTEIN1 and PROTEIN associated with PROTEIN does not change in a cell cycle-dependent fashion; in contrast, the amount of PROTEIN associated with PROTEIN2 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.";AIMed.d178.s1513
811;AIMed.d178;FALSE;"The amount of PROTEIN and PROTEIN1 associated with PROTEIN does not change in a cell cycle-dependent fashion; in contrast, the amount of PROTEIN associated with PROTEIN2 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.";AIMed.d178.s1513
812;AIMed.d178;TRUE;"The amount of PROTEIN and PROTEIN associated with PROTEIN does not change in a cell cycle-dependent fashion; in contrast, the amount of PROTEIN1 associated with PROTEIN2 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.";AIMed.d178.s1513
813;AIMed.d178;TRUE;"The amount of PROTEIN1 and PROTEIN associated with PROTEIN2 does not change in a cell cycle-dependent fashion; in contrast, the amount of PROTEIN associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.";AIMed.d178.s1513
814;AIMed.d178;TRUE;"The amount of PROTEIN and PROTEIN1 associated with PROTEIN2 does not change in a cell cycle-dependent fashion; in contrast, the amount of PROTEIN associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.";AIMed.d178.s1513
815;AIMed.d178;FALSE;"The amount of PROTEIN and PROTEIN associated with PROTEIN1 does not change in a cell cycle-dependent fashion; in contrast, the amount of PROTEIN2 associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.";AIMed.d178.s1513
816;AIMed.d178;FALSE;"The amount of PROTEIN1 and PROTEIN2 associated with PROTEIN does not change in a cell cycle-dependent fashion; in contrast, the amount of PROTEIN associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.";AIMed.d178.s1513
817;AIMed.d178;FALSE;"The amount of PROTEIN1 and PROTEIN associated with PROTEIN does not change in a cell cycle-dependent fashion; in contrast, the amount of PROTEIN2 associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.";AIMed.d178.s1513
818;AIMed.d178;FALSE;"The amount of PROTEIN and PROTEIN1 associated with PROTEIN does not change in a cell cycle-dependent fashion; in contrast, the amount of PROTEIN2 associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.";AIMed.d178.s1513
819;AIMed.d178;FALSE;The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a PROTEIN1 specific antibody suggest that the PROTEIN2 protein mediates, in part, the PROTEIN associated PROTEIN kinase activity.;AIMed.d178.s1516
820;AIMed.d178;FALSE;The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a PROTEIN1 specific antibody suggest that the PROTEIN protein mediates, in part, the PROTEIN associated PROTEIN2 kinase activity.;AIMed.d178.s1516
821;AIMed.d178;FALSE;The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a PROTEIN1 specific antibody suggest that the PROTEIN protein mediates, in part, the PROTEIN2 associated PROTEIN kinase activity.;AIMed.d178.s1516
822;AIMed.d178;FALSE;The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a PROTEIN specific antibody suggest that the PROTEIN1 protein mediates, in part, the PROTEIN associated PROTEIN2 kinase activity.;AIMed.d178.s1516
823;AIMed.d178;FALSE;The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a PROTEIN specific antibody suggest that the PROTEIN1 protein mediates, in part, the PROTEIN2 associated PROTEIN kinase activity.;AIMed.d178.s1516
824;AIMed.d178;FALSE;The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a PROTEIN specific antibody suggest that the PROTEIN protein mediates, in part, the PROTEIN1 associated PROTEIN2 kinase activity.;AIMed.d178.s1516
825;AIMed.d178;TRUE;In contrast, PROTEIN1 complexes containing PROTEIN2 are incapable of phosphorylating PROTEIN ;AIMed.d178.s1517
826;AIMed.d178;FALSE;In contrast, PROTEIN1 complexes containing PROTEIN are incapable of phosphorylating PROTEIN2 ;AIMed.d178.s1517
827;AIMed.d178;FALSE;In contrast, PROTEIN complexes containing PROTEIN1 are incapable of phosphorylating PROTEIN2 ;AIMed.d178.s1517
828;AIMed.d178;FALSE;These data are consistent with a model wherein PROTEIN1 CDK complexes sequester the PROTEIN2 dependent kinase inhibitory activity of PROTEIN ;AIMed.d178.s1518
829;AIMed.d178;FALSE;These data are consistent with a model wherein PROTEIN CDK complexes sequester the PROTEIN1 dependent kinase inhibitory activity of PROTEIN2 ;AIMed.d178.s1518
830;AIMed.d178;FALSE;These data are consistent with a model wherein PROTEIN1 CDK complexes sequester the PROTEIN dependent kinase inhibitory activity of PROTEIN2 ;AIMed.d178.s1518
831;AIMed.d181;TRUE;Structure of the PROTEIN1 tumor suppressor bound to the ankyrin and SH3 domains of PROTEIN2 ;AIMed.d181.s1538
832;AIMed.d181;TRUE;The core domain contains the sequence-specific DNA binding activity and the in vitro PROTEIN1 protein binding activity of PROTEIN2 ;AIMed.d181.s1540
833;AIMed.d181;FALSE;The crystal structure of the PROTEIN core domain bound to the PROTEIN1 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of PROTEIN2 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of PROTEIN ;AIMed.d181.s1541
834;AIMed.d181;FALSE;The crystal structure of the PROTEIN1 core domain bound to the PROTEIN protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of PROTEIN2 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of PROTEIN ;AIMed.d181.s1541
835;AIMed.d181;FALSE;The crystal structure of the PROTEIN core domain bound to the PROTEIN protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of PROTEIN1 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of PROTEIN2 ;AIMed.d181.s1541
836;AIMed.d181;TRUE;The crystal structure of the PROTEIN1 core domain bound to the PROTEIN2 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of PROTEIN in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of PROTEIN ;AIMed.d181.s1541
837;AIMed.d181;FALSE;The crystal structure of the PROTEIN core domain bound to the PROTEIN1 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of PROTEIN in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of PROTEIN2 ;AIMed.d181.s1541
838;AIMed.d181;FALSE;The crystal structure of the PROTEIN1 core domain bound to the PROTEIN protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of PROTEIN in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of PROTEIN2 ;AIMed.d181.s1541
839;AIMed.d181;TRUE;The structure of the complex shows that the PROTEIN1 binding site on the PROTEIN2 core domain consists of evolutionarily conserved regions that are frequently mutated in cancer and that it overlaps the site of DNA binding.;AIMed.d181.s1542
840;AIMed.d181;TRUE;The six most frequently observed PROTEIN1 mutations disrupt PROTEIN2 binding in vitro.;AIMed.d181.s1543
841;AIMed.d181;FALSE;The structure provides evidence that the PROTEIN1 PROTEIN complex forms in vivo and may have a critical role in the PROTEIN2 pathway of tumor suppression.;AIMed.d181.s1544
842;AIMed.d181;FALSE;The structure provides evidence that the PROTEIN PROTEIN1 complex forms in vivo and may have a critical role in the PROTEIN2 pathway of tumor suppression.;AIMed.d181.s1544
843;AIMed.d181;TRUE;The structure provides evidence that the PROTEIN1 PROTEIN2 complex forms in vivo and may have a critical role in the PROTEIN pathway of tumor suppression.;AIMed.d181.s1544
844;AIMed.d186;FALSE;cDNA cloning and characterization of the human PROTEIN1 ;AIMed.d186.s1579
845;AIMed.d186;FALSE;cDNA cloning and characterization of the human PROTEIN1 alpha chain.;AIMed.d186.s1579
846;AIMed.d186;FALSE;cDNA cloning and characterization of the human PROTEIN1 alpha chain.;AIMed.d186.s1579
847;AIMed.d186;FALSE;We have cloned cDNAs corresponding to the human PROTEIN1 alpha chain ( PROTEIN .;AIMed.d186.s1580
848;AIMed.d186;FALSE;We have cloned cDNAs corresponding to the human PROTEIN1 receptor alpha chain ( PROTEIN2 .;AIMed.d186.s1580
849;AIMed.d186;FALSE;We have cloned cDNAs corresponding to the human PROTEIN1 ( PROTEIN .;AIMed.d186.s1580
850;AIMed.d186;FALSE;We have cloned cDNAs corresponding to the human PROTEIN1 alpha chain ( PROTEIN2 .;AIMed.d186.s1580
851;AIMed.d186;FALSE;We have cloned cDNAs corresponding to the human PROTEIN1 ( PROTEIN .;AIMed.d186.s1580
852;AIMed.d186;FALSE;We have cloned cDNAs corresponding to the human PROTEIN1 ( PROTEIN2 .;AIMed.d186.s1580
853;AIMed.d186;FALSE;Only weak PROTEIN1 binding activity was found in cells transfected with only PROTEIN however, the combination of both PROTEIN and PROTEIN resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2 receptor.;AIMed.d186.s1582
854;AIMed.d186;FALSE;Only weak PROTEIN1 binding activity was found in cells transfected with only PROTEIN however, the combination of both PROTEIN2 and PROTEIN resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN ;AIMed.d186.s1582
855;AIMed.d186;FALSE;Only weak PROTEIN1 binding activity was found in cells transfected with only PROTEIN however, the combination of both PROTEIN and PROTEIN resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2 ;AIMed.d186.s1582
856;AIMed.d186;FALSE;Only weak PROTEIN1 binding activity was found in cells transfected with only PROTEIN however, the combination of both PROTEIN and PROTEIN2 resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN ;AIMed.d186.s1582
857;AIMed.d186;TRUE;Only weak PROTEIN1 binding activity was found in cells transfected with only PROTEIN2 however, the combination of both PROTEIN and PROTEIN resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN ;AIMed.d186.s1582
858;AIMed.d186;FALSE;Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN however, the combination of both PROTEIN1 and PROTEIN resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2 receptor.;AIMed.d186.s1582
859;AIMed.d186;FALSE;Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN however, the combination of both PROTEIN and PROTEIN resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN1 ;AIMed.d186.s1582
860;AIMed.d186;FALSE;Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN however, the combination of both PROTEIN and PROTEIN1 resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2 receptor.;AIMed.d186.s1582
861;AIMed.d186;FALSE;Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN1 however, the combination of both PROTEIN and PROTEIN resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2 receptor.;AIMed.d186.s1582
862;AIMed.d186;FALSE;Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN however, the combination of both PROTEIN1 and PROTEIN resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2 ;AIMed.d186.s1582
863;AIMed.d186;FALSE;Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN however, the combination of both PROTEIN1 and PROTEIN2 resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN ;AIMed.d186.s1582
864;AIMed.d186;FALSE;Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN1 however, the combination of both PROTEIN2 and PROTEIN resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN ;AIMed.d186.s1582
865;AIMed.d186;FALSE;Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN however, the combination of both PROTEIN and PROTEIN1 resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2 ;AIMed.d186.s1582
866;AIMed.d186;FALSE;Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN1 however, the combination of both PROTEIN and PROTEIN resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2 ;AIMed.d186.s1582
867;AIMed.d186;FALSE;Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN1 however, the combination of both PROTEIN and PROTEIN2 resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN ;AIMed.d186.s1582
868;AIMed.d186;FALSE;Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN1 ( PROTEIN for PROTEIN signaling, it could not replace the function of PROTEIN2 in allowing enhanced PROTEIN binding activity.;AIMed.d186.s1583
869;AIMed.d186;FALSE;Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN1 ( PROTEIN2 for PROTEIN signaling, it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity.;AIMed.d186.s1583
870;AIMed.d186;FALSE;Whereas PROTEIN1 serves as an alternative accessory protein to the common PROTEIN2 ( PROTEIN for PROTEIN signaling, it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity.;AIMed.d186.s1583
871;AIMed.d186;FALSE;Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN1 ( PROTEIN for PROTEIN2 signaling, it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity.;AIMed.d186.s1583
872;AIMed.d186;FALSE;Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN1 ( PROTEIN for PROTEIN signaling, it could not replace the function of PROTEIN in allowing enhanced PROTEIN2 binding activity.;AIMed.d186.s1583
873;AIMed.d186;FALSE;Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN ( PROTEIN1 for PROTEIN signaling, it could not replace the function of PROTEIN2 in allowing enhanced PROTEIN binding activity.;AIMed.d186.s1583
874;AIMed.d186;FALSE;Whereas PROTEIN1 serves as an alternative accessory protein to the common PROTEIN ( PROTEIN for PROTEIN signaling, it could not replace the function of PROTEIN2 in allowing enhanced PROTEIN binding activity.;AIMed.d186.s1583
875;AIMed.d186;FALSE;Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN ( PROTEIN for PROTEIN1 signaling, it could not replace the function of PROTEIN2 in allowing enhanced PROTEIN binding activity.;AIMed.d186.s1583
876;AIMed.d186;FALSE;Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN ( PROTEIN for PROTEIN signaling, it could not replace the function of PROTEIN1 in allowing enhanced PROTEIN2 binding activity.;AIMed.d186.s1583
877;AIMed.d186;FALSE;Whereas PROTEIN1 serves as an alternative accessory protein to the common PROTEIN ( PROTEIN2 for PROTEIN signaling, it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity.;AIMed.d186.s1583
878;AIMed.d186;FALSE;Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN ( PROTEIN1 for PROTEIN2 signaling, it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity.;AIMed.d186.s1583
879;AIMed.d186;FALSE;Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN ( PROTEIN1 for PROTEIN signaling, it could not replace the function of PROTEIN in allowing enhanced PROTEIN2 binding activity.;AIMed.d186.s1583
880;AIMed.d186;TRUE;Whereas PROTEIN1 serves as an alternative accessory protein to the common PROTEIN ( PROTEIN for PROTEIN2 signaling, it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity.;AIMed.d186.s1583
881;AIMed.d186;FALSE;Whereas PROTEIN1 serves as an alternative accessory protein to the common PROTEIN ( PROTEIN for PROTEIN signaling, it could not replace the function of PROTEIN in allowing enhanced PROTEIN2 binding activity.;AIMed.d186.s1583
882;AIMed.d186;FALSE;Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN ( PROTEIN for PROTEIN1 signaling, it could not replace the function of PROTEIN in allowing enhanced PROTEIN2 binding activity.;AIMed.d186.s1583
883;AIMed.d186;FALSE;Nevertheless, the overall size and length of the cytoplasmic domain of PROTEIN and PROTEIN1 are similar, and like PROTEIN PROTEIN2 is located on chromosome X.;AIMed.d186.s1584
884;AIMed.d186;FALSE;Nevertheless, the overall size and length of the cytoplasmic domain of PROTEIN1 and PROTEIN are similar, and like PROTEIN PROTEIN2 is located on chromosome X.;AIMed.d186.s1584
885;AIMed.d186;FALSE;Nevertheless, the overall size and length of the cytoplasmic domain of PROTEIN and PROTEIN are similar, and like PROTEIN1 PROTEIN2 is located on chromosome X.;AIMed.d186.s1584
886;AIMed.d186;FALSE;Nevertheless, the overall size and length of the cytoplasmic domain of PROTEIN1 and PROTEIN2 are similar, and like PROTEIN PROTEIN is located on chromosome X.;AIMed.d186.s1584
887;AIMed.d186;FALSE;Nevertheless, the overall size and length of the cytoplasmic domain of PROTEIN and PROTEIN1 are similar, and like PROTEIN2 PROTEIN is located on chromosome X.;AIMed.d186.s1584
888;AIMed.d186;FALSE;Nevertheless, the overall size and length of the cytoplasmic domain of PROTEIN1 and PROTEIN are similar, and like PROTEIN2 PROTEIN is located on chromosome X.;AIMed.d186.s1584
889;AIMed.d188;FALSE;SREBP transcriptional activity is mediated through an interaction with the PROTEIN1 binding protein.;AIMed.d188.s1595
890;AIMed.d188;FALSE;In an unbiased search for potential coactivators of SREBP, we isolated a protein of 265 kD from HeLa cells that directly bound PROTEIN1 and PROTEIN2 ;AIMed.d188.s1598
891;AIMed.d188;FALSE;Peptide sequencing and Western blot analysis established that the 265-kD protein was PROTEIN1 ( PROTEIN2 ,a recently identified transcriptional coactivator.;AIMed.d188.s1599
892;AIMed.d188;FALSE;The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant PROTEIN and PROTEIN1 (a PROTEIN2 related protein).;AIMed.d188.s1600
893;AIMed.d188;FALSE;The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant PROTEIN1 and PROTEIN (a PROTEIN2 related protein).;AIMed.d188.s1600
894;AIMed.d188;FALSE;The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant PROTEIN1 and PROTEIN2 (a PROTEIN related protein).;AIMed.d188.s1600
895;AIMed.d189;TRUE;Associations of PROTEIN1 with PROTEIN PROTEIN PROTEIN and PROTEIN2 proteins in a yeast two-hybrid system.;AIMed.d189.s1603
896;AIMed.d189;TRUE;Associations of PROTEIN1 with PROTEIN PROTEIN2 PROTEIN and PROTEIN proteins in a yeast two-hybrid system.;AIMed.d189.s1603
897;AIMed.d189;TRUE;Associations of PROTEIN1 with PROTEIN PROTEIN PROTEIN2 and PROTEIN proteins in a yeast two-hybrid system.;AIMed.d189.s1603
898;AIMed.d189;TRUE;Associations of PROTEIN1 with PROTEIN2 PROTEIN PROTEIN and PROTEIN proteins in a yeast two-hybrid system.;AIMed.d189.s1603
899;AIMed.d189;FALSE;Associations of PROTEIN with PROTEIN PROTEIN1 PROTEIN and PROTEIN2 proteins in a yeast two-hybrid system.;AIMed.d189.s1603
900;AIMed.d189;FALSE;Associations of PROTEIN with PROTEIN PROTEIN PROTEIN1 and PROTEIN2 proteins in a yeast two-hybrid system.;AIMed.d189.s1603
901;AIMed.d189;FALSE;Associations of PROTEIN with PROTEIN1 PROTEIN PROTEIN and PROTEIN2 proteins in a yeast two-hybrid system.;AIMed.d189.s1603
902;AIMed.d189;FALSE;Associations of PROTEIN with PROTEIN PROTEIN1 PROTEIN2 and PROTEIN proteins in a yeast two-hybrid system.;AIMed.d189.s1603
903;AIMed.d189;FALSE;Associations of PROTEIN with PROTEIN1 PROTEIN2 PROTEIN and PROTEIN proteins in a yeast two-hybrid system.;AIMed.d189.s1603
904;AIMed.d189;FALSE;Associations of PROTEIN with PROTEIN1 PROTEIN PROTEIN2 and PROTEIN proteins in a yeast two-hybrid system.;AIMed.d189.s1603
905;AIMed.d189;FALSE;"Using the human PROTEIN1 protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN that interacts with PROTEIN PROTEIN PROTEIN2 and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
906;AIMed.d189;FALSE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN that interacts with PROTEIN1 PROTEIN PROTEIN2 and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
907;AIMed.d189;TRUE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN1 that interacts with PROTEIN PROTEIN PROTEIN2 and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
908;AIMed.d189;FALSE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN that interacts with PROTEIN PROTEIN PROTEIN1 and a ubiquitin-like protein PROTEIN2 ";AIMed.d189.s1606
909;AIMed.d189;FALSE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN that interacts with PROTEIN PROTEIN1 PROTEIN2 and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
910;AIMed.d189;FALSE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN1 designated PROTEIN that interacts with PROTEIN PROTEIN PROTEIN2 and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
911;AIMed.d189;FALSE;"Using the human PROTEIN1 protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN that interacts with PROTEIN2 PROTEIN PROTEIN and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
912;AIMed.d189;FALSE;"Using the human PROTEIN1 protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN2 that interacts with PROTEIN PROTEIN PROTEIN and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
913;AIMed.d189;FALSE;"Using the human PROTEIN1 protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN that interacts with PROTEIN PROTEIN PROTEIN and a ubiquitin-like protein PROTEIN2 ";AIMed.d189.s1606
914;AIMed.d189;FALSE;"Using the human PROTEIN1 protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN that interacts with PROTEIN PROTEIN2 PROTEIN and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
915;AIMed.d189;FALSE;"Using the human PROTEIN1 protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN2 designated PROTEIN that interacts with PROTEIN PROTEIN PROTEIN and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
916;AIMed.d189;TRUE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN1 that interacts with PROTEIN2 PROTEIN PROTEIN and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
917;AIMed.d189;FALSE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN that interacts with PROTEIN1 PROTEIN PROTEIN and a ubiquitin-like protein PROTEIN2 ";AIMed.d189.s1606
918;AIMed.d189;FALSE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN that interacts with PROTEIN1 PROTEIN2 PROTEIN and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
919;AIMed.d189;FALSE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN1 designated PROTEIN that interacts with PROTEIN2 PROTEIN PROTEIN and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
920;AIMed.d189;TRUE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN1 that interacts with PROTEIN PROTEIN PROTEIN and a ubiquitin-like protein PROTEIN2 ";AIMed.d189.s1606
921;AIMed.d189;TRUE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN1 that interacts with PROTEIN PROTEIN2 PROTEIN and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
922;AIMed.d189;FALSE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN1 designated PROTEIN2 that interacts with PROTEIN PROTEIN PROTEIN and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
923;AIMed.d189;FALSE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN designated PROTEIN that interacts with PROTEIN PROTEIN1 PROTEIN and a ubiquitin-like protein PROTEIN2 ";AIMed.d189.s1606
924;AIMed.d189;FALSE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN1 designated PROTEIN that interacts with PROTEIN PROTEIN PROTEIN and a ubiquitin-like protein PROTEIN2 ";AIMed.d189.s1606
925;AIMed.d189;FALSE;"Using the human PROTEIN protein as the ""bait"" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN1 designated PROTEIN that interacts with PROTEIN PROTEIN2 PROTEIN and a ubiquitin-like protein PROTEIN ";AIMed.d189.s1606
926;AIMed.d189;FALSE;These interactions are PROTEIN1 specific, since another DNA repair-related ubiquitin-conjugating enzyme, PROTEIN2 ( PROTEIN , does not interact with these proteins.;AIMed.d189.s1607
927;AIMed.d189;FALSE;These interactions are PROTEIN1 specific, since another DNA repair-related ubiquitin-conjugating enzyme, PROTEIN ( PROTEIN2 , does not interact with these proteins.;AIMed.d189.s1607
928;AIMed.d189;FALSE;These interactions are PROTEIN specific, since another DNA repair-related ubiquitin-conjugating enzyme, PROTEIN1 ( PROTEIN2 , does not interact with these proteins.;AIMed.d189.s1607
929;AIMed.d189;TRUE;The interaction of PROTEIN1 with PROTEIN2 is mediated by PROTEIN s self-association region.;AIMed.d189.s1608
930;AIMed.d189;FALSE;The interaction of PROTEIN1 with PROTEIN is mediated by PROTEIN2 s self-association region.;AIMed.d189.s1608
931;AIMed.d189;FALSE;The interaction of PROTEIN with PROTEIN1 is mediated by PROTEIN2 s self-association region.;AIMed.d189.s1608
932;AIMed.d189;FALSE;These results suggest that the PROTEIN dependent processes, cell cycle control, PROTEIN1 mediated pathway(s), and ubiquitination interact through human PROTEIN2 ;AIMed.d189.s1609
933;AIMed.d189;FALSE;These results suggest that the PROTEIN1 dependent processes, cell cycle control, PROTEIN mediated pathway(s), and ubiquitination interact through human PROTEIN2 ;AIMed.d189.s1609
934;AIMed.d189;FALSE;These results suggest that the PROTEIN1 dependent processes, cell cycle control, PROTEIN2 mediated pathway(s), and ubiquitination interact through human PROTEIN ;AIMed.d189.s1609
935;AIMed.d191;FALSE;We now find that HIV-1 begins reverse transcription much more efficiently in DCs than T cells, even though T cells have higher levels of PROTEIN1 and PROTEIN2 binding.;AIMed.d191.s1623
936;AIMed.d191;FALSE; PROTEIN interacts with PROTEIN1 and PROTEIN with PROTEIN2 receptors.;AIMed.d191.s1631
937;AIMed.d191;TRUE; PROTEIN1 interacts with PROTEIN2 and PROTEIN with PROTEIN receptors.;AIMed.d191.s1631
938;AIMed.d191;FALSE; PROTEIN interacts with PROTEIN1 and PROTEIN2 with PROTEIN receptors.;AIMed.d191.s1631
939;AIMed.d191;FALSE; PROTEIN1 interacts with PROTEIN and PROTEIN with PROTEIN2 receptors.;AIMed.d191.s1631
940;AIMed.d191;TRUE; PROTEIN interacts with PROTEIN and PROTEIN1 with PROTEIN2 receptors.;AIMed.d191.s1631
941;AIMed.d191;FALSE; PROTEIN1 interacts with PROTEIN and PROTEIN2 with PROTEIN receptors.;AIMed.d191.s1631
942;AIMed.d191;FALSE;DCs express more PROTEIN1 and PROTEIN2 mRNA than T cells.;AIMed.d191.s1633
943;AIMed.d200;TRUE;Using epitope-tagging, interaction of PROTEIN1 basic-helix-loop-helix protein with the PROTEIN2 protein encoded by this novel cDNA was confirmed by immunoprecipitation experiments in COS7 cells.;AIMed.d200.s1722
944;AIMed.d200;FALSE;Interactions with human PROTEIN1 and mouse PROTEIN2 were confirmed using glutathione transferase-tagged cDNAs.;AIMed.d200.s1725
945;AIMed.d200;TRUE;A cDNA encoding part of the PROTEIN1 protein sequence interacted with the PROTEIN2 basic-helix-loop-helix only when fused to a beta-galactosidase tag.;AIMed.d200.s1726
946;AIMed.d201;FALSE; PROTEIN1 is a transcriptional modulator that communicates with PROTEIN2 and the PROTEIN ;AIMed.d201.s1727
947;AIMed.d201;FALSE; PROTEIN is a transcriptional modulator that communicates with PROTEIN1 and the PROTEIN2 ;AIMed.d201.s1727
948;AIMed.d201;FALSE; PROTEIN1 is a transcriptional modulator that communicates with PROTEIN and the PROTEIN2 ;AIMed.d201.s1727
949;AIMed.d201;FALSE; PROTEIN1 ( PROTEIN2 transactivates viral and cellular genes through a wide variety of cis-elements.;AIMed.d201.s1728
950;AIMed.d201;FALSE;Our finding that PROTEIN directly interacts with PROTEIN1 ( PROTEIN2 , a common subunit of RNA polymerases, implies that PROTEIN directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).;AIMed.d201.s1730
951;AIMed.d201;FALSE;Our finding that PROTEIN directly interacts with PROTEIN1 ( PROTEIN , a common subunit of RNA polymerases, implies that PROTEIN2 directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).;AIMed.d201.s1730
952;AIMed.d201;TRUE;Our finding that PROTEIN1 directly interacts with PROTEIN2 ( PROTEIN , a common subunit of RNA polymerases, implies that PROTEIN directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).;AIMed.d201.s1730
953;AIMed.d201;FALSE;Our finding that PROTEIN directly interacts with PROTEIN ( PROTEIN1 , a common subunit of RNA polymerases, implies that PROTEIN2 directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).;AIMed.d201.s1730
954;AIMed.d201;TRUE;Our finding that PROTEIN1 directly interacts with PROTEIN ( PROTEIN2 , a common subunit of RNA polymerases, implies that PROTEIN directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).;AIMed.d201.s1730
955;AIMed.d201;FALSE;Our finding that PROTEIN1 directly interacts with PROTEIN ( PROTEIN , a common subunit of RNA polymerases, implies that PROTEIN2 directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).;AIMed.d201.s1730
956;AIMed.d201;FALSE;In this context, we examined the possibility that PROTEIN1 and PROTEIN2 interact with other general transcription factors.;AIMed.d201.s1731
957;AIMed.d201;FALSE; PROTEIN and PROTEIN1 specifically bound to PROTEIN ( PROTEIN2 in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.;AIMed.d201.s1732
958;AIMed.d201;FALSE; PROTEIN and PROTEIN1 specifically bound to PROTEIN2 ( PROTEIN in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.;AIMed.d201.s1732
959;AIMed.d201;FALSE; PROTEIN1 and PROTEIN2 specifically bound to PROTEIN ( PROTEIN in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.;AIMed.d201.s1732
960;AIMed.d201;FALSE; PROTEIN and PROTEIN specifically bound to PROTEIN1 ( PROTEIN2 in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.;AIMed.d201.s1732
961;AIMed.d201;FALSE; PROTEIN1 and PROTEIN specifically bound to PROTEIN ( PROTEIN2 in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.;AIMed.d201.s1732
962;AIMed.d201;FALSE; PROTEIN1 and PROTEIN specifically bound to PROTEIN2 ( PROTEIN in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.;AIMed.d201.s1732
963;AIMed.d201;FALSE;Delineation of the binding regions of these three proteins revealed that PROTEIN1 PROTEIN and PROTEIN2 each has two binding regions for the other two proteins.;AIMed.d201.s1733
964;AIMed.d201;FALSE;Delineation of the binding regions of these three proteins revealed that PROTEIN PROTEIN1 and PROTEIN2 each has two binding regions for the other two proteins.;AIMed.d201.s1733
965;AIMed.d201;TRUE;Delineation of the binding regions of these three proteins revealed that PROTEIN1 PROTEIN2 and PROTEIN each has two binding regions for the other two proteins.;AIMed.d201.s1733
966;AIMed.d201;FALSE;Some PROTEIN substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN1 or PROTEIN in a mutually exclusive manner, suggesting that PROTEIN transactivation requires the interactions of both PROTEIN2 and PROTEIN ;AIMed.d201.s1735
967;AIMed.d201;FALSE;Some PROTEIN substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN1 or PROTEIN in a mutually exclusive manner, suggesting that PROTEIN2 transactivation requires the interactions of both PROTEIN and PROTEIN ;AIMed.d201.s1735
968;AIMed.d201;FALSE;Some PROTEIN1 substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN2 or PROTEIN in a mutually exclusive manner, suggesting that PROTEIN transactivation requires the interactions of both PROTEIN and PROTEIN ;AIMed.d201.s1735
969;AIMed.d201;FALSE;Some PROTEIN substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN1 or PROTEIN in a mutually exclusive manner, suggesting that PROTEIN transactivation requires the interactions of both PROTEIN and PROTEIN2 ;AIMed.d201.s1735
970;AIMed.d201;FALSE;Some PROTEIN substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN1 or PROTEIN2 in a mutually exclusive manner, suggesting that PROTEIN transactivation requires the interactions of both PROTEIN and PROTEIN ;AIMed.d201.s1735
971;AIMed.d201;TRUE;Some PROTEIN substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN or PROTEIN in a mutually exclusive manner, suggesting that PROTEIN1 transactivation requires the interactions of both PROTEIN2 and PROTEIN ;AIMed.d201.s1735
972;AIMed.d201;FALSE;Some PROTEIN1 substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN or PROTEIN in a mutually exclusive manner, suggesting that PROTEIN transactivation requires the interactions of both PROTEIN2 and PROTEIN ;AIMed.d201.s1735
973;AIMed.d201;FALSE;Some PROTEIN substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN or PROTEIN in a mutually exclusive manner, suggesting that PROTEIN transactivation requires the interactions of both PROTEIN1 and PROTEIN2 ;AIMed.d201.s1735
974;AIMed.d201;FALSE;Some PROTEIN substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN or PROTEIN1 in a mutually exclusive manner, suggesting that PROTEIN transactivation requires the interactions of both PROTEIN2 and PROTEIN ;AIMed.d201.s1735
975;AIMed.d201;FALSE;Some PROTEIN1 substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN or PROTEIN in a mutually exclusive manner, suggesting that PROTEIN2 transactivation requires the interactions of both PROTEIN and PROTEIN ;AIMed.d201.s1735
976;AIMed.d201;FALSE;Some PROTEIN substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN or PROTEIN in a mutually exclusive manner, suggesting that PROTEIN1 transactivation requires the interactions of both PROTEIN and PROTEIN2 ;AIMed.d201.s1735
977;AIMed.d201;FALSE;Some PROTEIN substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN or PROTEIN1 in a mutually exclusive manner, suggesting that PROTEIN2 transactivation requires the interactions of both PROTEIN and PROTEIN ;AIMed.d201.s1735
978;AIMed.d201;FALSE;Some PROTEIN1 substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN or PROTEIN in a mutually exclusive manner, suggesting that PROTEIN transactivation requires the interactions of both PROTEIN and PROTEIN2 ;AIMed.d201.s1735
979;AIMed.d201;TRUE;Some PROTEIN1 substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN or PROTEIN2 in a mutually exclusive manner, suggesting that PROTEIN transactivation requires the interactions of both PROTEIN and PROTEIN ;AIMed.d201.s1735
980;AIMed.d201;FALSE;Some PROTEIN substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN or PROTEIN1 in a mutually exclusive manner, suggesting that PROTEIN transactivation requires the interactions of both PROTEIN and PROTEIN2 ;AIMed.d201.s1735
981;AIMed.d201;FALSE;These results indicated that PROTEIN is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and PROTEIN1 through communication with PROTEIN2 and PROTEIN ;AIMed.d201.s1736
982;AIMed.d201;FALSE;These results indicated that PROTEIN1 is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and PROTEIN2 through communication with PROTEIN and PROTEIN ;AIMed.d201.s1736
983;AIMed.d201;FALSE;These results indicated that PROTEIN is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and PROTEIN1 through communication with PROTEIN and PROTEIN2 ;AIMed.d201.s1736
984;AIMed.d201;FALSE;These results indicated that PROTEIN1 is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and PROTEIN through communication with PROTEIN2 and PROTEIN ;AIMed.d201.s1736
985;AIMed.d201;FALSE;These results indicated that PROTEIN is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and PROTEIN through communication with PROTEIN1 and PROTEIN2 ;AIMed.d201.s1736
986;AIMed.d201;FALSE;These results indicated that PROTEIN1 is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and PROTEIN through communication with PROTEIN and PROTEIN2 ;AIMed.d201.s1736
987;AIMed.d203;FALSE;A new cytokine-receptor binding mode revealed by the crystal structure of the PROTEIN1 receptor with an antagonist.;AIMed.d203.s1746
988;AIMed.d203;FALSE;Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines PROTEIN1 ( PROTEIN2 and PROTEIN (ref. 1).;AIMed.d203.s1747
989;AIMed.d203;FALSE;Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines PROTEIN ( PROTEIN1 and PROTEIN2 (ref. 1).;AIMed.d203.s1747
990;AIMed.d203;FALSE;Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines PROTEIN1 ( PROTEIN and PROTEIN2 (ref. 1).;AIMed.d203.s1747
991;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN exist: the agonists PROTEIN1 and PROTEIN and the PROTEIN receptor antagonist PROTEIN2 (ref. 2).;AIMed.d203.s1748
992;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN exist: the agonists PROTEIN1 and PROTEIN and the PROTEIN2 PROTEIN (ref. 2).;AIMed.d203.s1748
993;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN exist: the agonists PROTEIN1 and PROTEIN and the PROTEIN2 antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
994;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN exist: the agonists PROTEIN1 and PROTEIN2 and the PROTEIN receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
995;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN exist: the agonists PROTEIN1 and PROTEIN and the PROTEIN2 receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
996;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN exist: the agonists PROTEIN2 and PROTEIN and the PROTEIN receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
997;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN1 exist: the agonists PROTEIN2 and PROTEIN and the PROTEIN receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
998;AIMed.d203;TRUE;Three naturally occurring ligands for the PROTEIN1 ( PROTEIN exist: the agonists PROTEIN2 and PROTEIN and the PROTEIN receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
999;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN1 PROTEIN2 (ref. 2).;AIMed.d203.s1748
1000;AIMed.d203;TRUE;Three naturally occurring ligands for the PROTEIN ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN1 antagonist PROTEIN2 (ref. 2).;AIMed.d203.s1748
1001;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN exist: the agonists PROTEIN and PROTEIN1 and the PROTEIN receptor antagonist PROTEIN2 (ref. 2).;AIMed.d203.s1748
1002;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN1 receptor antagonist PROTEIN2 (ref. 2).;AIMed.d203.s1748
1003;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN receptor antagonist PROTEIN2 (ref. 2).;AIMed.d203.s1748
1004;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN1 exist: the agonists PROTEIN and PROTEIN and the PROTEIN receptor antagonist PROTEIN2 (ref. 2).;AIMed.d203.s1748
1005;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN receptor antagonist PROTEIN2 (ref. 2).;AIMed.d203.s1748
1006;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN1 antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1007;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN exist: the agonists PROTEIN and PROTEIN1 and the PROTEIN2 PROTEIN (ref. 2).;AIMed.d203.s1748
1008;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN1 PROTEIN (ref. 2).;AIMed.d203.s1748
1009;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN2 PROTEIN (ref. 2).;AIMed.d203.s1748
1010;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN1 exist: the agonists PROTEIN and PROTEIN and the PROTEIN2 PROTEIN (ref. 2).;AIMed.d203.s1748
1011;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN2 PROTEIN (ref. 2).;AIMed.d203.s1748
1012;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN exist: the agonists PROTEIN and PROTEIN1 and the PROTEIN2 antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1013;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN1 antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1014;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN2 antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1015;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN1 exist: the agonists PROTEIN and PROTEIN and the PROTEIN2 antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1016;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN2 antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1017;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN exist: the agonists PROTEIN and PROTEIN1 and the PROTEIN2 receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1018;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN exist: the agonists PROTEIN and PROTEIN2 and the PROTEIN receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1019;AIMed.d203;TRUE;Three naturally occurring ligands for the PROTEIN ( PROTEIN1 exist: the agonists PROTEIN and PROTEIN2 and the PROTEIN receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1020;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 ( PROTEIN exist: the agonists PROTEIN and PROTEIN2 and the PROTEIN receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1021;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN2 receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1022;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN ( PROTEIN1 exist: the agonists PROTEIN and PROTEIN and the PROTEIN2 receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1023;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN2 receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1024;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN2 exist: the agonists PROTEIN and PROTEIN and the PROTEIN receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1025;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 ( PROTEIN exist: the agonists PROTEIN and PROTEIN and the PROTEIN receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1026;AIMed.d203;FALSE;Three naturally occurring ligands for the PROTEIN1 ( PROTEIN2 exist: the agonists PROTEIN and PROTEIN and the PROTEIN receptor antagonist PROTEIN (ref. 2).;AIMed.d203.s1748
1027;AIMed.d203;FALSE;Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of PROT PROTEIN2 complexed with PROTEIN ;AIMed.d203.s1750
1028;AIMed.d203;FALSE;Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of PRO PROTEIN1 complexed with PROTEIN2 ;AIMed.d203.s1750
1029;AIMed.d203;TRUE;Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of PROT PROTEIN complexed with PROTEIN2 ;AIMed.d203.s1750
1030;AIMed.d203;FALSE;A region that is important for biological function in PROTEIN1 the 'receptor trigger site' is not in direct contact with the receptor in the PROTEIN2 complex.;AIMed.d203.s1754
1031;AIMed.d210;TRUE;Cross-family interaction between the bHLHZip PROTEIN1 and bZip PROTEIN2 proteins results in down-regulation of PROTEIN activity.;AIMed.d210.s1817
1032;AIMed.d210;FALSE;Cross-family interaction between the bHLHZip PROTEIN1 and bZip PROTEIN proteins results in down-regulation of PROTEIN2 activity.;AIMed.d210.s1817
1033;AIMed.d210;FALSE;Cross-family interaction between the bHLHZip PROTEIN and bZip PROTEIN1 proteins results in down-regulation of PROTEIN2 activity.;AIMed.d210.s1817
1034;AIMed.d210;FALSE;To further examine the function of the bHLHZip protein, PROTEIN1 we screened for cellular proteins which could directly interact with PROTEIN2 using the yeast two-hybrid system.;AIMed.d210.s1819
1035;AIMed.d210;TRUE;A bZip protein, PROTEIN1 was found to efficiently interact with PROTEIN2 ;AIMed.d210.s1820
1036;AIMed.d210;FALSE; PROTEIN1 specifically interacts with PROTEIN but not with other closely related family members, PROTEIN PROTEIN2 PROTEIN or with PROTEIN ;AIMed.d210.s1821
1037;AIMed.d210;FALSE; PROTEIN1 specifically interacts with PROTEIN but not with other closely related family members, PROTEIN PROTEIN PROTEIN2 or with PROTEIN ;AIMed.d210.s1821
1038;AIMed.d210;FALSE; PROTEIN1 specifically interacts with PROTEIN but not with other closely related family members, PROTEIN PROTEIN PROTEIN or with PROTEIN2 ;AIMed.d210.s1821
1039;AIMed.d210;TRUE; PROTEIN1 specifically interacts with PROTEIN2 but not with other closely related family members, PROTEIN PROTEIN PROTEIN or with PROTEIN ;AIMed.d210.s1821
1040;AIMed.d210;FALSE; PROTEIN1 specifically interacts with PROTEIN but not with other closely related family members, PROTEIN2 PROTEIN PROTEIN or with PROTEIN ;AIMed.d210.s1821
1041;AIMed.d210;FALSE; PROTEIN specifically interacts with PROTEIN but not with other closely related family members, PROTEIN PROTEIN1 PROTEIN2 or with PROTEIN ;AIMed.d210.s1821
1042;AIMed.d210;FALSE; PROTEIN specifically interacts with PROTEIN but not with other closely related family members, PROTEIN PROTEIN1 PROTEIN or with PROTEIN2 ;AIMed.d210.s1821
1043;AIMed.d210;FALSE; PROTEIN specifically interacts with PROTEIN1 but not with other closely related family members, PROTEIN PROTEIN2 PROTEIN or with PROTEIN ;AIMed.d210.s1821
1044;AIMed.d210;FALSE; PROTEIN specifically interacts with PROTEIN but not with other closely related family members, PROTEIN1 PROTEIN2 PROTEIN or with PROTEIN ;AIMed.d210.s1821
1045;AIMed.d210;FALSE; PROTEIN specifically interacts with PROTEIN but not with other closely related family members, PROTEIN PROTEIN PROTEIN1 or with PROTEIN2 ;AIMed.d210.s1821
1046;AIMed.d210;FALSE; PROTEIN specifically interacts with PROTEIN1 but not with other closely related family members, PROTEIN PROTEIN PROTEIN2 or with PROTEIN ;AIMed.d210.s1821
1047;AIMed.d210;FALSE; PROTEIN specifically interacts with PROTEIN but not with other closely related family members, PROTEIN1 PROTEIN PROTEIN2 or with PROTEIN ;AIMed.d210.s1821
1048;AIMed.d210;FALSE; PROTEIN specifically interacts with PROTEIN1 but not with other closely related family members, PROTEIN PROTEIN PROTEIN or with PROTEIN2 ;AIMed.d210.s1821
1049;AIMed.d210;FALSE; PROTEIN specifically interacts with PROTEIN but not with other closely related family members, PROTEIN1 PROTEIN PROTEIN or with PROTEIN2 ;AIMed.d210.s1821
1050;AIMed.d210;FALSE; PROTEIN specifically interacts with PROTEIN1 but not with other closely related family members, PROTEIN2 PROTEIN PROTEIN or with PROTEIN ;AIMed.d210.s1821
1051;AIMed.d210;TRUE;Both the bHLHZip and the N-terminal regions of PROTEIN1 are required for efficient interaction with PROTEIN2 ;AIMed.d210.s1822
1052;AIMed.d210;TRUE;In vivo association between PROTEIN1 and PROTEIN2 has been demonstrated by co-immunoprecipitation.;AIMed.d210.s1823
1053;AIMed.d210;FALSE;Expression of exogenous PROTEIN1 led to a decrease in PROTEIN2 dependent transcription in F9 cells.;AIMed.d210.s1824
1054;AIMed.d210;FALSE;Co-expression of exogenous PROTEIN1 restored the PROTEIN2 activity in a dose-dependent manner.;AIMed.d210.s1825
1055;AIMed.d210;TRUE;These data show that PROTEIN1 and PROTEIN2 physically and functionally interact demonstrating that cross-talk occurs between factors of distantly related transcription families.;AIMed.d210.s1826
1056;AIMed.d212;TRUE;Interaction between PROTEIN1 protein and PROTEIN2 in response to DNA damage.;AIMed.d212.s1835
1057;AIMed.d212;FALSE;The gene mutated in the autosomal recessive disorder ataxia telangiectasia (AT), designated PROTEIN1 (for ' PROTEIN2 ), is a member of a family of phosphatidylinositol-3-kinase-like enzymes that are involved in cell-cycle control, meiotic recombination, telomere length monitoring and DNA-damage response.;AIMed.d212.s1836
1058;AIMed.d212;FALSE;Because cells lacking the protein tyrosine kinase PROTEIN1 are also defective in radiation-induced G1 arrest, we investigated the possibility that PROTEIN might interact with PROTEIN2 in response to radiation damage.;AIMed.d212.s1838
1059;AIMed.d212;TRUE;Because cells lacking the protein tyrosine kinase PROTEIN are also defective in radiation-induced G1 arrest, we investigated the possibility that PROTEIN1 might interact with PROTEIN2 in response to radiation damage.;AIMed.d212.s1838
1060;AIMed.d212;FALSE;Because cells lacking the protein tyrosine kinase PROTEIN1 are also defective in radiation-induced G1 arrest, we investigated the possibility that PROTEIN2 might interact with PROTEIN in response to radiation damage.;AIMed.d212.s1838
1061;AIMed.d212;TRUE;Here we show that PROTEIN1 binds PROTEIN2 constitutively in control cells but not in AT cells.;AIMed.d212.s1839
1062;AIMed.d212;TRUE;Our results demonstrate that the SH3 domain of PROTEIN1 interacts with a DPAPNPPHFP motif (residues 1,373-1,382) of PROTEIN2 ;AIMed.d212.s1840
1063;AIMed.d212;TRUE;These findings indicate that PROTEIN1 is involved in the activation of PROTEIN2 by DNA damage and this interaction may in part mediate radiation-induced G1 arrest.;AIMed.d212.s1842
1064;AIMed.d221;FALSE;A region of the beta subunit of the PROTEIN1 receptor different from box 1 interacts with PROTEIN2 and is sufficient to activate the PROTEIN Stat pathway and induce an antiviral state.;AIMed.d221.s1921
1065;AIMed.d221;FALSE;A region of the beta subunit of the PROTEIN1 receptor different from box 1 interacts with PROTEIN and is sufficient to activate the PROTEIN2 Stat pathway and induce an antiviral state.;AIMed.d221.s1921
1066;AIMed.d221;FALSE;A region of the beta subunit of the PROTEIN1 different from box 1 interacts with PROTEIN and is sufficient to activate the PROTEIN Stat pathway and induce an antiviral state.;AIMed.d221.s1921
1067;AIMed.d221;FALSE;A region of the beta subunit of the PROTEIN different from box 1 interacts with PROTEIN1 and is sufficient to activate the PROTEIN2 Stat pathway and induce an antiviral state.;AIMed.d221.s1921
1068;AIMed.d221;TRUE;A region of the beta subunit of the PROTEIN1 different from box 1 interacts with PROTEIN2 and is sufficient to activate the PROTEIN Stat pathway and induce an antiviral state.;AIMed.d221.s1921
1069;AIMed.d221;FALSE;A region of the beta subunit of the PROTEIN1 different from box 1 interacts with PROTEIN and is sufficient to activate the PROTEIN2 Stat pathway and induce an antiviral state.;AIMed.d221.s1921
1070;AIMed.d221;FALSE;Coexpression of the alpha and betaL subunits of t PROTEIN PROTEIN1 is required for the induction of an antiviral state by human PROTEIN2 ;AIMed.d221.s1922
1071;AIMed.d221;FALSE;Coexpression of the alpha and betaL subunits of the human PROTEIN1 ( PROTEIN receptor is required for the induction of an antiviral state by human PROTEIN ;AIMed.d221.s1922
1072;AIMed.d221;FALSE;Coexpression of the alpha and betaL subunits of t PROTEIN2 PROTEIN1 is required for the induction of an antiviral state by human PROTEIN ;AIMed.d221.s1922
1073;AIMed.d221;FALSE;Coexpression of the alpha and betaL subunits of the human PROTEIN1 ( PROTEIN receptor is required for the induction of an antiviral state by human PROTEIN2 ;AIMed.d221.s1922
1074;AIMed.d221;FALSE;Coexpression of the alpha and betaL subunits of the human PROTEIN ( PROTEIN1 receptor is required for the induction of an antiviral state by human PROTEIN2 ;AIMed.d221.s1922
1075;AIMed.d221;FALSE;Coexpression of the alpha and betaL subunits of the human PROTEIN1 ( PROTEIN2 receptor is required for the induction of an antiviral state by human PROTEIN ;AIMed.d221.s1922
1076;AIMed.d221;FALSE;Our results demonstrated that the first 82 amino acids (AAs) (AAs 265-346) of the cytoplasmic domain of the betaL chain are sufficient to activate the PROTEIN1 Stat pathway and trigger an antiviral state after PROTEIN2 binding to the receptor.;AIMed.d221.s1924
1077;AIMed.d221;FALSE;This region of the betaL chain, required for PROTEIN1 binding and activation, contains the Box 1 motif that is important for the interaction of some cytokine receptors with PROTEIN2 kinases.;AIMed.d221.s1925
1078;AIMed.d223;TRUE;Interaction between cell cycle regulator, PROTEIN1 and PROTEIN2 mediates repression of HIV-1 gene transcription.;AIMed.d223.s1934
1079;AIMed.d223;FALSE;The PROTEIN1 PROTEIN2 family of transcription factors is one of the main targets of cytokines and other agents that induce HIV-1 gene expression.;AIMed.d223.s1935
1080;AIMed.d223;TRUE;Some of these extracellular stimuli arrest cells in the G1 phase of the mitotic division cycle and modulate the activity of the tumor suppressor protein PROTEIN1 and its partner PROTEIN2 ;AIMed.d223.s1936
1081;AIMed.d223;TRUE;Here, we demonstrate that PROTEIN1 may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN enhancer region and to interact with the PROTEIN2 subunit, PROTEIN ;AIMed.d223.s1938
1082;AIMed.d223;TRUE;Here, we demonstrate that PROTEIN1 may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN enhancer region and to interact with the PROTEIN subunit, PROTEIN2 ;AIMed.d223.s1938
1083;AIMed.d223;FALSE;Here, we demonstrate that PROTEIN1 may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN2 enhancer region and to interact with the PROTEIN subunit, PROTEIN ;AIMed.d223.s1938
1084;AIMed.d223;FALSE;Here, we demonstrate that PROTEIN may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN enhancer region and to interact with the PROTEIN1 subunit, PROTEIN2 ;AIMed.d223.s1938
1085;AIMed.d223;FALSE;Here, we demonstrate that PROTEIN may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN1 enhancer region and to interact with the PROTEIN2 subunit, PROTEIN ;AIMed.d223.s1938
1086;AIMed.d223;FALSE;Here, we demonstrate that PROTEIN may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN1 enhancer region and to interact with the PROTEIN subunit, PROTEIN2 ;AIMed.d223.s1938
1087;AIMed.d223;FALSE;Gel retardation and methylation interference assays show that PROTEIN1 is able to bind specifically to a site embedded within the two PROTEIN2 elements.;AIMed.d223.s1939
1088;AIMed.d223;FALSE;Gel retardation/immunoblot analysis using purified PROTEIN1 and PROTEIN2 homodimers reveals the presence of complexes containing both proteins.;AIMed.d223.s1940
1089;AIMed.d223;TRUE;Affinity chromatography and co-immunoprecipitation assays provide evidence for direct interaction of PROTEIN1 and PROTEIN2 in the absence of their DNA target sequences.;AIMed.d223.s1941
1090;AIMed.d223;FALSE;In vitro transcription assay demonstrates that PROTEIN1 represses PROTEIN2 mediated transcription in a cell-free system.;AIMed.d223.s1942
1091;AIMed.d223;FALSE;Functional studies in Jurkat T lymphocytic cells point to the importance of both the PROTEIN and PROTEIN1 binding sites in PROTEIN2 mediated repression of HIV-1 promoter, in vivo.;AIMed.d223.s1943
1092;AIMed.d223;FALSE;Functional studies in Jurkat T lymphocytic cells point to the importance of both the PROTEIN1 and PROTEIN2 binding sites in PROTEIN mediated repression of HIV-1 promoter, in vivo.;AIMed.d223.s1943
1093;AIMed.d223;FALSE;Functional studies in Jurkat T lymphocytic cells point to the importance of both the PROTEIN1 and PROTEIN binding sites in PROTEIN2 mediated repression of HIV-1 promoter, in vivo.;AIMed.d223.s1943
1094;AIMed.d223;TRUE;The results of this study suggest that PROTEIN1 activity may be regulated by its interaction with the cell cycle regulatory protein, PROTEIN2 ;AIMed.d223.s1944
0;BioInfer.d13;TRUE; PROTEIN1 appears to control at least four functions that collectively lead to PROTEIN based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN2 polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN ;BioInfer.d13.s0
1;BioInfer.d13;TRUE; PROTEIN1 appears to control at least four functions that collectively lead to PROTEIN based motility: (1) initiation of PROTEIN2 polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN ;BioInfer.d13.s0
2;BioInfer.d13;TRUE; PROTEIN1 appears to control at least four functions that collectively lead to PROTEIN based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN2 function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN ;BioInfer.d13.s0
3;BioInfer.d13;FALSE; PROTEIN1 appears to control at least four functions that collectively lead to PROTEIN2 based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN ;BioInfer.d13.s0
4;BioInfer.d13;TRUE; PROTEIN1 appears to control at least four functions that collectively lead to PROTEIN based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN2 ;BioInfer.d13.s0
5;BioInfer.d13;FALSE; PROTEIN appears to control at least four functions that collectively lead to PROTEIN based motility: (1) initiation of PROTEIN1 polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN2 polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN ;BioInfer.d13.s0
6;BioInfer.d13;FALSE; PROTEIN appears to control at least four functions that collectively lead to PROTEIN based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN1 function, (3) transformation of PROTEIN2 polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN ;BioInfer.d13.s0
7;BioInfer.d13;TRUE; PROTEIN appears to control at least four functions that collectively lead to PROTEIN1 based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN2 polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN ;BioInfer.d13.s0
8;BioInfer.d13;FALSE; PROTEIN appears to control at least four functions that collectively lead to PROTEIN based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN1 polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN2 ;BioInfer.d13.s0
9;BioInfer.d13;FALSE; PROTEIN appears to control at least four functions that collectively lead to PROTEIN based motility: (1) initiation of PROTEIN1 polymerization, (2) polarization of PROTEIN2 function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN ;BioInfer.d13.s0
10;BioInfer.d13;TRUE; PROTEIN appears to control at least four functions that collectively lead to PROTEIN1 based motility: (1) initiation of PROTEIN2 polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN ;BioInfer.d13.s0
11;BioInfer.d13;FALSE; PROTEIN appears to control at least four functions that collectively lead to PROTEIN based motility: (1) initiation of PROTEIN1 polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN2 ;BioInfer.d13.s0
12;BioInfer.d13;TRUE; PROTEIN appears to control at least four functions that collectively lead to PROTEIN1 based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN2 function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN ;BioInfer.d13.s0
13;BioInfer.d13;FALSE; PROTEIN appears to control at least four functions that collectively lead to PROTEIN based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN1 function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN2 ;BioInfer.d13.s0
14;BioInfer.d13;TRUE; PROTEIN appears to control at least four functions that collectively lead to PROTEIN1 based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN2 ;BioInfer.d13.s0
15;BioInfer.d15;TRUE; PROTEIN1 such as PROTEIN2 participate in the restructuration of the PROTEIN cytoskeleton in plant cells.;BioInfer.d15.s0
16;BioInfer.d15;TRUE; PROTEIN1 such as PROTEIN participate in the restructuration of the PROTEIN2 cytoskeleton in plant cells.;BioInfer.d15.s0
17;BioInfer.d15;FALSE; PROTEIN such as PROTEIN1 participate in the restructuration of the PROTEIN2 cytoskeleton in plant cells.;BioInfer.d15.s0
18;BioInfer.d19;TRUE;[Activation induces dephosphorylation of PROTEIN1 (an PROTEIN2 PIP2-binding protein) and its translocation to plasma membranes in leukocytes].;BioInfer.d19.s0
19;BioInfer.d22;FALSE;Additional studies demonstrated the PROTEIN1 distribution to be remarkably similar to that of PROTEIN whereas PROTEIN2 staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.;BioInfer.d22.s0
20;BioInfer.d22;TRUE;Additional studies demonstrated the PROTEIN1 distribution to be remarkably similar to that of PROTEIN2 whereas PROTEIN staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.;BioInfer.d22.s0
21;BioInfer.d22;FALSE;Additional studies demonstrated the PROTEIN distribution to be remarkably similar to that of PROTEIN1 whereas PROTEIN2 staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.;BioInfer.d22.s0
22;BioInfer.d23;TRUE;Addition of Acanthamoeba PROTEIN1 in molar ratios to PROTEIN of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of PROTEIN2 incorporated into filaments.;BioInfer.d23.s0
23;BioInfer.d23;FALSE;Addition of Acanthamoeba PROTEIN1 in molar ratios to PROTEIN2 of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of PROTEIN incorporated into filaments.;BioInfer.d23.s0
24;BioInfer.d23;FALSE;Addition of Acanthamoeba PROTEIN in molar ratios to PROTEIN1 of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of PROTEIN2 incorporated into filaments.;BioInfer.d23.s0
25;BioInfer.d38;TRUE;All these results suggest that PROTEIN1 is a new type of PROTEIN2 associated protein.;BioInfer.d38.s0
26;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN1 to PROTEIN monomer in the filament and that PROTEIN2 increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
27;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN1 monomer in the filament and that PROTEIN2 increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
28;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN2 increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
29;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN1 filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN2 increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
30;BioInfer.d38;TRUE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN1 increases the monomeric PROTEIN2 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
31;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN1 binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN2 increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
32;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN1 to PROTEIN2 monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
33;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN2 to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
34;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN1 filaments in a 1:1 molar ratio of PROTEIN2 to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
35;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN1 to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN2 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
36;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN1 binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN2 to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
37;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN2 monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
38;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN1 filaments in a 1:1 molar ratio of PROTEIN to PROTEIN2 monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
39;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN1 monomer in the filament and that PROTEIN increases the monomeric PROTEIN2 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
40;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN1 binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN2 monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
41;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN binds to PROTEIN2 filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
42;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN2 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
43;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN2 binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
44;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN1 filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN2 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
45;BioInfer.d38;TRUE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN1 binds to PROTEIN2 filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
46;BioInfer.d38;FALSE;The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN1 binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN2 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.;BioInfer.d38.s1
47;BioInfer.d38;FALSE;The gel point assay using an PROTEIN1 cross-linking protein and the nucleation assay also suggested that PROTEIN2 shortens the PROTEIN filaments and hence increases the filament number.;BioInfer.d38.s2
48;BioInfer.d38;FALSE;The gel point assay using an PROTEIN1 cross-linking protein and the nucleation assay also suggested that PROTEIN shortens the PROTEIN2 filaments and hence increases the filament number.;BioInfer.d38.s2
49;BioInfer.d38;TRUE;The gel point assay using an PROTEIN cross-linking protein and the nucleation assay also suggested that PROTEIN1 shortens the PROTEIN2 filaments and hence increases the filament number.;BioInfer.d38.s2
50;BioInfer.d40;FALSE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN1 PROTEIN and the ends of PROTEIN2 filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
51;BioInfer.d40;FALSE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN1 only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN PROTEIN and the ends of PROTEIN2 filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
52;BioInfer.d40;FALSE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN PROTEIN and the ends of PROTEIN1 filaments, while PROTEIN2 shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
53;BioInfer.d40;FALSE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN PROTEIN1 and the ends of PROTEIN2 filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
54;BioInfer.d40;TRUE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN only a PROTEIN1 can be detected in focal contacts, colocalizing with PROTEIN PROTEIN and the ends of PROTEIN2 filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
55;BioInfer.d40;FALSE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN1 only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN2 PROTEIN and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
56;BioInfer.d40;FALSE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN1 PROTEIN and the ends of PROTEIN filaments, while PROTEIN2 shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
57;BioInfer.d40;FALSE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN1 PROTEIN2 and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
58;BioInfer.d40;TRUE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN only a PROTEIN1 can be detected in focal contacts, colocalizing with PROTEIN2 PROTEIN and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
59;BioInfer.d40;TRUE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN1 only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN PROTEIN and the ends of PROTEIN filaments, while PROTEIN2 shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
60;BioInfer.d40;FALSE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN1 only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN PROTEIN2 and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
61;BioInfer.d40;TRUE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN1 only a PROTEIN2 can be detected in focal contacts, colocalizing with PROTEIN PROTEIN and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
62;BioInfer.d40;FALSE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN PROTEIN1 and the ends of PROTEIN filaments, while PROTEIN2 shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
63;BioInfer.d40;FALSE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN only a PROTEIN1 can be detected in focal contacts, colocalizing with PROTEIN PROTEIN and the ends of PROTEIN filaments, while PROTEIN2 shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
64;BioInfer.d40;TRUE;Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN only a PROTEIN1 can be detected in focal contacts, colocalizing with PROTEIN PROTEIN2 and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.;BioInfer.d40.s0
65;BioInfer.d42;TRUE;Although PROTEIN1 has been suggested to act as a linkage protein mediating the attachment of PROTEIN2 IIIa to PROTEIN filaments, direct binding of PROTEIN IIIa to this cytoskeletal protein has not been demonstrated.;BioInfer.d42.s0
66;BioInfer.d42;TRUE;Although PROTEIN1 has been suggested to act as a linkage protein mediating the attachment of PROTEIN IIIa to PROTEIN filaments, direct binding of PROTEIN2 IIIa to this cytoskeletal protein has not been demonstrated.;BioInfer.d42.s0
67;BioInfer.d42;TRUE;Although PROTEIN1 has been suggested to act as a linkage protein mediating the attachment of PROTEIN IIIa to PROTEIN2 filaments, direct binding of PROTEIN IIIa to this cytoskeletal protein has not been demonstrated.;BioInfer.d42.s0
68;BioInfer.d42;FALSE;Although PROTEIN has been suggested to act as a linkage protein mediating the attachment of PROTEIN1 IIIa to PROTEIN filaments, direct binding of PROTEIN2 IIIa to this cytoskeletal protein has not been demonstrated.;BioInfer.d42.s0
69;BioInfer.d42;TRUE;Although PROTEIN has been suggested to act as a linkage protein mediating the attachment of PROTEIN1 IIIa to PROTEIN2 filaments, direct binding of PROTEIN IIIa to this cytoskeletal protein has not been demonstrated.;BioInfer.d42.s0
70;BioInfer.d42;FALSE;Although PROTEIN has been suggested to act as a linkage protein mediating the attachment of PROTEIN IIIa to PROTEIN1 filaments, direct binding of PROTEIN2 IIIa to this cytoskeletal protein has not been demonstrated.;BioInfer.d42.s0
71;BioInfer.d45;FALSE;Although platelets contain only 1 PROTEIN for every 5-10 PROTEIN1 molecules, these complex reactions may allow substoichiometric PROTEIN to have an important influence on PROTEIN2 assembly.;BioInfer.d45.s0
72;BioInfer.d45;TRUE;Although platelets contain only 1 PROTEIN for every 5-10 PROTEIN molecules, these complex reactions may allow substoichiometric PROTEIN1 to have an important influence on PROTEIN2 assembly.;BioInfer.d45.s0
73;BioInfer.d45;FALSE;Although platelets contain only 1 PROTEIN1 for every 5-10 PROTEIN molecules, these complex reactions may allow substoichiometric PROTEIN to have an important influence on PROTEIN2 assembly.;BioInfer.d45.s0
74;BioInfer.d45;FALSE;Although platelets contain only 1 PROTEIN for every 5-10 PROTEIN1 molecules, these complex reactions may allow substoichiometric PROTEIN2 to have an important influence on PROTEIN assembly.;BioInfer.d45.s0
75;BioInfer.d45;FALSE;Although platelets contain only 1 PROTEIN1 for every 5-10 PROTEIN2 molecules, these complex reactions may allow substoichiometric PROTEIN to have an important influence on PROTEIN assembly.;BioInfer.d45.s0
76;BioInfer.d45;FALSE;Although platelets contain only 1 PROTEIN1 for every 5-10 PROTEIN molecules, these complex reactions may allow substoichiometric PROTEIN2 to have an important influence on PROTEIN assembly.;BioInfer.d45.s0
77;BioInfer.d45;TRUE;Kinetic simulation showed that the PROTEIN1 exchanges between PROTEIN2 monomers on a subsecond time scale that allows it to catalyze nucleotide exchange.;BioInfer.d45.s1
78;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN1 has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN2 with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
79;BioInfer.d45;TRUE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN1 with PROTEIN2 cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
80;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN1 filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN2 with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
81;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN1 inhibits the elongation of PROTEIN much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN2 with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
82;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN1 and simple formation of 1:1 complexes of PROTEIN2 with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
83;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN1 much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN2 with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
84;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN1 has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN with PROTEIN2 cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
85;BioInfer.d45;TRUE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN1 has different effects on elongation at the two ends of PROTEIN2 filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
86;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN1 has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN2 inhibits the elongation of PROTEIN much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
87;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN1 has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN2 and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
88;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN1 has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN2 much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
89;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN1 filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN with PROTEIN2 cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
90;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN1 inhibits the elongation of PROTEIN much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN with PROTEIN2 cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
91;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN1 and simple formation of 1:1 complexes of PROTEIN with PROTEIN2 cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
92;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN1 much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN with PROTEIN2 cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
93;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN1 filaments; PROTEIN2 inhibits the elongation of PROTEIN much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
94;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN1 filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN2 and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
95;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN1 filaments; PROTEIN inhibits the elongation of PROTEIN2 much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
96;BioInfer.d45;TRUE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN1 inhibits the elongation of PROTEIN much more strongly than PROTEIN2 and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
97;BioInfer.d45;TRUE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN1 inhibits the elongation of PROTEIN2 much more strongly than PROTEIN and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
98;BioInfer.d45;FALSE;"On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN1 much more strongly than PROTEIN2 and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.";BioInfer.d45.s2
99;BioInfer.d47;TRUE;Although the chemical basis of these results is not known, they indicate that PROTEIN1 can tightly sequester PROTEIN2 monomers and support the earlier suggestion that the affinity of PROTEIN for PROTEIN may be under metabolic control.;BioInfer.d47.s0
100;BioInfer.d47;FALSE;Although the chemical basis of these results is not known, they indicate that PROTEIN1 can tightly sequester PROTEIN monomers and support the earlier suggestion that the affinity of PROTEIN for PROTEIN2 may be under metabolic control.;BioInfer.d47.s0
101;BioInfer.d47;FALSE;Although the chemical basis of these results is not known, they indicate that PROTEIN1 can tightly sequester PROTEIN monomers and support the earlier suggestion that the affinity of PROTEIN2 for PROTEIN may be under metabolic control.;BioInfer.d47.s0
102;BioInfer.d47;FALSE;Although the chemical basis of these results is not known, they indicate that PROTEIN can tightly sequester PROTEIN1 monomers and support the earlier suggestion that the affinity of PROTEIN for PROTEIN2 may be under metabolic control.;BioInfer.d47.s0
103;BioInfer.d47;FALSE;Although the chemical basis of these results is not known, they indicate that PROTEIN can tightly sequester PROTEIN1 monomers and support the earlier suggestion that the affinity of PROTEIN2 for PROTEIN may be under metabolic control.;BioInfer.d47.s0
104;BioInfer.d47;TRUE;Although the chemical basis of these results is not known, they indicate that PROTEIN can tightly sequester PROTEIN monomers and support the earlier suggestion that the affinity of PROTEIN1 for PROTEIN2 may be under metabolic control.;BioInfer.d47.s0
105;BioInfer.d47;TRUE;Recent evidence that PROTEIN1 inhibits PROTEIN and enhances nucleotide exchange of PROTEIN2 has led some to question whether PROTEIN is ever truly an PROTEIN monomer sequestering agent.;BioInfer.d47.s1
106;BioInfer.d47;FALSE;Recent evidence that PROTEIN1 inhibits PROTEIN and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN2 is ever truly an PROTEIN monomer sequestering agent.;BioInfer.d47.s1
107;BioInfer.d47;FALSE;Recent evidence that PROTEIN1 inhibits PROTEIN and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN is ever truly an PROTEIN2 monomer sequestering agent.;BioInfer.d47.s1
108;BioInfer.d47;TRUE;Recent evidence that PROTEIN1 inhibits PROTEIN2 and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN is ever truly an PROTEIN monomer sequestering agent.;BioInfer.d47.s1
109;BioInfer.d47;FALSE;Recent evidence that PROTEIN inhibits PROTEIN and enhances nucleotide exchange of PROTEIN1 has led some to question whether PROTEIN2 is ever truly an PROTEIN monomer sequestering agent.;BioInfer.d47.s1
110;BioInfer.d47;FALSE;Recent evidence that PROTEIN inhibits PROTEIN and enhances nucleotide exchange of PROTEIN1 has led some to question whether PROTEIN is ever truly an PROTEIN2 monomer sequestering agent.;BioInfer.d47.s1
111;BioInfer.d47;FALSE;Recent evidence that PROTEIN inhibits PROTEIN1 and enhances nucleotide exchange of PROTEIN2 has led some to question whether PROTEIN is ever truly an PROTEIN monomer sequestering agent.;BioInfer.d47.s1
112;BioInfer.d47;TRUE;Recent evidence that PROTEIN inhibits PROTEIN and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN1 is ever truly an PROTEIN2 monomer sequestering agent.;BioInfer.d47.s1
113;BioInfer.d47;FALSE;Recent evidence that PROTEIN inhibits PROTEIN1 and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN2 is ever truly an PROTEIN monomer sequestering agent.;BioInfer.d47.s1
114;BioInfer.d47;FALSE;Recent evidence that PROTEIN inhibits PROTEIN1 and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN is ever truly an PROTEIN2 monomer sequestering agent.;BioInfer.d47.s1
115;BioInfer.d54;FALSE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN1 has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN another PROTEIN2 and PROTEIN binding protein from focal adhesions.;BioInfer.d54.s0
116;BioInfer.d54;TRUE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN1 has a negligible influence on internal PROTEIN filament dynamics and PROTEIN2 bending stiffness which contrasts with our previous observations with PROTEIN another PROTEIN and PROTEIN binding protein from focal adhesions.;BioInfer.d54.s0
117;BioInfer.d54;TRUE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN1 has a negligible influence on internal PROTEIN2 filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN another PROTEIN and PROTEIN binding protein from focal adhesions.;BioInfer.d54.s0
118;BioInfer.d54;FALSE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN1 has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN2 another PROTEIN and PROTEIN binding protein from focal adhesions.;BioInfer.d54.s0
119;BioInfer.d54;FALSE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN1 has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN another PROTEIN and PROTEIN2 binding protein from focal adhesions.;BioInfer.d54.s0
120;BioInfer.d54;FALSE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN1 bending stiffness which contrasts with our previous observations with PROTEIN another PROTEIN2 and PROTEIN binding protein from focal adhesions.;BioInfer.d54.s0
121;BioInfer.d54;FALSE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN1 filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN another PROTEIN2 and PROTEIN binding protein from focal adhesions.;BioInfer.d54.s0
122;BioInfer.d54;TRUE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN1 another PROTEIN2 and PROTEIN binding protein from focal adhesions.;BioInfer.d54.s0
123;BioInfer.d54;FALSE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN another PROTEIN1 and PROTEIN2 binding protein from focal adhesions.;BioInfer.d54.s0
124;BioInfer.d54;FALSE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN1 filament dynamics and PROTEIN2 bending stiffness which contrasts with our previous observations with PROTEIN another PROTEIN and PROTEIN binding protein from focal adhesions.;BioInfer.d54.s0
125;BioInfer.d54;FALSE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN1 bending stiffness which contrasts with our previous observations with PROTEIN2 another PROTEIN and PROTEIN binding protein from focal adhesions.;BioInfer.d54.s0
126;BioInfer.d54;FALSE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN1 bending stiffness which contrasts with our previous observations with PROTEIN another PROTEIN and PROTEIN2 binding protein from focal adhesions.;BioInfer.d54.s0
127;BioInfer.d54;FALSE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN1 filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN2 another PROTEIN and PROTEIN binding protein from focal adhesions.;BioInfer.d54.s0
128;BioInfer.d54;FALSE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN1 filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN another PROTEIN and PROTEIN2 binding protein from focal adhesions.;BioInfer.d54.s0
129;BioInfer.d54;TRUE;Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN1 another PROTEIN and PROTEIN2 binding protein from focal adhesions.;BioInfer.d54.s0
130;BioInfer.d64;TRUE;An atomic model of PROTEIN1 filaments cross-linked by PROTEIN2 and its implications for bundle assembly and function.;BioInfer.d64.s0
131;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN1 and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN2 2tetramers.;BioInfer.d74.s0
132;BioInfer.d74;TRUE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN1 ( PROTEIN PROTEIN2 2tetramers.;BioInfer.d74.s0
133;BioInfer.d74;TRUE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN1 resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN2 2tetramers.;BioInfer.d74.s0
134;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN1 PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN2 2tetramers.;BioInfer.d74.s0
135;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN1 fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN2 2tetramers.;BioInfer.d74.s0
136;BioInfer.d74;TRUE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN1 PROTEIN2 2tetramers.;BioInfer.d74.s0
137;BioInfer.d74;FALSE;Archaeal PROTEIN1 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN2 2tetramers.;BioInfer.d74.s0
138;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN1 and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
139;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN1 and the results reported are consistent with archaeal PROTEIN2 resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
140;BioInfer.d74;TRUE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN1 PROTEIN2 and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
141;BioInfer.d74;TRUE;Archaeal PROTEIN are most similar to the globular PROTEIN1 fold region of eukaryal PROTEIN PROTEIN2 and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
142;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN1 and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN2 PROTEIN 2tetramers.;BioInfer.d74.s0
143;BioInfer.d74;FALSE;Archaeal PROTEIN1 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN2 and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
144;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN1 resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
145;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN1 PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
146;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN1 fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
147;BioInfer.d74;TRUE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN1 ( PROTEIN2 PROTEIN 2tetramers.;BioInfer.d74.s0
148;BioInfer.d74;FALSE;Archaeal PROTEIN1 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
149;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN1 PROTEIN and the results reported are consistent with archaeal PROTEIN2 resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
150;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN1 fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN2 resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
151;BioInfer.d74;TRUE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN1 resembling the structure formed by eukaryal PROTEIN ( PROTEIN2 PROTEIN 2tetramers.;BioInfer.d74.s0
152;BioInfer.d74;FALSE;Archaeal PROTEIN1 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN2 resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
153;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN1 fold region of eukaryal PROTEIN2 PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
154;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN1 PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN2 PROTEIN 2tetramers.;BioInfer.d74.s0
155;BioInfer.d74;FALSE;Archaeal PROTEIN1 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN2 PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
156;BioInfer.d74;FALSE;Archaeal PROTEIN are most similar to the globular PROTEIN1 fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN2 PROTEIN 2tetramers.;BioInfer.d74.s0
157;BioInfer.d74;TRUE;Archaeal PROTEIN1 are most similar to the globular PROTEIN2 fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN PROTEIN 2tetramers.;BioInfer.d74.s0
158;BioInfer.d74;FALSE;Archaeal PROTEIN1 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN PROTEIN and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN2 PROTEIN 2tetramers.;BioInfer.d74.s0
159;BioInfer.d80;TRUE;As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN1 PROTEIN2 interacting domain.;BioInfer.d80.s0
160;BioInfer.d80;FALSE;As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN1 binding domain or PROTEIN inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN PROTEIN2 interacting domain.;BioInfer.d80.s0
161;BioInfer.d80;TRUE;As expected, PROTEIN was found to interact with three domains of PROTEIN1 including PROTEIN binding domain or PROTEIN inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN PROTEIN2 interacting domain.;BioInfer.d80.s0
162;BioInfer.d80;FALSE;As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN1 inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN PROTEIN2 interacting domain.;BioInfer.d80.s0
163;BioInfer.d80;FALSE;As expected, PROTEIN1 was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN PROTEIN2 interacting domain.;BioInfer.d80.s0
164;BioInfer.d80;FALSE;As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN1 binding domain or PROTEIN inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN2 PROTEIN interacting domain.;BioInfer.d80.s0
165;BioInfer.d80;FALSE;As expected, PROTEIN was found to interact with three domains of PROTEIN1 including PROTEIN binding domain or PROTEIN inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN2 PROTEIN interacting domain.;BioInfer.d80.s0
166;BioInfer.d80;FALSE;As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN1 inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN2 PROTEIN interacting domain.;BioInfer.d80.s0
167;BioInfer.d80;FALSE;As expected, PROTEIN1 was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN2 PROTEIN interacting domain.;BioInfer.d80.s0
168;BioInfer.d80;TRUE;As expected, PROTEIN was found to interact with three domains of PROTEIN1 including PROTEIN2 binding domain or PROTEIN inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN PROTEIN interacting domain.;BioInfer.d80.s0
169;BioInfer.d80;FALSE;As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN1 binding domain or PROTEIN2 inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN PROTEIN interacting domain.;BioInfer.d80.s0
170;BioInfer.d80;FALSE;As expected, PROTEIN1 was found to interact with three domains of PROTEIN including PROTEIN2 binding domain or PROTEIN inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN PROTEIN interacting domain.;BioInfer.d80.s0
171;BioInfer.d80;FALSE;As expected, PROTEIN was found to interact with three domains of PROTEIN1 including PROTEIN binding domain or PROTEIN2 inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN PROTEIN interacting domain.;BioInfer.d80.s0
172;BioInfer.d80;TRUE;As expected, PROTEIN1 was found to interact with three domains of PROTEIN2 including PROTEIN binding domain or PROTEIN inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN PROTEIN interacting domain.;BioInfer.d80.s0
173;BioInfer.d80;FALSE;As expected, PROTEIN1 was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN2 inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN PROTEIN interacting domain.;BioInfer.d80.s0
174;BioInfer.d86;TRUE;At least one element of the PROTEIN1 binding region of human PROTEIN2 is an alpha-helix.;BioInfer.d86.s0
175;BioInfer.d90;FALSE;BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules ( PROTEIN1 PROTEIN and PROTEIN2 has been reported to be associated with tumor metastasis.;BioInfer.d90.s0
176;BioInfer.d90;FALSE;BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules ( PROTEIN PROTEIN1 and PROTEIN2 has been reported to be associated with tumor metastasis.;BioInfer.d90.s0
177;BioInfer.d90;FALSE;BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules ( PROTEIN1 PROTEIN2 and PROTEIN has been reported to be associated with tumor metastasis.;BioInfer.d90.s0
178;BioInfer.d90;FALSE;In this study, we evaluated the prognostic significance of PROTEIN PROTEIN1 and PROTEIN2 expressions in the metastatic foci of patients with colorectal carcinoma.;BioInfer.d90.s1
179;BioInfer.d90;FALSE;In this study, we evaluated the prognostic significance of PROTEIN1 PROTEIN2 and PROTEIN expressions in the metastatic foci of patients with colorectal carcinoma.;BioInfer.d90.s1
180;BioInfer.d90;FALSE;In this study, we evaluated the prognostic significance of PROTEIN1 PROTEIN and PROTEIN2 expressions in the metastatic foci of patients with colorectal carcinoma.;BioInfer.d90.s1
181;BioInfer.d90;FALSE;RESULTS: Reduced normal expression of PROTEIN PROTEIN1 and PROTEIN2 in comparison with normal epithelium was detected in 78 primary tumors, respectively.;BioInfer.d90.s2
182;BioInfer.d90;FALSE;RESULTS: Reduced normal expression of PROTEIN1 PROTEIN and PROTEIN2 in comparison with normal epithelium was detected in 78 primary tumors, respectively.;BioInfer.d90.s2
183;BioInfer.d90;FALSE;RESULTS: Reduced normal expression of PROTEIN1 PROTEIN2 and PROTEIN in comparison with normal epithelium was detected in 78 primary tumors, respectively.;BioInfer.d90.s2
184;BioInfer.d93;TRUE;Because PROTEIN PROTEIN shares many structural features with PROTEIN1 PROTEIN2 and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.;BioInfer.d93.s0
185;BioInfer.d93;FALSE;Because PROTEIN1 PROTEIN shares many structural features with PROTEIN PROTEIN2 and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.;BioInfer.d93.s0
186;BioInfer.d93;TRUE;Because PROTEIN PROTEIN1 shares many structural features with PROTEIN PROTEIN2 and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.;BioInfer.d93.s0
187;BioInfer.d93;FALSE;Because PROTEIN PROTEIN shares many structural features with PROTEIN PROTEIN1 and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN2 has similar functions.;BioInfer.d93.s0
188;BioInfer.d93;FALSE;Because PROTEIN PROTEIN shares many structural features with PROTEIN PROTEIN1 and is intimately associated with PROTEIN2 in the assembled nucleosome, we asked whether PROTEIN has similar functions.;BioInfer.d93.s0
189;BioInfer.d93;FALSE;Because PROTEIN1 PROTEIN shares many structural features with PROTEIN2 PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.;BioInfer.d93.s0
190;BioInfer.d93;FALSE;Because PROTEIN PROTEIN1 shares many structural features with PROTEIN2 PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.;BioInfer.d93.s0
191;BioInfer.d93;FALSE;Because PROTEIN PROTEIN shares many structural features with PROTEIN1 PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN2 has similar functions.;BioInfer.d93.s0
192;BioInfer.d93;FALSE;Because PROTEIN PROTEIN shares many structural features with PROTEIN1 PROTEIN and is intimately associated with PROTEIN2 in the assembled nucleosome, we asked whether PROTEIN has similar functions.;BioInfer.d93.s0
193;BioInfer.d93;TRUE;Because PROTEIN1 PROTEIN2 shares many structural features with PROTEIN PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.;BioInfer.d93.s0
194;BioInfer.d93;FALSE;Because PROTEIN1 PROTEIN shares many structural features with PROTEIN PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN2 has similar functions.;BioInfer.d93.s0
195;BioInfer.d93;FALSE;Because PROTEIN1 PROTEIN shares many structural features with PROTEIN PROTEIN and is intimately associated with PROTEIN2 in the assembled nucleosome, we asked whether PROTEIN has similar functions.;BioInfer.d93.s0
196;BioInfer.d93;FALSE;Because PROTEIN PROTEIN1 shares many structural features with PROTEIN PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN2 has similar functions.;BioInfer.d93.s0
197;BioInfer.d93;TRUE;Because PROTEIN PROTEIN1 shares many structural features with PROTEIN PROTEIN and is intimately associated with PROTEIN2 in the assembled nucleosome, we asked whether PROTEIN has similar functions.;BioInfer.d93.s0
198;BioInfer.d93;FALSE;Because PROTEIN PROTEIN shares many structural features with PROTEIN PROTEIN and is intimately associated with PROTEIN1 in the assembled nucleosome, we asked whether PROTEIN2 has similar functions.;BioInfer.d93.s0
199;BioInfer.d98;TRUE;Binding to human PROTEIN1 by PROTEIN2 and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.;BioInfer.d98.s0
200;BioInfer.d101;FALSE;Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN PROTEIN1 PROTEIN and CD44 isoform 6 ( PROTEIN2 , to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.;BioInfer.d101.s0
201;BioInfer.d101;FALSE;Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN PROTEIN1 PROTEIN2 and CD44 isoform 6 ( PROTEIN , to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.;BioInfer.d101.s0
202;BioInfer.d101;FALSE;Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN1 PROTEIN2 PROTEIN and CD44 isoform 6 ( PROTEIN , to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.;BioInfer.d101.s0
203;BioInfer.d101;FALSE;Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN PROTEIN PROTEIN1 and CD44 isoform 6 ( PROTEIN2 , to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.;BioInfer.d101.s0
204;BioInfer.d101;FALSE;Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN1 PROTEIN PROTEIN and CD44 isoform 6 ( PROTEIN2 , to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.;BioInfer.d101.s0
205;BioInfer.d101;FALSE;Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN1 PROTEIN PROTEIN2 and CD44 isoform 6 ( PROTEIN , to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.;BioInfer.d101.s0
206;BioInfer.d109;TRUE; PROTEIN1 ( PROTEIN is a 130-kDa transmembrane receptor for PROTEIN mediators of neuronal guidance, and for PROTEIN ( PROTEIN2 , an angiogenesis factor.;BioInfer.d109.s0
207;BioInfer.d109;FALSE; PROTEIN ( PROTEIN is a 130-kDa transmembrane receptor for PROTEIN1 mediators of neuronal guidance, and for PROTEIN ( PROTEIN2 , an angiogenesis factor.;BioInfer.d109.s0
208;BioInfer.d109;FALSE; PROTEIN ( PROTEIN is a 130-kDa transmembrane receptor for PROTEIN mediators of neuronal guidance, and for PROTEIN1 ( PROTEIN2 , an angiogenesis factor.;BioInfer.d109.s0
209;BioInfer.d109;TRUE; PROTEIN ( PROTEIN1 is a 130-kDa transmembrane receptor for PROTEIN mediators of neuronal guidance, and for PROTEIN ( PROTEIN2 , an angiogenesis factor.;BioInfer.d109.s0
210;BioInfer.d109;TRUE; PROTEIN1 ( PROTEIN is a 130-kDa transmembrane receptor for PROTEIN2 mediators of neuronal guidance, and for PROTEIN ( PROTEIN , an angiogenesis factor.;BioInfer.d109.s0
211;BioInfer.d109;TRUE; PROTEIN1 ( PROTEIN is a 130-kDa transmembrane receptor for PROTEIN mediators of neuronal guidance, and for PROTEIN2 ( PROTEIN , an angiogenesis factor.;BioInfer.d109.s0
212;BioInfer.d109;FALSE; PROTEIN1 ( PROTEIN2 is a 130-kDa transmembrane receptor for PROTEIN mediators of neuronal guidance, and for PROTEIN ( PROTEIN , an angiogenesis factor.;BioInfer.d109.s0
213;BioInfer.d109;FALSE; PROTEIN ( PROTEIN is a 130-kDa transmembrane receptor for PROTEIN1 mediators of neuronal guidance, and for PROTEIN2 ( PROTEIN , an angiogenesis factor.;BioInfer.d109.s0
214;BioInfer.d109;TRUE; PROTEIN ( PROTEIN1 is a 130-kDa transmembrane receptor for PROTEIN2 mediators of neuronal guidance, and for PROTEIN ( PROTEIN , an angiogenesis factor.;BioInfer.d109.s0
215;BioInfer.d109;TRUE; PROTEIN ( PROTEIN1 is a 130-kDa transmembrane receptor for PROTEIN mediators of neuronal guidance, and for PROTEIN2 ( PROTEIN , an angiogenesis factor.;BioInfer.d109.s0
216;BioInfer.d109;TRUE;A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN isoform containing just the a/ PROTEIN and b/ PROTEIN1 homology extracellular domains of PROTEIN2 ;BioInfer.d109.s1
217;BioInfer.d109;FALSE;A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN1 ( PROTEIN isoform containing just the a/ PROTEIN and b/ PROTEIN2 homology extracellular domains of PROTEIN ;BioInfer.d109.s1
218;BioInfer.d109;FALSE;A 2.2-kb truncated PROTEIN1 cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN isoform containing just the a/ PROTEIN and b/ PROTEIN2 homology extracellular domains of PROTEIN ;BioInfer.d109.s1
219;BioInfer.d109;FALSE;A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN1 isoform containing just the a/ PROTEIN and b/ PROTEIN2 homology extracellular domains of PROTEIN ;BioInfer.d109.s1
220;BioInfer.d109;FALSE;A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN isoform containing just the a/ PROTEIN1 and b/ PROTEIN2 homology extracellular domains of PROTEIN ;BioInfer.d109.s1
221;BioInfer.d109;FALSE;A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN1 ( PROTEIN isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN2 ;BioInfer.d109.s1
222;BioInfer.d109;FALSE;A 2.2-kb truncated PROTEIN1 cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN2 ;BioInfer.d109.s1
223;BioInfer.d109;FALSE;A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN1 isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN2 ;BioInfer.d109.s1
224;BioInfer.d109;TRUE;A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN isoform containing just the a/ PROTEIN1 and b/ PROTEIN homology extracellular domains of PROTEIN2 ;BioInfer.d109.s1
225;BioInfer.d109;TRUE;A 2.2-kb truncated PROTEIN1 cDNA was cloned that encodes a 644-aa PROTEIN2 ( PROTEIN isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN ;BioInfer.d109.s1
226;BioInfer.d109;FALSE;A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN1 ( PROTEIN2 isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN ;BioInfer.d109.s1
227;BioInfer.d109;FALSE;A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN1 ( PROTEIN isoform containing just the a/ PROTEIN2 and b/ PROTEIN homology extracellular domains of PROTEIN ;BioInfer.d109.s1
228;BioInfer.d109;TRUE;A 2.2-kb truncated PROTEIN1 cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN2 isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN ;BioInfer.d109.s1
229;BioInfer.d109;FALSE;A 2.2-kb truncated PROTEIN1 cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN isoform containing just the a/ PROTEIN2 and b/ PROTEIN homology extracellular domains of PROTEIN ;BioInfer.d109.s1
230;BioInfer.d109;FALSE;A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN1 isoform containing just the a/ PROTEIN2 and b/ PROTEIN homology extracellular domains of PROTEIN ;BioInfer.d109.s1
231;BioInfer.d109;FALSE; PROTEIN is secreted by cells as a 90-kDa protein that binds PROTEIN1 but not PROTEIN2 ;BioInfer.d109.s2
232;BioInfer.d109;TRUE; PROTEIN1 is secreted by cells as a 90-kDa protein that binds PROTEIN but not PROTEIN2 ;BioInfer.d109.s2
233;BioInfer.d109;TRUE; PROTEIN1 is secreted by cells as a 90-kDa protein that binds PROTEIN2 but not PROTEIN ;BioInfer.d109.s2
234;BioInfer.d110;TRUE;Both complexes are composed of PROTEIN and PROTEIN1 which bind to either PROTEIN or PROTEIN2 in a mutually exclusive manner.;BioInfer.d110.s0
235;BioInfer.d110;TRUE;Both complexes are composed of PROTEIN1 and PROTEIN2 which bind to either PROTEIN or PROTEIN in a mutually exclusive manner.;BioInfer.d110.s0
236;BioInfer.d110;TRUE;Both complexes are composed of PROTEIN and PROTEIN1 which bind to either PROTEIN2 or PROTEIN in a mutually exclusive manner.;BioInfer.d110.s0
237;BioInfer.d110;TRUE;Both complexes are composed of PROTEIN1 and PROTEIN which bind to either PROTEIN or PROTEIN2 in a mutually exclusive manner.;BioInfer.d110.s0
238;BioInfer.d110;FALSE;Both complexes are composed of PROTEIN and PROTEIN which bind to either PROTEIN1 or PROTEIN2 in a mutually exclusive manner.;BioInfer.d110.s0
239;BioInfer.d110;TRUE;Both complexes are composed of PROTEIN1 and PROTEIN which bind to either PROTEIN2 or PROTEIN in a mutually exclusive manner.;BioInfer.d110.s0
240;BioInfer.d120;FALSE;By the use of HSV mutants for the PROTEIN1 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the PROTEIN2 or PROTEIN gene used as control.;BioInfer.d120.s0
241;BioInfer.d120;FALSE;By the use of HSV mutants for the PROTEIN gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the PROTEIN1 or PROTEIN2 gene used as control.;BioInfer.d120.s0
242;BioInfer.d120;FALSE;By the use of HSV mutants for the PROTEIN1 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the PROTEIN or PROTEIN2 gene used as control.;BioInfer.d120.s0
243;BioInfer.d125;FALSE;Calculated solution molecular masses are 213 kDa for PROTEIN1 73 kDa for PROTEIN2 and 186 kDa for both.;BioInfer.d125.s0
244;BioInfer.d128;FALSE;"Cardiac hypertrophy and the steady state level of the ""fetal"" genes, PROTEIN PROTEIN1 ( PROTEIN2 , and PROTEIN ( PROTEIN mRNAs were assessed.";BioInfer.d128.s0
245;BioInfer.d128;FALSE;"Cardiac hypertrophy and the steady state level of the ""fetal"" genes, PROTEIN PROTEIN1 ( PROTEIN , and PROTEIN2 ( PROTEIN mRNAs were assessed.";BioInfer.d128.s0
246;BioInfer.d128;FALSE;"Cardiac hypertrophy and the steady state level of the ""fetal"" genes, PROTEIN1 PROTEIN2 ( PROTEIN , and PROTEIN ( PROTEIN mRNAs were assessed.";BioInfer.d128.s0
247;BioInfer.d128;FALSE;"Cardiac hypertrophy and the steady state level of the ""fetal"" genes, PROTEIN PROTEIN1 ( PROTEIN , and PROTEIN ( PROTEIN2 mRNAs were assessed.";BioInfer.d128.s0
248;BioInfer.d128;FALSE;"Cardiac hypertrophy and the steady state level of the ""fetal"" genes, PROTEIN PROTEIN ( PROTEIN1 , and PROTEIN2 ( PROTEIN mRNAs were assessed.";BioInfer.d128.s0
249;BioInfer.d128;FALSE;"Cardiac hypertrophy and the steady state level of the ""fetal"" genes, PROTEIN1 PROTEIN ( PROTEIN2 , and PROTEIN ( PROTEIN mRNAs were assessed.";BioInfer.d128.s0
250;BioInfer.d128;FALSE;"Cardiac hypertrophy and the steady state level of the ""fetal"" genes, PROTEIN PROTEIN ( PROTEIN1 , and PROTEIN ( PROTEIN2 mRNAs were assessed.";BioInfer.d128.s0
251;BioInfer.d128;FALSE;"Cardiac hypertrophy and the steady state level of the ""fetal"" genes, PROTEIN1 PROTEIN ( PROTEIN , and PROTEIN2 ( PROTEIN mRNAs were assessed.";BioInfer.d128.s0
252;BioInfer.d128;FALSE;"Cardiac hypertrophy and the steady state level of the ""fetal"" genes, PROTEIN PROTEIN ( PROTEIN , and PROTEIN1 ( PROTEIN2 mRNAs were assessed.";BioInfer.d128.s0
253;BioInfer.d128;FALSE;"Cardiac hypertrophy and the steady state level of the ""fetal"" genes, PROTEIN1 PROTEIN ( PROTEIN , and PROTEIN ( PROTEIN2 mRNAs were assessed.";BioInfer.d128.s0
254;BioInfer.d132;FALSE;Cells lacking PROTEIN1 a protein which in many mammalian cell types is a constituent of focal complexes that link the PROTEIN2 cytoskeleton to the plasma membrane, are strongly impaired in adhesion to external surfaces.;BioInfer.d132.s0
255;BioInfer.d138;FALSE;Characterization of PROTEIN1 and PROTEIN2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.;BioInfer.d138.s0
256;BioInfer.d145;FALSE;cDNA clones of the PROTEIN1 PROTEIN and PROTEIN2 genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.;BioInfer.d145.s0
257;BioInfer.d145;FALSE;cDNA clones of the PROTEIN1 PROTEIN2 and PROTEIN genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.;BioInfer.d145.s0
258;BioInfer.d145;FALSE;cDNA clones of the PROTEIN PROTEIN1 and PROTEIN2 genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.;BioInfer.d145.s0
259;BioInfer.d146;TRUE; PROTEIN1 and PROTEIN may also be involved in the redistribution of PROTEIN2 during myofibrillogenesis and in the process of PROTEIN disassembly in degenerating muscles.;BioInfer.d146.s0
260;BioInfer.d146;FALSE; PROTEIN1 and PROTEIN2 may also be involved in the redistribution of PROTEIN during myofibrillogenesis and in the process of PROTEIN disassembly in degenerating muscles.;BioInfer.d146.s0
261;BioInfer.d146;TRUE; PROTEIN1 and PROTEIN may also be involved in the redistribution of PROTEIN during myofibrillogenesis and in the process of PROTEIN2 disassembly in degenerating muscles.;BioInfer.d146.s0
262;BioInfer.d146;TRUE; PROTEIN and PROTEIN1 may also be involved in the redistribution of PROTEIN2 during myofibrillogenesis and in the process of PROTEIN disassembly in degenerating muscles.;BioInfer.d146.s0
263;BioInfer.d146;FALSE; PROTEIN and PROTEIN may also be involved in the redistribution of PROTEIN1 during myofibrillogenesis and in the process of PROTEIN2 disassembly in degenerating muscles.;BioInfer.d146.s0
264;BioInfer.d146;TRUE; PROTEIN and PROTEIN1 may also be involved in the redistribution of PROTEIN during myofibrillogenesis and in the process of PROTEIN2 disassembly in degenerating muscles.;BioInfer.d146.s0
265;BioInfer.d152;TRUE;CONCLUSION: The results show that PROTEIN1 and PROTEIN2 form a complex in vivo and suggest that they participate in epithelial cell differentiation and targeted vesicle transport processes in the developing kidney.;BioInfer.d152.s0
266;BioInfer.d176;FALSE;Dispersal of PROTEIN1 from such sites by oligoproline-rich peptide inhibitors suggests that PROTEIN2 is directly involved in intracellular pathogen locomotion and reorganization of PROTEIN cytoskeleton of the host cell peripheral membrane.;BioInfer.d176.s0
267;BioInfer.d176;FALSE;Dispersal of PROTEIN1 from such sites by oligoproline-rich peptide inhibitors suggests that PROTEIN is directly involved in intracellular pathogen locomotion and reorganization of PROTEIN2 cytoskeleton of the host cell peripheral membrane.;BioInfer.d176.s0
268;BioInfer.d176;TRUE;Dispersal of PROTEIN from such sites by oligoproline-rich peptide inhibitors suggests that PROTEIN1 is directly involved in intracellular pathogen locomotion and reorganization of PROTEIN2 cytoskeleton of the host cell peripheral membrane.;BioInfer.d176.s0
269;BioInfer.d194;FALSE;Even though rates of total protein and PROTEIN1 synthesis resembled values measured in vivo, PROTEIN2 fractional rate of synthesis was only 22% of in vivo levels.;BioInfer.d194.s0
270;BioInfer.d196;TRUE;Evidence suggests that this differential recognition bears functional significance concerning the intricate roles of PROTEIN1 and inositol lipids in modulating PROTEIN2 polymerization and PtdIns(4,5)P2 turnover.;BioInfer.d196.s0
271;BioInfer.d198;TRUE;Experiments performed using extracts from doubly infected cells indicated that PROTEIN could interact separately with both the PROTEIN1 and PROTEIN2 proteins.;BioInfer.d198.s0
272;BioInfer.d198;TRUE;Experiments performed using extracts from doubly infected cells indicated that PROTEIN1 could interact separately with both the PROTEIN2 and PROTEIN proteins.;BioInfer.d198.s0
273;BioInfer.d198;TRUE;Experiments performed using extracts from doubly infected cells indicated that PROTEIN1 could interact separately with both the PROTEIN and PROTEIN2 proteins.;BioInfer.d198.s0
274;BioInfer.d198;FALSE; PROTEIN was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN PROTEIN1 and PROTEIN2 polypeptides.;BioInfer.d198.s1
275;BioInfer.d198;FALSE; PROTEIN1 was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN PROTEIN and PROTEIN2 polypeptides.;BioInfer.d198.s1
276;BioInfer.d198;FALSE; PROTEIN was shown to recognize the PROTEIN1 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN PROTEIN and PROTEIN2 polypeptides.;BioInfer.d198.s1
277;BioInfer.d198;FALSE; PROTEIN was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN1 PROTEIN and PROTEIN2 polypeptides.;BioInfer.d198.s1
278;BioInfer.d198;FALSE; PROTEIN1 was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN PROTEIN2 and PROTEIN polypeptides.;BioInfer.d198.s1
279;BioInfer.d198;FALSE; PROTEIN was shown to recognize the PROTEIN1 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN PROTEIN2 and PROTEIN polypeptides.;BioInfer.d198.s1
280;BioInfer.d198;FALSE; PROTEIN was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN1 PROTEIN2 and PROTEIN polypeptides.;BioInfer.d198.s1
281;BioInfer.d198;TRUE; PROTEIN1 was shown to recognize the PROTEIN2 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN PROTEIN and PROTEIN polypeptides.;BioInfer.d198.s1
282;BioInfer.d198;FALSE; PROTEIN1 was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN2 PROTEIN and PROTEIN polypeptides.;BioInfer.d198.s1
283;BioInfer.d198;FALSE; PROTEIN was shown to recognize the PROTEIN1 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN2 PROTEIN and PROTEIN polypeptides.;BioInfer.d198.s1
284;BioInfer.d200;FALSE;Exposure of the rabbit retina to a combination of an PROTEIN1 antagonist, 8-cyclopentyl-1,3 dipropylxanthine (DPCPX), and PROTEIN2 did not affect the enhancing action of DAMGO on the light-evoked release of ACh.;BioInfer.d200.s0
285;BioInfer.d203;FALSE;Expression of PROTEIN1 was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN ( PROTEIN and PROTEIN2 ;BioInfer.d203.s0
286;BioInfer.d203;FALSE;Expression of PROTEIN was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN ( PROTEIN1 and PROTEIN2 ;BioInfer.d203.s0
287;BioInfer.d203;FALSE;Expression of PROTEIN was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN1 ( PROTEIN and PROTEIN2 ;BioInfer.d203.s0
288;BioInfer.d203;FALSE;Expression of PROTEIN1 was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN ( PROTEIN2 and PROTEIN ;BioInfer.d203.s0
289;BioInfer.d203;FALSE;Expression of PROTEIN1 was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN2 ( PROTEIN and PROTEIN ;BioInfer.d203.s0
290;BioInfer.d203;FALSE;Expression of PROTEIN was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN1 ( PROTEIN2 and PROTEIN ;BioInfer.d203.s0
291;BioInfer.d203;FALSE;In invasive ductal carcinomas, PROTEIN1 was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of PROTEIN2 and PROTEIN was unchanged between them.;BioInfer.d203.s1
292;BioInfer.d203;FALSE;In invasive ductal carcinomas, PROTEIN1 was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of PROTEIN and PROTEIN2 was unchanged between them.;BioInfer.d203.s1
293;BioInfer.d203;FALSE;In invasive ductal carcinomas, PROTEIN was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of PROTEIN1 and PROTEIN2 was unchanged between them.;BioInfer.d203.s1
294;BioInfer.d206;FALSE;Expressions of PROTEIN1 A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by PROTEIN2 PROTEIN expression.;BioInfer.d206.s0
295;BioInfer.d206;TRUE;Expressions of PROTEIN A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by PROTEIN1 PROTEIN2 expression.;BioInfer.d206.s0
296;BioInfer.d206;TRUE;Expressions of PROTEIN1 A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by PROTEIN PROTEIN2 expression.;BioInfer.d206.s0
297;BioInfer.d211;TRUE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN1 interact with peptides encoding the PROTEIN binding region of PROTEIN PROTEIN PROTEIN2 and the Torpedo PROTEIN protein.;BioInfer.d211.s0
298;BioInfer.d211;TRUE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN1 interact with peptides encoding the PROTEIN binding region of PROTEIN PROTEIN2 PROTEIN and the Torpedo PROTEIN protein.;BioInfer.d211.s0
299;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN2 interact with peptides encoding the PROTEIN binding region of PROTEIN PROTEIN PROTEIN and the Torpedo PROTEIN protein.;BioInfer.d211.s0
300;BioInfer.d211;TRUE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN1 interact with peptides encoding the PROTEIN binding region of PROTEIN2 PROTEIN PROTEIN and the Torpedo PROTEIN protein.;BioInfer.d211.s0
301;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN1 interact with peptides encoding the PROTEIN2 binding region of PROTEIN PROTEIN PROTEIN and the Torpedo PROTEIN protein.;BioInfer.d211.s0
302;BioInfer.d211;TRUE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN1 interact with peptides encoding the PROTEIN binding region of PROTEIN PROTEIN PROTEIN and the Torpedo PROTEIN2 protein.;BioInfer.d211.s0
303;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the PROTEIN binding region of PROTEIN PROTEIN1 PROTEIN2 and the Torpedo PROTEIN protein.;BioInfer.d211.s0
304;BioInfer.d211;TRUE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN interact with peptides encoding the PROTEIN binding region of PROTEIN PROTEIN PROTEIN2 and the Torpedo PROTEIN protein.;BioInfer.d211.s0
305;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the PROTEIN binding region of PROTEIN1 PROTEIN PROTEIN2 and the Torpedo PROTEIN protein.;BioInfer.d211.s0
306;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the PROTEIN1 binding region of PROTEIN PROTEIN PROTEIN2 and the Torpedo PROTEIN protein.;BioInfer.d211.s0
307;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the PROTEIN binding region of PROTEIN PROTEIN PROTEIN1 and the Torpedo PROTEIN2 protein.;BioInfer.d211.s0
308;BioInfer.d211;TRUE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN interact with peptides encoding the PROTEIN binding region of PROTEIN PROTEIN2 PROTEIN and the Torpedo PROTEIN protein.;BioInfer.d211.s0
309;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the PROTEIN binding region of PROTEIN1 PROTEIN2 PROTEIN and the Torpedo PROTEIN protein.;BioInfer.d211.s0
310;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the PROTEIN1 binding region of PROTEIN PROTEIN2 PROTEIN and the Torpedo PROTEIN protein.;BioInfer.d211.s0
311;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the PROTEIN binding region of PROTEIN PROTEIN1 PROTEIN and the Torpedo PROTEIN2 protein.;BioInfer.d211.s0
312;BioInfer.d211;TRUE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN interact with peptides encoding the PROTEIN binding region of PROTEIN2 PROTEIN PROTEIN and the Torpedo PROTEIN protein.;BioInfer.d211.s0
313;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN interact with peptides encoding the PROTEIN2 binding region of PROTEIN PROTEIN PROTEIN and the Torpedo PROTEIN protein.;BioInfer.d211.s0
314;BioInfer.d211;TRUE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN interact with peptides encoding the PROTEIN binding region of PROTEIN PROTEIN PROTEIN and the Torpedo PROTEIN2 protein.;BioInfer.d211.s0
315;BioInfer.d211;TRUE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the PROTEIN1 binding region of PROTEIN2 PROTEIN PROTEIN and the Torpedo PROTEIN protein.;BioInfer.d211.s0
316;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the PROTEIN binding region of PROTEIN1 PROTEIN PROTEIN and the Torpedo PROTEIN2 protein.;BioInfer.d211.s0
317;BioInfer.d211;FALSE;Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the PROTEIN1 binding region of PROTEIN PROTEIN PROTEIN and the Torpedo PROTEIN2 protein.;BioInfer.d211.s0
318;BioInfer.d217;FALSE;From previous work, the PROTEIN1 PROTEIN2 and PROTEIN gene products also appear to be involved in linking PROTEIN to the PROTEIN cytoskeleton.;BioInfer.d217.s0
319;BioInfer.d217;TRUE;From previous work, the PROTEIN1 PROTEIN and PROTEIN gene products also appear to be involved in linking PROTEIN to the PROTEIN2 cytoskeleton.;BioInfer.d217.s0
320;BioInfer.d217;FALSE;From previous work, the PROTEIN1 PROTEIN and PROTEIN2 gene products also appear to be involved in linking PROTEIN to the PROTEIN cytoskeleton.;BioInfer.d217.s0
321;BioInfer.d217;TRUE;From previous work, the PROTEIN1 PROTEIN and PROTEIN gene products also appear to be involved in linking PROTEIN2 to the PROTEIN cytoskeleton.;BioInfer.d217.s0
322;BioInfer.d217;TRUE;From previous work, the PROTEIN PROTEIN1 and PROTEIN gene products also appear to be involved in linking PROTEIN to the PROTEIN2 cytoskeleton.;BioInfer.d217.s0
323;BioInfer.d217;FALSE;From previous work, the PROTEIN PROTEIN1 and PROTEIN2 gene products also appear to be involved in linking PROTEIN to the PROTEIN cytoskeleton.;BioInfer.d217.s0
324;BioInfer.d217;TRUE;From previous work, the PROTEIN PROTEIN1 and PROTEIN gene products also appear to be involved in linking PROTEIN2 to the PROTEIN cytoskeleton.;BioInfer.d217.s0
325;BioInfer.d217;TRUE;From previous work, the PROTEIN PROTEIN and PROTEIN1 gene products also appear to be involved in linking PROTEIN to the PROTEIN2 cytoskeleton.;BioInfer.d217.s0
326;BioInfer.d217;TRUE;From previous work, the PROTEIN PROTEIN and PROTEIN gene products also appear to be involved in linking PROTEIN1 to the PROTEIN2 cytoskeleton.;BioInfer.d217.s0
327;BioInfer.d217;TRUE;From previous work, the PROTEIN PROTEIN and PROTEIN1 gene products also appear to be involved in linking PROTEIN2 to the PROTEIN cytoskeleton.;BioInfer.d217.s0
328;BioInfer.d219;FALSE;From these we have isolated eight viable and lethal alleles of the PROTEIN1 gene, and seven viable alleles of the indirect flight muscle (IFM)-specific PROTEIN2 PROTEIN gene.;BioInfer.d219.s0
329;BioInfer.d219;FALSE;From these we have isolated eight viable and lethal alleles of the PROTEIN1 gene, and seven viable alleles of the indirect flight muscle (IFM)-specific PROTEIN PROTEIN2 gene.;BioInfer.d219.s0
330;BioInfer.d219;TRUE;From these we have isolated eight viable and lethal alleles of the PROTEIN gene, and seven viable alleles of the indirect flight muscle (IFM)-specific PROTEIN1 PROTEIN2 gene.;BioInfer.d219.s0
331;BioInfer.d220;FALSE;Frozen tissue sections, isolated cardiomyocytes, cultured neonatal cardiomyocytes and fibroblasts were hybridized with DNA probes for type-specific PROTEIN1 PROTEIN2 and PROTEIN ;BioInfer.d220.s0
332;BioInfer.d220;FALSE;Frozen tissue sections, isolated cardiomyocytes, cultured neonatal cardiomyocytes and fibroblasts were hybridized with DNA probes for type-specific PROTEIN1 PROTEIN and PROTEIN2 ;BioInfer.d220.s0
333;BioInfer.d220;FALSE;Frozen tissue sections, isolated cardiomyocytes, cultured neonatal cardiomyocytes and fibroblasts were hybridized with DNA probes for type-specific PROTEIN PROTEIN1 and PROTEIN2 ;BioInfer.d220.s0
334;BioInfer.d221;TRUE;Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host PROTEIN1 family proteins: an acidic stretch, an PROTEIN monomer-binding region, and a PROTEIN2 homology sequence.;BioInfer.d221.s0
335;BioInfer.d221;FALSE;Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host PROTEIN family proteins: an acidic stretch, an PROTEIN1 monomer-binding region, and a PROTEIN2 homology sequence.;BioInfer.d221.s0
336;BioInfer.d221;TRUE;Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host PROTEIN1 family proteins: an acidic stretch, an PROTEIN2 monomer-binding region, and a PROTEIN homology sequence.;BioInfer.d221.s0
337;BioInfer.d221;TRUE;The PROTEIN1 homology sequence is critical for stimulating PROTEIN nucleation with the PROTEIN 3 complex in vitro, and is essential for PROTEIN2 polymerization and motility in cells.;BioInfer.d221.s1
338;BioInfer.d221;FALSE;The PROTEIN homology sequence is critical for stimulating PROTEIN1 nucleation with the PROTEIN 3 complex in vitro, and is essential for PROTEIN2 polymerization and motility in cells.;BioInfer.d221.s1
339;BioInfer.d221;FALSE;The PROTEIN homology sequence is critical for stimulating PROTEIN nucleation with the PROTEIN1 3 complex in vitro, and is essential for PROTEIN2 polymerization and motility in cells.;BioInfer.d221.s1
340;BioInfer.d221;TRUE;The PROTEIN1 homology sequence is critical for stimulating PROTEIN2 nucleation with the PROTEIN 3 complex in vitro, and is essential for PROTEIN polymerization and motility in cells.;BioInfer.d221.s1
341;BioInfer.d221;FALSE;The PROTEIN1 homology sequence is critical for stimulating PROTEIN nucleation with the PROTEIN2 3 complex in vitro, and is essential for PROTEIN polymerization and motility in cells.;BioInfer.d221.s1
342;BioInfer.d221;TRUE;The PROTEIN homology sequence is critical for stimulating PROTEIN1 nucleation with the PROTEIN2 3 complex in vitro, and is essential for PROTEIN polymerization and motility in cells.;BioInfer.d221.s1
343;BioInfer.d228;FALSE;Fusion of the endocardial ridges of the truncus on late ED13 is accompanied by the organization of PROTEIN1 and PROTEIN2 positive myofibroblasts into a central whorl and the appearance of the semilunar valve anlagen at their definitive topographical position within the proximal portion of the truncus.;BioInfer.d228.s0
344;BioInfer.d231;TRUE;Genetic analysis suggested that this phenotype was due to PROTEIN sequestering PROTEIN1 and preventing it from interacting with PROTEIN2 and PROTEIN ;BioInfer.d231.s0
345;BioInfer.d231;TRUE;Genetic analysis suggested that this phenotype was due to PROTEIN1 sequestering PROTEIN2 and preventing it from interacting with PROTEIN and PROTEIN ;BioInfer.d231.s0
346;BioInfer.d231;TRUE;Genetic analysis suggested that this phenotype was due to PROTEIN sequestering PROTEIN1 and preventing it from interacting with PROTEIN and PROTEIN2 ;BioInfer.d231.s0
347;BioInfer.d231;TRUE;Genetic analysis suggested that this phenotype was due to PROTEIN1 sequestering PROTEIN and preventing it from interacting with PROTEIN2 and PROTEIN ;BioInfer.d231.s0
348;BioInfer.d231;FALSE;Genetic analysis suggested that this phenotype was due to PROTEIN sequestering PROTEIN and preventing it from interacting with PROTEIN1 and PROTEIN2 ;BioInfer.d231.s0
349;BioInfer.d231;TRUE;Genetic analysis suggested that this phenotype was due to PROTEIN1 sequestering PROTEIN and preventing it from interacting with PROTEIN and PROTEIN2 ;BioInfer.d231.s0
350;BioInfer.d235;FALSE; PROTEIN1 is not likely to be a PROTEIN2 PROTEIN PROTEIN or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.;BioInfer.d235.s0
351;BioInfer.d235;FALSE; PROTEIN1 is not likely to be a PROTEIN PROTEIN PROTEIN or PROTEIN based on the lack of reactivity of PROTEIN2 with these polypeptides in immunoblots.;BioInfer.d235.s0
352;BioInfer.d235;FALSE; PROTEIN1 is not likely to be a PROTEIN PROTEIN PROTEIN2 or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.;BioInfer.d235.s0
353;BioInfer.d235;FALSE; PROTEIN1 is not likely to be a PROTEIN PROTEIN2 PROTEIN or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.;BioInfer.d235.s0
354;BioInfer.d235;FALSE; PROTEIN1 is not likely to be a PROTEIN PROTEIN PROTEIN or PROTEIN2 based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.;BioInfer.d235.s0
355;BioInfer.d235;TRUE; PROTEIN is not likely to be a PROTEIN1 PROTEIN PROTEIN or PROTEIN based on the lack of reactivity of PROTEIN2 with these polypeptides in immunoblots.;BioInfer.d235.s0
356;BioInfer.d235;FALSE; PROTEIN is not likely to be a PROTEIN1 PROTEIN PROTEIN2 or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.;BioInfer.d235.s0
357;BioInfer.d235;FALSE; PROTEIN is not likely to be a PROTEIN1 PROTEIN2 PROTEIN or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.;BioInfer.d235.s0
358;BioInfer.d235;FALSE; PROTEIN is not likely to be a PROTEIN1 PROTEIN PROTEIN or PROTEIN2 based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.;BioInfer.d235.s0
359;BioInfer.d235;TRUE; PROTEIN is not likely to be a PROTEIN PROTEIN PROTEIN1 or PROTEIN based on the lack of reactivity of PROTEIN2 with these polypeptides in immunoblots.;BioInfer.d235.s0
360;BioInfer.d235;TRUE; PROTEIN is not likely to be a PROTEIN PROTEIN1 PROTEIN or PROTEIN based on the lack of reactivity of PROTEIN2 with these polypeptides in immunoblots.;BioInfer.d235.s0
361;BioInfer.d235;TRUE; PROTEIN is not likely to be a PROTEIN PROTEIN PROTEIN or PROTEIN1 based on the lack of reactivity of PROTEIN2 with these polypeptides in immunoblots.;BioInfer.d235.s0
362;BioInfer.d235;FALSE; PROTEIN is not likely to be a PROTEIN PROTEIN1 PROTEIN2 or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.;BioInfer.d235.s0
363;BioInfer.d235;FALSE; PROTEIN is not likely to be a PROTEIN PROTEIN PROTEIN1 or PROTEIN2 based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.;BioInfer.d235.s0
364;BioInfer.d235;FALSE; PROTEIN is not likely to be a PROTEIN PROTEIN1 PROTEIN or PROTEIN2 based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.;BioInfer.d235.s0
365;BioInfer.d253;TRUE;Here we show that the PROTEIN1 dependent proteolysis system is involved in the regulation of PROTEIN2 turnover.;BioInfer.d253.s0
366;BioInfer.d253;FALSE; PROTEIN1 but not PROTEIN PROTEIN PROTEIN or PROTEIN2 becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
367;BioInfer.d253;FALSE; PROTEIN but not PROTEIN1 PROTEIN PROTEIN or PROTEIN2 becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
368;BioInfer.d253;FALSE; PROTEIN but not PROTEIN PROTEIN PROTEIN or PROTEIN1 becomes stabilized when PROTEIN2 mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
369;BioInfer.d253;FALSE; PROTEIN but not PROTEIN PROTEIN PROTEIN1 or PROTEIN2 becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
370;BioInfer.d253;FALSE; PROTEIN but not PROTEIN PROTEIN PROTEIN or PROTEIN1 becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN2 ;BioInfer.d253.s1
371;BioInfer.d253;FALSE; PROTEIN but not PROTEIN PROTEIN1 PROTEIN or PROTEIN2 becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
372;BioInfer.d253;FALSE; PROTEIN1 but not PROTEIN2 PROTEIN PROTEIN or PROTEIN becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
373;BioInfer.d253;FALSE; PROTEIN1 but not PROTEIN PROTEIN PROTEIN or PROTEIN becomes stabilized when PROTEIN2 mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
374;BioInfer.d253;FALSE; PROTEIN1 but not PROTEIN PROTEIN PROTEIN2 or PROTEIN becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
375;BioInfer.d253;FALSE; PROTEIN1 but not PROTEIN PROTEIN PROTEIN or PROTEIN becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN2 ;BioInfer.d253.s1
376;BioInfer.d253;FALSE; PROTEIN1 but not PROTEIN PROTEIN2 PROTEIN or PROTEIN becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
377;BioInfer.d253;FALSE; PROTEIN but not PROTEIN1 PROTEIN PROTEIN or PROTEIN becomes stabilized when PROTEIN2 mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
378;BioInfer.d253;FALSE; PROTEIN but not PROTEIN1 PROTEIN PROTEIN2 or PROTEIN becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
379;BioInfer.d253;FALSE; PROTEIN but not PROTEIN1 PROTEIN PROTEIN or PROTEIN becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN2 ;BioInfer.d253.s1
380;BioInfer.d253;FALSE; PROTEIN but not PROTEIN1 PROTEIN2 PROTEIN or PROTEIN becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
381;BioInfer.d253;FALSE; PROTEIN but not PROTEIN PROTEIN PROTEIN1 or PROTEIN becomes stabilized when PROTEIN2 mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
382;BioInfer.d253;FALSE; PROTEIN but not PROTEIN PROTEIN PROTEIN or PROTEIN becomes stabilized when PROTEIN1 mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN2 ;BioInfer.d253.s1
383;BioInfer.d253;FALSE; PROTEIN but not PROTEIN PROTEIN1 PROTEIN or PROTEIN becomes stabilized when PROTEIN2 mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
384;BioInfer.d253;FALSE; PROTEIN but not PROTEIN PROTEIN PROTEIN1 or PROTEIN becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN2 ;BioInfer.d253.s1
385;BioInfer.d253;FALSE; PROTEIN but not PROTEIN PROTEIN1 PROTEIN2 or PROTEIN becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN ;BioInfer.d253.s1
386;BioInfer.d253;FALSE; PROTEIN but not PROTEIN PROTEIN1 PROTEIN or PROTEIN becomes stabilized when PROTEIN mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN2 ;BioInfer.d253.s1
387;BioInfer.d265;TRUE;How PROTEIN1 barbed-end synergy controls PROTEIN2 polymerization: a kinetic model of the ATP hydrolysis circuit.;BioInfer.d265.s0
388;BioInfer.d265;FALSE;In particular, both PROTEIN1 and free filament barbed ends have been shown to play major roles in the processing of ATP by PROTEIN2 ;BioInfer.d265.s1
389;BioInfer.d265;TRUE;We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized PROTEIN1 and the flux of PROTEIN subunits through filaments are controlled by PROTEIN2 and free filament barbed ends through their interaction with ATP.;BioInfer.d265.s2
390;BioInfer.d265;FALSE;We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized PROTEIN1 and the flux of PROTEIN2 subunits through filaments are controlled by PROTEIN and free filament barbed ends through their interaction with ATP.;BioInfer.d265.s2
391;BioInfer.d265;TRUE;We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized PROTEIN and the flux of PROTEIN1 subunits through filaments are controlled by PROTEIN2 and free filament barbed ends through their interaction with ATP.;BioInfer.d265.s2
392;BioInfer.d271;FALSE;However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN PROTEIN1 ( PROTEIN2 , and the associated inhibition of PROTEIN PROTEIN ;BioInfer.d271.s0
393;BioInfer.d271;TRUE;However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN1 PROTEIN2 ( PROTEIN , and the associated inhibition of PROTEIN PROTEIN ;BioInfer.d271.s0
394;BioInfer.d271;FALSE;However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN PROTEIN1 ( PROTEIN , and the associated inhibition of PROTEIN2 PROTEIN ;BioInfer.d271.s0
395;BioInfer.d271;FALSE;However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN PROTEIN1 ( PROTEIN , and the associated inhibition of PROTEIN PROTEIN2 ;BioInfer.d271.s0
396;BioInfer.d271;TRUE;However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN1 PROTEIN ( PROTEIN2 , and the associated inhibition of PROTEIN PROTEIN ;BioInfer.d271.s0
397;BioInfer.d271;FALSE;However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN PROTEIN ( PROTEIN1 , and the associated inhibition of PROTEIN2 PROTEIN ;BioInfer.d271.s0
398;BioInfer.d271;FALSE;However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN PROTEIN ( PROTEIN1 , and the associated inhibition of PROTEIN PROTEIN2 ;BioInfer.d271.s0
399;BioInfer.d271;TRUE;However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN1 PROTEIN ( PROTEIN , and the associated inhibition of PROTEIN2 PROTEIN ;BioInfer.d271.s0
400;BioInfer.d271;TRUE;However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN1 PROTEIN ( PROTEIN , and the associated inhibition of PROTEIN PROTEIN2 ;BioInfer.d271.s0
401;BioInfer.d271;TRUE;However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN PROTEIN ( PROTEIN , and the associated inhibition of PROTEIN1 PROTEIN2 ;BioInfer.d271.s0
402;BioInfer.d273;TRUE;However, regulation of PROTEIN function is generally unknown and controversy exists regarding PROTEIN1 effects on PROTEIN2 polymerization.;BioInfer.d273.s0
403;BioInfer.d273;FALSE;However, regulation of PROTEIN1 function is generally unknown and controversy exists regarding PROTEIN effects on PROTEIN2 polymerization.;BioInfer.d273.s0
404;BioInfer.d273;FALSE;However, regulation of PROTEIN1 function is generally unknown and controversy exists regarding PROTEIN2 effects on PROTEIN polymerization.;BioInfer.d273.s0
405;BioInfer.d277;FALSE;However, there were no changes in the expression of PROTEIN1 PROTEIN2 and PROTEIN ;BioInfer.d277.s0
406;BioInfer.d277;FALSE;However, there were no changes in the expression of PROTEIN1 PROTEIN and PROTEIN2 ;BioInfer.d277.s0
407;BioInfer.d277;FALSE;However, there were no changes in the expression of PROTEIN PROTEIN1 and PROTEIN2 ;BioInfer.d277.s0
408;BioInfer.d286;FALSE;Immunoblot and Northern blot analyses also revealed the presence of PROTEIN PROTEIN and PROTEIN1 ( PROTEIN2 in these cell lines.;BioInfer.d286.s0
409;BioInfer.d286;FALSE;Immunoblot and Northern blot analyses also revealed the presence of PROTEIN PROTEIN1 and PROTEIN ( PROTEIN2 in these cell lines.;BioInfer.d286.s0
410;BioInfer.d286;FALSE;Immunoblot and Northern blot analyses also revealed the presence of PROTEIN1 PROTEIN and PROTEIN ( PROTEIN2 in these cell lines.;BioInfer.d286.s0
411;BioInfer.d286;FALSE;Immunoblot and Northern blot analyses also revealed the presence of PROTEIN PROTEIN1 and PROTEIN2 ( PROTEIN in these cell lines.;BioInfer.d286.s0
412;BioInfer.d286;FALSE;Immunoblot and Northern blot analyses also revealed the presence of PROTEIN1 PROTEIN and PROTEIN2 ( PROTEIN in these cell lines.;BioInfer.d286.s0
413;BioInfer.d286;FALSE;Immunoblot and Northern blot analyses also revealed the presence of PROTEIN1 PROTEIN2 and PROTEIN ( PROTEIN in these cell lines.;BioInfer.d286.s0
414;BioInfer.d290;FALSE;Immunofluorescence studies with these antibodies showed PROTEIN to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric PROTEIN1 also was present, as shown by labeling with fluorescent PROTEIN2 ;BioInfer.d290.s0
415;BioInfer.d290;TRUE;Immunofluorescence studies with these antibodies showed PROTEIN1 to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric PROTEIN2 also was present, as shown by labeling with fluorescent PROTEIN ;BioInfer.d290.s0
416;BioInfer.d290;FALSE;Immunofluorescence studies with these antibodies showed PROTEIN1 to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric PROTEIN also was present, as shown by labeling with fluorescent PROTEIN2 ;BioInfer.d290.s0
417;BioInfer.d290;TRUE;"The differential localization of the three PROTEIN1 monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN2 functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.";BioInfer.d290.s1
418;BioInfer.d290;FALSE;"The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN1 functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN2 inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.";BioInfer.d290.s1
419;BioInfer.d290;FALSE;"The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN1 functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN2 regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.";BioInfer.d290.s1
420;BioInfer.d290;TRUE;"The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN1 functions predominantly as an PROTEIN2 monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.";BioInfer.d290.s1
421;BioInfer.d290;TRUE;"The differential localization of the three PROTEIN1 monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN2 inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.";BioInfer.d290.s1
422;BioInfer.d290;TRUE;"The differential localization of the three PROTEIN1 monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN2 regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.";BioInfer.d290.s1
423;BioInfer.d290;FALSE;"The differential localization of the three PROTEIN1 monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN2 monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.";BioInfer.d290.s1
424;BioInfer.d290;FALSE;"The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN1 regulates, or is regulated by, PIP2; and (3) PROTEIN2 inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.";BioInfer.d290.s1
425;BioInfer.d290;FALSE;"The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN1 monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN2 inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.";BioInfer.d290.s1
426;BioInfer.d290;FALSE;"The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN1 monomer-binding protein; (2) PROTEIN2 regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.";BioInfer.d290.s1
427;BioInfer.d303;TRUE;Immunostaining showed that APBs also contain PROTEIN PROTEIN1 and PROTEIN2 proteins involved in DNA synthesis and recombination.;BioInfer.d303.s0
428;BioInfer.d303;TRUE;Immunostaining showed that APBs also contain PROTEIN1 PROTEIN2 and PROTEIN proteins involved in DNA synthesis and recombination.;BioInfer.d303.s0
429;BioInfer.d303;TRUE;Immunostaining showed that APBs also contain PROTEIN1 PROTEIN and PROTEIN2 proteins involved in DNA synthesis and recombination.;BioInfer.d303.s0
430;BioInfer.d310;TRUE;In addition, interactions with components of the phosphatidylinositol cycle and the PROTEIN1 pathway in yeast implicate PROTEIN2 as an important link through which the PROTEIN cytoskeleton is able to communicate with major signaling pathways.;BioInfer.d310.s0
431;BioInfer.d310;FALSE;In addition, interactions with components of the phosphatidylinositol cycle and the PROTEIN1 pathway in yeast implicate PROTEIN as an important link through which the PROTEIN2 cytoskeleton is able to communicate with major signaling pathways.;BioInfer.d310.s0
432;BioInfer.d310;TRUE;In addition, interactions with components of the phosphatidylinositol cycle and the PROTEIN pathway in yeast implicate PROTEIN1 as an important link through which the PROTEIN2 cytoskeleton is able to communicate with major signaling pathways.;BioInfer.d310.s0
433;BioInfer.d310;TRUE;So far, three ligands for PROTEIN1 have been well-characterized in vitro: PROTEIN2 monomers, membrane polyphosphoinositides and poly-L-proline.;BioInfer.d310.s1
434;BioInfer.d318;FALSE;In adherens junctions, the cytoplasmic domain of PROTEIN1 bind to PROTEIN which in turn binds to the PROTEIN associated protein PROTEIN2 ;BioInfer.d318.s0
435;BioInfer.d318;TRUE;In adherens junctions, the cytoplasmic domain of PROTEIN bind to PROTEIN which in turn binds to the PROTEIN1 associated protein PROTEIN2 ;BioInfer.d318.s0
436;BioInfer.d318;TRUE;In adherens junctions, the cytoplasmic domain of PROTEIN bind to PROTEIN1 which in turn binds to the PROTEIN associated protein PROTEIN2 ;BioInfer.d318.s0
437;BioInfer.d318;FALSE;In adherens junctions, the cytoplasmic domain of PROTEIN1 bind to PROTEIN which in turn binds to the PROTEIN2 associated protein PROTEIN ;BioInfer.d318.s0
438;BioInfer.d318;TRUE;In adherens junctions, the cytoplasmic domain of PROTEIN1 bind to PROTEIN2 which in turn binds to the PROTEIN associated protein PROTEIN ;BioInfer.d318.s0
439;BioInfer.d318;FALSE;In adherens junctions, the cytoplasmic domain of PROTEIN bind to PROTEIN1 which in turn binds to the PROTEIN2 associated protein PROTEIN ;BioInfer.d318.s0
440;BioInfer.d326;FALSE;In contrast, EC located immediately behind the migrating front retained junctional PROTEIN PROTEIN1 and PROTEIN while PROTEIN2 was absent from these sites.;BioInfer.d326.s0
441;BioInfer.d326;FALSE;In contrast, EC located immediately behind the migrating front retained junctional PROTEIN1 PROTEIN2 and PROTEIN while PROTEIN was absent from these sites.;BioInfer.d326.s0
442;BioInfer.d326;FALSE;In contrast, EC located immediately behind the migrating front retained junctional PROTEIN PROTEIN1 and PROTEIN2 while PROTEIN was absent from these sites.;BioInfer.d326.s0
443;BioInfer.d326;FALSE;In contrast, EC located immediately behind the migrating front retained junctional PROTEIN1 PROTEIN and PROTEIN while PROTEIN2 was absent from these sites.;BioInfer.d326.s0
444;BioInfer.d326;FALSE;In contrast, EC located immediately behind the migrating front retained junctional PROTEIN PROTEIN and PROTEIN1 while PROTEIN2 was absent from these sites.;BioInfer.d326.s0
445;BioInfer.d326;FALSE;In contrast, EC located immediately behind the migrating front retained junctional PROTEIN1 PROTEIN and PROTEIN2 while PROTEIN was absent from these sites.;BioInfer.d326.s0
446;BioInfer.d328;TRUE;In contrast to the PROTEIN Min/+) enterocytes, PROTEIN Min/-) adenomas displayed increased expression and association of PROTEIN1 PROTEIN and PROTEIN2 relative to PROTEIN +/+) controls.;BioInfer.d328.s0
447;BioInfer.d328;TRUE;In contrast to the PROTEIN Min/+) enterocytes, PROTEIN Min/-) adenomas displayed increased expression and association of PROTEIN1 PROTEIN2 and PROTEIN relative to PROTEIN +/+) controls.;BioInfer.d328.s0
448;BioInfer.d328;FALSE;In contrast to the PROTEIN Min/+) enterocytes, PROTEIN1 Min/-) adenomas displayed increased expression and association of PROTEIN2 PROTEIN and PROTEIN relative to PROTEIN +/+) controls.;BioInfer.d328.s0
449;BioInfer.d328;FALSE;In contrast to the PROTEIN1 Min/+) enterocytes, PROTEIN Min/-) adenomas displayed increased expression and association of PROTEIN2 PROTEIN and PROTEIN relative to PROTEIN +/+) controls.;BioInfer.d328.s0
450;BioInfer.d328;FALSE;In contrast to the PROTEIN Min/+) enterocytes, PROTEIN Min/-) adenomas displayed increased expression and association of PROTEIN1 PROTEIN and PROTEIN relative to PROTEIN2 +/+) controls.;BioInfer.d328.s0
451;BioInfer.d328;TRUE;In contrast to the PROTEIN Min/+) enterocytes, PROTEIN Min/-) adenomas displayed increased expression and association of PROTEIN PROTEIN1 and PROTEIN2 relative to PROTEIN +/+) controls.;BioInfer.d328.s0
452;BioInfer.d328;FALSE;In contrast to the PROTEIN Min/+) enterocytes, PROTEIN1 Min/-) adenomas displayed increased expression and association of PROTEIN PROTEIN and PROTEIN2 relative to PROTEIN +/+) controls.;BioInfer.d328.s0
453;BioInfer.d328;FALSE;In contrast to the PROTEIN1 Min/+) enterocytes, PROTEIN Min/-) adenomas displayed increased expression and association of PROTEIN PROTEIN and PROTEIN2 relative to PROTEIN +/+) controls.;BioInfer.d328.s0
454;BioInfer.d328;FALSE;In contrast to the PROTEIN Min/+) enterocytes, PROTEIN Min/-) adenomas displayed increased expression and association of PROTEIN PROTEIN and PROTEIN1 relative to PROTEIN2 +/+) controls.;BioInfer.d328.s0
455;BioInfer.d328;FALSE;In contrast to the PROTEIN Min/+) enterocytes, PROTEIN1 Min/-) adenomas displayed increased expression and association of PROTEIN PROTEIN2 and PROTEIN relative to PROTEIN +/+) controls.;BioInfer.d328.s0
456;BioInfer.d328;FALSE;In contrast to the PROTEIN1 Min/+) enterocytes, PROTEIN Min/-) adenomas displayed increased expression and association of PROTEIN PROTEIN2 and PROTEIN relative to PROTEIN +/+) controls.;BioInfer.d328.s0
457;BioInfer.d328;FALSE;In contrast to the PROTEIN Min/+) enterocytes, PROTEIN Min/-) adenomas displayed increased expression and association of PROTEIN PROTEIN1 and PROTEIN relative to PROTEIN2 +/+) controls.;BioInfer.d328.s0
458;BioInfer.d328;FALSE;In contrast to the PROTEIN1 Min/+) enterocytes, PROTEIN2 Min/-) adenomas displayed increased expression and association of PROTEIN PROTEIN and PROTEIN relative to PROTEIN +/+) controls.;BioInfer.d328.s0
459;BioInfer.d328;FALSE;In contrast to the PROTEIN Min/+) enterocytes, PROTEIN1 Min/-) adenomas displayed increased expression and association of PROTEIN PROTEIN and PROTEIN relative to PROTEIN2 +/+) controls.;BioInfer.d328.s0
460;BioInfer.d328;FALSE;In contrast to the PROTEIN1 Min/+) enterocytes, PROTEIN Min/-) adenomas displayed increased expression and association of PROTEIN PROTEIN and PROTEIN relative to PROTEIN2 +/+) controls.;BioInfer.d328.s0
461;BioInfer.d341;FALSE;Inhibition of PROTEIN1 expression or induction of PROTEIN PROTEIN2 expression was found in mimosine-treated lung cancer cells.;BioInfer.d341.s0
462;BioInfer.d341;FALSE;Inhibition of PROTEIN1 expression or induction of PROTEIN2 PROTEIN expression was found in mimosine-treated lung cancer cells.;BioInfer.d341.s0
463;BioInfer.d341;TRUE;Inhibition of PROTEIN expression or induction of PROTEIN1 PROTEIN2 expression was found in mimosine-treated lung cancer cells.;BioInfer.d341.s0
464;BioInfer.d344;TRUE;In infected cells, PROTEIN1 was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN PROTEIN and PROTEIN PROTEIN2 which were also detected with specific antisera.;BioInfer.d344.s0
465;BioInfer.d344;FALSE;In infected cells, PROTEIN1 was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN PROTEIN and PROTEIN2 PROTEIN which were also detected with specific antisera.;BioInfer.d344.s0
466;BioInfer.d344;FALSE;In infected cells, PROTEIN1 was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN2 PROTEIN and PROTEIN PROTEIN which were also detected with specific antisera.;BioInfer.d344.s0
467;BioInfer.d344;TRUE;In infected cells, PROTEIN1 was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN PROTEIN2 and PROTEIN PROTEIN which were also detected with specific antisera.;BioInfer.d344.s0
468;BioInfer.d344;TRUE;In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN PROTEIN and PROTEIN1 PROTEIN2 which were also detected with specific antisera.;BioInfer.d344.s0
469;BioInfer.d344;FALSE;In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN1 PROTEIN and PROTEIN PROTEIN2 which were also detected with specific antisera.;BioInfer.d344.s0
470;BioInfer.d344;FALSE;In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN PROTEIN1 and PROTEIN PROTEIN2 which were also detected with specific antisera.;BioInfer.d344.s0
471;BioInfer.d344;FALSE;In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN1 PROTEIN and PROTEIN2 PROTEIN which were also detected with specific antisera.;BioInfer.d344.s0
472;BioInfer.d344;FALSE;In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN PROTEIN1 and PROTEIN2 PROTEIN which were also detected with specific antisera.;BioInfer.d344.s0
473;BioInfer.d344;TRUE;In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN1 PROTEIN2 and PROTEIN PROTEIN which were also detected with specific antisera.;BioInfer.d344.s0
474;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN1 and a concomitant decrease in PROTEIN2 activity.;BioInfer.d345.s0
475;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1 PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN2 and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
476;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN1 specifically bound to PROTEIN2 and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
477;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN1 causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN2 and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
478;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN1 that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN2 and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
479;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN1 PROTEIN specifically bound to PROTEIN2 and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
480;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN1 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN2 and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
481;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN1 PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN2 and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
482;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1 PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN2 activity.;BioInfer.d345.s0
483;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN1 specifically bound to PROTEIN and a concomitant decrease in PROTEIN2 activity.;BioInfer.d345.s0
484;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN1 causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN2 activity.;BioInfer.d345.s0
485;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN1 that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN2 activity.;BioInfer.d345.s0
486;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN1 PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN2 activity.;BioInfer.d345.s0
487;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN1 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN2 activity.;BioInfer.d345.s0
488;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN1 PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN2 activity.;BioInfer.d345.s0
489;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1 PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN2 specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
490;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN1 causes a posttranscriptional accumulation of the PROTEIN2 PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
491;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1 PROTEIN PROTEIN2 that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
492;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1 PROTEIN PROTEIN that is accompanied by an increase in PROTEIN2 PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
493;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN1 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN2 PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
494;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1 PROTEIN2 PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
495;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN1 causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN2 specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
496;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN1 that is accompanied by an increase in PROTEIN PROTEIN2 specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
497;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN1 PROTEIN2 specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
498;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN1 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN2 specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
499;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN1 PROTEIN that is accompanied by an increase in PROTEIN PROTEIN2 specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
500;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN1 causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN2 that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
501;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN1 causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN2 PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
502;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN1 induces senescence, we have found that PROTEIN2 causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
503;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN1 causes a posttranscriptional accumulation of the PROTEIN PROTEIN2 PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
504;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN1 that is accompanied by an increase in PROTEIN2 PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
505;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN1 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN2 that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
506;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN1 PROTEIN2 that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
507;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN1 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN PROTEIN that is accompanied by an increase in PROTEIN2 PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
508;BioInfer.d345;TRUE;In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN1 PROTEIN that is accompanied by an increase in PROTEIN2 PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
509;BioInfer.d345;FALSE;In investigating the mechanism by which PROTEIN1 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN PROTEIN2 PROTEIN that is accompanied by an increase in PROTEIN PROTEIN specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.;BioInfer.d345.s0
510;BioInfer.d349;FALSE;In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of PROTEIN microfilaments, i.e. PROTEIN1 and PROTEIN2 during the ontogeny of the neural crest and its derivatives in the avian embryo.;BioInfer.d349.s0
511;BioInfer.d349;TRUE;In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of PROTEIN1 microfilaments, i.e. PROTEIN2 and PROTEIN during the ontogeny of the neural crest and its derivatives in the avian embryo.;BioInfer.d349.s0
512;BioInfer.d349;TRUE;In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of PROTEIN1 microfilaments, i.e. PROTEIN and PROTEIN2 during the ontogeny of the neural crest and its derivatives in the avian embryo.;BioInfer.d349.s0
513;BioInfer.d362;TRUE;Interestingly, the regions that show the most structural diversity are located at or near the PROTEIN1 binding site of PROTEIN2 ;BioInfer.d362.s0
514;BioInfer.d363;TRUE;Interestingly, two major PROTEIN1 found in brain, PROTEIN2 and PROTEIN specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.;BioInfer.d363.s0
515;BioInfer.d363;FALSE;Interestingly, two major PROTEIN found in brain, PROTEIN1 and PROTEIN2 specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.;BioInfer.d363.s0
516;BioInfer.d363;TRUE;Interestingly, two major PROTEIN1 found in brain, PROTEIN and PROTEIN2 specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.;BioInfer.d363.s0
517;BioInfer.d368;FALSE;In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the PROTEIN1 inhibitor alpha,beta-methylene ADP (100 microM), by PROTEIN (2 U/ml) and by the PROTEIN2 antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).;BioInfer.d368.s0
518;BioInfer.d368;FALSE;In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the PROTEIN1 inhibitor alpha,beta-methylene ADP (100 microM), by PROTEIN2 (2 U/ml) and by the PROTEIN antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).;BioInfer.d368.s0
519;BioInfer.d368;FALSE;In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the PROTEIN inhibitor alpha,beta-methylene ADP (100 microM), by PROTEIN1 (2 U/ml) and by the PROTEIN2 antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).;BioInfer.d368.s0
520;BioInfer.d369;TRUE;In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN1 associated protein PROTEIN2 PROTEIN or the PROTEIN associated protein PROTEIN [2-4].;BioInfer.d369.s0
521;BioInfer.d369;FALSE;In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN1 associated protein PROTEIN PROTEIN or the PROTEIN associated protein PROTEIN2 [2-4].;BioInfer.d369.s0
522;BioInfer.d369;TRUE;In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN1 associated protein PROTEIN PROTEIN2 or the PROTEIN associated protein PROTEIN [2-4].;BioInfer.d369.s0
523;BioInfer.d369;FALSE;In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN1 associated protein PROTEIN PROTEIN or the PROTEIN2 associated protein PROTEIN [2-4].;BioInfer.d369.s0
524;BioInfer.d369;FALSE;In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN associated protein PROTEIN1 PROTEIN or the PROTEIN associated protein PROTEIN2 [2-4].;BioInfer.d369.s0
525;BioInfer.d369;FALSE;In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN associated protein PROTEIN1 PROTEIN2 or the PROTEIN associated protein PROTEIN [2-4].;BioInfer.d369.s0
526;BioInfer.d369;FALSE;In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN associated protein PROTEIN1 PROTEIN or the PROTEIN2 associated protein PROTEIN [2-4].;BioInfer.d369.s0
527;BioInfer.d369;FALSE;In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN associated protein PROTEIN PROTEIN1 or the PROTEIN associated protein PROTEIN2 [2-4].;BioInfer.d369.s0
528;BioInfer.d369;TRUE;In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN associated protein PROTEIN PROTEIN or the PROTEIN1 associated protein PROTEIN2 [2-4].;BioInfer.d369.s0
529;BioInfer.d369;FALSE;In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN associated protein PROTEIN PROTEIN1 or the PROTEIN2 associated protein PROTEIN [2-4].;BioInfer.d369.s0
530;BioInfer.d371;FALSE;In the present work we have used PROTEIN and PROTEIN1 injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb PROTEIN2 microfilament structure and assembly in an attempt to answer this question.;BioInfer.d371.s0
531;BioInfer.d371;FALSE;In the present work we have used PROTEIN1 and PROTEIN injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb PROTEIN2 microfilament structure and assembly in an attempt to answer this question.;BioInfer.d371.s0
532;BioInfer.d371;FALSE;In the present work we have used PROTEIN1 and PROTEIN2 injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb PROTEIN microfilament structure and assembly in an attempt to answer this question.;BioInfer.d371.s0
533;BioInfer.d380;FALSE;In this study we aimed to determine which type of expression abnormalities for PROTEIN PROTEIN1 and PROTEIN2 correlate with clinico-pathological features and survival in gastric cancer.;BioInfer.d380.s0
534;BioInfer.d380;FALSE;In this study we aimed to determine which type of expression abnormalities for PROTEIN1 PROTEIN and PROTEIN2 correlate with clinico-pathological features and survival in gastric cancer.;BioInfer.d380.s0
535;BioInfer.d380;FALSE;In this study we aimed to determine which type of expression abnormalities for PROTEIN1 PROTEIN2 and PROTEIN correlate with clinico-pathological features and survival in gastric cancer.;BioInfer.d380.s0
536;BioInfer.d382;FALSE;In this study, we demonstrate that PROTEIN1 isoforms expressed in a single cell can have different effects on PROTEIN in living cells and that the poly-L-proline binding function of PROTEIN2 may have important consequences for the regulation of PROTEIN cytoskeletal dynamics in plant cells.;BioInfer.d382.s0
537;BioInfer.d382;TRUE;In this study, we demonstrate that PROTEIN1 isoforms expressed in a single cell can have different effects on PROTEIN2 in living cells and that the poly-L-proline binding function of PROTEIN may have important consequences for the regulation of PROTEIN cytoskeletal dynamics in plant cells.;BioInfer.d382.s0
538;BioInfer.d382;FALSE;In this study, we demonstrate that PROTEIN1 isoforms expressed in a single cell can have different effects on PROTEIN in living cells and that the poly-L-proline binding function of PROTEIN may have important consequences for the regulation of PROTEIN2 cytoskeletal dynamics in plant cells.;BioInfer.d382.s0
539;BioInfer.d382;FALSE;In this study, we demonstrate that PROTEIN isoforms expressed in a single cell can have different effects on PROTEIN1 in living cells and that the poly-L-proline binding function of PROTEIN2 may have important consequences for the regulation of PROTEIN cytoskeletal dynamics in plant cells.;BioInfer.d382.s0
540;BioInfer.d382;TRUE;In this study, we demonstrate that PROTEIN isoforms expressed in a single cell can have different effects on PROTEIN in living cells and that the poly-L-proline binding function of PROTEIN1 may have important consequences for the regulation of PROTEIN2 cytoskeletal dynamics in plant cells.;BioInfer.d382.s0
541;BioInfer.d382;FALSE;In this study, we demonstrate that PROTEIN isoforms expressed in a single cell can have different effects on PROTEIN1 in living cells and that the poly-L-proline binding function of PROTEIN may have important consequences for the regulation of PROTEIN2 cytoskeletal dynamics in plant cells.;BioInfer.d382.s0
542;BioInfer.d382;TRUE;Recently, we characterized several PROTEIN1 isoforms from maize pollen for their ability to alter cytoarchitecture when microinjected into living plant cells and for their association with poly-L-proline and monomeric PROTEIN2 from maize pollen.;BioInfer.d382.s1
543;BioInfer.d382;TRUE;The affinity of PROTEIN1 for monomeric PROTEIN2 which was measured by two independent methods, is similar to that of the three PROTEIN isoforms previously identified in pollen.;BioInfer.d382.s2
544;BioInfer.d382;FALSE;The affinity of PROTEIN1 for monomeric PROTEIN which was measured by two independent methods, is similar to that of the three PROTEIN2 isoforms previously identified in pollen.;BioInfer.d382.s2
545;BioInfer.d382;TRUE;The affinity of PROTEIN for monomeric PROTEIN1 which was measured by two independent methods, is similar to that of the three PROTEIN2 isoforms previously identified in pollen.;BioInfer.d382.s2
546;BioInfer.d382;TRUE;When PROTEIN1 was microinjected into plant cells, the effect on PROTEIN2 dependent nuclear position was significantly more rapid than that of another pollen PROTEIN isoform, PROTEIN ;BioInfer.d382.s3
547;BioInfer.d382;FALSE;When PROTEIN1 was microinjected into plant cells, the effect on PROTEIN dependent nuclear position was significantly more rapid than that of another pollen PROTEIN isoform, PROTEIN2 ;BioInfer.d382.s3
548;BioInfer.d382;FALSE;When PROTEIN1 was microinjected into plant cells, the effect on PROTEIN dependent nuclear position was significantly more rapid than that of another pollen PROTEIN2 isoform, PROTEIN ;BioInfer.d382.s3
549;BioInfer.d382;TRUE;When PROTEIN was microinjected into plant cells, the effect on PROTEIN1 dependent nuclear position was significantly more rapid than that of another pollen PROTEIN isoform, PROTEIN2 ;BioInfer.d382.s3
550;BioInfer.d382;FALSE;When PROTEIN was microinjected into plant cells, the effect on PROTEIN1 dependent nuclear position was significantly more rapid than that of another pollen PROTEIN2 isoform, PROTEIN ;BioInfer.d382.s3
551;BioInfer.d382;TRUE;When PROTEIN was microinjected into plant cells, the effect on PROTEIN dependent nuclear position was significantly more rapid than that of another pollen PROTEIN1 isoform, PROTEIN2 ;BioInfer.d382.s3
552;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN2 checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
553;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN2 checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
554;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN2 checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
555;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN2 checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
556;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
557;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
558;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
559;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
560;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
561;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
562;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
563;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
564;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
565;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
566;BioInfer.d383;FALSE;In this work we report that the Saccharomyces cerevisiae PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).;BioInfer.d383.s0
567;BioInfer.d386;TRUE;In vitro, PROTEIN1 purified from some of these mutants is defective in polymerization or binding PROTEIN2 ;BioInfer.d386.s0
568;BioInfer.d402;FALSE;Like PROTEIN1 the PROTEIN2 associated proteins PROTEIN PROTEIN and the PROTEIN were also found to accumulate around entering bacteria.;BioInfer.d402.s0
569;BioInfer.d402;TRUE;Like PROTEIN the PROTEIN1 associated proteins PROTEIN PROTEIN2 and the PROTEIN were also found to accumulate around entering bacteria.;BioInfer.d402.s0
570;BioInfer.d402;TRUE;Like PROTEIN the PROTEIN1 associated proteins PROTEIN PROTEIN and the PROTEIN2 were also found to accumulate around entering bacteria.;BioInfer.d402.s0
571;BioInfer.d402;TRUE;Like PROTEIN the PROTEIN1 associated proteins PROTEIN2 PROTEIN and the PROTEIN were also found to accumulate around entering bacteria.;BioInfer.d402.s0
572;BioInfer.d402;TRUE;Like PROTEIN1 the PROTEIN associated proteins PROTEIN PROTEIN2 and the PROTEIN were also found to accumulate around entering bacteria.;BioInfer.d402.s0
573;BioInfer.d402;TRUE;Like PROTEIN1 the PROTEIN associated proteins PROTEIN PROTEIN and the PROTEIN2 were also found to accumulate around entering bacteria.;BioInfer.d402.s0
574;BioInfer.d402;TRUE;Like PROTEIN1 the PROTEIN associated proteins PROTEIN2 PROTEIN and the PROTEIN were also found to accumulate around entering bacteria.;BioInfer.d402.s0
575;BioInfer.d402;TRUE;Like PROTEIN the PROTEIN associated proteins PROTEIN PROTEIN1 and the PROTEIN2 were also found to accumulate around entering bacteria.;BioInfer.d402.s0
576;BioInfer.d402;TRUE;Like PROTEIN the PROTEIN associated proteins PROTEIN1 PROTEIN2 and the PROTEIN were also found to accumulate around entering bacteria.;BioInfer.d402.s0
577;BioInfer.d402;TRUE;Like PROTEIN the PROTEIN associated proteins PROTEIN1 PROTEIN and the PROTEIN2 were also found to accumulate around entering bacteria.;BioInfer.d402.s0
578;BioInfer.d403;TRUE;Like PROTEIN1 PROTEIN phosphorylated PROTEIN2 specifically at Ser-3 and induced formation of PROTEIN stress fibers and focal adhesions.;BioInfer.d403.s0
579;BioInfer.d403;FALSE;Like PROTEIN1 PROTEIN2 phosphorylated PROTEIN specifically at Ser-3 and induced formation of PROTEIN stress fibers and focal adhesions.;BioInfer.d403.s0
580;BioInfer.d403;TRUE;Like PROTEIN1 PROTEIN phosphorylated PROTEIN specifically at Ser-3 and induced formation of PROTEIN2 stress fibers and focal adhesions.;BioInfer.d403.s0
581;BioInfer.d403;TRUE;Like PROTEIN PROTEIN1 phosphorylated PROTEIN2 specifically at Ser-3 and induced formation of PROTEIN stress fibers and focal adhesions.;BioInfer.d403.s0
582;BioInfer.d403;FALSE;Like PROTEIN PROTEIN phosphorylated PROTEIN1 specifically at Ser-3 and induced formation of PROTEIN2 stress fibers and focal adhesions.;BioInfer.d403.s0
583;BioInfer.d403;TRUE;Like PROTEIN PROTEIN1 phosphorylated PROTEIN specifically at Ser-3 and induced formation of PROTEIN2 stress fibers and focal adhesions.;BioInfer.d403.s0
584;BioInfer.d414;FALSE; PROTEIN1 and PROTEIN2 inhibited both PROTEIN and PROTEIN induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN ;BioInfer.d414.s0
585;BioInfer.d414;FALSE; PROTEIN and PROTEIN1 inhibited both PROTEIN2 and PROTEIN induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN ;BioInfer.d414.s0
586;BioInfer.d414;FALSE; PROTEIN and PROTEIN1 inhibited both PROTEIN and PROTEIN induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN2 and PROTEIN ;BioInfer.d414.s0
587;BioInfer.d414;FALSE; PROTEIN and PROTEIN1 inhibited both PROTEIN and PROTEIN induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN2 ;BioInfer.d414.s0
588;BioInfer.d414;FALSE; PROTEIN and PROTEIN1 inhibited both PROTEIN and PROTEIN2 induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN ;BioInfer.d414.s0
589;BioInfer.d414;FALSE; PROTEIN1 and PROTEIN inhibited both PROTEIN2 and PROTEIN induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN ;BioInfer.d414.s0
590;BioInfer.d414;FALSE; PROTEIN1 and PROTEIN inhibited both PROTEIN and PROTEIN induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN2 and PROTEIN ;BioInfer.d414.s0
591;BioInfer.d414;FALSE; PROTEIN1 and PROTEIN inhibited both PROTEIN and PROTEIN induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN2 ;BioInfer.d414.s0
592;BioInfer.d414;FALSE; PROTEIN1 and PROTEIN inhibited both PROTEIN and PROTEIN2 induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN ;BioInfer.d414.s0
593;BioInfer.d414;FALSE; PROTEIN and PROTEIN inhibited both PROTEIN1 and PROTEIN induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN2 and PROTEIN ;BioInfer.d414.s0
594;BioInfer.d414;FALSE; PROTEIN and PROTEIN inhibited both PROTEIN1 and PROTEIN induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN2 ;BioInfer.d414.s0
595;BioInfer.d414;FALSE; PROTEIN and PROTEIN inhibited both PROTEIN1 and PROTEIN2 induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN ;BioInfer.d414.s0
596;BioInfer.d414;FALSE; PROTEIN and PROTEIN inhibited both PROTEIN and PROTEIN induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN1 and PROTEIN2 ;BioInfer.d414.s0
597;BioInfer.d414;FALSE; PROTEIN and PROTEIN inhibited both PROTEIN and PROTEIN1 induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN2 and PROTEIN ;BioInfer.d414.s0
598;BioInfer.d414;FALSE; PROTEIN and PROTEIN inhibited both PROTEIN and PROTEIN1 induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN2 ;BioInfer.d414.s0
599;BioInfer.d415;FALSE; PROTEIN1 is the previously identified PROTEIN which encodes PROTEIN2 required for proper organization of the PROTEIN cytoskeleton.;BioInfer.d415.s0
600;BioInfer.d415;FALSE; PROTEIN1 is the previously identified PROTEIN which encodes PROTEIN required for proper organization of the PROTEIN2 cytoskeleton.;BioInfer.d415.s0
601;BioInfer.d415;FALSE; PROTEIN1 is the previously identified PROTEIN2 which encodes PROTEIN required for proper organization of the PROTEIN cytoskeleton.;BioInfer.d415.s0
602;BioInfer.d415;TRUE; PROTEIN is the previously identified PROTEIN which encodes PROTEIN1 required for proper organization of the PROTEIN2 cytoskeleton.;BioInfer.d415.s0
603;BioInfer.d415;TRUE; PROTEIN is the previously identified PROTEIN1 which encodes PROTEIN2 required for proper organization of the PROTEIN cytoskeleton.;BioInfer.d415.s0
604;BioInfer.d415;FALSE; PROTEIN is the previously identified PROTEIN1 which encodes PROTEIN required for proper organization of the PROTEIN2 cytoskeleton.;BioInfer.d415.s0
605;BioInfer.d419;FALSE;METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of PROTEIN1 , erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of PROTEIN , draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the PROTEIN2 binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.;BioInfer.d419.s0
606;BioInfer.d419;FALSE;METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of PROTEIN1 , erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of PROTEIN2 , draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the PROTEIN binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.;BioInfer.d419.s0
607;BioInfer.d419;FALSE;METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of PROTEIN , erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of PROTEIN1 , draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the PROTEIN2 binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.;BioInfer.d419.s0
608;BioInfer.d419;FALSE;The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the PROTEIN antagonist 8-cyclopentyltheophylline and PROTEIN1 implicating endogenous adenosine acting at the PROTEIN2 ;BioInfer.d419.s1
609;BioInfer.d419;FALSE;The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the PROTEIN1 antagonist 8-cyclopentyltheophylline and PROTEIN2 implicating endogenous adenosine acting at the PROTEIN ;BioInfer.d419.s1
610;BioInfer.d419;FALSE;The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the PROTEIN1 antagonist 8-cyclopentyltheophylline and PROTEIN implicating endogenous adenosine acting at the PROTEIN2 ;BioInfer.d419.s1
611;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN1 the cell-cell adhesion molecules of PROTEIN2 PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
612;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN2 PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
613;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN1 PROTEIN2 and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
614;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN the cell-cell adhesion molecules of PROTEIN2 PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
615;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN1 PROTEIN and PROTEIN and the PROTEIN of PROTEIN2 and PROTEIN ;BioInfer.d422.s0
616;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN1 PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN2 ;BioInfer.d422.s0
617;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN2 PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
618;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN2 PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
619;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN1 PROTEIN and PROTEIN2 and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
620;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN1 PROTEIN and PROTEIN and the PROTEIN2 of PROTEIN and PROTEIN ;BioInfer.d422.s0
621;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN2 the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
622;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN1 the cell-cell adhesion molecules of PROTEIN PROTEIN2 and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
623;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN2 the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
624;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN1 the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN2 and PROTEIN ;BioInfer.d422.s0
625;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN1 the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN2 ;BioInfer.d422.s0
626;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN2 the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
627;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN2 the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
628;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN1 the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN2 and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
629;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN1 the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN2 of PROTEIN and PROTEIN ;BioInfer.d422.s0
630;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN2 and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
631;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 PROTEIN PROTEIN PROTEIN2 and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
632;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN2 and PROTEIN ;BioInfer.d422.s0
633;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN2 ;BioInfer.d422.s0
634;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 PROTEIN2 PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
635;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 PROTEIN PROTEIN2 PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
636;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN2 and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
637;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN2 of PROTEIN and PROTEIN ;BioInfer.d422.s0
638;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN2 and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
639;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN1 and PROTEIN and the PROTEIN of PROTEIN2 and PROTEIN ;BioInfer.d422.s0
640;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN1 and PROTEIN and the PROTEIN of PROTEIN and PROTEIN2 ;BioInfer.d422.s0
641;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN2 and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
642;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN2 and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
643;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN1 and PROTEIN2 and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
644;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN1 and PROTEIN and the PROTEIN2 of PROTEIN and PROTEIN ;BioInfer.d422.s0
645;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN2 and PROTEIN ;BioInfer.d422.s0
646;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN2 ;BioInfer.d422.s0
647;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN1 PROTEIN PROTEIN2 and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
648;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN1 PROTEIN2 and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
649;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN2 and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
650;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN2 of PROTEIN and PROTEIN ;BioInfer.d422.s0
651;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN1 and PROTEIN2 ;BioInfer.d422.s0
652;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN2 and PROTEIN ;BioInfer.d422.s0
653;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN2 and PROTEIN ;BioInfer.d422.s0
654;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN1 and the PROTEIN of PROTEIN2 and PROTEIN ;BioInfer.d422.s0
655;BioInfer.d422;TRUE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN1 of PROTEIN2 and PROTEIN ;BioInfer.d422.s0
656;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN2 ;BioInfer.d422.s0
657;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN2 ;BioInfer.d422.s0
658;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN1 and the PROTEIN of PROTEIN and PROTEIN2 ;BioInfer.d422.s0
659;BioInfer.d422;TRUE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN1 of PROTEIN and PROTEIN2 ;BioInfer.d422.s0
660;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN1 PROTEIN2 PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
661;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN2 and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
662;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN2 of PROTEIN and PROTEIN ;BioInfer.d422.s0
663;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN2 and the PROTEIN of PROTEIN and PROTEIN ;BioInfer.d422.s0
664;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN and the PROTEIN2 of PROTEIN and PROTEIN ;BioInfer.d422.s0
665;BioInfer.d422;FALSE;METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN the cell-cell adhesion molecules of PROTEIN PROTEIN and PROTEIN1 and the PROTEIN2 of PROTEIN and PROTEIN ;BioInfer.d422.s0
666;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN and PROTEIN ( PROTEIN2 during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
667;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN , PROTEIN ( PROTEIN and PROTEIN1 ( PROTEIN2 during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
668;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN and PROTEIN ( PROTEIN2 during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
669;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 and PROTEIN ( PROTEIN2 during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
670;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN and PROTEIN ( PROTEIN2 during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
671;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN and PROTEIN2 ( PROTEIN during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
672;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN1 , PROTEIN2 ( PROTEIN and PROTEIN ( PROTEIN during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
673;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN2 and PROTEIN ( PROTEIN during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
674;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN1 ( PROTEIN2 , PROTEIN ( PROTEIN and PROTEIN ( PROTEIN during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
675;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN and PROTEIN2 ( PROTEIN during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
676;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 and PROTEIN2 ( PROTEIN during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
677;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN and PROTEIN2 ( PROTEIN during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
678;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN2 and PROTEIN ( PROTEIN during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
679;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN1 ( PROTEIN , PROTEIN2 ( PROTEIN and PROTEIN ( PROTEIN during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
680;BioInfer.d424;FALSE;METHODS: We immunohistochemically investigated the expression of PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN2 and PROTEIN ( PROTEIN during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.;BioInfer.d424.s0
681;BioInfer.d426;FALSE;Mitochondrial genes (16.2%), PROTEIN1 genes (9%) and the PROTEIN2 gene (9%) were the most abundant transcripts.;BioInfer.d426.s0
682;BioInfer.d436;FALSE;Moreover, ectopic expression of PROTEIN1 and PROTEIN2 can stimulate the PROTEIN promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN PROTEIN ;BioInfer.d436.s0
683;BioInfer.d436;TRUE;Moreover, ectopic expression of PROTEIN1 and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN2 PROTEIN PROTEIN ;BioInfer.d436.s0
684;BioInfer.d436;TRUE;Moreover, ectopic expression of PROTEIN1 and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN2 PROTEIN ;BioInfer.d436.s0
685;BioInfer.d436;FALSE;Moreover, ectopic expression of PROTEIN1 and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN2 dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN PROTEIN ;BioInfer.d436.s0
686;BioInfer.d436;TRUE;Moreover, ectopic expression of PROTEIN1 and PROTEIN can stimulate the PROTEIN2 promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN PROTEIN ;BioInfer.d436.s0
687;BioInfer.d436;FALSE;Moreover, ectopic expression of PROTEIN1 and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN PROTEIN2 ;BioInfer.d436.s0
688;BioInfer.d436;TRUE;Moreover, ectopic expression of PROTEIN and PROTEIN1 can stimulate the PROTEIN promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN2 PROTEIN PROTEIN ;BioInfer.d436.s0
689;BioInfer.d436;TRUE;Moreover, ectopic expression of PROTEIN and PROTEIN1 can stimulate the PROTEIN promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN2 PROTEIN ;BioInfer.d436.s0
690;BioInfer.d436;FALSE;Moreover, ectopic expression of PROTEIN and PROTEIN1 can stimulate the PROTEIN promoter in an PROTEIN2 dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN PROTEIN ;BioInfer.d436.s0
691;BioInfer.d436;TRUE;Moreover, ectopic expression of PROTEIN and PROTEIN1 can stimulate the PROTEIN2 promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN PROTEIN ;BioInfer.d436.s0
692;BioInfer.d436;FALSE;Moreover, ectopic expression of PROTEIN and PROTEIN1 can stimulate the PROTEIN promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN PROTEIN2 ;BioInfer.d436.s0
693;BioInfer.d436;FALSE;Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN1 PROTEIN2 PROTEIN ;BioInfer.d436.s0
694;BioInfer.d436;FALSE;Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN1 dependent manner, and this is inhibited by coexpression of the PROTEIN2 PROTEIN PROTEIN ;BioInfer.d436.s0
695;BioInfer.d436;TRUE;Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN1 promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN2 PROTEIN PROTEIN ;BioInfer.d436.s0
696;BioInfer.d436;TRUE;Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN1 PROTEIN PROTEIN2 ;BioInfer.d436.s0
697;BioInfer.d436;FALSE;Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN1 dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN2 PROTEIN ;BioInfer.d436.s0
698;BioInfer.d436;TRUE;Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN1 promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN2 PROTEIN ;BioInfer.d436.s0
699;BioInfer.d436;TRUE;Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN1 PROTEIN2 ;BioInfer.d436.s0
700;BioInfer.d436;TRUE;Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN1 promoter in an PROTEIN2 dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN PROTEIN ;BioInfer.d436.s0
701;BioInfer.d436;FALSE;Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN1 dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN PROTEIN2 ;BioInfer.d436.s0
702;BioInfer.d436;FALSE;Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN1 promoter in an PROTEIN dependent manner, and this is inhibited by coexpression of the PROTEIN PROTEIN PROTEIN2 ;BioInfer.d436.s0
703;BioInfer.d439;TRUE;Most of these PROTEIN1 with their intracellular domains, interact with the PROTEIN containing cytoskeleton, via linking proteins such as PROTEIN2 and PROTEIN while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).;BioInfer.d439.s0
704;BioInfer.d439;TRUE;Most of these PROTEIN1 with their intracellular domains, interact with the PROTEIN2 containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).;BioInfer.d439.s0
705;BioInfer.d439;TRUE;Most of these PROTEIN1 with their intracellular domains, interact with the PROTEIN containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN while one of them interacts with the PROTEIN2 filaments, via an as yet unknown linking molecule(s).;BioInfer.d439.s0
706;BioInfer.d439;TRUE;Most of these PROTEIN1 with their intracellular domains, interact with the PROTEIN containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN2 while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).;BioInfer.d439.s0
707;BioInfer.d439;TRUE;Most of these PROTEIN with their intracellular domains, interact with the PROTEIN1 containing cytoskeleton, via linking proteins such as PROTEIN2 and PROTEIN while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).;BioInfer.d439.s0
708;BioInfer.d439;FALSE;Most of these PROTEIN with their intracellular domains, interact with the PROTEIN containing cytoskeleton, via linking proteins such as PROTEIN1 and PROTEIN while one of them interacts with the PROTEIN2 filaments, via an as yet unknown linking molecule(s).;BioInfer.d439.s0
709;BioInfer.d439;FALSE;Most of these PROTEIN with their intracellular domains, interact with the PROTEIN containing cytoskeleton, via linking proteins such as PROTEIN1 and PROTEIN2 while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).;BioInfer.d439.s0
710;BioInfer.d439;FALSE;Most of these PROTEIN with their intracellular domains, interact with the PROTEIN1 containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN while one of them interacts with the PROTEIN2 filaments, via an as yet unknown linking molecule(s).;BioInfer.d439.s0
711;BioInfer.d439;TRUE;Most of these PROTEIN with their intracellular domains, interact with the PROTEIN1 containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN2 while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).;BioInfer.d439.s0
712;BioInfer.d439;FALSE;Most of these PROTEIN with their intracellular domains, interact with the PROTEIN containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN1 while one of them interacts with the PROTEIN2 filaments, via an as yet unknown linking molecule(s).;BioInfer.d439.s0
713;BioInfer.d445;FALSE;Mutations in PROTEIN1 cause increased rates of mitotic crossing over and are lethal in combination with mutations in PROTEIN and PROTEIN2 ;BioInfer.d445.s0
714;BioInfer.d445;FALSE;Mutations in PROTEIN1 cause increased rates of mitotic crossing over and are lethal in combination with mutations in PROTEIN2 and PROTEIN ;BioInfer.d445.s0
715;BioInfer.d445;FALSE;Mutations in PROTEIN cause increased rates of mitotic crossing over and are lethal in combination with mutations in PROTEIN1 and PROTEIN2 ;BioInfer.d445.s0
716;BioInfer.d458;FALSE; PROTEIN1 and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN2 PROTEIN and PROTEIN was released.;BioInfer.d458.s0
717;BioInfer.d458;TRUE; PROTEIN1 and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN PROTEIN2 and PROTEIN was released.;BioInfer.d458.s0
718;BioInfer.d458;FALSE; PROTEIN1 and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN PROTEIN and PROTEIN2 was released.;BioInfer.d458.s0
719;BioInfer.d458;FALSE; PROTEIN1 and PROTEIN2 were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN PROTEIN and PROTEIN was released.;BioInfer.d458.s0
720;BioInfer.d458;TRUE; PROTEIN and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN1 PROTEIN2 and PROTEIN was released.;BioInfer.d458.s0
721;BioInfer.d458;FALSE; PROTEIN and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN1 PROTEIN and PROTEIN2 was released.;BioInfer.d458.s0
722;BioInfer.d458;FALSE; PROTEIN and PROTEIN1 were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN2 PROTEIN and PROTEIN was released.;BioInfer.d458.s0
723;BioInfer.d458;FALSE; PROTEIN and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN PROTEIN1 and PROTEIN2 was released.;BioInfer.d458.s0
724;BioInfer.d458;TRUE; PROTEIN and PROTEIN1 were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN PROTEIN2 and PROTEIN was released.;BioInfer.d458.s0
725;BioInfer.d458;FALSE; PROTEIN and PROTEIN1 were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN PROTEIN and PROTEIN2 was released.;BioInfer.d458.s0
726;BioInfer.d462;FALSE;One mutation, PROTEIN is in the gene encoding PROTEIN1 another PROTEIN which was expected because null mutations in PROTEIN2 and PROTEIN are known to be synthetic-lethal.;BioInfer.d462.s0
727;BioInfer.d462;FALSE;One mutation, PROTEIN is in the gene encoding PROTEIN another PROTEIN which was expected because null mutations in PROTEIN1 and PROTEIN2 are known to be synthetic-lethal.;BioInfer.d462.s0
728;BioInfer.d462;FALSE;One mutation, PROTEIN1 is in the gene encoding PROTEIN another PROTEIN which was expected because null mutations in PROTEIN2 and PROTEIN are known to be synthetic-lethal.;BioInfer.d462.s0
729;BioInfer.d462;FALSE;One mutation, PROTEIN is in the gene encoding PROTEIN another PROTEIN1 which was expected because null mutations in PROTEIN2 and PROTEIN are known to be synthetic-lethal.;BioInfer.d462.s0
730;BioInfer.d462;FALSE;One mutation, PROTEIN is in the gene encoding PROTEIN1 another PROTEIN which was expected because null mutations in PROTEIN and PROTEIN2 are known to be synthetic-lethal.;BioInfer.d462.s0
731;BioInfer.d462;FALSE;One mutation, PROTEIN1 is in the gene encoding PROTEIN2 another PROTEIN which was expected because null mutations in PROTEIN and PROTEIN are known to be synthetic-lethal.;BioInfer.d462.s0
732;BioInfer.d462;TRUE;One mutation, PROTEIN is in the gene encoding PROTEIN1 another PROTEIN2 which was expected because null mutations in PROTEIN and PROTEIN are known to be synthetic-lethal.;BioInfer.d462.s0
733;BioInfer.d462;FALSE;One mutation, PROTEIN1 is in the gene encoding PROTEIN another PROTEIN which was expected because null mutations in PROTEIN and PROTEIN2 are known to be synthetic-lethal.;BioInfer.d462.s0
734;BioInfer.d462;FALSE;One mutation, PROTEIN is in the gene encoding PROTEIN another PROTEIN1 which was expected because null mutations in PROTEIN and PROTEIN2 are known to be synthetic-lethal.;BioInfer.d462.s0
735;BioInfer.d462;FALSE;One mutation, PROTEIN1 is in the gene encoding PROTEIN another PROTEIN2 which was expected because null mutations in PROTEIN and PROTEIN are known to be synthetic-lethal.;BioInfer.d462.s0
736;BioInfer.d472;FALSE;Our data indicate that even PROTEIN1 of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, PROTEIN2 are engaged in regulating either the stability or the kinetic properties of PROTEIN filaments.;BioInfer.d472.s0
737;BioInfer.d472;FALSE;Our data indicate that even PROTEIN1 of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, PROTEIN are engaged in regulating either the stability or the kinetic properties of PROTEIN2 filaments.;BioInfer.d472.s0
738;BioInfer.d472;TRUE;Our data indicate that even PROTEIN of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, PROTEIN1 are engaged in regulating either the stability or the kinetic properties of PROTEIN2 filaments.;BioInfer.d472.s0
739;BioInfer.d475;FALSE;Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN1 subunits, PROTEIN PROTEIN2 and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN ;BioInfer.d475.s0
740;BioInfer.d475;FALSE;Our results showed that cell morphology, cell adhesion pattern, PROTEIN1 organization, and distribution of PROTEIN2 subunits, PROTEIN PROTEIN and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN ;BioInfer.d475.s0
741;BioInfer.d475;TRUE;Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN1 subunits, PROTEIN PROTEIN and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN2 ;BioInfer.d475.s0
742;BioInfer.d475;FALSE;Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN1 subunits, PROTEIN2 PROTEIN and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN ;BioInfer.d475.s0
743;BioInfer.d475;FALSE;Our results showed that cell morphology, cell adhesion pattern, PROTEIN1 organization, and distribution of PROTEIN subunits, PROTEIN PROTEIN2 and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN ;BioInfer.d475.s0
744;BioInfer.d475;TRUE;Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN subunits, PROTEIN PROTEIN1 and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN2 ;BioInfer.d475.s0
745;BioInfer.d475;FALSE;Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN subunits, PROTEIN1 PROTEIN2 and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN ;BioInfer.d475.s0
746;BioInfer.d475;TRUE;Our results showed that cell morphology, cell adhesion pattern, PROTEIN1 organization, and distribution of PROTEIN subunits, PROTEIN PROTEIN and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN2 ;BioInfer.d475.s0
747;BioInfer.d475;FALSE;Our results showed that cell morphology, cell adhesion pattern, PROTEIN1 organization, and distribution of PROTEIN subunits, PROTEIN2 PROTEIN and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN ;BioInfer.d475.s0
748;BioInfer.d475;TRUE;Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN subunits, PROTEIN1 PROTEIN and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN2 ;BioInfer.d475.s0
749;BioInfer.d476;TRUE;Overexpression of a gene fragment encoding the PROTEIN binding domain of PROTEIN1 stimulates transcription from the PROTEIN2 gene promoter.;BioInfer.d476.s0
750;BioInfer.d476;FALSE;Overexpression of a gene fragment encoding the PROTEIN1 binding domain of PROTEIN stimulates transcription from the PROTEIN2 gene promoter.;BioInfer.d476.s0
751;BioInfer.d476;TRUE;Overexpression of a gene fragment encoding the PROTEIN1 binding domain of PROTEIN2 stimulates transcription from the PROTEIN gene promoter.;BioInfer.d476.s0
752;BioInfer.d477;TRUE;Overexpression of PROTEIN1 stimulates bundling of PROTEIN2 filaments, membrane ruffling, and cell movement in Dictyostelium.;BioInfer.d477.s0
753;BioInfer.d478;FALSE;Overexpression of PROTEIN1 and PROTEIN2 ( PROTEIN : effect on cell cycle regulation in HeLa cells.;BioInfer.d478.s0
754;BioInfer.d478;FALSE;Overexpression of PROTEIN1 and PROTEIN ( PROTEIN2 : effect on cell cycle regulation in HeLa cells.;BioInfer.d478.s0
755;BioInfer.d478;TRUE;Overexpression of PROTEIN and PROTEIN1 ( PROTEIN2 : effect on cell cycle regulation in HeLa cells.;BioInfer.d478.s0
756;BioInfer.d483;FALSE;" PROTEIN1 treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN2 or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
757;BioInfer.d483;FALSE;" PROTEIN1 treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN2 or PROTEIN distribution.";BioInfer.d483.s0
758;BioInfer.d483;FALSE;" PROTEIN1 treatment had no effect on PROTEIN PROTEIN2 or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
759;BioInfer.d483;FALSE;" PROTEIN1 treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN2 distribution.";BioInfer.d483.s0
760;BioInfer.d483;FALSE;" PROTEIN1 treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN2 also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
761;BioInfer.d483;FALSE;" PROTEIN1 treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN2 , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
762;BioInfer.d483;FALSE;" PROTEIN1 treatment had no effect on PROTEIN2 PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
763;BioInfer.d483;FALSE;" PROTEIN1 treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN2 ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
764;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN1 or 10 microM PROTEIN also had no effect on PROTEIN2 or PROTEIN distribution.";BioInfer.d483.s0
765;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN1 or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN2 or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
766;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN1 or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN2 distribution.";BioInfer.d483.s0
767;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN1 or 10 microM PROTEIN2 also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
768;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN1 , 30 ng/ml PROTEIN2 or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
769;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN1 PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN2 or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
770;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN1 ( PROTEIN , 30 ng/ml PROTEIN2 or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
771;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN1 or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN2 or PROTEIN distribution.";BioInfer.d483.s0
772;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN1 or PROTEIN2 distribution.";BioInfer.d483.s0
773;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN1 also had no effect on PROTEIN2 or PROTEIN distribution.";BioInfer.d483.s0
774;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN1 , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN2 or PROTEIN distribution.";BioInfer.d483.s0
775;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN1 PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN2 or PROTEIN distribution.";BioInfer.d483.s0
776;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN1 ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN2 or PROTEIN distribution.";BioInfer.d483.s0
777;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN1 or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN2 distribution.";BioInfer.d483.s0
778;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN1 or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN2 also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
779;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN1 or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN2 , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
780;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN1 PROTEIN2 or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
781;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN1 or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN2 ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
782;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN1 also had no effect on PROTEIN or PROTEIN2 distribution.";BioInfer.d483.s0
783;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN1 , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN2 distribution.";BioInfer.d483.s0
784;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN1 PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN2 distribution.";BioInfer.d483.s0
785;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN1 ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN2 distribution.";BioInfer.d483.s0
786;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN1 , 30 ng/ml PROTEIN or 10 microM PROTEIN2 also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
787;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN1 PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN2 also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
788;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN1 ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN2 also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
789;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN1 PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN2 , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
790;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN1 ( PROTEIN2 , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
791;BioInfer.d483;FALSE;" PROTEIN treatment had no effect on PROTEIN1 PROTEIN or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN2 ( PROTEIN , 30 ng/ml PROTEIN or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.";BioInfer.d483.s0
792;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN1 PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN2 PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
793;BioInfer.d485;FALSE; PROTEIN1 dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN2 PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
794;BioInfer.d485;FALSE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN1 PROTEIN2 PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
795;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN1 activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN2 PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
796;BioInfer.d485;FALSE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN1 PROTEIN2 , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
797;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN1 PROTEIN , to the PROTEIN PROTEIN2 complex.;BioInfer.d485.s0
798;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN1 PROTEIN PROTEIN2 PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
799;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN1 PROTEIN , to the PROTEIN2 PROTEIN complex.;BioInfer.d485.s0
800;BioInfer.d485;TRUE; PROTEIN1 dependent downregulation of PROTEIN2 PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
801;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN1 PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN2 PROTEIN PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
802;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN1 PROTEIN2 activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
803;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN1 PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN2 , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
804;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN1 PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN , to the PROTEIN PROTEIN2 complex.;BioInfer.d485.s0
805;BioInfer.d485;FALSE; PROTEIN dependent downregulation of PROTEIN1 PROTEIN activity was associated with increased binding of the PROTEIN2 PROTEIN PROTEIN PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
806;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN1 PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN , to the PROTEIN2 PROTEIN complex.;BioInfer.d485.s0
807;BioInfer.d485;FALSE; PROTEIN1 dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN2 PROTEIN PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
808;BioInfer.d485;TRUE; PROTEIN1 dependent downregulation of PROTEIN PROTEIN2 activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
809;BioInfer.d485;FALSE; PROTEIN1 dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN2 , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
810;BioInfer.d485;FALSE; PROTEIN1 dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN , to the PROTEIN PROTEIN2 complex.;BioInfer.d485.s0
811;BioInfer.d485;FALSE; PROTEIN1 dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN2 PROTEIN PROTEIN PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
812;BioInfer.d485;FALSE; PROTEIN1 dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN , to the PROTEIN2 PROTEIN complex.;BioInfer.d485.s0
813;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN1 activity was associated with increased binding of the PROTEIN PROTEIN2 PROTEIN PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
814;BioInfer.d485;FALSE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN1 PROTEIN PROTEIN2 , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
815;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN1 PROTEIN PROTEIN , to the PROTEIN PROTEIN2 complex.;BioInfer.d485.s0
816;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN1 PROTEIN2 PROTEIN PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
817;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN1 PROTEIN PROTEIN , to the PROTEIN2 PROTEIN complex.;BioInfer.d485.s0
818;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN1 activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN2 , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
819;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN1 activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN , to the PROTEIN PROTEIN2 complex.;BioInfer.d485.s0
820;BioInfer.d485;FALSE; PROTEIN dependent downregulation of PROTEIN PROTEIN1 activity was associated with increased binding of the PROTEIN2 PROTEIN PROTEIN PROTEIN , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
821;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN1 activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN , to the PROTEIN2 PROTEIN complex.;BioInfer.d485.s0
822;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN1 , to the PROTEIN PROTEIN2 complex.;BioInfer.d485.s0
823;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN1 PROTEIN PROTEIN PROTEIN2 , to the PROTEIN PROTEIN complex.;BioInfer.d485.s0
824;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN1 , to the PROTEIN2 PROTEIN complex.;BioInfer.d485.s0
825;BioInfer.d485;FALSE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN1 PROTEIN PROTEIN PROTEIN , to the PROTEIN PROTEIN2 complex.;BioInfer.d485.s0
826;BioInfer.d485;TRUE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN PROTEIN PROTEIN PROTEIN , to the PROTEIN1 PROTEIN2 complex.;BioInfer.d485.s0
827;BioInfer.d485;FALSE; PROTEIN dependent downregulation of PROTEIN PROTEIN activity was associated with increased binding of the PROTEIN1 PROTEIN PROTEIN PROTEIN , to the PROTEIN2 PROTEIN complex.;BioInfer.d485.s0
828;BioInfer.d489;FALSE; PROTEIN1 is one of a complex of genes encoding DNA repair proteins that includes PROTEIN PROTEIN PROTEIN and PROTEIN2 ;BioInfer.d489.s0
829;BioInfer.d489;FALSE; PROTEIN1 is one of a complex of genes encoding DNA repair proteins that includes PROTEIN2 PROTEIN PROTEIN and PROTEIN ;BioInfer.d489.s0
830;BioInfer.d489;FALSE; PROTEIN1 is one of a complex of genes encoding DNA repair proteins that includes PROTEIN PROTEIN2 PROTEIN and PROTEIN ;BioInfer.d489.s0
831;BioInfer.d489;FALSE; PROTEIN1 is one of a complex of genes encoding DNA repair proteins that includes PROTEIN PROTEIN PROTEIN2 and PROTEIN ;BioInfer.d489.s0
832;BioInfer.d489;FALSE; PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN1 PROTEIN PROTEIN and PROTEIN2 ;BioInfer.d489.s0
833;BioInfer.d489;FALSE; PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN PROTEIN1 PROTEIN and PROTEIN2 ;BioInfer.d489.s0
834;BioInfer.d489;FALSE; PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN PROTEIN PROTEIN1 and PROTEIN2 ;BioInfer.d489.s0
835;BioInfer.d489;FALSE; PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN1 PROTEIN2 PROTEIN and PROTEIN ;BioInfer.d489.s0
836;BioInfer.d489;FALSE; PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN1 PROTEIN PROTEIN2 and PROTEIN ;BioInfer.d489.s0
837;BioInfer.d489;FALSE; PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN PROTEIN1 PROTEIN2 and PROTEIN ;BioInfer.d489.s0
838;BioInfer.d491;FALSE;Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, PROTEIN1 and PROTEIN2 a recently described late differentiation marker of vascular SMCs.;BioInfer.d491.s0
839;BioInfer.d499;TRUE;Protein phosphorylation of PROTEIN1 an PROTEIN that depolymerizes PROTEIN2 filaments, suppresses its function.;BioInfer.d499.s0
840;BioInfer.d499;TRUE;Protein phosphorylation of PROTEIN1 an PROTEIN2 that depolymerizes PROTEIN filaments, suppresses its function.;BioInfer.d499.s0
841;BioInfer.d499;FALSE;Protein phosphorylation of PROTEIN an PROTEIN1 that depolymerizes PROTEIN2 filaments, suppresses its function.;BioInfer.d499.s0
842;BioInfer.d503;FALSE;Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN ( PROTEIN1 , and PROTEIN2 but not PROTEIN ;BioInfer.d503.s0
843;BioInfer.d503;FALSE;Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN1 ( PROTEIN , and PROTEIN2 but not PROTEIN ;BioInfer.d503.s0
844;BioInfer.d503;FALSE;Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN ( PROTEIN , and PROTEIN1 but not PROTEIN2 ;BioInfer.d503.s0
845;BioInfer.d503;FALSE;Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN1 ( PROTEIN2 , and PROTEIN but not PROTEIN ;BioInfer.d503.s0
846;BioInfer.d503;FALSE;Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN ( PROTEIN1 , and PROTEIN but not PROTEIN2 ;BioInfer.d503.s0
847;BioInfer.d503;FALSE;Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN1 ( PROTEIN , and PROTEIN but not PROTEIN2 ;BioInfer.d503.s0
848;BioInfer.d504;FALSE;Purification of a cortical complex containing two unconventional PROTEIN1 from Acanthamoeba by affinity chromatography on PROTEIN2 agarose.;BioInfer.d504.s0
849;BioInfer.d508;TRUE;Recently we reported that the isolated 23 kDa N-terminal fragment of PROTEIN1 which contains the 'consensus' ATP binding site, binds to PROTEIN2 in an ATP-sensitive manner (Muhlrad, A. (1989) Biochemistry 28, 4002).;BioInfer.d508.s0
850;BioInfer.d511;FALSE;Redistribution of PROTEIN1 PROTEIN2 and phosphatidylinositol-4, 5-bisphosphate in growing and maturing root hairs;BioInfer.d511.s0
851;BioInfer.d513;FALSE;Reduced expression of PROTEIN1 PROTEIN2 and PROTEIN was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.;BioInfer.d513.s0
852;BioInfer.d513;FALSE;Reduced expression of PROTEIN1 PROTEIN and PROTEIN2 was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.;BioInfer.d513.s0
853;BioInfer.d513;FALSE;Reduced expression of PROTEIN PROTEIN1 and PROTEIN2 was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.;BioInfer.d513.s0
854;BioInfer.d516;TRUE;Reinvestigation of the inhibition of PROTEIN1 polymerization by PROTEIN2 ;BioInfer.d516.s0
855;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN1 for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN2 of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN ;BioInfer.d516.s1
856;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN1 for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN2 ;BioInfer.d516.s1
857;BioInfer.d516;TRUE;The very much lower affinity of PROTEIN1 for modified PROTEIN2 explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN ;BioInfer.d516.s1
858;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN1 for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN2 in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN ;BioInfer.d516.s1
859;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN1 for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN2 and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN ;BioInfer.d516.s1
860;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN1 of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN2 ;BioInfer.d516.s1
861;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN for modified PROTEIN1 explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN2 of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN ;BioInfer.d516.s1
862;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN1 in the presence of PROTEIN and the apparently weak inhibition by PROTEIN2 of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN ;BioInfer.d516.s1
863;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN1 and the apparently weak inhibition by PROTEIN2 of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN ;BioInfer.d516.s1
864;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN for modified PROTEIN1 explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN2 ;BioInfer.d516.s1
865;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN1 in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN2 ;BioInfer.d516.s1
866;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN1 and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN2 ;BioInfer.d516.s1
867;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN for modified PROTEIN1 explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN2 in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN ;BioInfer.d516.s1
868;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN for modified PROTEIN1 explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN2 and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN ;BioInfer.d516.s1
869;BioInfer.d516;FALSE;The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN1 in the presence of PROTEIN2 and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN ;BioInfer.d516.s1
870;BioInfer.d518;TRUE;Removal of the amino-terminal tails of either PROTEIN1 PROTEIN2 or PROTEIN PROTEIN allowed these polyamides to bind.;BioInfer.d518.s0
871;BioInfer.d518;FALSE;Removal of the amino-terminal tails of either PROTEIN PROTEIN1 or PROTEIN PROTEIN2 allowed these polyamides to bind.;BioInfer.d518.s0
872;BioInfer.d518;FALSE;Removal of the amino-terminal tails of either PROTEIN PROTEIN1 or PROTEIN2 PROTEIN allowed these polyamides to bind.;BioInfer.d518.s0
873;BioInfer.d518;FALSE;Removal of the amino-terminal tails of either PROTEIN1 PROTEIN or PROTEIN PROTEIN2 allowed these polyamides to bind.;BioInfer.d518.s0
874;BioInfer.d518;FALSE;Removal of the amino-terminal tails of either PROTEIN1 PROTEIN or PROTEIN2 PROTEIN allowed these polyamides to bind.;BioInfer.d518.s0
875;BioInfer.d518;TRUE;Removal of the amino-terminal tails of either PROTEIN PROTEIN or PROTEIN1 PROTEIN2 allowed these polyamides to bind.;BioInfer.d518.s0
876;BioInfer.d524;TRUE;Rod formation was prevented by coexpression of PROTEIN1 PROTEIN and PROTEIN which bind to the PROTEIN repeats of PROTEIN2 but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
877;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN1 PROTEIN and PROTEIN which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN2 although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
878;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN1 PROTEIN and PROTEIN which bind to the PROTEIN2 repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
879;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN1 PROTEIN and PROTEIN2 which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
880;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN1 PROTEIN and PROTEIN which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN2 expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
881;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN1 PROTEIN and PROTEIN which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN2 in the nucleus.;BioInfer.d524.s0
882;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN1 PROTEIN2 and PROTEIN which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
883;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN which bind to the PROTEIN repeats of PROTEIN1 but not by coexpression of PROTEIN2 although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
884;BioInfer.d524;TRUE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN which bind to the PROTEIN1 repeats of PROTEIN2 but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
885;BioInfer.d524;TRUE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN1 which bind to the PROTEIN repeats of PROTEIN2 but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
886;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN which bind to the PROTEIN repeats of PROTEIN1 but not by coexpression of PROTEIN although PROTEIN2 expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
887;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN which bind to the PROTEIN repeats of PROTEIN1 but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN2 in the nucleus.;BioInfer.d524.s0
888;BioInfer.d524;TRUE;Rod formation was prevented by coexpression of PROTEIN PROTEIN1 and PROTEIN which bind to the PROTEIN repeats of PROTEIN2 but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
889;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN which bind to the PROTEIN1 repeats of PROTEIN but not by coexpression of PROTEIN2 although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
890;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN1 which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN2 although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
891;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN1 although PROTEIN2 expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
892;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN1 although PROTEIN expression did prevent accumulation of PROTEIN2 in the nucleus.;BioInfer.d524.s0
893;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN1 and PROTEIN which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN2 although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
894;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN1 which bind to the PROTEIN2 repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
895;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN which bind to the PROTEIN1 repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN2 expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
896;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN which bind to the PROTEIN1 repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN2 in the nucleus.;BioInfer.d524.s0
897;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN1 and PROTEIN which bind to the PROTEIN2 repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
898;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN1 which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN2 expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
899;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN1 which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN2 in the nucleus.;BioInfer.d524.s0
900;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN1 and PROTEIN2 which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
901;BioInfer.d524;TRUE;Rod formation was prevented by coexpression of PROTEIN PROTEIN and PROTEIN which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN1 expression did prevent accumulation of PROTEIN2 in the nucleus.;BioInfer.d524.s0
902;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN1 and PROTEIN which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN2 expression did prevent accumulation of PROTEIN in the nucleus.;BioInfer.d524.s0
903;BioInfer.d524;FALSE;Rod formation was prevented by coexpression of PROTEIN PROTEIN1 and PROTEIN which bind to the PROTEIN repeats of PROTEIN but not by coexpression of PROTEIN although PROTEIN expression did prevent accumulation of PROTEIN2 in the nucleus.;BioInfer.d524.s0
904;BioInfer.d525;FALSE;Role of PROTEIN1 in PROTEIN2 stimulated PROTEIN polymerization and lamellipod protrusion.;BioInfer.d525.s0
905;BioInfer.d525;TRUE;Role of PROTEIN in PROTEIN1 stimulated PROTEIN2 polymerization and lamellipod protrusion.;BioInfer.d525.s0
906;BioInfer.d525;TRUE;Role of PROTEIN1 in PROTEIN stimulated PROTEIN2 polymerization and lamellipod protrusion.;BioInfer.d525.s0
907;BioInfer.d525;TRUE;These results support a model in which PROTEIN stimulation recruits PROTEIN1 to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN2 filaments with free barbed ends that participate in the nucleation of PROTEIN polymerization.;BioInfer.d525.s1
908;BioInfer.d525;FALSE;These results support a model in which PROTEIN1 stimulation recruits PROTEIN to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN2 filaments with free barbed ends that participate in the nucleation of PROTEIN polymerization.;BioInfer.d525.s1
909;BioInfer.d525;TRUE;These results support a model in which PROTEIN stimulation recruits PROTEIN to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN1 filaments with free barbed ends that participate in the nucleation of PROTEIN2 polymerization.;BioInfer.d525.s1
910;BioInfer.d525;TRUE;These results support a model in which PROTEIN1 stimulation recruits PROTEIN2 to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN filaments with free barbed ends that participate in the nucleation of PROTEIN polymerization.;BioInfer.d525.s1
911;BioInfer.d525;FALSE;These results support a model in which PROTEIN stimulation recruits PROTEIN1 to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN filaments with free barbed ends that participate in the nucleation of PROTEIN2 polymerization.;BioInfer.d525.s1
912;BioInfer.d525;FALSE;These results support a model in which PROTEIN1 stimulation recruits PROTEIN to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN filaments with free barbed ends that participate in the nucleation of PROTEIN2 polymerization.;BioInfer.d525.s1
913;BioInfer.d525;FALSE;To investigate the role of PROTEIN in PROTEIN1 stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN2 relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.;BioInfer.d525.s2
914;BioInfer.d525;FALSE;To investigate the role of PROTEIN in PROTEIN stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN1 relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN2 filaments.;BioInfer.d525.s2
915;BioInfer.d525;FALSE;To investigate the role of PROTEIN in PROTEIN stimulated PROTEIN1 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN2 relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.;BioInfer.d525.s2
916;BioInfer.d525;FALSE;To investigate the role of PROTEIN1 in PROTEIN stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN2 relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.;BioInfer.d525.s2
917;BioInfer.d525;FALSE;To investigate the role of PROTEIN in PROTEIN stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN1 relative to free barbed ends and characterized the PROTEIN2 dynamics by measuring the changes in the number of PROTEIN filaments.;BioInfer.d525.s2
918;BioInfer.d525;FALSE;To investigate the role of PROTEIN in PROTEIN1 stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN2 filaments.;BioInfer.d525.s2
919;BioInfer.d525;TRUE;To investigate the role of PROTEIN in PROTEIN1 stimulated PROTEIN2 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.;BioInfer.d525.s2
920;BioInfer.d525;FALSE;To investigate the role of PROTEIN1 in PROTEIN2 stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.;BioInfer.d525.s2
921;BioInfer.d525;FALSE;To investigate the role of PROTEIN in PROTEIN1 stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN2 dynamics by measuring the changes in the number of PROTEIN filaments.;BioInfer.d525.s2
922;BioInfer.d525;FALSE;To investigate the role of PROTEIN in PROTEIN stimulated PROTEIN1 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN2 filaments.;BioInfer.d525.s2
923;BioInfer.d525;FALSE;To investigate the role of PROTEIN1 in PROTEIN stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN2 filaments.;BioInfer.d525.s2
924;BioInfer.d525;FALSE;To investigate the role of PROTEIN in PROTEIN stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN1 dynamics by measuring the changes in the number of PROTEIN2 filaments.;BioInfer.d525.s2
925;BioInfer.d525;TRUE;To investigate the role of PROTEIN1 in PROTEIN stimulated PROTEIN2 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.;BioInfer.d525.s2
926;BioInfer.d525;FALSE;To investigate the role of PROTEIN in PROTEIN stimulated PROTEIN1 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN2 dynamics by measuring the changes in the number of PROTEIN filaments.;BioInfer.d525.s2
927;BioInfer.d525;FALSE;To investigate the role of PROTEIN1 in PROTEIN stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN2 dynamics by measuring the changes in the number of PROTEIN filaments.;BioInfer.d525.s2
928;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
929;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
930;BioInfer.d527;TRUE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN1 and PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
931;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
932;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
933;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
934;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
935;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
936;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
937;BioInfer.d527;TRUE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN1 and PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
938;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
939;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
940;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
941;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
942;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
943;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN2 and PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
944;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
945;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
946;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
947;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN2 as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
948;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
949;BioInfer.d527;TRUE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN1 and PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
950;BioInfer.d527;TRUE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN1 and PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
951;BioInfer.d527;TRUE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN1 and PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
952;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as ""bait,"" and pairwise interactions between PROTEIN2 and PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
953;BioInfer.d527;TRUE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN1 and PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
954;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
955;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
956;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
957;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
958;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
959;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
960;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
961;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
962;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
963;BioInfer.d527;FALSE;"Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as ""bait,"" and pairwise interactions between PROTEIN and PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN subsequently were demonstrated by two-hybrid analysis.";BioInfer.d527.s0
964;BioInfer.d531;FALSE;Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN1 the presence of PROTEIN2 restriction sites has been associated with cell cycle regulation.;BioInfer.d531.s0
965;BioInfer.d531;TRUE;Sequences upstream of the coding region for PROTEIN1 protein share homology with the damage response sequence element of PROTEIN an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN2 the presence of PROTEIN restriction sites has been associated with cell cycle regulation.;BioInfer.d531.s0
966;BioInfer.d531;FALSE;Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN1 an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN2 the presence of PROTEIN restriction sites has been associated with cell cycle regulation.;BioInfer.d531.s0
967;BioInfer.d531;FALSE;Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN an upstream activating sequence required for damage regulation of the PROTEIN1 transcript, and also contain two sites for restriction enzyme PROTEIN2 the presence of PROTEIN restriction sites has been associated with cell cycle regulation.;BioInfer.d531.s0
968;BioInfer.d531;FALSE;Sequences upstream of the coding region for PROTEIN1 protein share homology with the damage response sequence element of PROTEIN an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN the presence of PROTEIN2 restriction sites has been associated with cell cycle regulation.;BioInfer.d531.s0
969;BioInfer.d531;FALSE;Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN1 an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN the presence of PROTEIN2 restriction sites has been associated with cell cycle regulation.;BioInfer.d531.s0
970;BioInfer.d531;FALSE;Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN an upstream activating sequence required for damage regulation of the PROTEIN1 transcript, and also contain two sites for restriction enzyme PROTEIN the presence of PROTEIN2 restriction sites has been associated with cell cycle regulation.;BioInfer.d531.s0
971;BioInfer.d531;TRUE;Sequences upstream of the coding region for PROTEIN1 protein share homology with the damage response sequence element of PROTEIN2 an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN the presence of PROTEIN restriction sites has been associated with cell cycle regulation.;BioInfer.d531.s0
972;BioInfer.d531;FALSE;Sequences upstream of the coding region for PROTEIN1 protein share homology with the damage response sequence element of PROTEIN an upstream activating sequence required for damage regulation of the PROTEIN2 transcript, and also contain two sites for restriction enzyme PROTEIN the presence of PROTEIN restriction sites has been associated with cell cycle regulation.;BioInfer.d531.s0
973;BioInfer.d531;TRUE;Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN1 an upstream activating sequence required for damage regulation of the PROTEIN2 transcript, and also contain two sites for restriction enzyme PROTEIN the presence of PROTEIN restriction sites has been associated with cell cycle regulation.;BioInfer.d531.s0
974;BioInfer.d541;TRUE;Since both PROTEIN1 and PROTEIN2 have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of PROTEIN filaments in living cells.;BioInfer.d541.s0
975;BioInfer.d541;FALSE;Since both PROTEIN1 and PROTEIN have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of PROTEIN2 filaments in living cells.;BioInfer.d541.s0
976;BioInfer.d541;FALSE;Since both PROTEIN and PROTEIN1 have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of PROTEIN2 filaments in living cells.;BioInfer.d541.s0
977;BioInfer.d548;TRUE;Specific interactions between the PROTEIN1 ( PROTEIN and the PROTEIN ( PROTEIN2 of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.;BioInfer.d548.s0
978;BioInfer.d548;TRUE;Specific interactions between the PROTEIN1 ( PROTEIN and the PROTEIN2 ( PROTEIN of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.;BioInfer.d548.s0
979;BioInfer.d548;FALSE;Specific interactions between the PROTEIN1 ( PROTEIN2 and the PROTEIN ( PROTEIN of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.;BioInfer.d548.s0
980;BioInfer.d548;FALSE;Specific interactions between the PROTEIN ( PROTEIN and the PROTEIN1 ( PROTEIN2 of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.;BioInfer.d548.s0
981;BioInfer.d548;TRUE;Specific interactions between the PROTEIN ( PROTEIN1 and the PROTEIN ( PROTEIN2 of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.;BioInfer.d548.s0
982;BioInfer.d548;TRUE;Specific interactions between the PROTEIN ( PROTEIN1 and the PROTEIN2 ( PROTEIN of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.;BioInfer.d548.s0
983;BioInfer.d555;TRUE;Such motifs are known to bind to PROTEIN1 ( PROTEIN , small proteins engaged in the control of PROTEIN2 dynamics.;BioInfer.d555.s0
984;BioInfer.d555;FALSE;Such motifs are known to bind to PROTEIN1 ( PROTEIN2 , small proteins engaged in the control of PROTEIN dynamics.;BioInfer.d555.s0
985;BioInfer.d555;TRUE;Such motifs are known to bind to PROTEIN ( PROTEIN1 , small proteins engaged in the control of PROTEIN2 dynamics.;BioInfer.d555.s0
986;BioInfer.d565;TRUE;The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN1 and PROTEIN2 indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.;BioInfer.d565.s0
987;BioInfer.d565;FALSE;The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN1 and PROTEIN indicates that the functional domains required for replication activity of PROTEIN2 are separable from domains responsible for protein-protein interactions.;BioInfer.d565.s0
988;BioInfer.d565;TRUE;The ability of these three mutant PROTEIN1 proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN2 and PROTEIN indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.;BioInfer.d565.s0
989;BioInfer.d565;TRUE;The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN1 complex, PROTEIN2 and PROTEIN indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.;BioInfer.d565.s0
990;BioInfer.d565;FALSE;The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN and PROTEIN1 indicates that the functional domains required for replication activity of PROTEIN2 are separable from domains responsible for protein-protein interactions.;BioInfer.d565.s0
991;BioInfer.d565;TRUE;The ability of these three mutant PROTEIN1 proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN and PROTEIN2 indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.;BioInfer.d565.s0
992;BioInfer.d565;TRUE;The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN1 complex, PROTEIN and PROTEIN2 indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.;BioInfer.d565.s0
993;BioInfer.d565;FALSE;The ability of these three mutant PROTEIN1 proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN and PROTEIN indicates that the functional domains required for replication activity of PROTEIN2 are separable from domains responsible for protein-protein interactions.;BioInfer.d565.s0
994;BioInfer.d565;FALSE;The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN1 complex, PROTEIN and PROTEIN indicates that the functional domains required for replication activity of PROTEIN2 are separable from domains responsible for protein-protein interactions.;BioInfer.d565.s0
995;BioInfer.d565;FALSE;The ability of these three mutant PROTEIN1 proteins to form specific interactions with other members of the PROTEIN2 complex, PROTEIN and PROTEIN indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.;BioInfer.d565.s0
996;BioInfer.d570;FALSE;The affinity of yeast PROTEIN for rabbit PROTEIN1 (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN2 (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN ;BioInfer.d570.s0
997;BioInfer.d570;FALSE;The affinity of yeast PROTEIN for rabbit PROTEIN1 (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN2 for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN ;BioInfer.d570.s0
998;BioInfer.d570;TRUE;The affinity of yeast PROTEIN1 for rabbit PROTEIN2 (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN ;BioInfer.d570.s0
999;BioInfer.d570;FALSE;The affinity of yeast PROTEIN for rabbit PROTEIN1 (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN2 ;BioInfer.d570.s0
1000;BioInfer.d570;TRUE;The affinity of yeast PROTEIN for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN1 for rabbit PROTEIN2 (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN ;BioInfer.d570.s0
1001;BioInfer.d570;FALSE;The affinity of yeast PROTEIN1 for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN2 (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN ;BioInfer.d570.s0
1002;BioInfer.d570;FALSE;The affinity of yeast PROTEIN for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN1 (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN2 ;BioInfer.d570.s0
1003;BioInfer.d570;FALSE;The affinity of yeast PROTEIN1 for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN2 for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN ;BioInfer.d570.s0
1004;BioInfer.d570;FALSE;The affinity of yeast PROTEIN for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN1 for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN2 ;BioInfer.d570.s0
1005;BioInfer.d570;FALSE;The affinity of yeast PROTEIN1 for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN2 ;BioInfer.d570.s0
1006;BioInfer.d570;FALSE;The interactions of yeast and human PROTEIN2 with rabbit PROTEIN were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.;BioInfer.d570.s1
1007;BioInfer.d570;TRUE;The interactions of yeast and human PROTEIN1 with rabbit PROTEIN2 were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.;BioInfer.d570.s1
1008;BioInfer.d570;TRUE;The interactions of yeast and human PROTEIN with rabbit PROTEIN2 were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.;BioInfer.d570.s1
1009;BioInfer.d570;TRUE;The in vivo and in vitro properties of yeast PROTEIN1 mutants with altered poly-L-proline and PROTEIN2 binding sites are discussed in the context of the crystal structure.;BioInfer.d570.s2
1010;BioInfer.d570;TRUE;The titration of pyrene-labeled rabbit PROTEIN1 with human PROTEIN2 yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN and pyrene-labeled yeast PROTEIN ;BioInfer.d570.s3
1011;BioInfer.d570;FALSE;The titration of pyrene-labeled rabbit PROTEIN1 with human PROTEIN yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN and pyrene-labeled yeast PROTEIN2 ;BioInfer.d570.s3
1012;BioInfer.d570;FALSE;The titration of pyrene-labeled rabbit PROTEIN1 with human PROTEIN yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN2 and pyrene-labeled yeast PROTEIN ;BioInfer.d570.s3
1013;BioInfer.d570;FALSE;The titration of pyrene-labeled rabbit PROTEIN with human PROTEIN1 yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN and pyrene-labeled yeast PROTEIN2 ;BioInfer.d570.s3
1014;BioInfer.d570;FALSE;The titration of pyrene-labeled rabbit PROTEIN with human PROTEIN1 yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN2 and pyrene-labeled yeast PROTEIN ;BioInfer.d570.s3
1015;BioInfer.d570;TRUE;The titration of pyrene-labeled rabbit PROTEIN with human PROTEIN yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN1 and pyrene-labeled yeast PROTEIN2 ;BioInfer.d570.s3
1016;BioInfer.d570;FALSE;Yeast PROTEIN was shown to catalyze adenine nucleotide exchange from yeast PROTEIN1 almost 2 orders of magnitude less efficiently than human PROTEIN and rabbit PROTEIN2 ;BioInfer.d570.s4
1017;BioInfer.d570;FALSE;Yeast PROTEIN1 was shown to catalyze adenine nucleotide exchange from yeast PROTEIN2 almost 2 orders of magnitude less efficiently than human PROTEIN and rabbit PROTEIN ;BioInfer.d570.s4
1018;BioInfer.d570;FALSE;Yeast PROTEIN was shown to catalyze adenine nucleotide exchange from yeast PROTEIN1 almost 2 orders of magnitude less efficiently than human PROTEIN2 and rabbit PROTEIN ;BioInfer.d570.s4
1019;BioInfer.d570;FALSE;Yeast PROTEIN1 was shown to catalyze adenine nucleotide exchange from yeast PROTEIN almost 2 orders of magnitude less efficiently than human PROTEIN and rabbit PROTEIN2 ;BioInfer.d570.s4
1020;BioInfer.d570;FALSE;Yeast PROTEIN was shown to catalyze adenine nucleotide exchange from yeast PROTEIN almost 2 orders of magnitude less efficiently than human PROTEIN1 and rabbit PROTEIN2 ;BioInfer.d570.s4
1021;BioInfer.d570;FALSE;Yeast PROTEIN1 was shown to catalyze adenine nucleotide exchange from yeast PROTEIN almost 2 orders of magnitude less efficiently than human PROTEIN2 and rabbit PROTEIN ;BioInfer.d570.s4
1022;BioInfer.d572;FALSE;The amino acid composition of the 15-kDa protein was similar to that of mammalian PROTEIN1 and it inhibited the salt-induced polymerization of rabbit PROTEIN2 ;BioInfer.d572.s0
1023;BioInfer.d578;TRUE;The assay detects the high-affinity binding of PROTEIN1 to PROTEIN ( PROTEIN , PROTEIN2 or PROTEIN ;BioInfer.d578.s0
1024;BioInfer.d578;TRUE;The assay detects the high-affinity binding of PROTEIN1 to PROTEIN ( PROTEIN2 , PROTEIN or PROTEIN ;BioInfer.d578.s0
1025;BioInfer.d578;TRUE;The assay detects the high-affinity binding of PROTEIN1 to PROTEIN2 ( PROTEIN , PROTEIN or PROTEIN ;BioInfer.d578.s0
1026;BioInfer.d578;TRUE;The assay detects the high-affinity binding of PROTEIN1 to PROTEIN ( PROTEIN , PROTEIN or PROTEIN2 ;BioInfer.d578.s0
1027;BioInfer.d578;FALSE;The assay detects the high-affinity binding of PROTEIN to PROTEIN ( PROTEIN1 , PROTEIN2 or PROTEIN ;BioInfer.d578.s0
1028;BioInfer.d578;FALSE;The assay detects the high-affinity binding of PROTEIN to PROTEIN1 ( PROTEIN , PROTEIN2 or PROTEIN ;BioInfer.d578.s0
1029;BioInfer.d578;FALSE;The assay detects the high-affinity binding of PROTEIN to PROTEIN ( PROTEIN , PROTEIN1 or PROTEIN2 ;BioInfer.d578.s0
1030;BioInfer.d578;FALSE;The assay detects the high-affinity binding of PROTEIN to PROTEIN1 ( PROTEIN2 , PROTEIN or PROTEIN ;BioInfer.d578.s0
1031;BioInfer.d578;FALSE;The assay detects the high-affinity binding of PROTEIN to PROTEIN ( PROTEIN1 , PROTEIN or PROTEIN2 ;BioInfer.d578.s0
1032;BioInfer.d578;FALSE;The assay detects the high-affinity binding of PROTEIN to PROTEIN1 ( PROTEIN , PROTEIN or PROTEIN2 ;BioInfer.d578.s0
1033;BioInfer.d582;FALSE;The binding constants of Acanthamoeba PROTEIN1 to fluorescein-labeled PROTEIN from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN2 concentration.;BioInfer.d582.s0
1034;BioInfer.d582;FALSE;The binding constants of Acanthamoeba PROTEIN to fluorescein-labeled PROTEIN1 from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN2 concentration.;BioInfer.d582.s0
1035;BioInfer.d582;FALSE;The binding constants of Acanthamoeba PROTEIN to fluorescein-labeled PROTEIN from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN1 tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN2 concentration.;BioInfer.d582.s0
1036;BioInfer.d582;TRUE;The binding constants of Acanthamoeba PROTEIN1 to fluorescein-labeled PROTEIN2 from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN concentration.;BioInfer.d582.s0
1037;BioInfer.d582;FALSE;The binding constants of Acanthamoeba PROTEIN1 to fluorescein-labeled PROTEIN from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN2 tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN concentration.;BioInfer.d582.s0
1038;BioInfer.d582;FALSE;The binding constants of Acanthamoeba PROTEIN to fluorescein-labeled PROTEIN1 from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN2 tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN concentration.;BioInfer.d582.s0
1039;BioInfer.d582;TRUE;"These dissociation constants are the first to be determined from direct physical measurement; they are in agreement with values inferred from earlier studies on the effect of PROTEIN1 on the assembly of PROTEIN2 that had been fluorescently labeled or otherwise modified at Cys 374.";BioInfer.d582.s1
1040;BioInfer.d582;FALSE;These results place important restrictions on the interpretation of experiments in which fluorescently labeled PROTEIN1 is used as a probe of living cytoplasm or cytoplasmic extracts that include PROTEIN2 ;BioInfer.d582.s2
1041;BioInfer.d585;TRUE;The PROTEIN ( PROTEIN of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN and Indiana [ PROTEIN1 contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN PROTEIN2 in vivo.;BioInfer.d585.s0
1042;BioInfer.d585;TRUE;The PROTEIN ( PROTEIN of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN1 and Indiana [ PROTEIN contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN PROTEIN2 in vivo.;BioInfer.d585.s0
1043;BioInfer.d585;TRUE;The PROTEIN ( PROTEIN of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN and Indiana [ PROTEIN contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN1 PROTEIN2 in vivo.;BioInfer.d585.s0
1044;BioInfer.d585;TRUE;The PROTEIN ( PROTEIN1 of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN and Indiana [ PROTEIN contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN PROTEIN2 in vivo.;BioInfer.d585.s0
1045;BioInfer.d585;TRUE;The PROTEIN1 ( PROTEIN of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN and Indiana [ PROTEIN contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN PROTEIN2 in vivo.;BioInfer.d585.s0
1046;BioInfer.d585;FALSE;The PROTEIN ( PROTEIN of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN1 and Indiana [ PROTEIN2 contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN PROTEIN in vivo.;BioInfer.d585.s0
1047;BioInfer.d585;FALSE;The PROTEIN ( PROTEIN of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN and Indiana [ PROTEIN1 contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN2 PROTEIN in vivo.;BioInfer.d585.s0
1048;BioInfer.d585;TRUE;The PROTEIN ( PROTEIN1 of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN and Indiana [ PROTEIN2 contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN PROTEIN in vivo.;BioInfer.d585.s0
1049;BioInfer.d585;TRUE;The PROTEIN1 ( PROTEIN of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN and Indiana [ PROTEIN2 contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN PROTEIN in vivo.;BioInfer.d585.s0
1050;BioInfer.d585;FALSE;The PROTEIN ( PROTEIN of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN1 and Indiana [ PROTEIN contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN2 PROTEIN in vivo.;BioInfer.d585.s0
1051;BioInfer.d585;TRUE;The PROTEIN ( PROTEIN1 of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN2 and Indiana [ PROTEIN contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN PROTEIN in vivo.;BioInfer.d585.s0
1052;BioInfer.d585;TRUE;The PROTEIN1 ( PROTEIN of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN2 and Indiana [ PROTEIN contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN PROTEIN in vivo.;BioInfer.d585.s0
1053;BioInfer.d585;FALSE;The PROTEIN ( PROTEIN1 of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN and Indiana [ PROTEIN contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN2 PROTEIN in vivo.;BioInfer.d585.s0
1054;BioInfer.d585;FALSE;The PROTEIN1 ( PROTEIN of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN and Indiana [ PROTEIN contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN2 PROTEIN in vivo.;BioInfer.d585.s0
1055;BioInfer.d585;FALSE;The PROTEIN1 ( PROTEIN2 of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN and Indiana [ PROTEIN contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN PROTEIN in vivo.;BioInfer.d585.s0
1056;BioInfer.d589;TRUE;The PROTEIN1 associated proteins, PROTEIN and PROTEIN2 were present in both mesotheliomas and adenocarcinomas.;BioInfer.d589.s0
1057;BioInfer.d589;TRUE;The PROTEIN1 associated proteins, PROTEIN2 and PROTEIN were present in both mesotheliomas and adenocarcinomas.;BioInfer.d589.s0
1058;BioInfer.d589;FALSE;The PROTEIN associated proteins, PROTEIN1 and PROTEIN2 were present in both mesotheliomas and adenocarcinomas.;BioInfer.d589.s0
1059;BioInfer.d593;TRUE;The characteristics of the PROTEIN1 and PROTEIN2 interactions with PROTEIN are similar.;BioInfer.d593.s0
1060;BioInfer.d593;TRUE;The characteristics of the PROTEIN1 and PROTEIN interactions with PROTEIN2 are similar.;BioInfer.d593.s0
1061;BioInfer.d593;TRUE;The characteristics of the PROTEIN and PROTEIN1 interactions with PROTEIN2 are similar.;BioInfer.d593.s0
1062;BioInfer.d594;TRUE;The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN1 ( PROTEIN , PROTEIN2 and PROTEIN ;BioInfer.d594.s0
1063;BioInfer.d594;TRUE;The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN1 ( PROTEIN , PROTEIN and PROTEIN2 ;BioInfer.d594.s0
1064;BioInfer.d594;FALSE;The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN1 ( PROTEIN2 , PROTEIN and PROTEIN ;BioInfer.d594.s0
1065;BioInfer.d594;FALSE;The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN ( PROTEIN , PROTEIN1 and PROTEIN2 ;BioInfer.d594.s0
1066;BioInfer.d594;TRUE;The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN ( PROTEIN1 , PROTEIN2 and PROTEIN ;BioInfer.d594.s0
1067;BioInfer.d594;TRUE;The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN ( PROTEIN1 , PROTEIN and PROTEIN2 ;BioInfer.d594.s0
1068;BioInfer.d598;FALSE;The contents of PROTEIN PROTEIN1 PROTEIN2 PROTEIN in 125-week-old rats decreased compared with those of 12-week-old rats.;BioInfer.d598.s0
1069;BioInfer.d598;FALSE;The contents of PROTEIN PROTEIN1 PROTEIN PROTEIN2 in 125-week-old rats decreased compared with those of 12-week-old rats.;BioInfer.d598.s0
1070;BioInfer.d598;FALSE;The contents of PROTEIN1 PROTEIN2 PROTEIN PROTEIN in 125-week-old rats decreased compared with those of 12-week-old rats.;BioInfer.d598.s0
1071;BioInfer.d598;FALSE;The contents of PROTEIN PROTEIN PROTEIN1 PROTEIN2 in 125-week-old rats decreased compared with those of 12-week-old rats.;BioInfer.d598.s0
1072;BioInfer.d598;FALSE;The contents of PROTEIN1 PROTEIN PROTEIN2 PROTEIN in 125-week-old rats decreased compared with those of 12-week-old rats.;BioInfer.d598.s0
1073;BioInfer.d598;FALSE;The contents of PROTEIN1 PROTEIN PROTEIN PROTEIN2 in 125-week-old rats decreased compared with those of 12-week-old rats.;BioInfer.d598.s0
1074;BioInfer.d600;FALSE;The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN1 (Mr 43 000) that makes up the filaments, the PROTEIN2 (Mr 95 000) and PROTEIN (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.;BioInfer.d600.s0
1075;BioInfer.d600;FALSE;The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN1 (Mr 43 000) that makes up the filaments, the PROTEIN (Mr 95 000) and PROTEIN2 (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.;BioInfer.d600.s0
1076;BioInfer.d600;FALSE;The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN1 (Mr 43 000) that makes up the filaments, the PROTEIN (Mr 95 000) and PROTEIN (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN2 complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.;BioInfer.d600.s0
1077;BioInfer.d600;FALSE;The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN (Mr 43 000) that makes up the filaments, the PROTEIN1 (Mr 95 000) and PROTEIN2 (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.;BioInfer.d600.s0
1078;BioInfer.d600;FALSE;The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN (Mr 43 000) that makes up the filaments, the PROTEIN1 (Mr 95 000) and PROTEIN (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN2 complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.;BioInfer.d600.s0
1079;BioInfer.d600;FALSE;The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN (Mr 43 000) that makes up the filaments, the PROTEIN (Mr 95 000) and PROTEIN1 (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN2 complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.;BioInfer.d600.s0
1080;BioInfer.d601;FALSE;"The C-terminal of PROTEIN1 comprises the ""death domain"" that is responsible for association of PROTEIN2 and other death domain-containing proteins such as PROTEIN and PROTEIN ";BioInfer.d601.s0
1081;BioInfer.d601;FALSE;"The C-terminal of PROTEIN1 comprises the ""death domain"" that is responsible for association of PROTEIN and other death domain-containing proteins such as PROTEIN and PROTEIN2 ";BioInfer.d601.s0
1082;BioInfer.d601;FALSE;"The C-terminal of PROTEIN1 comprises the ""death domain"" that is responsible for association of PROTEIN and other death domain-containing proteins such as PROTEIN2 and PROTEIN ";BioInfer.d601.s0
1083;BioInfer.d601;TRUE;"The C-terminal of PROTEIN comprises the ""death domain"" that is responsible for association of PROTEIN1 and other death domain-containing proteins such as PROTEIN and PROTEIN2 ";BioInfer.d601.s0
1084;BioInfer.d601;TRUE;"The C-terminal of PROTEIN comprises the ""death domain"" that is responsible for association of PROTEIN1 and other death domain-containing proteins such as PROTEIN2 and PROTEIN ";BioInfer.d601.s0
1085;BioInfer.d601;FALSE;"The C-terminal of PROTEIN comprises the ""death domain"" that is responsible for association of PROTEIN and other death domain-containing proteins such as PROTEIN1 and PROTEIN2 ";BioInfer.d601.s0
1086;BioInfer.d619;FALSE;The herpes simplex virus type 1 PROTEIN protein influences the intracellular localization of the PROTEIN1 but not the PROTEIN2 or PROTEIN replication proteins in virus-infected cells.;BioInfer.d619.s0
1087;BioInfer.d619;FALSE;The herpes simplex virus type 1 PROTEIN protein influences the intracellular localization of the PROTEIN1 but not the PROTEIN or PROTEIN2 replication proteins in virus-infected cells.;BioInfer.d619.s0
1088;BioInfer.d619;TRUE;The herpes simplex virus type 1 PROTEIN1 protein influences the intracellular localization of the PROTEIN2 but not the PROTEIN or PROTEIN replication proteins in virus-infected cells.;BioInfer.d619.s0
1089;BioInfer.d619;FALSE;The herpes simplex virus type 1 PROTEIN protein influences the intracellular localization of the PROTEIN but not the PROTEIN1 or PROTEIN2 replication proteins in virus-infected cells.;BioInfer.d619.s0
1090;BioInfer.d619;TRUE;The herpes simplex virus type 1 PROTEIN1 protein influences the intracellular localization of the PROTEIN but not the PROTEIN2 or PROTEIN replication proteins in virus-infected cells.;BioInfer.d619.s0
1091;BioInfer.d619;TRUE;The herpes simplex virus type 1 PROTEIN1 protein influences the intracellular localization of the PROTEIN but not the PROTEIN or PROTEIN2 replication proteins in virus-infected cells.;BioInfer.d619.s0
1092;BioInfer.d626;TRUE;The I/LWEQ module is a conserved sequence that we have identified as an PROTEIN1 binding motif in the metazoan focal adhesion protein PROTEIN and the yeast protein PROTEIN2 ;BioInfer.d626.s0
1093;BioInfer.d626;FALSE;The I/LWEQ module is a conserved sequence that we have identified as an PROTEIN binding motif in the metazoan focal adhesion protein PROTEIN1 and the yeast protein PROTEIN2 ;BioInfer.d626.s0
1094;BioInfer.d626;TRUE;The I/LWEQ module is a conserved sequence that we have identified as an PROTEIN1 binding motif in the metazoan focal adhesion protein PROTEIN2 and the yeast protein PROTEIN ;BioInfer.d626.s0
1095;BioInfer.d630;TRUE;The interaction of a mouse monoclonal antibody ( PROTEIN1 and birch PROTEIN2 a structurally well conserved PROTEIN and phosphoinositide-binding protein and cross-reactive allergen, was characterized.;BioInfer.d630.s0
1096;BioInfer.d630;TRUE;The interaction of a mouse monoclonal antibody ( PROTEIN and birch PROTEIN1 a structurally well conserved PROTEIN2 and phosphoinositide-binding protein and cross-reactive allergen, was characterized.;BioInfer.d630.s0
1097;BioInfer.d630;FALSE;The interaction of a mouse monoclonal antibody ( PROTEIN1 and birch PROTEIN a structurally well conserved PROTEIN2 and phosphoinositide-binding protein and cross-reactive allergen, was characterized.;BioInfer.d630.s0
1098;BioInfer.d642;FALSE;The map locates the N-terminal calcium-binding domain and identifies PROTEIN1 binding site residues on the two PROTEIN2 homology domains of PROTEIN ;BioInfer.d642.s0
1099;BioInfer.d642;TRUE;The map locates the N-terminal calcium-binding domain and identifies PROTEIN1 binding site residues on the two PROTEIN homology domains of PROTEIN2 ;BioInfer.d642.s0
1100;BioInfer.d642;TRUE;The map locates the N-terminal calcium-binding domain and identifies PROTEIN binding site residues on the two PROTEIN1 homology domains of PROTEIN2 ;BioInfer.d642.s0
1101;BioInfer.d643;TRUE;The mechanism of PROTEIN1 promoted PROTEIN2 polymerization has been systematically reinvestigated.;BioInfer.d643.s0
1102;BioInfer.d643;FALSE;When measured in the absence of PROTEIN PROTEIN1 assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN2 PROTEIN .;BioInfer.d643.s1
1103;BioInfer.d643;TRUE;When measured in the absence of PROTEIN PROTEIN assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN1 PROTEIN2 .;BioInfer.d643.s1
1104;BioInfer.d643;FALSE;When measured in the absence of PROTEIN PROTEIN assembly curves over a 0.7-4 microM PROTEIN1 concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN2 PROTEIN .;BioInfer.d643.s1
1105;BioInfer.d643;FALSE;When measured in the absence of PROTEIN1 PROTEIN assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN2 PROTEIN .;BioInfer.d643.s1
1106;BioInfer.d643;FALSE;When measured in the absence of PROTEIN PROTEIN1 assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN PROTEIN2 .;BioInfer.d643.s1
1107;BioInfer.d643;FALSE;When measured in the absence of PROTEIN PROTEIN1 assembly curves over a 0.7-4 microM PROTEIN2 concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN PROTEIN .;BioInfer.d643.s1
1108;BioInfer.d643;FALSE;When measured in the absence of PROTEIN1 PROTEIN2 assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN PROTEIN .;BioInfer.d643.s1
1109;BioInfer.d643;FALSE;When measured in the absence of PROTEIN PROTEIN assembly curves over a 0.7-4 microM PROTEIN1 concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN PROTEIN2 .;BioInfer.d643.s1
1110;BioInfer.d643;FALSE;When measured in the absence of PROTEIN1 PROTEIN assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN PROTEIN2 .;BioInfer.d643.s1
1111;BioInfer.d643;FALSE;When measured in the absence of PROTEIN1 PROTEIN assembly curves over a 0.7-4 microM PROTEIN2 concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN PROTEIN .;BioInfer.d643.s1
1112;BioInfer.d643;FALSE;With solutions of PROTEIN (2 microM) and PROTEIN1 (2 or 4 microM), the barbed-end assembly rate rose with increasing PROTEIN2 concentration (0.7-2 microM).;BioInfer.d643.s2
1113;BioInfer.d643;FALSE;With solutions of PROTEIN1 (2 microM) and PROTEIN2 (2 or 4 microM), the barbed-end assembly rate rose with increasing PROTEIN concentration (0.7-2 microM).;BioInfer.d643.s2
1114;BioInfer.d643;FALSE;With solutions of PROTEIN1 (2 microM) and PROTEIN (2 or 4 microM), the barbed-end assembly rate rose with increasing PROTEIN2 concentration (0.7-2 microM).;BioInfer.d643.s2
1115;BioInfer.d655;TRUE;The ordered assembly of the PROTEIN1 homologue together with PROTEIN2 and a series of other proteins is considered to play a key role in chemotactic orientation.;BioInfer.d655.s0
1116;BioInfer.d660;TRUE;The polypeptide folds and the PROTEIN1 binding surfaces of the amoeba PROTEIN2 are very similar to those of bovine and human PROTEIN ;BioInfer.d660.s0
1117;BioInfer.d660;TRUE;The polypeptide folds and the PROTEIN binding surfaces of the amoeba PROTEIN1 are very similar to those of bovine and human PROTEIN2 ;BioInfer.d660.s0
1118;BioInfer.d660;TRUE;The polypeptide folds and the PROTEIN1 binding surfaces of the amoeba PROTEIN are very similar to those of bovine and human PROTEIN2 ;BioInfer.d660.s0
1119;BioInfer.d660;FALSE;The proximity of these sites to the PROTEIN1 binding site provides an explanation for the competition between PROTEIN2 and lipids for binding PROTEIN ;BioInfer.d660.s1
1120;BioInfer.d660;TRUE;The proximity of these sites to the PROTEIN1 binding site provides an explanation for the competition between PROTEIN and lipids for binding PROTEIN2 ;BioInfer.d660.s1
1121;BioInfer.d660;TRUE;The proximity of these sites to the PROTEIN binding site provides an explanation for the competition between PROTEIN1 and lipids for binding PROTEIN2 ;BioInfer.d660.s1
1122;BioInfer.d660;TRUE;X-ray structures of isoforms of the PROTEIN1 PROTEIN2 that differ in their affinity for phosphatidylinositol phosphates.;BioInfer.d660.s2
1123;BioInfer.d661;FALSE;The position of the PROTEIN1 binding site at the C terminal suggests that PROTEIN may work as a crosslinker between PROTEIN and PROTEIN2 ;BioInfer.d661.s0
1124;BioInfer.d661;TRUE;The position of the PROTEIN binding site at the C terminal suggests that PROTEIN may work as a crosslinker between PROTEIN1 and PROTEIN2 ;BioInfer.d661.s0
1125;BioInfer.d661;TRUE;The position of the PROTEIN binding site at the C terminal suggests that PROTEIN1 may work as a crosslinker between PROTEIN and PROTEIN2 ;BioInfer.d661.s0
1126;BioInfer.d661;FALSE;The position of the PROTEIN1 binding site at the C terminal suggests that PROTEIN may work as a crosslinker between PROTEIN2 and PROTEIN ;BioInfer.d661.s0
1127;BioInfer.d661;TRUE;The position of the PROTEIN1 binding site at the C terminal suggests that PROTEIN2 may work as a crosslinker between PROTEIN and PROTEIN ;BioInfer.d661.s0
1128;BioInfer.d661;TRUE;The position of the PROTEIN binding site at the C terminal suggests that PROTEIN1 may work as a crosslinker between PROTEIN2 and PROTEIN ;BioInfer.d661.s0
1129;BioInfer.d664;TRUE;The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN1 binding domain in PROTEIN2 and in a larger family of PROTEIN cross-linking proteins.;BioInfer.d664.s0
1130;BioInfer.d664;FALSE;The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN1 binding domain in PROTEIN and in a larger family of PROTEIN2 cross-linking proteins.;BioInfer.d664.s0
1131;BioInfer.d664;TRUE;The predicted sequence of PROTEIN1 shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN2 binding domain in PROTEIN and in a larger family of PROTEIN cross-linking proteins.;BioInfer.d664.s0
1132;BioInfer.d664;FALSE;The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN1 and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN2 binding domain in PROTEIN and in a larger family of PROTEIN cross-linking proteins.;BioInfer.d664.s0
1133;BioInfer.d664;FALSE;The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN binding domain in PROTEIN1 and in a larger family of PROTEIN2 cross-linking proteins.;BioInfer.d664.s0
1134;BioInfer.d664;FALSE;The predicted sequence of PROTEIN1 shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN binding domain in PROTEIN2 and in a larger family of PROTEIN cross-linking proteins.;BioInfer.d664.s0
1135;BioInfer.d664;FALSE;The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN1 and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN binding domain in PROTEIN2 and in a larger family of PROTEIN cross-linking proteins.;BioInfer.d664.s0
1136;BioInfer.d664;FALSE;The predicted sequence of PROTEIN1 shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN binding domain in PROTEIN and in a larger family of PROTEIN2 cross-linking proteins.;BioInfer.d664.s0
1137;BioInfer.d664;FALSE;The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN1 and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN binding domain in PROTEIN and in a larger family of PROTEIN2 cross-linking proteins.;BioInfer.d664.s0
1138;BioInfer.d664;TRUE;The predicted sequence of PROTEIN1 shares ca. 40% identity with nonplant PROTEIN2 and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN binding domain in PROTEIN and in a larger family of PROTEIN cross-linking proteins.;BioInfer.d664.s0
1139;BioInfer.d677;FALSE;The qualitative changes involve differential expression of multigene families of contractile proteins, especially PROTEIN1 ( PROTEIN and PROTEIN2 ;BioInfer.d677.s0
1140;BioInfer.d677;FALSE;The qualitative changes involve differential expression of multigene families of contractile proteins, especially PROTEIN ( PROTEIN1 and PROTEIN2 ;BioInfer.d677.s0
1141;BioInfer.d677;FALSE;The qualitative changes involve differential expression of multigene families of contractile proteins, especially PROTEIN1 ( PROTEIN2 and PROTEIN ;BioInfer.d677.s0
1142;BioInfer.d679;FALSE;The ratios PROTEIN mRNA: PROTEIN and PROTEIN1 mRNA: PROTEIN2 were unaffected by clenbuterol.;BioInfer.d679.s0
1143;BioInfer.d679;FALSE;The ratios PROTEIN1 mRNA: PROTEIN and PROTEIN mRNA: PROTEIN2 were unaffected by clenbuterol.;BioInfer.d679.s0
1144;BioInfer.d679;FALSE;The ratios PROTEIN mRNA: PROTEIN1 and PROTEIN mRNA: PROTEIN2 were unaffected by clenbuterol.;BioInfer.d679.s0
1145;BioInfer.d679;FALSE;The ratios PROTEIN1 mRNA: PROTEIN and PROTEIN2 mRNA: PROTEIN were unaffected by clenbuterol.;BioInfer.d679.s0
1146;BioInfer.d679;FALSE;The ratios PROTEIN mRNA: PROTEIN1 and PROTEIN2 mRNA: PROTEIN were unaffected by clenbuterol.;BioInfer.d679.s0
1147;BioInfer.d679;FALSE;The ratios PROTEIN1 mRNA: PROTEIN2 and PROTEIN mRNA: PROTEIN were unaffected by clenbuterol.;BioInfer.d679.s0
1148;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN1 genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN2 PROTEIN genes.";BioInfer.d681.s0
1149;BioInfer.d681;TRUE;"There are three PROTEIN1 PROTEIN2 genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1150;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN1 genes, two of which are identical; four PROTEIN PROTEIN2 genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1151;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN1 genes, two of which are identical; four PROTEIN2 PROTEIN genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1152;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN1 genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN PROTEIN2 genes.";BioInfer.d681.s0
1153;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN1 genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN2 PROTEIN gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1154;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN1 genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN PROTEIN2 gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1155;BioInfer.d681;FALSE;"There are three PROTEIN1 PROTEIN genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN2 PROTEIN genes.";BioInfer.d681.s0
1156;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN PROTEIN1 genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN2 PROTEIN genes.";BioInfer.d681.s0
1157;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN1 PROTEIN genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN2 PROTEIN genes.";BioInfer.d681.s0
1158;BioInfer.d681;TRUE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN1 PROTEIN2 genes.";BioInfer.d681.s0
1159;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN1 PROTEIN gene; and two PROTEIN2 PROTEIN genes.";BioInfer.d681.s0
1160;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN PROTEIN1 gene; and two PROTEIN2 PROTEIN genes.";BioInfer.d681.s0
1161;BioInfer.d681;FALSE;"There are three PROTEIN1 PROTEIN genes, two of which are identical; four PROTEIN PROTEIN2 genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1162;BioInfer.d681;FALSE;"There are three PROTEIN1 PROTEIN genes, two of which are identical; four PROTEIN2 PROTEIN genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1163;BioInfer.d681;FALSE;"There are three PROTEIN1 PROTEIN genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN PROTEIN2 genes.";BioInfer.d681.s0
1164;BioInfer.d681;FALSE;"There are three PROTEIN1 PROTEIN genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN2 PROTEIN gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1165;BioInfer.d681;FALSE;"There are three PROTEIN1 PROTEIN genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN PROTEIN2 gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1166;BioInfer.d681;TRUE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN1 PROTEIN2 genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1167;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN PROTEIN1 genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN PROTEIN2 genes.";BioInfer.d681.s0
1168;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN PROTEIN1 genes, two of which are identical, one PROTEIN2 PROTEIN gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1169;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN PROTEIN1 genes, two of which are identical, one PROTEIN PROTEIN2 gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1170;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN1 PROTEIN genes, two of which are identical, one PROTEIN PROTEIN gene; and two PROTEIN PROTEIN2 genes.";BioInfer.d681.s0
1171;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN1 PROTEIN genes, two of which are identical, one PROTEIN2 PROTEIN gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1172;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN1 PROTEIN genes, two of which are identical, one PROTEIN PROTEIN2 gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1173;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN1 PROTEIN gene; and two PROTEIN PROTEIN2 genes.";BioInfer.d681.s0
1174;BioInfer.d681;FALSE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN PROTEIN1 gene; and two PROTEIN PROTEIN2 genes.";BioInfer.d681.s0
1175;BioInfer.d681;TRUE;"There are three PROTEIN PROTEIN genes, two of which are identical; four PROTEIN PROTEIN genes, two of which are identical, one PROTEIN1 PROTEIN2 gene; and two PROTEIN PROTEIN genes.";BioInfer.d681.s0
1176;BioInfer.d681;FALSE;These PROTEIN1 PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN2 PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1177;BioInfer.d681;TRUE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN1 PROTEIN2 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1178;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN1 and PROTEIN2 PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1179;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN1 PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.;BioInfer.d681.s1
1180;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN PROTEIN and PROTEIN2 PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1181;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN1 PROTEIN and PROTEIN2 PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1182;BioInfer.d681;FALSE;These PROTEIN PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN2 PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1183;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN1 PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN2 mRNA.;BioInfer.d681.s1
1184;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN1 and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN2 PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1185;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN2 PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1186;BioInfer.d681;FALSE;These PROTEIN1 PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN2 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1187;BioInfer.d681;FALSE;These PROTEIN1 PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN2 and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1188;BioInfer.d681;FALSE;These PROTEIN1 PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.;BioInfer.d681.s1
1189;BioInfer.d681;FALSE;These PROTEIN1 PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN2 mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1190;BioInfer.d681;FALSE;These PROTEIN1 PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN2 PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1191;BioInfer.d681;TRUE;These PROTEIN1 PROTEIN2 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1192;BioInfer.d681;FALSE;These PROTEIN1 PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN2 mRNA.;BioInfer.d681.s1
1193;BioInfer.d681;FALSE;These PROTEIN1 PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN2 and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1194;BioInfer.d681;TRUE;These PROTEIN1 PROTEIN and PROTEIN2 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1195;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN1 and PROTEIN PROTEIN2 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1196;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN1 genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.;BioInfer.d681.s1
1197;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN2 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1198;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN1 PROTEIN and PROTEIN PROTEIN2 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1199;BioInfer.d681;FALSE;These PROTEIN PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN2 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1200;BioInfer.d681;TRUE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN1 genes encode < 10% of the total PROTEIN and PROTEIN2 mRNA.;BioInfer.d681.s1
1201;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN1 and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN2 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1202;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN2 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1203;BioInfer.d681;TRUE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN1 and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.;BioInfer.d681.s1
1204;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN PROTEIN2 and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1205;BioInfer.d681;TRUE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN1 PROTEIN2 and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1206;BioInfer.d681;FALSE;These PROTEIN PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN2 and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1207;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN1 and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN2 mRNA.;BioInfer.d681.s1
1208;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN1 and PROTEIN mRNA, whereas the PROTEIN PROTEIN2 and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1209;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN2 and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1210;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.;BioInfer.d681.s1
1211;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN1 PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.;BioInfer.d681.s1
1212;BioInfer.d681;FALSE;These PROTEIN PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.;BioInfer.d681.s1
1213;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN1 and PROTEIN2 mRNA.;BioInfer.d681.s1
1214;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN1 and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.;BioInfer.d681.s1
1215;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.;BioInfer.d681.s1
1216;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN2 PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1217;BioInfer.d681;FALSE;These PROTEIN PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN2 mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1218;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN2 mRNA.;BioInfer.d681.s1
1219;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN1 and PROTEIN2 mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1220;BioInfer.d681;TRUE;These PROTEIN PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN and PROTEIN2 mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1221;BioInfer.d681;FALSE;These PROTEIN PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN2 PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1222;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN1 PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN2 mRNA.;BioInfer.d681.s1
1223;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN1 and PROTEIN mRNA, whereas the PROTEIN2 PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1224;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN2 PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1225;BioInfer.d681;FALSE;These PROTEIN PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN2 mRNA.;BioInfer.d681.s1
1226;BioInfer.d681;TRUE;These PROTEIN PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN2 and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1227;BioInfer.d681;FALSE;These PROTEIN PROTEIN1 and PROTEIN2 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1228;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN1 and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN2 mRNA.;BioInfer.d681.s1
1229;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN2 mRNA.;BioInfer.d681.s1
1230;BioInfer.d681;FALSE;These PROTEIN PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN2 and PROTEIN mRNA, whereas the PROTEIN PROTEIN and PROTEIN PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.;BioInfer.d681.s1
1231;BioInfer.d684;TRUE;The relatively conservative sequence of PROTEIN1 from yeast, Physarum, Acanthamoeba, echinoid eggs and mammalian cells was found in the N-terminal region, which was suggested to be a common PROTEIN2 binding region.;BioInfer.d684.s0
1232;BioInfer.d687;FALSE;The results indicate increased fractional synthesis and degradation of PROTEIN1 and light chains, but not PROTEIN2 in the left compared to the right ventricular free wall.;BioInfer.d687.s0
1233;BioInfer.d687;FALSE;To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN1 PROTEIN2 PROTEIN and PROTEIN in the right and left ventricular free walls of growing, New Zealand White rabbits.;BioInfer.d687.s1
1234;BioInfer.d687;FALSE;To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN1 PROTEIN PROTEIN and PROTEIN2 in the right and left ventricular free walls of growing, New Zealand White rabbits.;BioInfer.d687.s1
1235;BioInfer.d687;FALSE;To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN1 PROTEIN PROTEIN2 and PROTEIN in the right and left ventricular free walls of growing, New Zealand White rabbits.;BioInfer.d687.s1
1236;BioInfer.d687;FALSE;To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN PROTEIN1 PROTEIN and PROTEIN2 in the right and left ventricular free walls of growing, New Zealand White rabbits.;BioInfer.d687.s1
1237;BioInfer.d687;FALSE;To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN PROTEIN1 PROTEIN2 and PROTEIN in the right and left ventricular free walls of growing, New Zealand White rabbits.;BioInfer.d687.s1
1238;BioInfer.d687;FALSE;To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN PROTEIN PROTEIN1 and PROTEIN2 in the right and left ventricular free walls of growing, New Zealand White rabbits.;BioInfer.d687.s1
1239;BioInfer.d689;FALSE;The Saccharomyces cerevisiae PROTEIN1 and PROTEIN2 genes are both required for the occurrence of homologous recombination and for the repair of double-stranded DNA breaks.;BioInfer.d689.s0
1240;BioInfer.d690;TRUE;The Saccharomyces cerevisiae PROTEIN1 gene belongs to the PROTEIN PROTEIN and PROTEIN2 epistasis group which, together with PROTEIN is proposed to act at the beginning of the DNA damage checkpoint pathway.;BioInfer.d690.s0
1241;BioInfer.d690;FALSE;The Saccharomyces cerevisiae PROTEIN1 gene belongs to the PROTEIN PROTEIN and PROTEIN epistasis group which, together with PROTEIN2 is proposed to act at the beginning of the DNA damage checkpoint pathway.;BioInfer.d690.s0
1242;BioInfer.d690;TRUE;The Saccharomyces cerevisiae PROTEIN1 gene belongs to the PROTEIN PROTEIN2 and PROTEIN epistasis group which, together with PROTEIN is proposed to act at the beginning of the DNA damage checkpoint pathway.;BioInfer.d690.s0
1243;BioInfer.d690;TRUE;The Saccharomyces cerevisiae PROTEIN1 gene belongs to the PROTEIN2 PROTEIN and PROTEIN epistasis group which, together with PROTEIN is proposed to act at the beginning of the DNA damage checkpoint pathway.;BioInfer.d690.s0
1244;BioInfer.d690;FALSE;The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN PROTEIN and PROTEIN1 epistasis group which, together with PROTEIN2 is proposed to act at the beginning of the DNA damage checkpoint pathway.;BioInfer.d690.s0
1245;BioInfer.d690;TRUE;The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN PROTEIN1 and PROTEIN2 epistasis group which, together with PROTEIN is proposed to act at the beginning of the DNA damage checkpoint pathway.;BioInfer.d690.s0
1246;BioInfer.d690;TRUE;The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN1 PROTEIN and PROTEIN2 epistasis group which, together with PROTEIN is proposed to act at the beginning of the DNA damage checkpoint pathway.;BioInfer.d690.s0
1247;BioInfer.d690;FALSE;The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN PROTEIN1 and PROTEIN epistasis group which, together with PROTEIN2 is proposed to act at the beginning of the DNA damage checkpoint pathway.;BioInfer.d690.s0
1248;BioInfer.d690;FALSE;The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN1 PROTEIN and PROTEIN epistasis group which, together with PROTEIN2 is proposed to act at the beginning of the DNA damage checkpoint pathway.;BioInfer.d690.s0
1249;BioInfer.d690;TRUE;The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN1 PROTEIN2 and PROTEIN epistasis group which, together with PROTEIN is proposed to act at the beginning of the DNA damage checkpoint pathway.;BioInfer.d690.s0
1250;BioInfer.d691;FALSE;The same steady state concentrations of polymerized and nonpolymerized PROTEIN1 are reached whether PROTEIN2 is added before initiation of polymerization or after polymerization is complete.;BioInfer.d691.s0
1251;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN1 which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN2 and PROTEIN ;BioInfer.d698.s0
1252;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN1 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN2 and PROTEIN ;BioInfer.d698.s0
1253;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN2 and PROTEIN ;BioInfer.d698.s0
1254;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN1 related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN2 and PROTEIN ;BioInfer.d698.s0
1255;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN1 and PROTEIN2 ;BioInfer.d698.s0
1256;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN1 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN2 and PROTEIN ;BioInfer.d698.s0
1257;BioInfer.d698;TRUE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN1 such as PROTEIN2 and PROTEIN ;BioInfer.d698.s0
1258;BioInfer.d698;TRUE;These findings suggest that this novel PROTEIN1 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN2 which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1259;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of PROTEIN2 which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1260;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN1 which leads to PROTEIN2 related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1261;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN1 which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN2 ;BioInfer.d698.s0
1262;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN1 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN2 which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1263;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN1 which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1264;BioInfer.d698;TRUE;These findings suggest that this novel PROTEIN1 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN2 activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1265;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN1 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN2 related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1266;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN1 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN2 ;BioInfer.d698.s0
1267;BioInfer.d698;TRUE;These findings suggest that this novel PROTEIN1 is involved in the PROTEIN2 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1268;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN1 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1269;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of PROTEIN which leads to PROTEIN2 related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1270;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN2 ;BioInfer.d698.s0
1271;BioInfer.d698;TRUE;These findings suggest that this novel PROTEIN is involved in the PROTEIN1 signalling pathway, probably downstream of PROTEIN2 activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1272;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1273;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN1 related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN2 ;BioInfer.d698.s0
1274;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN1 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN2 related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1275;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN1 related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1276;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN1 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN2 ;BioInfer.d698.s0
1277;BioInfer.d698;TRUE;These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN1 such as PROTEIN and PROTEIN2 ;BioInfer.d698.s0
1278;BioInfer.d698;FALSE;These findings suggest that this novel PROTEIN is involved in the PROTEIN1 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN which leads to PROTEIN related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as PROTEIN and PROTEIN ;BioInfer.d698.s0
1279;BioInfer.d703;FALSE;These proteins also compose the essential heterotrimeric splicing factor PROTEIN and products of yeast pre-mRNA processing genes PROTEIN PROTEIN1 and PROTEIN2 are their likely yeast counterparts.;BioInfer.d703.s0
1280;BioInfer.d703;FALSE;These proteins also compose the essential heterotrimeric splicing factor PROTEIN1 and products of yeast pre-mRNA processing genes PROTEIN PROTEIN and PROTEIN2 are their likely yeast counterparts.;BioInfer.d703.s0
1281;BioInfer.d703;FALSE;These proteins also compose the essential heterotrimeric splicing factor PROTEIN and products of yeast pre-mRNA processing genes PROTEIN1 PROTEIN and PROTEIN2 are their likely yeast counterparts.;BioInfer.d703.s0
1282;BioInfer.d703;FALSE;These proteins also compose the essential heterotrimeric splicing factor PROTEIN1 and products of yeast pre-mRNA processing genes PROTEIN PROTEIN2 and PROTEIN are their likely yeast counterparts.;BioInfer.d703.s0
1283;BioInfer.d703;FALSE;These proteins also compose the essential heterotrimeric splicing factor PROTEIN and products of yeast pre-mRNA processing genes PROTEIN1 PROTEIN2 and PROTEIN are their likely yeast counterparts.;BioInfer.d703.s0
1284;BioInfer.d703;FALSE;These proteins also compose the essential heterotrimeric splicing factor PROTEIN1 and products of yeast pre-mRNA processing genes PROTEIN2 PROTEIN and PROTEIN are their likely yeast counterparts.;BioInfer.d703.s0
1285;BioInfer.d708;TRUE;These results indicate that (i) cotranslational assembly of PROTEIN1 is developmentally regulated, (ii) structures containing PROTEIN2 and not microtubules may mediate initial association of the heavy chains with the cytoskeleton, and (iii) the site of translation dictates where a significant fraction of the heavy chains will be inserted into the cytoskeleton.;BioInfer.d708.s0
1286;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN PROTEIN the PROTEIN1 PROTEIN and the PROTEIN2 PROTEIN ;BioInfer.d717.s0
1287;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN PROTEIN the PROTEIN PROTEIN1 and the PROTEIN2 PROTEIN ;BioInfer.d717.s0
1288;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1 PROTEIN the PROTEIN PROTEIN and the PROTEIN2 PROTEIN ;BioInfer.d717.s0
1289;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN PROTEIN1 the PROTEIN PROTEIN and the PROTEIN2 PROTEIN ;BioInfer.d717.s0
1290;BioInfer.d717;TRUE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN PROTEIN the PROTEIN PROTEIN and the PROTEIN1 PROTEIN2 ;BioInfer.d717.s0
1291;BioInfer.d717;TRUE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN PROTEIN the PROTEIN1 PROTEIN2 and the PROTEIN PROTEIN ;BioInfer.d717.s0
1292;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1 PROTEIN the PROTEIN2 PROTEIN and the PROTEIN PROTEIN ;BioInfer.d717.s0
1293;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN PROTEIN1 the PROTEIN2 PROTEIN and the PROTEIN PROTEIN ;BioInfer.d717.s0
1294;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN PROTEIN the PROTEIN1 PROTEIN and the PROTEIN PROTEIN2 ;BioInfer.d717.s0
1295;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1 PROTEIN the PROTEIN PROTEIN2 and the PROTEIN PROTEIN ;BioInfer.d717.s0
1296;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN PROTEIN1 the PROTEIN PROTEIN2 and the PROTEIN PROTEIN ;BioInfer.d717.s0
1297;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN PROTEIN the PROTEIN PROTEIN1 and the PROTEIN PROTEIN2 ;BioInfer.d717.s0
1298;BioInfer.d717;TRUE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1 PROTEIN2 the PROTEIN PROTEIN and the PROTEIN PROTEIN ;BioInfer.d717.s0
1299;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1 PROTEIN the PROTEIN PROTEIN and the PROTEIN PROTEIN2 ;BioInfer.d717.s0
1300;BioInfer.d717;FALSE;These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN PROTEIN1 the PROTEIN PROTEIN and the PROTEIN PROTEIN2 ;BioInfer.d717.s0
1301;BioInfer.d719;FALSE;These were identified as PROTEIN1 PROTEIN PROTEIN heat shock protein ( PROTEIN -60, an unidentified protein and PROTEIN2 respectively.;BioInfer.d719.s0
1302;BioInfer.d719;FALSE;These were identified as PROTEIN PROTEIN PROTEIN1 heat shock protein ( PROTEIN -60, an unidentified protein and PROTEIN2 respectively.;BioInfer.d719.s0
1303;BioInfer.d719;FALSE;These were identified as PROTEIN PROTEIN1 PROTEIN heat shock protein ( PROTEIN -60, an unidentified protein and PROTEIN2 respectively.;BioInfer.d719.s0
1304;BioInfer.d719;FALSE;These were identified as PROTEIN PROTEIN PROTEIN heat shock protein ( PROTEIN1 -60, an unidentified protein and PROTEIN2 respectively.;BioInfer.d719.s0
1305;BioInfer.d719;FALSE;These were identified as PROTEIN1 PROTEIN PROTEIN2 heat shock protein ( PROTEIN -60, an unidentified protein and PROTEIN respectively.;BioInfer.d719.s0
1306;BioInfer.d719;FALSE;These were identified as PROTEIN1 PROTEIN2 PROTEIN heat shock protein ( PROTEIN -60, an unidentified protein and PROTEIN respectively.;BioInfer.d719.s0
1307;BioInfer.d719;FALSE;These were identified as PROTEIN1 PROTEIN PROTEIN heat shock protein ( PROTEIN2 -60, an unidentified protein and PROTEIN respectively.;BioInfer.d719.s0
1308;BioInfer.d719;FALSE;These were identified as PROTEIN PROTEIN1 PROTEIN2 heat shock protein ( PROTEIN -60, an unidentified protein and PROTEIN respectively.;BioInfer.d719.s0
1309;BioInfer.d719;FALSE;These were identified as PROTEIN PROTEIN PROTEIN1 heat shock protein ( PROTEIN2 -60, an unidentified protein and PROTEIN respectively.;BioInfer.d719.s0
1310;BioInfer.d719;FALSE;These were identified as PROTEIN PROTEIN1 PROTEIN heat shock protein ( PROTEIN2 -60, an unidentified protein and PROTEIN respectively.;BioInfer.d719.s0
1311;BioInfer.d720;FALSE;The sites on the PROTEIN that interact with PROTEIN1 and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN2 head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN head (subfragment 1, S1) in this process.;BioInfer.d720.s0
1312;BioInfer.d720;TRUE;The sites on the PROTEIN1 that interact with PROTEIN2 and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN head (subfragment 1, S1) in this process.;BioInfer.d720.s0
1313;BioInfer.d720;FALSE;The sites on the PROTEIN that interact with PROTEIN1 and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN2 head (subfragment 1, S1) in this process.;BioInfer.d720.s0
1314;BioInfer.d720;FALSE;The sites on the PROTEIN1 that interact with PROTEIN and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN2 head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN head (subfragment 1, S1) in this process.;BioInfer.d720.s0
1315;BioInfer.d720;FALSE;The sites on the PROTEIN that interact with PROTEIN and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN1 head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN2 head (subfragment 1, S1) in this process.;BioInfer.d720.s0
1316;BioInfer.d720;FALSE;The sites on the PROTEIN1 that interact with PROTEIN and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN2 head (subfragment 1, S1) in this process.;BioInfer.d720.s0
1317;BioInfer.d738;TRUE;This PROTEIN1 PROTEIN2 complex plays an indispensable role in construction of ordered multicellular structures such as polarized epithelium.;BioInfer.d738.s0
1318;BioInfer.d738;TRUE; PROTEIN1 and PROTEIN possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified PROTEIN2 activities.;BioInfer.d738.s1
1319;BioInfer.d738;FALSE; PROTEIN1 and PROTEIN2 possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified PROTEIN activities.;BioInfer.d738.s1
1320;BioInfer.d738;TRUE; PROTEIN and PROTEIN1 possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified PROTEIN2 activities.;BioInfer.d738.s1
1321;BioInfer.d743;TRUE;This paper describes the structural and biochemical characterization of PROTEIN1 a protein localized to various cellular sites where bundles of PROTEIN2 filaments attach to the plasma membrane.;BioInfer.d743.s0
1322;BioInfer.d744;TRUE;This process involves other PROTEIN1 such as PROTEIN and PROTEIN2 ;BioInfer.d744.s0
1323;BioInfer.d744;FALSE;This process involves other PROTEIN such as PROTEIN1 and PROTEIN2 ;BioInfer.d744.s0
1324;BioInfer.d744;TRUE;This process involves other PROTEIN1 such as PROTEIN2 and PROTEIN ;BioInfer.d744.s0
1325;BioInfer.d745;TRUE;This result was supported by a high protein expression of the PROTEIN1 PROTEIN2 in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN protein level.;BioInfer.d745.s0
1326;BioInfer.d745;FALSE;This result was supported by a high protein expression of the PROTEIN PROTEIN1 in 44% of the tumours with high PROTEIN2 and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN protein level.;BioInfer.d745.s0
1327;BioInfer.d745;FALSE;This result was supported by a high protein expression of the PROTEIN PROTEIN1 in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN2 protein level.;BioInfer.d745.s0
1328;BioInfer.d745;FALSE;This result was supported by a high protein expression of the PROTEIN PROTEIN1 in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN2 defect tumours showed a high PROTEIN protein level.;BioInfer.d745.s0
1329;BioInfer.d745;FALSE;This result was supported by a high protein expression of the PROTEIN1 PROTEIN in 44% of the tumours with high PROTEIN2 and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN protein level.;BioInfer.d745.s0
1330;BioInfer.d745;FALSE;This result was supported by a high protein expression of the PROTEIN1 PROTEIN in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN2 protein level.;BioInfer.d745.s0
1331;BioInfer.d745;FALSE;This result was supported by a high protein expression of the PROTEIN1 PROTEIN in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN2 defect tumours showed a high PROTEIN protein level.;BioInfer.d745.s0
1332;BioInfer.d745;FALSE;This result was supported by a high protein expression of the PROTEIN PROTEIN in 44% of the tumours with high PROTEIN1 and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN2 protein level.;BioInfer.d745.s0
1333;BioInfer.d745;FALSE;This result was supported by a high protein expression of the PROTEIN PROTEIN in 44% of the tumours with high PROTEIN1 and low D1 expression, and all immunohistochemical PROTEIN2 defect tumours showed a high PROTEIN protein level.;BioInfer.d745.s0
1334;BioInfer.d745;FALSE;This result was supported by a high protein expression of the PROTEIN PROTEIN in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN1 defect tumours showed a high PROTEIN2 protein level.;BioInfer.d745.s0
1335;BioInfer.d748;FALSE;Those observations were extended to include a spatiotemporal immunohistochemical analyses of PROTEIN1 and PROTEIN2 as well as a more detailed study of PROTEIN during segmentation, compaction, and compartmentalization of the somite.;BioInfer.d748.s0
1336;BioInfer.d748;FALSE;Those observations were extended to include a spatiotemporal immunohistochemical analyses of PROTEIN1 and PROTEIN as well as a more detailed study of PROTEIN2 during segmentation, compaction, and compartmentalization of the somite.;BioInfer.d748.s0
1337;BioInfer.d748;FALSE;Those observations were extended to include a spatiotemporal immunohistochemical analyses of PROTEIN and PROTEIN1 as well as a more detailed study of PROTEIN2 during segmentation, compaction, and compartmentalization of the somite.;BioInfer.d748.s0
1338;BioInfer.d753;TRUE;Thus, PROTEIN1 and PROTEIN2 expression are not co-regulated in all cells.;BioInfer.d753.s0
1339;BioInfer.d754;TRUE;Thus, it is likely that the both PROTEIN1 isoforms are involved in the regulation of PROTEIN2 assembly during myofibrillogenesis.;BioInfer.d754.s0
1340;BioInfer.d759;FALSE;To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different PROTEIN ( PROTEIN1 isoforms along with a clone containing carp PROTEIN2 sequences.;BioInfer.d759.s0
1341;BioInfer.d759;FALSE;To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different PROTEIN1 ( PROTEIN isoforms along with a clone containing carp PROTEIN2 sequences.;BioInfer.d759.s0
1342;BioInfer.d759;FALSE;To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different PROTEIN1 ( PROTEIN2 isoforms along with a clone containing carp PROTEIN sequences.;BioInfer.d759.s0
1343;BioInfer.d770;FALSE;Total PROTEIN1 and PROTEIN2 mRNAs, and polyadenylated RNA, were determined using slot-blot assays.;BioInfer.d770.s0
1344;BioInfer.d771;FALSE;Total protein, PROTEIN1 ( PROTEIN , and PROTEIN2 appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.;BioInfer.d771.s0
1345;BioInfer.d771;FALSE;Total protein, PROTEIN ( PROTEIN1 , and PROTEIN2 appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.;BioInfer.d771.s0
1346;BioInfer.d771;FALSE;Total protein, PROTEIN1 ( PROTEIN2 , and PROTEIN appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.;BioInfer.d771.s0
1347;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN2 and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1348;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN2 and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1349;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN2 activity and progeny with the minigenome.;BioInfer.d775.s0
1350;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1351;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN2 gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1352;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN2 and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1353;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN1 , PROTEIN2 ( PROTEIN and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1354;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN2 activity and progeny with the minigenome.;BioInfer.d775.s0
1355;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1356;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN2 gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1357;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 ( PROTEIN2 , PROTEIN ( PROTEIN and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1358;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN2 activity and progeny with the minigenome.;BioInfer.d775.s0
1359;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1360;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN2 gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1361;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 ( PROTEIN , PROTEIN2 ( PROTEIN and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1362;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN , PROTEIN ( PROTEIN and PROTEIN1 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN2 activity and progeny with the minigenome.;BioInfer.d775.s0
1363;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN , PROTEIN ( PROTEIN and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN1 gave rise to PROTEIN2 activity and progeny with the minigenome.;BioInfer.d775.s0
1364;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN2 activity and progeny with the minigenome.;BioInfer.d775.s0
1365;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN , PROTEIN ( PROTEIN and PROTEIN1 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN2 gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1366;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1367;BioInfer.d775;FALSE;Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN2 gave rise to PROTEIN activity and progeny with the minigenome.;BioInfer.d775.s0
1368;BioInfer.d778;TRUE;Two PROTEIN1 PROTEIN2 and PROTEIN are associated with Hirano bodies.;BioInfer.d778.s0
1369;BioInfer.d778;TRUE;Two PROTEIN PROTEIN1 and PROTEIN2 are associated with Hirano bodies.;BioInfer.d778.s0
1370;BioInfer.d778;TRUE;Two PROTEIN1 PROTEIN and PROTEIN2 are associated with Hirano bodies.;BioInfer.d778.s0
1371;BioInfer.d780;TRUE;"Two isoforms of PROTEIN ( PROTEIN are generated by alternative splicing; PROTEIN1 differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN2 binding region.";BioInfer.d780.s0
1372;BioInfer.d780;FALSE;"Two isoforms of PROTEIN1 ( PROTEIN are generated by alternative splicing; PROTEIN differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN2 binding region.";BioInfer.d780.s0
1373;BioInfer.d780;FALSE;"Two isoforms of PROTEIN ( PROTEIN1 are generated by alternative splicing; PROTEIN differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN2 binding region.";BioInfer.d780.s0
1374;BioInfer.d780;TRUE;"Two isoforms of PROTEIN ( PROTEIN are generated by alternative splicing; PROTEIN differs from PROTEIN1 by the insertion of B2 exon cassette near the PROTEIN2 binding region.";BioInfer.d780.s0
1375;BioInfer.d780;FALSE;"Two isoforms of PROTEIN1 ( PROTEIN are generated by alternative splicing; PROTEIN2 differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN binding region.";BioInfer.d780.s0
1376;BioInfer.d780;FALSE;"Two isoforms of PROTEIN ( PROTEIN1 are generated by alternative splicing; PROTEIN2 differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN binding region.";BioInfer.d780.s0
1377;BioInfer.d780;TRUE;"Two isoforms of PROTEIN ( PROTEIN are generated by alternative splicing; PROTEIN1 differs from PROTEIN2 by the insertion of B2 exon cassette near the PROTEIN binding region.";BioInfer.d780.s0
1378;BioInfer.d780;FALSE;"Two isoforms of PROTEIN1 ( PROTEIN2 are generated by alternative splicing; PROTEIN differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN binding region.";BioInfer.d780.s0
1379;BioInfer.d780;FALSE;"Two isoforms of PROTEIN1 ( PROTEIN are generated by alternative splicing; PROTEIN differs from PROTEIN2 by the insertion of B2 exon cassette near the PROTEIN binding region.";BioInfer.d780.s0
1380;BioInfer.d780;FALSE;"Two isoforms of PROTEIN ( PROTEIN1 are generated by alternative splicing; PROTEIN differs from PROTEIN2 by the insertion of B2 exon cassette near the PROTEIN binding region.";BioInfer.d780.s0
1381;BioInfer.d785;FALSE;"Up to now three allergens have been identified as responsible for cross-reactivity in these associations: PROTEIN a 14 kd protein that regulates PROTEIN1 PROTEIN2 the 18 kd birch pollen allergen; and a 60-69 kd allergen.";BioInfer.d785.s0
1382;BioInfer.d785;FALSE;"Up to now three allergens have been identified as responsible for cross-reactivity in these associations: PROTEIN1 a 14 kd protein that regulates PROTEIN PROTEIN2 the 18 kd birch pollen allergen; and a 60-69 kd allergen.";BioInfer.d785.s0
1383;BioInfer.d785;TRUE;"Up to now three allergens have been identified as responsible for cross-reactivity in these associations: PROTEIN1 a 14 kd protein that regulates PROTEIN2 PROTEIN the 18 kd birch pollen allergen; and a 60-69 kd allergen.";BioInfer.d785.s0
1384;BioInfer.d794;FALSE; PROTEIN1 and PROTEIN were also up-regulated, whereas an isoform of PROTEIN2 was down-regulated.;BioInfer.d794.s0
1385;BioInfer.d794;FALSE; PROTEIN1 and PROTEIN2 were also up-regulated, whereas an isoform of PROTEIN was down-regulated.;BioInfer.d794.s0
1386;BioInfer.d794;FALSE; PROTEIN and PROTEIN1 were also up-regulated, whereas an isoform of PROTEIN2 was down-regulated.;BioInfer.d794.s0
1387;BioInfer.d798;FALSE;We conclude that germ-line involvement of PROTEIN1 and PROTEIN is rare and that other genes are likely to account for a majority of PROTEIN , PROTEIN2 mutation negative families with nonpolypotic colon cancer.;BioInfer.d798.s0
1388;BioInfer.d798;FALSE;We conclude that germ-line involvement of PROTEIN1 and PROTEIN is rare and that other genes are likely to account for a majority of PROTEIN2 , PROTEIN mutation negative families with nonpolypotic colon cancer.;BioInfer.d798.s0
1389;BioInfer.d798;FALSE;We conclude that germ-line involvement of PROTEIN1 and PROTEIN2 is rare and that other genes are likely to account for a majority of PROTEIN , PROTEIN mutation negative families with nonpolypotic colon cancer.;BioInfer.d798.s0
1390;BioInfer.d798;FALSE;We conclude that germ-line involvement of PROTEIN and PROTEIN is rare and that other genes are likely to account for a majority of PROTEIN1 , PROTEIN2 mutation negative families with nonpolypotic colon cancer.;BioInfer.d798.s0
1391;BioInfer.d798;FALSE;We conclude that germ-line involvement of PROTEIN and PROTEIN1 is rare and that other genes are likely to account for a majority of PROTEIN , PROTEIN2 mutation negative families with nonpolypotic colon cancer.;BioInfer.d798.s0
1392;BioInfer.d798;FALSE;We conclude that germ-line involvement of PROTEIN and PROTEIN1 is rare and that other genes are likely to account for a majority of PROTEIN2 , PROTEIN mutation negative families with nonpolypotic colon cancer.;BioInfer.d798.s0
1393;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN2 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1394;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN2 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1395;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN2 , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1396;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN2 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1397;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1398;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN2 ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1399;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN2 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1400;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN2 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1401;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1402;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN2 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1403;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1404;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1405;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN2 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1406;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN2 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1407;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN2 , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1408;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 PROTEIN PROTEIN PROTEIN2 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1409;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN2 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1410;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 PROTEIN PROTEIN2 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1411;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1412;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN2 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1413;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN2 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1414;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN2 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1415;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1416;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN2 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1417;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1418;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1419;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN2 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1420;BioInfer.d806;TRUE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 PROTEIN2 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1421;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN2 PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1422;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN PROTEIN PROTEIN PROTEIN2 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1423;BioInfer.d806;TRUE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN1 PROTEIN2 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1424;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN1 + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1425;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN2 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1426;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN2 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1427;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN2 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1428;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN1 + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1429;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN2 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1430;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN1 + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1431;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN1 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1432;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN2 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1433;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN1 PROTEIN PROTEIN2 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1434;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN2 + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1435;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN PROTEIN PROTEIN2 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1436;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1437;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN2 , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1438;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN2 , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1439;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN2 , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1440;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1441;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN2 , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1442;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1443;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1444;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN2 , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1445;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN PROTEIN2 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1446;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN2 , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1447;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN1 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1448;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN PROTEIN PROTEIN2 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1449;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN2 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1450;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN2 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1451;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN1 PROTEIN + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1452;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN2 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1453;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN1 PROTEIN + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1454;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN1 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1455;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN2 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1456;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN1 PROTEIN2 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1457;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN2 PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1458;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1459;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1460;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1461;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN1 PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1462;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1463;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN1 and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1464;BioInfer.d806;TRUE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN1 PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1465;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1466;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN1 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1467;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN2 PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1468;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN2 ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1469;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN2 ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1470;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1471;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN2 ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1472;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1473;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1474;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN2 ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1475;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN PROTEIN2 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1476;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN2 ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1477;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN2 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1478;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1479;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN2 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1480;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1481;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1482;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN2 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1483;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN2 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1484;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN2 , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1485;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1486;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN2 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1487;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1488;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1489;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN2 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1490;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN2 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1491;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN2 , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1492;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1493;BioInfer.d806;TRUE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN1 PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1494;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN1 PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1495;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1496;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN1 PROTEIN PROTEIN + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1497;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN2 PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1498;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1499;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1500;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN2 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1501;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN2 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1502;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN2 , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1503;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN1 and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1504;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1505;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN1 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1506;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN2 and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1507;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1508;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN1 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1509;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN2 was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1510;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN PROTEIN2 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1511;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN2 , PROTEIN ( PROTEIN , PROTEIN PROTEIN PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1512;BioInfer.d806;FALSE;We found that the expression of all these genes, including PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , PROTEIN PROTEIN2 PROTEIN PROTEIN + 2B, PROTEIN PROTEIN and PROTEIN PROTEIN was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.;BioInfer.d806.s0
1513;BioInfer.d808;TRUE;We have characterized the interaction and nuclear localization of the nucleocapsid ( PROTEIN1 protein and PROTEIN ( PROTEIN2 of sonchus yellow net nucleorhabdovirus.;BioInfer.d808.s0
1514;BioInfer.d808;TRUE;We have characterized the interaction and nuclear localization of the nucleocapsid ( PROTEIN1 protein and PROTEIN2 ( PROTEIN of sonchus yellow net nucleorhabdovirus.;BioInfer.d808.s0
1515;BioInfer.d808;FALSE;We have characterized the interaction and nuclear localization of the nucleocapsid ( PROTEIN protein and PROTEIN1 ( PROTEIN2 of sonchus yellow net nucleorhabdovirus.;BioInfer.d808.s0
1516;BioInfer.d811;FALSE;We have established an PROTEIN1 deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type PROTEIN and PROTEIN2 genes, to HHUA cells.;BioInfer.d811.s0
1517;BioInfer.d811;FALSE;We have established an PROTEIN deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type PROTEIN1 and PROTEIN2 genes, to HHUA cells.;BioInfer.d811.s0
1518;BioInfer.d811;FALSE;We have established an PROTEIN1 deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type PROTEIN2 and PROTEIN genes, to HHUA cells.;BioInfer.d811.s0
1519;BioInfer.d816;TRUE;We investigated PROTEIN1 filament turnover rates, length, number, barbed end exposure, and binding of PROTEIN2 in bovine arterial endothelial cells moving at different speeds depending on their position in a confluent monolayer.;BioInfer.d816.s0
1520;BioInfer.d818;FALSE;We propose that PROTEIN may act by forming, during the critical period of cerebellar development, a reserve pool of monomeric PROTEIN1 that can easily be mobilized in cell regions such as growth cones or synaptic junctions where filamentous PROTEIN2 is highly concentrated.;BioInfer.d818.s0
1521;BioInfer.d818;FALSE;We propose that PROTEIN1 may act by forming, during the critical period of cerebellar development, a reserve pool of monomeric PROTEIN that can easily be mobilized in cell regions such as growth cones or synaptic junctions where filamentous PROTEIN2 is highly concentrated.;BioInfer.d818.s0
1522;BioInfer.d818;TRUE;We propose that PROTEIN1 may act by forming, during the critical period of cerebellar development, a reserve pool of monomeric PROTEIN2 that can easily be mobilized in cell regions such as growth cones or synaptic junctions where filamentous PROTEIN is highly concentrated.;BioInfer.d818.s0
1523;BioInfer.d820;FALSE;We show here that the phenotype of ts PROTEIN1 is highly similar to that of PROTEIN and that the functions of the gene products of PROTEIN2 and PROTEIN are closely interrelated.;BioInfer.d820.s0
1524;BioInfer.d820;TRUE;We show here that the phenotype of ts PROTEIN is highly similar to that of PROTEIN and that the functions of the gene products of PROTEIN1 and PROTEIN2 are closely interrelated.;BioInfer.d820.s0
1525;BioInfer.d820;FALSE;We show here that the phenotype of ts PROTEIN is highly similar to that of PROTEIN1 and that the functions of the gene products of PROTEIN2 and PROTEIN are closely interrelated.;BioInfer.d820.s0
1526;BioInfer.d820;FALSE;We show here that the phenotype of ts PROTEIN1 is highly similar to that of PROTEIN and that the functions of the gene products of PROTEIN and PROTEIN2 are closely interrelated.;BioInfer.d820.s0
1527;BioInfer.d820;FALSE;We show here that the phenotype of ts PROTEIN1 is highly similar to that of PROTEIN2 and that the functions of the gene products of PROTEIN and PROTEIN are closely interrelated.;BioInfer.d820.s0
1528;BioInfer.d820;FALSE;We show here that the phenotype of ts PROTEIN is highly similar to that of PROTEIN1 and that the functions of the gene products of PROTEIN and PROTEIN2 are closely interrelated.;BioInfer.d820.s0
1529;BioInfer.d824;TRUE;We studied the roles of PROTEIN1 an PROTEIN2 binding phosphoprotein, in superoxide production of neutrophil-like HL-60 cells triggered by opsonized zymosan (OZ).;BioInfer.d824.s0
1530;BioInfer.d825;TRUE;We suggest that the PROTEIN1 in the nodes functions, via a cross-linking activity, in the convergence of PROTEIN2 filaments at the membrane during development of the ribs.;BioInfer.d825.s0
1531;BioInfer.d826;FALSE;We tested for the presence of PROTEIN PROTEIN PROTEIN1 smooth muscle myosin (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN2 ;BioInfer.d826.s0
1532;BioInfer.d826;FALSE;We tested for the presence of PROTEIN1 PROTEIN PROTEIN smooth muscle myosin (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN2 ;BioInfer.d826.s0
1533;BioInfer.d826;FALSE;We tested for the presence of PROTEIN PROTEIN1 PROTEIN smooth muscle myosin (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN2 ;BioInfer.d826.s0
1534;BioInfer.d826;FALSE;We tested for the presence of PROTEIN PROTEIN PROTEIN smooth muscle myosin (heavy chain) and cytoskeletal proteins PROTEIN1 and PROTEIN2 ;BioInfer.d826.s0
1535;BioInfer.d826;FALSE;We tested for the presence of PROTEIN1 PROTEIN PROTEIN2 smooth muscle myosin (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN ;BioInfer.d826.s0
1536;BioInfer.d826;FALSE;We tested for the presence of PROTEIN PROTEIN1 PROTEIN2 smooth muscle myosin (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN ;BioInfer.d826.s0
1537;BioInfer.d826;FALSE;We tested for the presence of PROTEIN PROTEIN PROTEIN1 smooth muscle myosin (heavy chain) and cytoskeletal proteins PROTEIN2 and PROTEIN ;BioInfer.d826.s0
1538;BioInfer.d826;FALSE;We tested for the presence of PROTEIN1 PROTEIN2 PROTEIN smooth muscle myosin (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN ;BioInfer.d826.s0
1539;BioInfer.d826;FALSE;We tested for the presence of PROTEIN1 PROTEIN PROTEIN smooth muscle myosin (heavy chain) and cytoskeletal proteins PROTEIN2 and PROTEIN ;BioInfer.d826.s0
1540;BioInfer.d826;FALSE;We tested for the presence of PROTEIN PROTEIN1 PROTEIN smooth muscle myosin (heavy chain) and cytoskeletal proteins PROTEIN2 and PROTEIN ;BioInfer.d826.s0
0;HPRD50.d6;FALSE;Regulation of neutrophil adhesion by pituitary growth hormone accompanies tyrosine phosphorylation of PROTEIN1 p125FAK, and PROTEIN2 ;HPRD50.d6.s0
1;HPRD50.d6;FALSE;These results suggest that pituitary GH modulates neutrophil adhesion through tyrosine phosphorylation of PROTEIN1 p125FAK, and PROTEIN2 and actin polymerization;HPRD50.d6.s1
2;HPRD50.d6;FALSE;Pituitary GH triggered the tyrosine phosphorylation of PROTEIN1 ( PROTEIN2 and PROTEIN in neutrophils;HPRD50.d6.s2
3;HPRD50.d6;FALSE;Pituitary GH triggered the tyrosine phosphorylation of PROTEIN1 ( PROTEIN and PROTEIN2 in neutrophils;HPRD50.d6.s2
4;HPRD50.d6;FALSE;Pituitary GH triggered the tyrosine phosphorylation of PROTEIN ( PROTEIN1 and PROTEIN2 in neutrophils;HPRD50.d6.s2
5;HPRD50.d6;FALSE;Preincubation with genistein, a tyrosine kinase inhibitor, blocked the GH-stimulated adhesion and PROTEIN1 PROTEIN p125FAK, and PROTEIN2 phosphorylation;HPRD50.d6.s3
6;HPRD50.d6;FALSE;Preincubation with genistein, a tyrosine kinase inhibitor, blocked the GH-stimulated adhesion and PROTEIN1 PROTEIN2 p125FAK, and PROTEIN phosphorylation;HPRD50.d6.s3
7;HPRD50.d6;FALSE;Preincubation with genistein, a tyrosine kinase inhibitor, blocked the GH-stimulated adhesion and PROTEIN PROTEIN1 p125FAK, and PROTEIN2 phosphorylation;HPRD50.d6.s3
8;HPRD50.d6;TRUE;Immunoprecipitation experiments revealed a physical association of PROTEIN1 with p125FAK via PROTEIN2 in vivo;HPRD50.d6.s4
9;HPRD50.d10;TRUE;Cutting edge: PROTEIN1 functions as a T cell counterreceptor for the macrophage adhesion receptor PROTEIN2 ( PROTEIN ;HPRD50.d10.s0
10;HPRD50.d10;FALSE;Cutting edge: PROTEIN functions as a T cell counterreceptor for the macrophage adhesion receptor PROTEIN1 ( PROTEIN2 ;HPRD50.d10.s0
11;HPRD50.d10;TRUE;Cutting edge: PROTEIN1 functions as a T cell counterreceptor for the macrophage adhesion receptor PROTEIN ( PROTEIN2 ;HPRD50.d10.s0
12;HPRD50.d10;FALSE;The 130- and 240-kDa sialoadhesin-binding glycoproteins were identified as the sialomucins PROTEIN1 and PROTEIN ( PROTEIN2 , respectively;HPRD50.d10.s1
13;HPRD50.d10;FALSE;The 130- and 240-kDa sialoadhesin-binding glycoproteins were identified as the sialomucins PROTEIN1 and PROTEIN2 ( PROTEIN , respectively;HPRD50.d10.s1
14;HPRD50.d10;FALSE;The 130- and 240-kDa sialoadhesin-binding glycoproteins were identified as the sialomucins PROTEIN and PROTEIN1 ( PROTEIN2 , respectively;HPRD50.d10.s1
15;HPRD50.d10;TRUE; PROTEIN1 expressed in COS cells supported increased binding to immobilized PROTEIN2 ;HPRD50.d10.s2
16;HPRD50.d10;TRUE;Finally, PROTEIN1 bound different glycoforms of PROTEIN2 expressed in Chinese hamster ovary cells, including unbranched (core 1) and branched (core 2) O:-linked glycans, that are normally found on PROTEIN in resting and activated T cells, respectively;HPRD50.d10.s3
17;HPRD50.d10;FALSE;Finally, PROTEIN bound different glycoforms of PROTEIN1 expressed in Chinese hamster ovary cells, including unbranched (core 1) and branched (core 2) O:-linked glycans, that are normally found on PROTEIN2 in resting and activated T cells, respectively;HPRD50.d10.s3
18;HPRD50.d10;FALSE;Finally, PROTEIN1 bound different glycoforms of PROTEIN expressed in Chinese hamster ovary cells, including unbranched (core 1) and branched (core 2) O:-linked glycans, that are normally found on PROTEIN2 in resting and activated T cells, respectively;HPRD50.d10.s3
19;HPRD50.d10;FALSE;These results identify PROTEIN as a T cell counterreceptor for PROTEIN1 and suggest that in addition to its anti-adhesive role PROTEIN2 may promote cell-cell interactions;HPRD50.d10.s4
20;HPRD50.d10;FALSE;These results identify PROTEIN1 as a T cell counterreceptor for PROTEIN and suggest that in addition to its anti-adhesive role PROTEIN2 may promote cell-cell interactions;HPRD50.d10.s4
21;HPRD50.d10;TRUE;These results identify PROTEIN1 as a T cell counterreceptor for PROTEIN2 and suggest that in addition to its anti-adhesive role PROTEIN may promote cell-cell interactions;HPRD50.d10.s4
22;HPRD50.d15;TRUE;Physical association of PROTEIN1 with PROTEIN2 a novel glycosylphosphatidylinositol-anchored protein with potential for regulating adhesion and migration;HPRD50.d15.s0
23;HPRD50.d15;TRUE;To clarify the mechanisms by which PROTEIN1 functions on leukocytes, we explored the possibility of its physical association with PROTEIN2 which is important for leukocyte adherence, locomotion, and extravasation;HPRD50.d15.s1
24;HPRD50.d15;TRUE; PROTEIN1 detected by anti-CD18 mAb, was coprecipitated with PROTEIN2 from human neutrophil lysates by a mAb to PROTEIN ;HPRD50.d15.s2
25;HPRD50.d15;FALSE; PROTEIN1 detected by anti-CD18 mAb, was coprecipitated with PROTEIN from human neutrophil lysates by a mAb to PROTEIN2 ;HPRD50.d15.s2
26;HPRD50.d15;FALSE; PROTEIN detected by anti-CD18 mAb, was coprecipitated with PROTEIN1 from human neutrophil lysates by a mAb to PROTEIN2 ;HPRD50.d15.s2
27;HPRD50.d15;TRUE;In addition, PROTEIN1 was immunoprecipitated from human neutrophil lysates by anti-human PROTEIN2 mAb;HPRD50.d15.s3
28;HPRD50.d15;TRUE;These results clearly show that PROTEIN1 is physically associated with PROTEIN2 in human neutrophils;HPRD50.d15.s4
29;HPRD50.d17;FALSE; PROTEIN1 (type II isozyme) contains a PROTEIN2 homology domain at the N terminus and a sterile alpha motif domain at the C terminus;HPRD50.d17.s0
30;HPRD50.d28;TRUE;We report that PROTEIN1 (MutS homolog 2) protein interacts with the ATR (ATM- and Rad3-related) kinase to form a signaling module and regulate the phosphorylation of PROTEIN2 and PROTEIN (structure maintenance of chromosome 1);HPRD50.d28.s0
31;HPRD50.d28;TRUE;We report that PROTEIN1 (MutS homolog 2) protein interacts with the ATR (ATM- and Rad3-related) kinase to form a signaling module and regulate the phosphorylation of PROTEIN and PROTEIN2 (structure maintenance of chromosome 1);HPRD50.d28.s0
32;HPRD50.d28;FALSE;We report that PROTEIN (MutS homolog 2) protein interacts with the ATR (ATM- and Rad3-related) kinase to form a signaling module and regulate the phosphorylation of PROTEIN1 and PROTEIN2 (structure maintenance of chromosome 1);HPRD50.d28.s0
33;HPRD50.d28;TRUE;We found that phosphorylation of PROTEIN1 by ATR also requires checkpoint proteins PROTEIN2 and replication protein A;HPRD50.d28.s1
34;HPRD50.d28;FALSE;In contrast, phosphorylation of PROTEIN by ATR is independent of PROTEIN1 and replication protein A, suggesting that the signaling pathway leading to PROTEIN2 phosphorylation is distinct from that mediated by the checkpoint proteins;HPRD50.d28.s2
35;HPRD50.d28;FALSE;In contrast, phosphorylation of PROTEIN1 by ATR is independent of PROTEIN and replication protein A, suggesting that the signaling pathway leading to PROTEIN2 phosphorylation is distinct from that mediated by the checkpoint proteins;HPRD50.d28.s2
36;HPRD50.d28;FALSE;In contrast, phosphorylation of PROTEIN1 by ATR is independent of PROTEIN2 and replication protein A, suggesting that the signaling pathway leading to PROTEIN phosphorylation is distinct from that mediated by the checkpoint proteins;HPRD50.d28.s2
37;HPRD50.d28;FALSE;In addition, both PROTEIN and PROTEIN1 are required for the activation of the S-phase checkpoint to suppress DNA synthesis in response to MNNG, and phosphorylation of PROTEIN2 is required for cellular survival;HPRD50.d28.s3
38;HPRD50.d28;FALSE;In addition, both PROTEIN1 and PROTEIN2 are required for the activation of the S-phase checkpoint to suppress DNA synthesis in response to MNNG, and phosphorylation of PROTEIN is required for cellular survival;HPRD50.d28.s3
39;HPRD50.d28;FALSE;In addition, both PROTEIN1 and PROTEIN are required for the activation of the S-phase checkpoint to suppress DNA synthesis in response to MNNG, and phosphorylation of PROTEIN2 is required for cellular survival;HPRD50.d28.s3
40;HPRD50.d36;TRUE; PROTEIN1 associates with PROTEIN2 Syk, and phospholipase C-gamma(1) upon B cell activation;HPRD50.d36.s0
41;HPRD50.d36;TRUE;These results suggest that tyrosyl-phosphorylated PROTEIN may be a substrate for PROTEIN1 regulates tyrosyl phosphorylation of PROTEIN2 ;HPRD50.d36.s1
42;HPRD50.d36;FALSE;These results suggest that tyrosyl-phosphorylated PROTEIN1 may be a substrate for PROTEIN regulates tyrosyl phosphorylation of PROTEIN2 ;HPRD50.d36.s1
43;HPRD50.d36;TRUE;These results suggest that tyrosyl-phosphorylated PROTEIN1 may be a substrate for PROTEIN2 regulates tyrosyl phosphorylation of PROTEIN ;HPRD50.d36.s1
44;HPRD50.d36;FALSE;The association of PROTEIN1 with PROTEIN was mediated by the NH2-terminal Src homology 2 (SH2) domain of PROTEIN2 ;HPRD50.d36.s2
45;HPRD50.d36;TRUE;The association of PROTEIN1 with PROTEIN2 was mediated by the NH2-terminal Src homology 2 (SH2) domain of PROTEIN ;HPRD50.d36.s2
46;HPRD50.d36;TRUE;The association of PROTEIN with PROTEIN1 was mediated by the NH2-terminal Src homology 2 (SH2) domain of PROTEIN2 ;HPRD50.d36.s2
47;HPRD50.d36;TRUE;Complexes of either PROTEIN1 PROTEIN2 Syk/PLC-gamma(1) could be isolated from B cells stimulated by BCR engagement or a mixture of hydrogen peroxidase and sodium orthovanadate, respectively;HPRD50.d36.s3
48;HPRD50.d36;FALSE;Transient expression of PROTEIN1 and a null mutant of PROTEIN (PTP-1CM) in COS cells resulted in an increase in tyrosyl phosphorylation of PROTEIN2 and its interaction with PTP-1CM;HPRD50.d36.s4
49;HPRD50.d36;TRUE;Transient expression of PROTEIN and a null mutant of PROTEIN1 (PTP-1CM) in COS cells resulted in an increase in tyrosyl phosphorylation of PROTEIN2 and its interaction with PTP-1CM;HPRD50.d36.s4
50;HPRD50.d36;FALSE;Transient expression of PROTEIN1 and a null mutant of PROTEIN2 (PTP-1CM) in COS cells resulted in an increase in tyrosyl phosphorylation of PROTEIN and its interaction with PTP-1CM;HPRD50.d36.s4
51;HPRD50.d36;FALSE;By contrast, PROTEIN1 was not tyrosyl phosphorylated or associated with PTP-1CM in the presence of wild-type PROTEIN2 ;HPRD50.d36.s5
52;HPRD50.d37;TRUE; PROTEIN1 dimers formed through self-association of the TATA-binding polypeptide ( PROTEIN subunit and could be immunoprecipitated with antibodies to PROTEIN2 the core subunit of PROTEIN ;HPRD50.d37.s0
53;HPRD50.d37;FALSE; PROTEIN1 dimers formed through self-association of the TATA-binding polypeptide ( PROTEIN2 subunit and could be immunoprecipitated with antibodies to PROTEIN the core subunit of PROTEIN ;HPRD50.d37.s0
54;HPRD50.d37;FALSE; PROTEIN1 dimers formed through self-association of the TATA-binding polypeptide ( PROTEIN subunit and could be immunoprecipitated with antibodies to PROTEIN the core subunit of PROTEIN2 ;HPRD50.d37.s0
55;HPRD50.d37;FALSE; PROTEIN dimers formed through self-association of the TATA-binding polypeptide ( PROTEIN1 subunit and could be immunoprecipitated with antibodies to PROTEIN2 the core subunit of PROTEIN ;HPRD50.d37.s0
56;HPRD50.d37;TRUE; PROTEIN dimers formed through self-association of the TATA-binding polypeptide ( PROTEIN subunit and could be immunoprecipitated with antibodies to PROTEIN1 the core subunit of PROTEIN2 ;HPRD50.d37.s0
57;HPRD50.d37;FALSE; PROTEIN dimers formed through self-association of the TATA-binding polypeptide ( PROTEIN1 subunit and could be immunoprecipitated with antibodies to PROTEIN the core subunit of PROTEIN2 ;HPRD50.d37.s0
58;HPRD50.d41;TRUE;We report here that PLZF, and a structurally similar transcriptional repressor, PROTEIN1 can interact with a variety of corepressor proteins in addition to SMRT, including the mSin3A protein and (for PLZF) PROTEIN2 ;HPRD50.d41.s0
59;HPRD50.d42;FALSE;Herein, we show that a distinct IkappaB protein PROTEIN1 also interacts with RXR, as shown in the yeast two-hybrid tests and PROTEIN2 pull-down assays;HPRD50.d42.s0
60;HPRD50.d42;FALSE;In contrast to PROTEIN1 PROTEIN2 did not interact with the AF2 domain of RXR;HPRD50.d42.s1
61;HPRD50.d42;TRUE; PROTEIN1 specifically interacted with the general transcription factors PROTEIN2 TBP, and PROTEIN but not with TFIIEalpha in the PROTEIN pull-down assays;HPRD50.d42.s2
62;HPRD50.d42;TRUE; PROTEIN1 specifically interacted with the general transcription factors PROTEIN TBP, and PROTEIN2 but not with TFIIEalpha in the PROTEIN pull-down assays;HPRD50.d42.s2
63;HPRD50.d42;FALSE; PROTEIN1 specifically interacted with the general transcription factors PROTEIN TBP, and PROTEIN but not with TFIIEalpha in the PROTEIN2 pull-down assays;HPRD50.d42.s2
64;HPRD50.d42;FALSE; PROTEIN specifically interacted with the general transcription factors PROTEIN1 TBP, and PROTEIN2 but not with TFIIEalpha in the PROTEIN pull-down assays;HPRD50.d42.s2
65;HPRD50.d42;FALSE; PROTEIN specifically interacted with the general transcription factors PROTEIN1 TBP, and PROTEIN but not with TFIIEalpha in the PROTEIN2 pull-down assays;HPRD50.d42.s2
66;HPRD50.d42;FALSE; PROTEIN specifically interacted with the general transcription factors PROTEIN TBP, and PROTEIN1 but not with TFIIEalpha in the PROTEIN2 pull-down assays;HPRD50.d42.s2
67;HPRD50.d42;FALSE;TBP and PROTEIN1 however, were not able to interact with PROTEIN2 ;HPRD50.d42.s3
68;HPRD50.d42;FALSE;Accordingly, PROTEIN1 coactivated the 9-cis-RA-induced transactivations of RXR, in contrast to the inhibitory actions of PROTEIN2 ;HPRD50.d42.s4
69;HPRD50.d42;FALSE;In addition, coexpression of PROTEIN1 but not PROTEIN2 further stimulated the Bcl3-mediated enhancement of the 9-cis-RA-induced transactivations of RXR;HPRD50.d42.s5
0;IEPA.d5;TRUE; PROTEIN1 stimulated PROTEIN2 turnover in endometrium of ewes is influenced by stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins;IEPA.d5.s8
1;IEPA.d5;TRUE;Three experiments (Exp) assessed the influence of stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins (oCSP) on turnover of PROTEIN1 (the putative second-messenger for PROTEIN2 stimulated secretion of prostaglandin F2 alpha) in ovine endometrium during luteolysis and maternal recognition of pregnancy;IEPA.d5.s9
2;IEPA.d5;FALSE;For each Exp, 100 mg endometrium was incubated, in duplicate, for 2 h with 10 microCi [3H] inositol and treated with 0 or 100 nM PROTEIN1 (OT) for 20 min, then [3H]inositol mono-, bis-, and trisphosphates (IP1, IP2, and PROTEIN2 respectively) were quantified;IEPA.d5.s10
3;IEPA.d6;TRUE;Carbachol and PROTEIN1 stimulate the generation of PROTEIN2 in the guinea pig myometrium;IEPA.d6.s11
4;IEPA.d6;TRUE;In the guinea pig myometrium prelabelled with myo-[2-3H]inositol, carbachol and PROTEIN1 enhanced a concentration-dependent and rapid release of PROTEIN2 which preceded that of IP2 and IP1;IEPA.d6.s12
5;IEPA.d7;TRUE;Hesperidin, the most important PROTEIN1 of Citrus sp., significantly increases HDL and lowers PROTEIN2 LDL, total lipid and triglyceride plasma levels in normolipidemic rats and in rats with diet- and triton-induced hyperlipidemia;IEPA.d7.s13
6;IEPA.d29;FALSE;This action of PROTEIN1 25-35 is not altered by pretreatment with the calcium channel blockers nifedipine or cobalt, with the depleter of intracellular calcium stores cyclopiazonic acid, or with the PROTEIN2 inhibitor neomycin;IEPA.d29.s61
7;IEPA.d30;FALSE;The influence of myrigalone B, a PROTEIN1 from the fruit exudate of Myrica gale L. on Cu(2+)-induced oxidation of low density lipoprotein from PROTEIN2 fed rabbits was investigated;IEPA.d30.s62
8;IEPA.d35;TRUE; PROTEIN1 (OT) and vasopressin (AVP) stimulate PROTEIN2 and glucagon release from the pancreas, and evoke PROTEIN secretion from the rat insulinoma cell line, RINm5F;IEPA.d35.s86
9;IEPA.d35;FALSE; PROTEIN (OT) and vasopressin (AVP) stimulate PROTEIN1 and glucagon release from the pancreas, and evoke PROTEIN2 secretion from the rat insulinoma cell line, RINm5F;IEPA.d35.s86
10;IEPA.d35;TRUE; PROTEIN1 (OT) and vasopressin (AVP) stimulate PROTEIN and glucagon release from the pancreas, and evoke PROTEIN2 secretion from the rat insulinoma cell line, RINm5F;IEPA.d35.s86
11;IEPA.d42;TRUE;Signal transduction in pancreatic beta-cells: Regulation of PROTEIN1 secretion by information flow in the PROTEIN2 Protein kinase C pathway;IEPA.d42.s103
12;IEPA.d42;TRUE;The physiologic regulation of glucose-induced PROTEIN1 secretion is dependent upon the activation of information flow in the PROTEIN2 (PLC)/protein kinase C (PKC) signal transduction system;IEPA.d42.s104
13;IEPA.d42;FALSE;When rat islet are cultured for short periods, the content and activation of PROTEIN1 in response to glucose decreases and this biochemical defect in signal transduction is paralleled by significant reductions in glucose-induced PROTEIN2 secretion;IEPA.d42.s105
14;IEPA.d42;TRUE;Biphasic PROTEIN1 secretion can be evoked and time-dependent potentiation can be induced in mouse islets by carbachol, an agonist that activates an isozyme of PROTEIN2 distinct from that activated by glucose;IEPA.d42.s106
15;IEPA.d42;FALSE;When taken in their entirety, the experimental evidence suggests that the activation of PROTEIN is an essential component in the physiologic regulation of PROTEIN1 secretion and that disordered activation of the enzyme culminates in disordered PROTEIN2 release;IEPA.d42.s107
16;IEPA.d42;TRUE;When taken in their entirety, the experimental evidence suggests that the activation of PROTEIN1 is an essential component in the physiologic regulation of PROTEIN2 secretion and that disordered activation of the enzyme culminates in disordered PROTEIN release;IEPA.d42.s107
17;IEPA.d42;FALSE;When taken in their entirety, the experimental evidence suggests that the activation of PROTEIN1 is an essential component in the physiologic regulation of PROTEIN secretion and that disordered activation of the enzyme culminates in disordered PROTEIN2 release;IEPA.d42.s107
18;IEPA.d46;TRUE; PROTEIN1 beta protein (25-35) stimulation of PROTEIN2 in LA-N-2 cells;IEPA.d46.s115
19;IEPA.d46;TRUE;This PROTEIN1 stimulation by PROTEIN2 beta protein appeared to be pertussis toxin sensitive;IEPA.d46.s116
20;IEPA.d46;TRUE;It is possible that this PROTEIN1 stimulation by PROTEIN2 beta protein is a receptor-mediated process;IEPA.d46.s117
21;IEPA.d46;TRUE; PROTEIN1 beta protein stimulation of PROTEIN2 was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or PROTEIN beta peptide;IEPA.d46.s118
22;IEPA.d46;FALSE; PROTEIN1 beta protein stimulation of PROTEIN was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or PROTEIN2 beta peptide;IEPA.d46.s118
23;IEPA.d46;FALSE; PROTEIN beta protein stimulation of PROTEIN1 was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or PROTEIN2 beta peptide;IEPA.d46.s118
24;IEPA.d46;TRUE;It is suggested that this observed PROTEIN1 beta protein stimulation of PROTEIN2 may be responsible for the elevated quantity of inositol seen in the brains of Alzheimer's disease patients;IEPA.d46.s119
25;IEPA.d47;TRUE;Effects of PROTEIN1 arginine-vasopressin and lysine-vasopressin on PROTEIN2 and glucagon secretion in sheep;IEPA.d47.s120
26;IEPA.d47;TRUE;The effects of the posterior-pituitary peptides PROTEIN1 (OT), arginine-vasopressin (AVP) and lysine-vasopressin (LVP) on PROTEIN2 and glucagon secretion were examined in adult sheep;IEPA.d47.s121
27;IEPA.d47;FALSE;The maximal PROTEIN responses induced by PROTEIN1 and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN2 were higher than those of PROTEIN ;IEPA.d47.s122
28;IEPA.d47;TRUE;The maximal PROTEIN1 responses induced by PROTEIN2 and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN were higher than those of PROTEIN ;IEPA.d47.s122
29;IEPA.d47;FALSE;The maximal PROTEIN responses induced by PROTEIN1 and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN were higher than those of PROTEIN2 ;IEPA.d47.s122
30;IEPA.d47;FALSE;The maximal PROTEIN1 responses induced by PROTEIN and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN2 were higher than those of PROTEIN ;IEPA.d47.s122
31;IEPA.d47;TRUE;The maximal PROTEIN responses induced by PROTEIN and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN1 were higher than those of PROTEIN2 ;IEPA.d47.s122
32;IEPA.d47;FALSE;The maximal PROTEIN1 responses induced by PROTEIN and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN were higher than those of PROTEIN2 ;IEPA.d47.s122
33;IEPA.d49;TRUE; PROTEIN1 upregulates the expression of PROTEIN2 (UCP-2) mRNA in islets of normal rats, but has no effect in islets of obese Zucker Diabetic Fatty (ZDF) rats with mutated leptin receptors;IEPA.d49.s126
34;IEPA.d50;FALSE; PROTEIN1 secretion is regulated by changes in blood glucose, as well as by peptides from the gastrointestinal tract and neurotransmitters that activate the pancreatic islet adenylyl cyclase (e.g., glucagon-like peptide-1) and PROTEIN (PLC) (e.g., acetylcholine) signaling pathways to further potentiate glucose-induced PROTEIN2 secretion;IEPA.d50.s127
35;IEPA.d50;FALSE; PROTEIN1 secretion is regulated by changes in blood glucose, as well as by peptides from the gastrointestinal tract and neurotransmitters that activate the pancreatic islet adenylyl cyclase (e.g., glucagon-like peptide-1) and PROTEIN2 (PLC) (e.g., acetylcholine) signaling pathways to further potentiate glucose-induced PROTEIN secretion;IEPA.d50.s127
36;IEPA.d50;TRUE; PROTEIN secretion is regulated by changes in blood glucose, as well as by peptides from the gastrointestinal tract and neurotransmitters that activate the pancreatic islet adenylyl cyclase (e.g., glucagon-like peptide-1) and PROTEIN1 (PLC) (e.g., acetylcholine) signaling pathways to further potentiate glucose-induced PROTEIN2 secretion;IEPA.d50.s127
37;IEPA.d50;TRUE;However, leptin did constrain the enhanced PROTEIN1 mediated PROTEIN2 secretion characteristic of islets from ob/ob mice, without influencing release from islets of lean mice;IEPA.d50.s128
38;IEPA.d50;TRUE;A specific enhancement in PROTEIN1 mediated PROTEIN2 secretion is the earliest reported developmental alteration in PROTEIN secretion from islets of ob/ob mice, and thus a logical target for leptin action;IEPA.d50.s129
39;IEPA.d50;FALSE;A specific enhancement in PROTEIN mediated PROTEIN1 secretion is the earliest reported developmental alteration in PROTEIN2 secretion from islets of ob/ob mice, and thus a logical target for leptin action;IEPA.d50.s129
40;IEPA.d50;FALSE;A specific enhancement in PROTEIN1 mediated PROTEIN secretion is the earliest reported developmental alteration in PROTEIN2 secretion from islets of ob/ob mice, and thus a logical target for leptin action;IEPA.d50.s129
41;IEPA.d50;TRUE;This action of leptin on PROTEIN1 mediated PROTEIN2 secretion was dose-dependent, rapid-onset (i.e., within 3 min), and reversible;IEPA.d50.s130
42;IEPA.d50;FALSE;Leptin was equally effective in constraining the enhanced PROTEIN1 release from islets of ob/ob mice caused by protein kinase C (PKC) activation, a downstream mediator of the PROTEIN2 signal pathway;IEPA.d50.s131
43;IEPA.d50;FALSE;One function of leptin in control of body composition is thus to target a PKC-regulated component of the PROTEIN1 PKC signaling system within islets to prevent hypersecretion of PROTEIN2 ;IEPA.d50.s132
44;IEPA.d51;TRUE; PROTEIN1 stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a PROTEIN2 ;IEPA.d51.s133
45;IEPA.d51;TRUE;The hydrophilic form of MDP released from the cells on stimulation with PROTEIN1 was recognized by antibodies against the inositol 1,2-cyclic monophosphate cross-reacting determinant, indicating that it had been generated by cleavage of its GPI anchor through the action of a PROTEIN2 ;IEPA.d51.s134
46;IEPA.d53;FALSE;During luteinization of bovine granulosa cells in vitro in the presence of PROTEIN1 or PROTEIN2 plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone PROTEIN with secretion of the peptide into the medium;IEPA.d53.s137
47;IEPA.d53;TRUE;During luteinization of bovine granulosa cells in vitro in the presence of PROTEIN1 or PROTEIN plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone PROTEIN2 with secretion of the peptide into the medium;IEPA.d53.s137
48;IEPA.d53;TRUE;During luteinization of bovine granulosa cells in vitro in the presence of PROTEIN or PROTEIN1 plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone PROTEIN2 with secretion of the peptide into the medium;IEPA.d53.s137
49;IEPA.d56;FALSE;Interleukin-1 beta inhibits PROTEIN1 and PROTEIN2 secretion at sites apart from KATP channel;IEPA.d56.s143
50;IEPA.d56;FALSE;Surprisingly, however, when islets were depolarized directly using either of two agonists, glyburide (which does not act via generation of purine nucleotides) or 40 mM K+ (which acts distal to KATP channel), PROTEIN1 and PROTEIN2 secretion were again obliterated by IL-1 beta;IEPA.d56.s144
51;IEPA.d56;FALSE;These data (together with the finding that IL-1 beta inhibited Ca(2+)-induced PROTEIN1 release) suggest that, in addition to its effects on ATP synthesis and thereby on the KATP channel, IL-1 beta has at least two undescribed, distal effects to block both PROTEIN2 as well as Ca(2+)-induced exocytosis;IEPA.d56.s145
52;IEPA.d59;FALSE;PKB, which is an important early PI 3-kinase-dependent component of PROTEIN1 signalling pathways, is also down-regulated by PROTEIN2 coupled agonists;IEPA.d59.s154
53;IEPA.d64;FALSE;Similarly, carbachol, but not PROTEIN1 or DDAVP, induced a significant increase in membrane-associated PROTEIN2 (PKC) enzyme activity;IEPA.d64.s161
54;IEPA.d64;FALSE;In contrast, PROTEIN1 had no effect on the distribution of any PROTEIN2 isoform tested;IEPA.d64.s162
55;IEPA.d68;TRUE;The results demonstrate that potent antioxidants, such as PROTEIN1 protect MM-LDL from lipoperoxidation and preserve their ability to efficiently deliver PROTEIN2 to cells;IEPA.d68.s169
56;IEPA.d69;FALSE;During wk 6, milk yield and dry matter intake (DMI) were recorded daily, and plasma concentrations of glucose, nonesterified fatty acids, urea, protein, growth hormone, PROTEIN1 insulin-like growth factor I, PROTEIN2 and prolactin were determined;IEPA.d69.s170
57;IEPA.d75;FALSE;Concurrent decrease of PROTEIN1 and PROTEIN2 immunoreactivity during the light phase in the vole suprachiasmatic nucleus;IEPA.d75.s179
58;IEPA.d75;FALSE;Mean numbers of PROTEIN1 and PROTEIN2 immunoreactive neurons were determined in the suprachiasmatic nucleus of common voles, entrained to a 12:12 h light-dark (LD) cycle, at the beginning of the light period (zeitgeber time zero) and 6 h later (zeitgeber time six);IEPA.d75.s180
59;IEPA.d75;FALSE;At zeitgeber time zero, mean numbers of PROTEIN1 and PROTEIN2 immunoreactive neurons were 2194 and 9897, respectively;IEPA.d75.s181
60;IEPA.d78;FALSE;To assess the possible involvement of PROTEIN1 in PROTEIN and IL-1 action in Leydig cells, the PROTEIN2 inhibitor Calphostin C was tested;IEPA.d78.s187
61;IEPA.d78;FALSE;To assess the possible involvement of PROTEIN in PROTEIN1 and IL-1 action in Leydig cells, the PROTEIN2 inhibitor Calphostin C was tested;IEPA.d78.s187
62;IEPA.d78;TRUE;To assess the possible involvement of PROTEIN1 in PROTEIN2 and IL-1 action in Leydig cells, the PROTEIN inhibitor Calphostin C was tested;IEPA.d78.s187
63;IEPA.d78;TRUE;These results confirm that PROTEIN1 and PMA activate PROTEIN2 and indicate that IL-1 likely does not activate PROTEIN in Leydig cells;IEPA.d78.s188
64;IEPA.d78;FALSE;These results confirm that PROTEIN1 and PMA activate PROTEIN and indicate that IL-1 likely does not activate PROTEIN2 in Leydig cells;IEPA.d78.s188
65;IEPA.d78;FALSE;These results confirm that PROTEIN and PMA activate PROTEIN1 and indicate that IL-1 likely does not activate PROTEIN2 in Leydig cells;IEPA.d78.s188
66;IEPA.d95;TRUE;The distribution of PROTEIN1 (AVP) cells in the SCN overlapped with that of PROTEIN2 in both species;IEPA.d95.s229
67;IEPA.d95;FALSE;Species differences in the location of the Ca2+-dependent PROTEIN1 isoforms suggest differences in function such as the relaying of photic or non-photic information to the clock mechanism, or the synchronization of PROTEIN2 neurons and their subsequent output signals;IEPA.d95.s230
68;IEPA.d101;FALSE;The two groups were similar in their morning thyroxin, triiodothyronine, TSH, estradiol, cortisol, gastrin, cholecystokinin, somatostatin, PROTEIN1 PROTEIN2 and IGF-1 levels;IEPA.d101.s240
69;IEPA.d102;TRUE;Constitutive expression of PKABA1 drastically suppressed expression of low- and high-pI PROTEIN1 and protease genes induced by PROTEIN2 ;IEPA.d102.s241
70;IEPA.d103;TRUE;The bovine ovarian granulosa cell model is a primary culture system where under stimulation by PROTEIN1 or IGF-I and LH the endogenous PROTEIN2 gene is massively upregulated;IEPA.d103.s242
71;IEPA.d105;TRUE;The deduced consensus closely resembled PROTEIN1 response elements in PROTEIN2 promoters;IEPA.d105.s244
72;IEPA.d108;TRUE;Long-term changes in gastrin, cholecystokinin and PROTEIN1 in response to PROTEIN2 treatment;IEPA.d108.s251
73;IEPA.d108;FALSE;The present study was designed to investigate how repeated injections of PROTEIN1 influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), PROTEIN and somatostatin, as well as of endogenous PROTEIN2 and glucose;IEPA.d108.s252
74;IEPA.d108;FALSE;The present study was designed to investigate how repeated injections of PROTEIN influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), PROTEIN1 and somatostatin, as well as of endogenous PROTEIN2 and glucose;IEPA.d108.s252
75;IEPA.d108;TRUE;The present study was designed to investigate how repeated injections of PROTEIN1 influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), PROTEIN2 and somatostatin, as well as of endogenous PROTEIN and glucose;IEPA.d108.s252
76;IEPA.d108;TRUE;"In addition, both PROTEIN1 and CCK levels were decreased in response to the PROTEIN2 treatment when measured 3 and 10 days after the last injection (ANOVA; PROTEIN p < 0.01, CCK p < 0.05)";IEPA.d108.s253
77;IEPA.d108;FALSE;"In addition, both PROTEIN1 and CCK levels were decreased in response to the PROTEIN treatment when measured 3 and 10 days after the last injection (ANOVA; PROTEIN2 p < 0.01, CCK p < 0.05)";IEPA.d108.s253
78;IEPA.d108;FALSE;"In addition, both PROTEIN and CCK levels were decreased in response to the PROTEIN1 treatment when measured 3 and 10 days after the last injection (ANOVA; PROTEIN2 p < 0.01, CCK p < 0.05)";IEPA.d108.s253
79;IEPA.d108;FALSE;When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with PROTEIN1 or saline, plasma levels of PROTEIN and CCK increased significantly (p < 0.05) in the PROTEIN2 treated rats, when compared to saline-treated controls receiving clonidine only;IEPA.d108.s254
80;IEPA.d108;FALSE;When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with PROTEIN or saline, plasma levels of PROTEIN1 and CCK increased significantly (p < 0.05) in the PROTEIN2 treated rats, when compared to saline-treated controls receiving clonidine only;IEPA.d108.s254
81;IEPA.d108;FALSE;When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with PROTEIN1 or saline, plasma levels of PROTEIN2 and CCK increased significantly (p < 0.05) in the PROTEIN treated rats, when compared to saline-treated controls receiving clonidine only;IEPA.d108.s254
82;IEPA.d108;TRUE;In conclusion, these results show that PROTEIN1 induces long-lasting changes in plasma levels of gastrin, CCK and PROTEIN2 without affecting somatostatin or glucose levels;IEPA.d108.s255
83;IEPA.d110;TRUE;Signal transduction of PROTEIN1 induced arachidonic acid release in H9c2 cardiac myoblasts: role of Ca2+ and the PROTEIN2 dependent activation of p42 mitogen-activated protein kinase;IEPA.d110.s264
84;IEPA.d110;FALSE;The Ca2+ ionophore, A23187 or ionomycin, mimicked the effect of PROTEIN1 whereas the PROTEIN2 (PKC) activator, TPA, only induced a slight increase in AA release;IEPA.d110.s265
85;IEPA.d110;FALSE;"Western blots demonstrated expression of PKCalpha, betaI, epsilon, delta, and zeta in H9c2 cells; PROTEIN1 inhibitors (staurosporine or Ro 31-8220) or down-regulation of PROTEIN2 betaI, epsilon, and delta by long-term (24 h) TPA treatment caused a partial blockade of the PROTEIN induced response, whereas the A23187-induced AA release was unaffected by down-regulation of these isoforms";IEPA.d110.s266
86;IEPA.d110;FALSE;"Western blots demonstrated expression of PKCalpha, betaI, epsilon, delta, and zeta in H9c2 cells; PROTEIN inhibitors (staurosporine or Ro 31-8220) or down-regulation of PROTEIN1 betaI, epsilon, and delta by long-term (24 h) TPA treatment caused a partial blockade of the PROTEIN2 induced response, whereas the A23187-induced AA release was unaffected by down-regulation of these isoforms";IEPA.d110.s266
87;IEPA.d110;FALSE;"Western blots demonstrated expression of PKCalpha, betaI, epsilon, delta, and zeta in H9c2 cells; PROTEIN1 inhibitors (staurosporine or Ro 31-8220) or down-regulation of PROTEIN betaI, epsilon, and delta by long-term (24 h) TPA treatment caused a partial blockade of the PROTEIN2 induced response, whereas the A23187-induced AA release was unaffected by down-regulation of these isoforms";IEPA.d110.s266
88;IEPA.d110;TRUE; PROTEIN1 or TPA-induced activation and tyrosine phosphorylation of p42 MAPK were completely blocked by down-regulation of PROTEIN2 betaI, epsilon, and delta, but still occurred, together with the cytosolic PLA2 mobility shift, in the absence of external Ca2+;IEPA.d110.s267
89;IEPA.d110;TRUE;These results show that PROTEIN1 induced AA release in H9c2 cells is secondary to activation of the V1 receptor/Gq protein/PLCP pathway, leading to an influx of extracellular Ca2+ and activation of PROTEIN2 betaI, epsilon, and delta;IEPA.d110.s268
90;IEPA.d115;FALSE;Overexpression of G11alpha and isoforms of PROTEIN1 in islet beta-cells reveals a lack of correlation between inositol phosphate accumulation and PROTEIN2 secretion.;IEPA.d115.s277
91;IEPA.d115;TRUE;It has been suggested that PROTEIN1 secretion from pancreatic islets may be mediated in part by activation of PROTEIN2 (PLCs) and phosphoinositide hydrolysis.;IEPA.d115.s278
92;IEPA.d115;TRUE;The purpose of this study was to determine whether the relatively modest fuel-stimulated PROTEIN1 secretion responses of rodent beta-cell lines might be explained by inadequate expression or activation of PROTEIN2 isoforms.;IEPA.d115.s279
93;IEPA.d115;FALSE;Adenovirus-mediated overexpression of PROTEIN1 delta1, -beta1, or -beta3 in INS-1 or betaG 40/110 cells results in little or no enhancement in inositol phosphate (IP) accumulation and no improvement in PROTEIN2 secretion when the cells are stimulated with glucose or carbachol, despite the fact that the overexpressed proteins are fully active in cell extracts.;IEPA.d115.s280
94;IEPA.d115;FALSE;Overexpression of PROTEIN1 beta1 or -beta3 in normal rat islets elicits a larger increase in IP accumulation but, again, has no effect on PROTEIN2 secretion.;IEPA.d115.s281
95;IEPA.d115;FALSE;Because the effect of carbachol on PROTEIN1 secretion is thought to be mediated through muscarinic receptors that link to the Gq/11 class of heterotrimeric G proteins, we also overexpressed G11alpha in INS-1 cells, either alone or in concert with overexpression of PROTEIN2 beta1 or -beta3.;IEPA.d115.s282
96;IEPA.d115;FALSE;Overexpression of G11alpha enhances IP accumulation, an effect slightly potentiated by co-overexpression of PROTEIN1 beta1 or -beta3, but these maneuvers do not affect glucose or carbachol-stimulated PROTEIN2 secretion.;IEPA.d115.s283
97;IEPA.d116;TRUE;In the present study we found that at increasing PROTEIN1 concentrations, increasing numbers of barley (Hordeum vulgare) cells showed the enhanced PROTEIN2 secretion and vacuolation characteristic of the PROTEIN response;IEPA.d116.s284
98;IEPA.d116;FALSE;In the present study we found that at increasing PROTEIN concentrations, increasing numbers of barley (Hordeum vulgare) cells showed the enhanced PROTEIN1 secretion and vacuolation characteristic of the PROTEIN2 response;IEPA.d116.s284
99;IEPA.d116;FALSE;In the present study we found that at increasing PROTEIN1 concentrations, increasing numbers of barley (Hordeum vulgare) cells showed the enhanced PROTEIN secretion and vacuolation characteristic of the PROTEIN2 response;IEPA.d116.s284
100;IEPA.d123;FALSE;The activity of catalase was found to be significantly enhanced in the tissues of normal and PROTEIN1 fed rats administered 1 mg PROTEIN2 from brinjal/100 g BW/day;IEPA.d123.s296
101;IEPA.d124;TRUE;By comparison with the promoters of PROTEIN1 genes, which are also induced by PROTEIN2 we suggest that GARE is coupled with the upstream element and the pyrimidine box to form a PROTEIN response complex;IEPA.d124.s297
102;IEPA.d124;FALSE;By comparison with the promoters of PROTEIN1 genes, which are also induced by PROTEIN we suggest that GARE is coupled with the upstream element and the pyrimidine box to form a PROTEIN2 response complex;IEPA.d124.s297
103;IEPA.d124;FALSE;By comparison with the promoters of PROTEIN genes, which are also induced by PROTEIN1 we suggest that GARE is coupled with the upstream element and the pyrimidine box to form a PROTEIN2 response complex;IEPA.d124.s297
104;IEPA.d125;FALSE;Our data demonstrate, that activation of mitogen activated protein (MAP) kinase alone is sufficient to promote PROTEIN1 secretion, whereas inhibition of MAP kinase will reduce PROTEIN secretion only when PROTEIN2 or phosphatidylinositol 3-kinase are additionally inhibited;IEPA.d125.s298
105;IEPA.d125;FALSE;Our data demonstrate, that activation of mitogen activated protein (MAP) kinase alone is sufficient to promote PROTEIN secretion, whereas inhibition of MAP kinase will reduce PROTEIN1 secretion only when PROTEIN2 or phosphatidylinositol 3-kinase are additionally inhibited;IEPA.d125.s298
106;IEPA.d125;FALSE;Our data demonstrate, that activation of mitogen activated protein (MAP) kinase alone is sufficient to promote PROTEIN1 secretion, whereas inhibition of MAP kinase will reduce PROTEIN2 secretion only when PROTEIN or phosphatidylinositol 3-kinase are additionally inhibited;IEPA.d125.s298
107;IEPA.d135;TRUE;These results suggest that, in isolated white adipocytes, the released adenosine acts as a helper and/or a positive regulator for PROTEIN1 in the release of leptin via an activation of adenosine A1 receptors that involves the PROTEIN2 PKC pathway.;IEPA.d135.s323
108;IEPA.d136;FALSE;The etiology for diabetes mellitus in PWS may be related to the morbid obesity and consequent PROTEIN1 resistance, because a decrease of PROTEIN2 neurons and leptin resistance in PWS may cause hyperphagia, inducing obesity;IEPA.d136.s324
109;IEPA.d142;FALSE;METHODS: We have therefore studied possible associations of the Gln27Glu and the Gly16Arg polymorphisms in the beta2AR with BMI, plasma PROTEIN1 and PROTEIN2 mRNA expression in the intraperitoneal adipose tissue in a population of Caucasian women;IEPA.d142.s341
110;IEPA.d142;FALSE;Furthermore, no association was found between the Gln27Glu or the Gly16Arg polymorphisms and plasma PROTEIN1 or adipose tissue PROTEIN2 gene expression in either group;IEPA.d142.s342
111;IEPA.d145;TRUE;Aggregated beta PROTEIN1 peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic PROTEIN2 in brain cortex;IEPA.d145.s346
112;IEPA.d145;FALSE;The effects of full-length PROTEIN1 beta protein, A(beta) (1-40), on phosphoinositide-specific PROTEIN2 (PLC) were investigated in synaptic plasma membranes (SPM) and cytosol prepared from the cerebral cortex of adult rats;IEPA.d145.s347
113;IEPA.d145;FALSE;Aggregated PROTEIN1 also decreased significantly the level of diacylglycerol, the product of PROTEIN2 ;IEPA.d145.s348
114;IEPA.d145;TRUE;This additionally supports the inhibitory effect of PROTEIN1 on membrane-bound and cytosolic PROTEIN2 ;IEPA.d145.s349
115;IEPA.d145;TRUE;Moreover, PROTEIN1 significantly decreased the basal activity of the PROTEIN2 in SPM and the enzyme activity regulated through cholinergic receptors;IEPA.d145.s350
116;IEPA.d167;FALSE;Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal PROTEIN stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not PROTEIN1 and largely enhanced PROTEIN2 sensitivity to these RTK agonists;IEPA.d167.s403
117;IEPA.d167;FALSE;Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal PROTEIN1 stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not PROTEIN2 and largely enhanced PROTEIN sensitivity to these RTK agonists;IEPA.d167.s403
118;IEPA.d167;FALSE;Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal PROTEIN1 stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not PROTEIN and largely enhanced PROTEIN2 sensitivity to these RTK agonists;IEPA.d167.s403
119;IEPA.d170;FALSE;Influence of obesity and menopausal status on serum PROTEIN1 cholecystokinin, galanin and PROTEIN2 levels;IEPA.d170.s410
120;IEPA.d170;FALSE;Obesity occurs in 60% of women after menopause and is characterized by an excess of adipose tissue that depends on several orexigenic ( PROTEIN1 (NPY) stimulates carbohydrate ingestion, galanin stimulates fat intake) and anorectic ( PROTEIN2 cholecystokinin (CCK)) factors;IEPA.d170.s411
121;IEPA.d170;TRUE;Both PROTEIN1 and insulin can reduce hypothalamic PROTEIN2 production and secretion;IEPA.d170.s412
122;IEPA.d170;FALSE;We investigated basal levels of serum PROTEIN1 CCK, galanin and PROTEIN2 in 16 non-obese premenopausal women, in 15 obese premenopausal women (body mass index (BMI) 34.6 +/- 1.3 SD) and in ten obese postmenopausal women (BMI 34.7 +/- 1.5 SD) to determine the relationship between obesity, menopause and these neuropeptides;IEPA.d170.s413
123;IEPA.d170;FALSE;Significantly increased PROTEIN1 and galanin levels in postmenopausal obese women coupled with decreased PROTEIN2 levels revealed some changes in the neuropeptides regulating eating behavior, which may be the reason for the onset of postmenopausal obesity;IEPA.d170.s414
124;IEPA.d189;FALSE;These findings are consistent with increased PROTEIN1 signaling to the PROTEIN and POMC neurons in the ARC by physiological levels of circulating PROTEIN2 during normal feeding;IEPA.d189.s453
125;IEPA.d189;FALSE;These findings are consistent with increased PROTEIN1 signaling to the PROTEIN2 and POMC neurons in the ARC by physiological levels of circulating PROTEIN during normal feeding;IEPA.d189.s453
126;IEPA.d189;FALSE;These findings are consistent with increased PROTEIN signaling to the PROTEIN1 and POMC neurons in the ARC by physiological levels of circulating PROTEIN2 during normal feeding;IEPA.d189.s453
127;IEPA.d195;TRUE; PROTEIN1 Rapidly Inhibits Hypothalamic PROTEIN2 Secretion and Stimulates Corticotropin-Releasing Hormone Secretion in Adrenalectomized Mice;IEPA.d195.s469
128;IEPA.d195;TRUE; PROTEIN1 may rapidly inhibit food intake by altering the secretion of hypothalamic neuropeptides such as PROTEIN2 (NPY), a stimulator of food intake, and/or corticotropin-releasing hormone (CRH), an inhibitor of food intake;IEPA.d195.s470
129;IEPA.d195;FALSE;We measured concentrations of PROTEIN1 and CRH in specific hypothalamic regions [i.e., arcuate nucleus (ARC), paraventricular nucleus (PVN), ventromedial nucleus and dorsomedial nucleus] of 7- to 8-wk-old lean and ob/ob mice at 1 or 3 h after intracerebroventricular PROTEIN2 administration;IEPA.d195.s471
130;IEPA.d195;FALSE;No rapid-onset effects of PROTEIN1 on hypothalamic PROTEIN2 or CRH concentrations were observed in intact mice;IEPA.d195.s472
131;IEPA.d195;FALSE;The addition of PROTEIN1 to hypothalamic preparations from intact mice also did not alter PROTEIN2 or CRH secretion;IEPA.d195.s473
132;IEPA.d195;TRUE;Within 20 min after exposure to PROTEIN1 PROTEIN2 secretion from hypothalamic preparations obtained from adrenalectomized mice was lowered by 27% and CRH secretion was elevated by 51%;IEPA.d195.s474
133;IEPA.d195;FALSE;The current study demonstrates that PROTEIN rapidly influences the secretion of hypothalamic PROTEIN1 and CRH and that these actions of PROTEIN2 within the hypothalamus are restrained by the presence of endogenous corticosterone;IEPA.d195.s475
134;IEPA.d195;TRUE;The current study demonstrates that PROTEIN1 rapidly influences the secretion of hypothalamic PROTEIN2 and CRH and that these actions of PROTEIN within the hypothalamus are restrained by the presence of endogenous corticosterone;IEPA.d195.s475
135;IEPA.d195;FALSE;The current study demonstrates that PROTEIN1 rapidly influences the secretion of hypothalamic PROTEIN and CRH and that these actions of PROTEIN2 within the hypothalamus are restrained by the presence of endogenous corticosterone;IEPA.d195.s475
0;LLL.d11;TRUE;In addition to controlling transcription of PROTEIN1 PROTEIN2 appears to control expression of at least one other gene required for production of CSF.;LLL.d11.s0
1;LLL.d13;TRUE;Production of PROTEIN1 about 1 h earlier than normal does affect PROTEIN2 which when phosphorylated is an activator of PROTEIN transcription.;LLL.d13.s0
2;LLL.d13;TRUE;Production of PROTEIN about 1 h earlier than normal does affect PROTEIN1 which when phosphorylated is an activator of PROTEIN2 transcription.;LLL.d13.s0
3;LLL.d13;FALSE;Production of PROTEIN1 about 1 h earlier than normal does affect PROTEIN which when phosphorylated is an activator of PROTEIN2 transcription.;LLL.d13.s0
4;LLL.d13;FALSE;The PROTEIN promoter, like the PROTEIN promoter, is believed to be recognized by PROTEIN1 RNA polymerase, suggesting that PROTEIN2 may inhibit PROTEIN activity late in sporulation.;LLL.d13.s1
5;LLL.d13;FALSE;The PROTEIN1 promoter, like the PROTEIN promoter, is believed to be recognized by PROTEIN RNA polymerase, suggesting that PROTEIN2 may inhibit PROTEIN activity late in sporulation.;LLL.d13.s1
6;LLL.d13;TRUE;The PROTEIN promoter, like the PROTEIN promoter, is believed to be recognized by PROTEIN RNA polymerase, suggesting that PROTEIN1 may inhibit PROTEIN2 activity late in sporulation.;LLL.d13.s1
7;LLL.d13;FALSE;The PROTEIN promoter, like the PROTEIN1 promoter, is believed to be recognized by PROTEIN RNA polymerase, suggesting that PROTEIN2 may inhibit PROTEIN activity late in sporulation.;LLL.d13.s1
8;LLL.d13;TRUE;The PROTEIN1 promoter, like the PROTEIN promoter, is believed to be recognized by PROTEIN2 RNA polymerase, suggesting that PROTEIN may inhibit PROTEIN activity late in sporulation.;LLL.d13.s1
9;LLL.d13;FALSE;The PROTEIN promoter, like the PROTEIN promoter, is believed to be recognized by PROTEIN1 RNA polymerase, suggesting that PROTEIN may inhibit PROTEIN2 activity late in sporulation.;LLL.d13.s1
10;LLL.d13;TRUE;The PROTEIN promoter, like the PROTEIN1 promoter, is believed to be recognized by PROTEIN2 RNA polymerase, suggesting that PROTEIN may inhibit PROTEIN activity late in sporulation.;LLL.d13.s1
11;LLL.d13;FALSE;The PROTEIN1 promoter, like the PROTEIN promoter, is believed to be recognized by PROTEIN RNA polymerase, suggesting that PROTEIN may inhibit PROTEIN2 activity late in sporulation.;LLL.d13.s1
12;LLL.d13;FALSE;The PROTEIN1 promoter, like the PROTEIN2 promoter, is believed to be recognized by PROTEIN RNA polymerase, suggesting that PROTEIN may inhibit PROTEIN activity late in sporulation.;LLL.d13.s1
13;LLL.d13;FALSE;The PROTEIN promoter, like the PROTEIN1 promoter, is believed to be recognized by PROTEIN RNA polymerase, suggesting that PROTEIN may inhibit PROTEIN2 activity late in sporulation.;LLL.d13.s1
14;LLL.d13;TRUE;In the mother cell compartment of sporulating cells, expression of the PROTEIN1 gene, encoding the earlier-acting sigma factor, sigmaE, is negatively regulated by the later-acting sigma factor, PROTEIN2 ;LLL.d13.s2
15;LLL.d28;TRUE;Primer extension experiments and Northern blot analysis show that an active PROTEIN1 dependent promoter precedes PROTEIN2 and transcription is terminated at the putative p-independent terminator downstream of kdgT.;LLL.d28.s0
16;LLL.d30;TRUE;We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both PROTEIN and PROTEIN1 holoenzymes recognize promoter elements within the PROTEIN PROTEIN2 control region.;LLL.d30.s0
17;LLL.d30;TRUE;We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both PROTEIN1 and PROTEIN holoenzymes recognize promoter elements within the PROTEIN PROTEIN2 control region.;LLL.d30.s0
18;LLL.d30;FALSE;We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both PROTEIN and PROTEIN holoenzymes recognize promoter elements within the PROTEIN1 PROTEIN2 control region.;LLL.d30.s0
19;LLL.d30;FALSE;We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both PROTEIN1 and PROTEIN2 holoenzymes recognize promoter elements within the PROTEIN PROTEIN control region.;LLL.d30.s0
20;LLL.d30;TRUE;We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both PROTEIN and PROTEIN1 holoenzymes recognize promoter elements within the PROTEIN2 PROTEIN control region.;LLL.d30.s0
21;LLL.d30;TRUE;We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both PROTEIN1 and PROTEIN holoenzymes recognize promoter elements within the PROTEIN2 PROTEIN control region.;LLL.d30.s0
22;LLL.d34;TRUE;However, the mutant was unable to stimulate transcription by final PROTEIN1 RNA polymerase from the PROTEIN2 dependent PROTEIN operon promoter.;LLL.d34.s0
23;LLL.d34;TRUE;However, the mutant was unable to stimulate transcription by final PROTEIN RNA polymerase from the PROTEIN1 dependent PROTEIN2 operon promoter.;LLL.d34.s0
24;LLL.d34;TRUE;However, the mutant was unable to stimulate transcription by final PROTEIN1 RNA polymerase from the PROTEIN dependent PROTEIN2 operon promoter.;LLL.d34.s0
25;LLL.d35;TRUE;The Bacillus subtilis PROTEIN1 operon is regulated by two stress induction pathways relying on either PROTEIN or a class III stress induction mechanism acting at a PROTEIN2 like promoter.;LLL.d35.s0
26;LLL.d35;TRUE;The Bacillus subtilis PROTEIN1 operon is regulated by two stress induction pathways relying on either PROTEIN2 or a class III stress induction mechanism acting at a PROTEIN like promoter.;LLL.d35.s0
27;LLL.d35;FALSE;The Bacillus subtilis PROTEIN operon is regulated by two stress induction pathways relying on either PROTEIN1 or a class III stress induction mechanism acting at a PROTEIN2 like promoter.;LLL.d35.s0
28;LLL.d35;FALSE;Our data demonstrate that the PROTEIN1 protein acts as a global repressor of the PROTEIN operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the PROTEIN2 or PROTEIN dependent promoter and might be inactivated or dissociate under inducing stress conditions.;LLL.d35.s1
29;LLL.d35;FALSE;Our data demonstrate that the PROTEIN1 protein acts as a global repressor of the PROTEIN operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the PROTEIN or PROTEIN2 dependent promoter and might be inactivated or dissociate under inducing stress conditions.;LLL.d35.s1
30;LLL.d35;TRUE;Our data demonstrate that the PROTEIN1 protein acts as a global repressor of the PROTEIN2 operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the PROTEIN or PROTEIN dependent promoter and might be inactivated or dissociate under inducing stress conditions.;LLL.d35.s1
31;LLL.d35;FALSE;Our data demonstrate that the PROTEIN protein acts as a global repressor of the PROTEIN operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the PROTEIN1 or PROTEIN2 dependent promoter and might be inactivated or dissociate under inducing stress conditions.;LLL.d35.s1
32;LLL.d35;TRUE;Our data demonstrate that the PROTEIN protein acts as a global repressor of the PROTEIN1 operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the PROTEIN2 or PROTEIN dependent promoter and might be inactivated or dissociate under inducing stress conditions.;LLL.d35.s1
33;LLL.d35;TRUE;Our data demonstrate that the PROTEIN protein acts as a global repressor of the PROTEIN1 operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the PROTEIN or PROTEIN2 dependent promoter and might be inactivated or dissociate under inducing stress conditions.;LLL.d35.s1
34;LLL.d37;TRUE;Therefore, PROTEIN1 is solely expressed during sporulation from a PROTEIN and PROTEIN2 controlled promoter that is located immediately upstream of ftsY inside the smc gene.;LLL.d37.s0
35;LLL.d37;TRUE;Therefore, PROTEIN1 is solely expressed during sporulation from a PROTEIN2 and PROTEIN controlled promoter that is located immediately upstream of ftsY inside the smc gene.;LLL.d37.s0
36;LLL.d37;FALSE;Therefore, PROTEIN is solely expressed during sporulation from a PROTEIN1 and PROTEIN2 controlled promoter that is located immediately upstream of ftsY inside the smc gene.;LLL.d37.s0
37;LLL.d38;TRUE;In that respect PROTEIN1 is similar to the previously described gene PROTEIN which is also a member of the PROTEIN2 regulon.;LLL.d38.s0
38;LLL.d38;FALSE;In that respect PROTEIN1 is similar to the previously described gene PROTEIN2 which is also a member of the PROTEIN regulon.;LLL.d38.s0
39;LLL.d38;TRUE;In that respect PROTEIN is similar to the previously described gene PROTEIN1 which is also a member of the PROTEIN2 regulon.;LLL.d38.s0
40;LLL.d43;TRUE;The PROTEIN1 and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN2 the PROTEIN PROTEIN operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
41;LLL.d43;FALSE;The PROTEIN and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN1 the PROTEIN2 PROTEIN operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
42;LLL.d43;FALSE;The PROTEIN and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN1 the PROTEIN PROTEIN2 operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
43;LLL.d43;FALSE;The PROTEIN and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN1 the PROTEIN PROTEIN operon is recognized equally well by PROTEIN2 and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
44;LLL.d43;TRUE;The PROTEIN and PROTEIN1 genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN2 the PROTEIN PROTEIN operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
45;LLL.d43;FALSE;The PROTEIN and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN1 the PROTEIN PROTEIN operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN2 ;LLL.d43.s0
46;LLL.d43;FALSE;The PROTEIN1 and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN2 PROTEIN operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
47;LLL.d43;FALSE;The PROTEIN1 and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN PROTEIN2 operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
48;LLL.d43;FALSE;The PROTEIN1 and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN PROTEIN operon is recognized equally well by PROTEIN2 and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
49;LLL.d43;FALSE;The PROTEIN1 and PROTEIN2 genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN PROTEIN operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
50;LLL.d43;FALSE;The PROTEIN1 and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN PROTEIN operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN2 ;LLL.d43.s0
51;LLL.d43;FALSE;The PROTEIN and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN1 PROTEIN2 operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
52;LLL.d43;TRUE;The PROTEIN and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN1 PROTEIN operon is recognized equally well by PROTEIN2 and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
53;LLL.d43;FALSE;The PROTEIN and PROTEIN1 genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN2 PROTEIN operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
54;LLL.d43;TRUE;The PROTEIN and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN1 PROTEIN operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN2 ;LLL.d43.s0
55;LLL.d43;TRUE;The PROTEIN and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN PROTEIN1 operon is recognized equally well by PROTEIN2 and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
56;LLL.d43;FALSE;The PROTEIN and PROTEIN1 genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN PROTEIN2 operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
57;LLL.d43;TRUE;The PROTEIN and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN PROTEIN1 operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN2 ;LLL.d43.s0
58;LLL.d43;FALSE;The PROTEIN and PROTEIN1 genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN PROTEIN operon is recognized equally well by PROTEIN2 and the other forespore-specific sigma factor, PROTEIN ;LLL.d43.s0
59;LLL.d43;FALSE;The PROTEIN and PROTEIN genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN PROTEIN operon is recognized equally well by PROTEIN1 and the other forespore-specific sigma factor, PROTEIN2 ;LLL.d43.s0
60;LLL.d43;FALSE;The PROTEIN and PROTEIN1 genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, PROTEIN the PROTEIN PROTEIN operon is recognized equally well by PROTEIN and the other forespore-specific sigma factor, PROTEIN2 ;LLL.d43.s0
